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Abstract 
Pathology reports provide vital information for the clinical management of cancer patients, 
allowing accurate diagnosis, staging and determination of treatment and prognosis. However, 
there are several issues resulting from traditional narrative reports compared to structured 
reports. For example, essential elements are occasionally omitted, especially negative results, 
which are not always reported clearly. As well, the referring doctors often find it difficult to 
identify the necessary elements in a free-text pathology report to justify a given diagnosis. 
There are a number of advantages for the use of structured pathology reports: they can ensure 
the accuracy and completeness of pathology reporting; it is easier for the referring doctors to 
glean pertinent information from them, thus improving the communication between 
pathologists and clinicians. Furthermore, they also facilitate efficient extraction of information 
for cancer registries, data collection and research purposes. 
 
The goal of this thesis is to extract pertinent information from free-text pathology reports and 
automatically populate structured reports for three cancer diseases, namely melanoma, colorectal 
cancer, lymphoma and identify the commonalities and differences in processing principles to obtain 
maximum accuracy. 
 
Unlike previous works that regard the task as automatic structuring of sentences of interest in 
narrative medical reports, this study aims to populate certain fields in structured reports based on the 
global view of the entire document. This is challenging, as it requires either inference from the entities 
or combination of various entities as well. The fields predefined in structured templates were 
determined mainly by utilizing three structured cancer reporting protocols from the Australia and the 
Royal College of Pathologists of Australia as well as advice from clinicians and pathologists.  
 
A detailed corpus analysis was conducted on a set of pathology notes, with the objectives of 
identifying lexical and linguistic characteristics in the narratives, and the difficulties or challenges that 
may be encountered when processing these texts. Assessment of the level of completeness of original 
reports, and proposals for appropriate strategies for the establishment of structured templates were 
subsequently completed. 
 
Three pathology corpora were annotated with entities and relationships between the entities in this 
study, namely the melanoma corpus, the colorectal cancer corpus and the lymphoma corpus. Detailed 
annotation schemas and guidelines were developed in an iterative process to ensure annotation 
consistency. 
 
A supervised machine-learning based-approach was developed to recognise medical entities from the 
corpora. Specifically, the medical entity recognition system used conditional random fields (CRF) 
learners. The CRF-based models were able to capture a significant portion of the entity boundaries by 
 iii 
 
using contextual information. The application of rich feature sets provided useful clues for the 
classification of entity types. By feature engineering, the best feature configurations were attained, 
which boosted the F-scores significantly from 4.2% to 6.8% in 10-fold cross-validation experiments 
on the training sets. Several common effective features across the three corpora were identified, which 
can be beneficial for other medical entity recognition tasks. 
 
Without proper negation and uncertainty detection, final outputs for several fields in the structured 
templates will be affected, and consequently the quality of the structured reports will be diminished. 
The negation and uncertainty detection modules were built to handle this problem. The modules 
obtained very good performance (with over 99% overall F-scores) on the training sets, which dropped 
on the test sets (where overall F-scores decreased to 76.6% – 91.0%).  
 
A relation extraction system was presented to extract four relations from the lymphoma corpus. A 
rule-based approach was applied to classify Spatial Specialization relation, while a supervised 
machine learning-based approach was adopted to identify Result-Positive, Result- Negative and 
Result-Equivocal relations. Simple heuristic rules were applied in the rule-based module, while 
several useful features were prepared for the support vector machines (SVM) classifier. The system 
achieved very good performance on the training set, with 100% F-score obtained by the rule-based 
module and 97.2% micro-averaged F-score attained by the SVM classifier. 
 
Predefined templates were designed based on a thorough review of the structured reporting protocols 
and analysis of the training corpora. Rule-based approaches were used to generate the structured 
outputs and populate them to the templates. The rule-based system attained over 97% F-scores on the 
training sets. A pipeline system was implemented with an assembly of all the components described 
above. It achieved promising results in the end-to-end evaluations, with 86.5%, 84.2% and 78.9% 
micro-averaged F-scores on the melanoma, colorectal cancer and lymphoma test sets respectively. 
 
The pipeline system can be applied to cancer registries, clinical audits and epidemiology research. 
With further improvement, it can also significantly improve the quality of pathology reporting in the 
clinical setting. 
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Chapter 1 Introduction 
1 
 
Chapter 1  Introduction  
1.1 Structured Reporting 
The treatment of cancer is often made based on input from a multidisciplinary team including 
surgeons, oncologists, radiologists, and pathologists. In particular, a pathology report on a cancer 
specimen can provide critical information related to diagnosis and prognosis, which should be 
accurate and complete. If a pathologist is not guided by a cancer-specific standardized template, but 
rather writes a non-organised prose report, it is easy to omit information that may be required for 
clinical decision making. The purpose of this research is to investigate models of how prose pathology 
reports might be automatically converted into structured reports and to build a technology that 
demonstrates the feasibility and accuracy at which the task can be performed. 
 
Traditional narrative reports have significant variability since different pathologists use a multitude of 
different reporting styles to describe their findings. Such variability often results in missing important 
clinically relevant data elements such as margins, lymphatic invasion etc. Research indicate that the 
presence of both perineural invasion (Griffantibartoli et al., 1994; Nagakawa et al., 1993) and 
lymphovascular invasion (Tannapfel et al., 1992) which are poor prognostic indicators, were not 
reported in 16% and 34% respectively in free-text reports (Gill et al., 2009). As well, study points out 
that traditional pathology reporting underestimates the rate of margin positivity in pancreatic 
carcinoma (Verbeke et al., 2006). As a result, clinicians cannot make a proper management plan for an 
individual case, as they usually rely on the pathology reports to diagnose the patient.  However, with 
the introduction of structured reporting, these issuses can be mitigated to a great extent. The 
completeness of information presented in pathology reports can be improved significantly. The 
structured format has been proven to result in more complete reports for patients with melanoma and 
breast cancer (Scolyer et al., 2004; Harvey et al., 2005). Moreover, the free-text reports affect the 
efficiency of clinical decision making, as clinicians sometimes find it difficult to pull out the relevant 
information from a long paragraph of continuous text, and they often have to search through 
paragraphs of information in various sections in order to find the key elements to manage clinical care 
(Srigley et al., 2009). 
 
A great number of studies have emphasized the importance of structured reporting (also called 
synoptic reporting in some cases) for diverse cancers, including melanoma (Haydu et al., 2010; Karim 
et al., 2008), colorectal cancer (Beattie et al., 2003; Chan et al., 2008; Chapuis et al., 2007), 
haematologic and lymphoid neoplasms (Mohanty et al., 2007), etc. 
 
Structured reports can ensure the accuracy and completeness of pathology reports. A structured report 
can ensure the pathologists avoid omission of all relevant data and necessary details, especially 
trainees and new pathologists. A survey on the reporting of colorectal cancer specimens in a tertiary 
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care pathology department (Chan et al., 2008)  found that before synoptic reporting, macroscopic 
features such as the presence or absence of serosal involvement, and distance to the radial margin, 
microscopic parameters such as radial resection margin status, extramural venous invasion and host 
inflammatory response were underreported. Such features showed significant improvement after 
synoptic reporting (ranging from 50% to 80%). 
 
It is easier for the referring doctors to glean pertinent information from structured reports, thus it is 
more user-friendly for both clinicians and pathologists since it can improve communication between 
them and thus reduce requests for repeat pathology and call-back for explanations from clinicians.  
 
Furthermore, structured reports can also facilitate efficient extraction of information for cancer 
registries, data collection and research purposes. A lot of information regarding TNM and stage 
grouping is embedded in the pathology reports on resection specimens (Hammond and Henson, 1995). 
The information is critical for cancer surveillance systems and it is also used by cancer registrars, 
cancer agencies, and epidemiology researchers. Structured reports are much more readily usable than 
traditional narrative reports, since the information is populated in the reports or easy to be inferred 
from the reports. Structured pathology reports can also be used in quality improvement. One of the 
examples is the information about the retrieval of lymph nodes from colorectal cancer resection 
specimens (Wright et al., 2004). Lack of sufficient sampling nodes will lead to under-staging and 
consequently over-utilization of adjuvant chemotherapy. The total count of lymph nodes retrieved and 
the number involved by metastatic tumour can be derived with ease from a report in structured format. 
Likewise, clinical audits for tumour stage or margin positivity in resection specimens can also be 
facilitated by structured reporting. 
 
Currently, there are many researchers focused on developing synoptic or structured reporting tools for 
pathologists to edit and standardize their reports, to simplify the process of routine reporting of 
pathology. For example, Qu et al. introduced a template-based tumour reporting system that 
minimized exhaustive list checking and extensive text editing to reduce reporting errors and improve 
work efficiency (Qu et al., 2007). However, these methods also have some potential disadvantages. 
Pathologists may be reluctant to change reporting practice with concerns that such tools may lack 
space for sufficient observations and flexibility for recording of microscopic details (Dworak, 1992; 
Nochomovitz, 1998). Some may regard this as a relatively cumbersome and time-consuming process, 
which requires additional steps to enter or edit the contents compared to traditional reporting formats 
(Mohanty et al., 2007). Besides, such tools cannot handle the free-text reports that have already been 
written or dictated, as, there is still much useful information in the reports which can be reused with 
other feasible and efficient approaches.    
 
To avoid these issues and maintain the benefits of structured reporting, natural language processing 
(NLP) is one promising approach to extract critical findings and incorporate them into a predefined 
structured template, thereby achieving the goal of automatic population of structured reports. 
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1.2 Information Extraction 
Generally, information extraction (IE) is a sub-discipline of NLP, which focuses on the identification 
of the specific facts and relations within unstructured texts, the extraction of the relevant values, and 
their transformation into standardized codes and/or structured information. The goal of IE is to extract 
significant information from unstructured data sources and transform it into structured data to 
facilitate access and retrieval of information. 
 
Previous works on automatic structuring of free-text medical reports have attained some successes by 
classifying the relationships (e.g., dependencies) among medical entities with statistical methods at 
sentence level. In other words, they regard the task as automatic structuring of sentences of interest in 
the free texts. For example, useful information can be output in a frame from a radiology natural 
language processor with this method (Taira et al., 2001). An example is presented in Table 1.1: 
 
Input: “A mass is seen in the right lower lobe that measures 5 cm in maximum diameter and is 
unchanged from the previous examination.” 
has location Value right lower lobe 
Relation in 
has size Value 5cm 
Dimension maximum diameter 
has size trend Value unchanged 
Reference event previous examination 
Table 1.1 Output knowledge frame from a radiology natural language processor. 
 
However, such approaches would not be a best fit for this study, since the population of fields in a 
structured report should be based on the full view of the whole document rather than each sentence; 
besides, in many cases, it also requires inference from the entities or combination of various entities to 
instantiate a knowledge representation model. For instance, by using such approaches, the maximum 
dimension measurement (4.5cm) cannot be directly extracted from this example “Measurements: 
Length 4.5cm, width 4cm, depth 0.6cm” but rather only inferred by an added processing system. It 
suggests that more complex methods implemented in an IE system are preferable for this study.  
 
From the author’s point of view, a desirable clinical IE system for automatic structured reporting 
should consist of three major processes, which are medical entity recognition (MER), relation 
extraction (RE), and structured representation (SR).  
 
Named entity recognition (NER) aims at identifying specific words or phrases (“entities”) and 
categorizing them. In the general English domain, NER focuses on person, location, and organization; 
in the biomedical domain, genes and proteins are its main themes. In the clinical narrative, however, 
the semantic types for it are likely to be medical entities (e.g., disorders, signs or symptoms, 
anatomical sites, medications, and procedures). Moreover, in a particular sub-domain, the semantic 
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types can be problem-specific. For example, the Third i2b2 Workshop on Natural Language 
Processing Challenges for Clinical Records focused on the identification of medications in discharge 
summaries, including dosages, modes of administration, frequencies, durations, and reasons for 
administration (Uzuner et al., 2010). For this reason, although medical entity recognition (MER) is 
derived from NER, it can be more complicated than NER.  
 
As in NER, several issues can make MER challenging, such as word/phrase order variation (varying 
order of words or phrases appears in instances), derivation (suffixes transform one part of speech to 
another), inflection (changes in number, tense, comparative/superlative forms), synonyms, 
homographs and abbreviations. Table 1.2 illustrates some examples of these issues collected from 
narrative pathology reports. 
 
Relationship extraction (RE) focuses on determining relationships between entities or events. By 
extracting relations among the entities involved and how these entities are described, a clearer picture 
of the semantics is obtained. For instance, to answer questions like “what is the positive biomarker for 
the immunohistochemistry results on this patient?”, not only “positive” and “CD20” should be 
extracted, but also the relation between these entities should be extracted from this sentence “CD20: 
most cells positive”. 
 
 
The relations embedded in a clinical document can be explicit as well as implicit, such as negation and 
uncertainty. Negation and uncertainty identification aims at inferring whether an entity is present or 
absent, and quantifying that inference’s uncertainty. In fact, nearly half of all symptoms, diagnoses, 
and findings in clinical reports are estimated to be negative or uncertain (Chapman et al., 2001a). 
Take, for example, the clinical coding of medical concepts in a report, where the coding of a negative 
or uncertain finding or diagnosis may result in an over-coding financial penalty.  
 
Without appropriate representation, the extracted entities and relations can be meaningless for the 
users. Structured representation involves construction of a predefined template and population of the 
template. The template is usually user-oriented, depends on the specific requirement of the users. For 
example, in the radiology domain, the radiologists often need to determine the size and the location of 
Issues Examples 
word/phrase order variation Site of tumour: caecum vs. Tumour site: Caecum 
derivation caecum (noun) vs. caecal (adjective)  
inflection nodes (plural) vs. node (singular) 
identify (present tense) vs. identified (past tense) 
larger (comparative) vs. largest (superlative) 
synonyms right colon vs. ascending colon 
homographs MM has two expansions malignant melanoma vs. millimeter 
abbreviations ICV vs. ileocaecal valve   
Table 1.2 Challenging issues and examples in a medical entity recognition task. 
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a tumour. Thus there ought to be associated items (e.g., “tumour size”, “tumour location”) in the 
template.  
 
1.3 The Obstacles to Information Extraction 
Building such an IE system to fulfil this task is usually a slow and laborious process, because clinical 
reports often contain multiple sections, for instance, a typical pathology report may consist of these 
sections: Diagnosis, Macroscopic Description, Microscopic Description, and Comments, which often 
vary in narrative structure and uniformity; and there is also institutional or individual variation in 
reporting practices (e.g., the same clinical concept can be expressed in different ways). 
 
Currently, there are known barriers to information extraction in the clinical domain. 
 
On the one hand, it is difficult to access available clinical data for training and evaluation from many 
hospitals and clinics, due to concerns regarding patient privacy and revealing unfavourable 
institutional practices. As a result, annotated data are usually unique to a research group or laboratory 
that generated them for some tasks and that cannot be reused for other tasks without considerable 
translational effort. 
 
On the other hand, clinical notes are more difficult to handle than newswire text, because it requires 
both linguistic expertise and understanding clinical domain knowledge. Moreover, in different sub-
domains, there are different sub-languages used. For instance, abbreviations like “HMF (Hutchinson’s 
melanotic freckle)” and “SSM (superficial spreading melanoma)” appear frequently in melanoma 
pathology reports, but rarely in other pathology reports (e.g., colorectal cancer reports). 
 
Moreover, unlike radiology reports, the information reported in pathology notes can differ from one 
disease to another. Thus a general template prepared for reports of all kinds of diseases seems 
inappropriate and cannot satisfy the requirements of the pathologists and clinicians. In the past, due to 
a lack of consensus and authorized materials as standards, it was very difficult to obtain such disease-
specific templates. However, in recent years, the United Kingdom and the United States have defined 
processes for the development and review of structured reporting protocols. In line with these 
international developments the Royal College of Pathologists of Australasia (RCPA) is also 
implementing structured pathology reporting of cancer through its Cancer Services Advisory 
Committee to ensure that pathologists throughout Australasia have access to appropriate, nationally 
endorsed protocols (RCPA, 2013a). The RCPA structured cancer reporting protocols (RCPA, 2013b) 
served as the main sources for building standardized templates for this research. 
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1.4 Research Problems and Approaches 
Since NLP techniques have been applied to different IE tasks and achieved state-of-art performance, 
this thesis addresses an issue as to whether these techniques can be utilised or modified to resolve 
automatic structured reporting from narrative notes. 
 
The goal of this thesis is to extract pertinent information from free-text pathology reports and 
automatically populate structured reports. Specifically, the work focuses on medical entity 
recognition, negation and uncertainty detection, relation extraction, and structured output generation.  
 
In this study, both rule-based approaches and machine learning methods are used, depending on the 
particular problem to be solved. 
 
In order to utilize the machine learning approaches and evaluate system performance, it was necessary 
to acquire semantically annotated corpora for medical entity recognition, negation and uncertainty 
detection and relation extraction. Annotation schemas and annotation guidelines were also developed 
to ensure annotation consistency. 
 
1.4.1 Corpus Analysis 
A lexical analysis was completed on three pathology corpora of different cancers: melanoma, 
colorectal cancer and lymphoma. 
 
The aim of the corpus analysis was to identify the characteristics and language phenomena of the 
pathology notes as well as identify necessary processing steps required to reduce noise in processing. 
 
1.4.2 Corpus Annotation 
Annotated corpora are prerequisites for IE systems with supervised machine learning methods. The 
process of annotation is mainly to add linguistic and semantic information to the raw texts. The 
annotation schema defines the types of information needed to be associated with the raw texts. 
 
Three corpora were annotated in this study. Detailed annotation guidelines were developed in an 
iterative process to ensure annotation quality. The annotations were used as the training data to build a 
supervised machine learning system as well as gold-standards for evaluation on medical entity 
recognition, negation and uncertainty detection and relation extraction. 
 
1.4.3 Medical Entity Recognition 
Since supervised machine learning-based approaches have been widely adopted and achieved 
encouraging results in many tasks of MER (Patrick and Li, 2010; Patrick et al., 2011), they were also 
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adopted in this study. One of the advantages of using supervised machine learning-based approaches 
is that the entities can be classified into broader categories rather than restricted to a concept in a 
controlled terminology. Another advantage is that it can resolve lexical ambiguity to some extent. 
 
1.4.4 Negation and Uncertainty Detection 
Study of the training materials indicated that utilization of an existing algorithm without tuning could 
not attain satisfactory results in an IE system to detect negation in pathology reports. It was necessary 
to build a specific module to handle this problem. 
 
There is comparatively smaller amount of research into solving uncertainty problems than negation 
detection in pathology reports, probably because it represents a reasoning process, which is usually 
hard to capture. However, it is a common language phenomenon in the reports. Resolving it can help 
users better understand the reports and direct their attention to the undetermined findings or diagnoses 
to make plans for further examinations or tests.   
 
1.4.5 Relation Extraction  
Relationship extraction is intended to find associations between medical entities. It may not be easy 
for a rule-based system to extract complex relations, but it is a suitable strategy when the training 
sample size is small. Machine learning methods are better at identifying the different forms of 
linguistic patterns to represent relationships between medical entities when there are sufficiently large 
training samples. Hence, given different training sample sizes, both rule-based and machine learning 
approaches have been adopted in this study.  
 
1.4.6 Structured Output Generation 
After a thorough review of the protocols and the training corpora, predefined templates were designed, 
and associated entities and relation types were mapped to the items in the templates.  
 
The structured report components required either very large segments of text that would have been 
impossible to infer reliably, or inferences from the structure of a variety of medical entities to be 
properly constructed. Therefore, rule-based approaches were used to generate the structured output 
and populate the templates. 
 
1.5 Contributions   
As a result of a systematic study of IE problem in the clinical domain, one of the main contributions is 
the establishment of a methodology to make full use of NLP techniques to instantiate a knowledge 
representation model.  Other primary contributions of this research can be concluded as follows: 
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• A comprehensive study of the language phenomena in narrative pathology notes. 
• A detailed process to annotate pathology notes, as well as the annotation guidelines. 
• Annotated corpora with both entities and relations suitable for training a supervised IE 
system. 
• Ideas of how to achieve state-of -the-art performance on medical entity recognition, negation 
and uncertainty detection, relation extraction, and structured output generation. 
• An implementation of a pipeline system which is able to achieve encouraging performance 
so that it can help pathologists to validate their reports and improve communication between 
pathologists and clinicians. 
 
1.6 Thesis Organization 
This thesis is organized in the order of the workflow in an automatic structured reporting system. 
Apart from chapters 2 and 9, each chapter presents one of the major components in the pipeline 
system, which is illustrated in Figure 1.1. 
 
 
Figure 1.1 Organisation of the thesis. Relation extraction is performed on the lymphoma corpus. 
 
Chapter 2 presents a survey of previous works on information extraction. The four major subtasks in 
information extraction: medical entity recognition, negation and uncertainty detection, relation 
extraction and structured output generation are reviewed. 
 
Chapter 3 presents the detailed analysis of the training data in this study.  
 
Chapter 4 describes a process for annotating pathology reports. Three semantically annotated corpora 
were developed, and annotation schemas and annotation guidelines are introduced. 
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In Chapter 5, a machine learning-based MER system is developed. Various features are explored, and 
integrated into the machine learner. 
 
In Chapter 6, three different approaches including lexical-based approach, syntactic-based approach 
and supervised machine learning based approach have been experimented with for negation detection. 
To resolve uncertainty, a rule-based module is also proposed. 
 
Chapter 7 shows a relationship extraction system, using both rule-based approaches and machine 
learning methods to extract relations from the lymphoma corpus. 
 
Chapter 8 illustrates the design of predefined templates, ranking criteria and special rules tailored to 
the corpus, and development of a structured output generation system. 
 
Chapter 9 sums up all the ideas presented in the thesis and suggests some directions for future work. 
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Chapter 2  Literature Review 
2.1 Introduction 
This chapter introduces previous works related to information extraction (IE). It gives a general 
overview about the current state of the art techniques in information extraction, and includes reviews 
of the four main subtasks: medical entity recognition (MER), negation and uncertainty detection, 
relation extraction (RE), and automatic structuring. 
 
2.2 Medical Entity Recognition 
2.2.1 Dictionary Look-up Approaches 
A dictionary look-up approach also refers to concept mapping or encoding (Friedman et al., 2004) in 
some cases. It deals with the identification of relevant term(s) by mapping a concept from textual 
notes into a reference terminology, and it also links the concept with a referent identifier. Encoding 
information into a standard terminology can not only increase the accessibility of the information, 
facilitating storage and retrieval of it, but also achieve better interoperability between different 
information resources and enable the exchange and sharing of data. 
 
Standard terminologies or a collection of terminologies with large lexical resources, such as the 
Unified Medical Language System (UMLS) (McCray, 2003), the Systematized Nomenclature of 
Medicine Clinical Terms (SNOMED CT) (IHTSDO, 2007-2014) and International Classification of 
Diseases (ICD) (WHO, 2009-2014), provide vast and rich lexical resources for these approaches to 
map the text in clinical notes to concepts. 
 
The UMLS contains the greatest number of concepts in the medical domain, including three 
Knowledge Sources: Metathesaurus, Semantic Network and Specialist Lexicon (NLM, 2006-2014). 
There are more than 100 source vocabularies in the UMLS Metathesaurus, including terminologies 
designed for use in patient-record systems; large disease and procedure classifications used for 
statistical reporting and billing; vocabularies used to record data related to psychiatry, nursing, 
medical devices, and adverse drug reactions. The Semantic Network consists of a set of Semantic 
Types, that provide a consistent categorization of all concepts represented in the UMLS 
Metathesaurus, and a set of Semantic Relations between these concepts. The SPECIALIST Lexicon 
has been developed to provide the lexical information needed for the SPECIALIST natural language 
processing (NLP) System, including both common English words and biomedical vocabulary. The 
lexicon entry for each word records the syntactic, morphological, and orthographic information 
needed by the SPECIALIST NLP System. 
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The MetaMap Program is a well-known system that can parse free-text into simple noun phrases, and 
then map them to UMLS concepts (Aronson, 2001). In the program, first, the input text is parsed into 
simple noun phrases to limit the scope of further processing so that the mapping can be more tractable. 
For each phrase, the program generates rich variants, including acronyms, abbreviations, synonyms, 
derivational variants, meaningful combinations of these, and inflectional and spelling variants. Then it 
evaluates each candidate retrieved from UMLS Metathesaurus against the input text by first 
computing a mapping from the phrase words to the candidate’s words and then calculating the 
strength of the mapping with four metrics: centrality, variation, coverage and cohesiveness. Complete 
mappings are constructed by combining candidates involved in disjoint parts of the phrase. The 
highest scoring complete mappings were chosen to represent the input. 
 
The large number of source dictionaries in UMLS can help a dictionary look-up method to attain a 
high recall, however, they also bring some problems, e.g., indiscriminate use of a large set of 
overlapping terminologies in UMLS can introduce too much noise, and it can lower the efficiency of a 
dictionary-based system as well.  
 
To overcome these issues, Huang et al proposed a context-based mapping method by restricting the 
concepts in different sections of the reports and mapping them to specific UMLS vocabularies (Huang 
et al., 2003). They found that this could increase precision effectively without a significant decrease in 
recall. 
 
Another possible solution is to prune the mapping sources according to the focus of the research 
problem. For example, Long developed a program by using a small dictionary to divide disease 
statements into phrases for coding (Long, 2005). It was able to quickly identify the most specific 
codes available in SNOMED CT from UMLS for the statements in the discharge summaries. It was 
tested on 23 discharge summaries with 250 phrases to be coded, with only 19 false positives returned. 
 
SNOMED CT is a comprehensive clinical terminology that provides clinical content and expressivity 
for clinical documentation and reporting. In 2004, the American Consolidated Health Informatics 
initiative identified SNOMED CT as the standard ontology for diagnoses, problem lists, and anatomy 
(Richesson and Krischer, 2007). There are over 400,000 atomic concepts and pre-coordinated 
concepts which are organized into 19 top-level hierarchies in SNOMED CT (in the January 2013 
Release). It offers even more expressiveness through post-coordination (Elkin et al., 2003). Each 
concept in SNOMED CT is logically defined through its relationships to other concepts. 
 
The Text to SNOMED CT (TTSCT) system was developed to detect SNOMED CT’s concepts in free 
text and to annotate them with clinical reference terms (Patrick et al., 2007a). It generated an 
augmented lexicon composed of atomic words of SNOMED CT descriptions which were normalized 
with removal of all stop words, and each word was indexed with a list of associated DescriptionIDs 
(whose full names contain the word). A token matching algorithm was applied to the input text after 
Chapter 2 Literature Review 
12 
 
pre-processing (i.e., sentence boundary detection, stemming, lower case conversion, spelling variation 
generation, abbreviation expansion), the candidate DescriptionIDs are extracted by looking up the 
augmented lexicon. Then a dynamic programming algorithm checks all candidate combinations, and 
finds the combination with the maximum coverage of the text. In the evaluation of 487 clinical notes 
from an Intensive Care Service with 4,054 medical concepts, the system correctly identified 2,852 
concepts, results in a precision of 70.4%, although the recall rate could not be fully evaluated (Wang 
and Patrick, 2008). 
 
To reduce the ambiguities when mapping text to SNOMED CT core concepts, Hina et al first 
extracted 390023 SNOMED CT core concepts from SNOMED CT as a single gazetteer, and then 
developed separate gazetteers for each class defined in SNOMED CT (Hina et al., 2010). Evaluations 
on 300 discharge summaries showed that there is considerable improvement in reducing ambiguities 
by identifying the concepts in separate gazetteers rather than a single gazetteer. 
 
The dictionary look-up component of the Mayo Clinic’s Information Extraction system (renamed as 
clinical Text Analysis and Knowledge Extraction System (cTAKES) at present) was tested on a 
corpus of 160 free-text clinical notes (Kipper-Schuler et al., 2008), showing that such an approach had 
the potential to work well on MER, as it achieved an F-score of 0.56 for exact matches. However, it 
also indicated that the characteristics of clinical texts which include many lexical variations, disjoint 
concepts, and extensive use of abbreviations and acronyms could make the task more complex. 
 
To address these issues, Wang performed some dictionary look-up experiments to match the concepts 
in the clinical notes with the SNOMED CT concepts (Wang, 2009). Removing unrelated terms and 
concept categories in the lexicon could reduce the ambiguity of the lexicon, leading to higher 
precision and recall. Proofreading such as correcting spelling errors or irregular conventions, 
resolution and expansion of abbreviations and acronyms in the notes, further increased both precision 
and recall. The dictionary look-up method finally achieved a relatively high precision with 74.81%, 
suggesting that it is an effective method to identify clinical concepts, but the extensive efforts it 
requires on pre-processing may not be easy to adapt to other corpora. In addition, it fails to identify 
some long and complex terms and resolve term disambiguation. 
 
There are also other issues that should be noticed about dictionary look-up approaches. For example, 
the number of extracted entities is definitely hindered by the coverage of the terminologies in the 
medical corpora. For instance, a study pointed out that the Specialist Lexicon of UMLS only had 
about 79% coverage for syntactic information and 38% coverage for semantic information in a corpus 
of discharge summaries (Johnson, 1999). Thus, it is very likely that some entities will be overlooked 
in extraction with these approaches. 
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2.2.2 Rule-based Approaches 
Rule-based methods were also prevalent in many early works on MER, and usually comprised hand-
crafted rules and regular expressions to define patterns. 
 
One of the typical rule-based systems is the medical language extraction and encoding (MedLEE) 
system (Friedman et al., 1994). It consisted of a pre-processor, a parser, a compositional regularizer, 
an encoder and a recovery component, which are described below: the pre-processor first identified 
sentences and abbreviations with rules, recognized and categorized words and phrases with lexical 
lookup; the parser used a grammar, a set of rules based on semantic and syntactic co-occurrence 
patterns to identify the structure of a sentence and to generate an intermediate structure that consisted 
of primary findings and different types of modifiers for the sentence; the compositional regularizer 
used a table of structural mappings to compose individual words into phrases when applicable; the 
encoder mapped words and phrases into codes with an encoding table; the recovery component 
allowed the parser to choose alternative strategies to structure the text if the initial one failed. 
 
It was originally developed for the domain of radiological chest reports, but has subsequently been 
extended to mammography, discharge summaries, electrocardiography, echocardiography, and 
pathology (Friedman, 2000).  
 
In general, rule-based methods are suitable to extract entities with explicit lexical, morphologic or 
orthographic patterns, e.g., medication information, test results and scores. 
 
Turchin et al designed software with regular expressions to identify and extract blood pressure values 
and anti-hypertensive treatment intensification from physician notes with high accuracy (Turchin et 
al., 2006). This approach has both advantages and disadvantages. A set of regular expressions can be 
developed much faster than a full-fledged natural language processor, however, it lacks generality so 
that a new set of regular expressions has to be developed and validated for another particular task. Its 
applications are limited to data items with a constrained lexical scope, and variants like synonyms 
have to be manually generated as well. 
 
To extract medication information from discharge summaries, Yang developed a relatively simple 
rule-based approach with manually curated feature term lists and token-based regular expressions 
(Yang, 2010). This approach performed reasonably well with a micro-averaged F-score of 80% for the 
term-level results and 81% for the token-level results. It was based on few annotated data, and was 
competitive without using pre-existing domain-specific tools and resources. 
 
Similarly, without any deep NLP, such as part-of-speech (POS) tagging, chunking or syntactic 
parsing, a medication detection system first recognized drug names with a semantic lexicon, and then 
explored the context of these names to extract related information (mode, dosage, etc) according to 
rules capturing the document structure and the syntax of each kind of information (Deleger et al., 
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2010). It initially obtained an F-measure of 77% in the 2009 i2b2/VA Challenge and increased to 81% 
with lexicon filtering and rule refinement. It demonstrated that a simple NLP system with surface 
rules could achieve high performance to capture medication-related information in clinical records.  
 
The above methods could not perform well when encountering complicated medications that contain 
multiple signatures or contextual level information. MedEx adopted a more sophisticated method to 
cope with the task (Xu et al., 2010). It consisted of a sequential tagger and a combined parser: the 
sequential tagger combined lexical look-up, regular expression, and rule-based disambiguation 
components, could sigificantly improve the accuracy of semantic labeling of drug names and 
signatures. The parser combined a Chart parser and a regular expression-based Chunker to improve 
the ability to parse more complicated medications. The evaluation showed that MedEx can accurately 
extract not only drug names, but also associated information, such as strength, route, and frequency, 
with high F-scores (from 93.2% to 96.0%).  
 
There are a number of research works indicating that dictionary look-up methods can also benefit 
from integrating with rules. 
 
An NLP engine was developed to measure the quality of colonoscopy procedures, based on rules and 
dictionary look-ups (Harkema et al., 2011). Firstly, it utilized the MetaMap Transfer (MMTx) 
program (NLM, 2008-2014) to map words and phrases in each sentence in the report to a subset of 
concepts in the UMLS Metathesaurus, including the following semantic categories: Anatomical 
Structure, Neoplastic Process, and Sign or Symptom. Then a set of regular expression patterns was 
prepared to parse and interpret the temporal expressions and measurements of size. The ConText 
algorithm was used to identify the clinical and linguistic properties of the extracted concepts 
(Harkema et al., 2009). The values of the target variables were established by using some simple rules. 
The NLP engine attained encouraging results with 0.89 of average accuracy and 0.74 of average F-
score. 
 
A more detailed study was performed on a MER task with two dictionary-based systems MetaMap 
and Peregrine (Schuemie et al., 2007), by comparing with and without the use of a rule-based NLP 
module, which was composed of a set of post-processing rules that utilized POS and chunking 
information (Kang et al., 2013). It revealed that with this module, the F-scores of MetaMap and 
Peregrine improved by 12.3% and 14.1% respectively for exact boundary matching, and by 11.1% and 
12.9% respectively for concept identifier matching, compared to those without this module.  
 
However, it should be noted that the limitations of the rules can also propagate to dictionary look-up 
methods when they are integrated. Schadow et al used a rule-based parser by employing regular 
expressions to search for specimen headers in the diagnosis section of pathology reports, and guide 
the coding process by accepting only certain UMLS semantic types that fit the expected meaning of 
the input phrase (Schadow and McDonald, 2003). They found that 91% of 275 reviewed reports were 
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coded by this approach with the parser relying on regular expressions to attain structural clues. Thus it 
faced great difficulties when processing less consistently formatted reports. 
 
2.2.3 Statistical Approaches 
Recently, with more advanced machine learning algorithms being released, statistical methods have 
become more popular. One of the main characteristics of these methods is that they can utilize 
contextual information to predict the entities, which is especially useful when the coverage of the 
dictionary is quite limited, or rules or patterns are too difficult to be captured from the training 
examples. 
 
According to the strategies by which machine learners generate their models, they can be classified as 
either generative techniques or discriminative techniques. Generative techniques seek to create rich 
models of probability distributions, and with such models, they can generate synthetic data; 
discriminative techniques are usually thought to be more utilitarian, since they directly estimate 
posterior probabilities based on observations. Besides, discriminative models often allow using more 
features than generative models, since when many features are used, generative models can become 
intractable. Bayesian networks (Ben-Gal, 2007) and hidden Markov models (HMM) (Stamp, 2004) 
are examples of generative methods, while support vector machines (SVM) (Cristianini and Shawe-
Taylor, 2000) and conditional random fields (CRF) (Sutton et al., 2007) are examples of 
discriminative methods.  
 
SymText uses probabilistic Bayesian networks to represent semantic types and relations (Haug et al., 
1994). Syntactic knowledge comes from augmented transition networks. The system depends on a set 
of reports to train the network for a specific medical domain. For instance, when extracting 
pneumonia-related concepts from chest x-ray reports, it utilized three Bayesian networks: the first 
Bayesian network represented radiographic findings; the second one modeled the diseases that can be 
described in the reports; the third one modeled the devices that are frequently described in the chest x-
ray reports (Fiszman et al., 2000). The performance of SymText was compared against four 
physicians, two different keyword searches, and three lay persons. The accuracy of SymText was 
similar to that of physicians and better than that of lay persons and keyword searches. 
 
In its successor M+ (Christensen et al., 2002), Bayesian networks were represented in an object-
oriented format and a bottom-up chart parser provided syntactic analysis. In addition, M+ used an 
abstract semantic language to link Bayesian network types to each other in a predication format. The 
advantages of using Bayesian networks for semantic representation include tolerance of noise and 
partial matches and sensitivity of context to the recognition of semantic patterns. In addition, its 
ability to guess the semantic types of unknown words is very valuable for bootstrapping semantic 
knowledge. 
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Nonetheless, both systems are limited to the domain covered by the semantic knowledge that is stored 
within the Bayesian networks. The creation of training cases is also a time-consuming task. 
MER is one the tasks of the 2009 and 2010 i2b2/VA Challenges. The 2009 Challenge focused on the 
identification of seven types of medication information in discharge summaries, including dosages, 
modes of administration, frequencies, durations, and reasons for administration (Uzuner et al., 2010). 
The winner used a CRF model to extract the entities and achieved the best micro-averaged F-score of 
85.65% (Patrick and Li, 2010). The 2010 Challenge defined three classes which were Test, Problem, 
and Treatment were extracted (Uzuner et al., 2011). Most of participants used CRF as the framework 
together with feature engineering specific to these classes in the challenge. For example, Patrick et al 
adopted a CRF learner to identify the entities and attained a micro-averaged F-score of 81.79% 
(Patrick et al., 2011). 
 
Theoretically, CRF is a representative sequence labelling algorithm, which is suitable for the MER 
tasks, while SVM is based on large margin theory and has difficulty handling sequence labelling 
problems as it ignores the relationships between neighbouring tokens in sequences. For instance, Li et 
al proved that CRF outperformed SVM on MER of disorders in clinical notes (Li et al., 2008). 
However, CRF also has its own weaknesses, e.g., it is unable to utilize the global information in the 
notes. 
 
To combine the advantages of both CRF and SVM, Tsochantaridis et al proposed a new machine 
learning algorithm named Structural Support Vector Machines (SSVM) for structural data, which is 
an SVM-based discriminative algorithm for structural prediction (Tsochantaridis et al., 2005). Tang et 
al applied SSVM to recognize clinical entities in discharge summaries and compared the performance 
of CRF and SSVM on the 2010 i2b2/VA Challenge data (Tang et al., 2012). Their evaluation showed 
that the SSVM-based system required less training time, but achieved better performance than the 
CRF-based system with the same features. 
 
A combination of machine learners can also overcome some shortcomings of a stand-alone classifier. 
 
Wang and Patrick presented a machine learning approach to MER using a combination of machine 
learners (Wang and Patrick, 2009). They firstly built a CRF based model to identify the entities and 
then reclassified the identified entities by Maximum Entropy and SVM models. A voting strategy was 
employed between the three classifiers to determine the class of the recognized entities. The results 
showed that the reclassifier effectively boosted the F-score by 3.35% over the stand-alone CRF model. 
 
Xu et al purposed a novel method for MER of follow-up and time information in radiology reports 
which combined a labeled sequential pattern (LSP) classifier with a CRF recognizer (Xu et al., 2012). 
The LSP classifier was an SVM classifier that used binary features, each of which corresponds to a set 
of patterns mined for positive set and negative set respectively. In the training phase, the LSP 
classifier disregarded a large number of negative examples and thereby improved the consistency of 
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local contexts of positive examples; in the test stage, it used global patterns in a sentence to narrow 
down a set of candidate sentences. The experiment showed significant improvement of the 
performance of the CRF recognizer, due to the process of cleaning-up the training data and 
compensation for CRF’s inability to use global information by the LSP classifier. 
  
Feature Selection 
Choosing proper features for machine learners is as important as selecting an appropriate machine 
learning technique, as features can provide critical clues for the learners to construct the models and 
make prediction on the test data. Usually, features can be categorized as follows: 
• Contextual features: local context features (e.g., the bag-of-words (BOW), also called context 
window of words), global context features (e.g., section context, document types).  
• Lexical features: such as lemma, lowercase of words. 
• Syntactic Features: part-of-speech (POS) tags, chunking information, etc. 
• Morphological features: affixes, orthography and so on. 
• Semantic features: for example, exploring external resources can provide additional domain 
knowledge. 
 
There is much research addressing the importance of feature selection or feature engineering.  
 
The results from Li and Martinez’s experiments on the extraction of a large number of categories from 
pathology reports (Li and Martinez, 2010) showed that a high level of accuracy could be attained on 
predicting nominal categories by using BOW feature. This indicated that pathology reports contain 
similar lexical items that can be captured by a BOW model. It also revealed that for numeric 
categories, richer features were required to improve the performance. 
 
To minimize this limitation by combining supervised machine learning with empirical learning of 
semantic relatedness from the distribution of the relevant words in unannotated text, Jonnalagadda et 
al used a feature of distributional semantics with words that appear in similar contexts to the word in 
question, in addition to the traditional features such as dictionary matching, pattern matching and POS 
tags (Jonnalagadda et al., 2012). The evaluation of this approach on the i2b2/VA concept extraction 
corpus showed that incorporating this feature significantly aids MER. 
 
The semantic domain knowledge from terminologies can be very helpful for determining the correct 
concept boundary and the semantic category of these concepts. Wang boosted the performance of a 
machine learning-based system significantly by using the results from the dictionary look-up on 
SNOMED CT as a feature, particularly on the recall. On another MER task, Abacha and 
Zweigenbaum obtained the best results from a CRF classifier combined with semantic features 
obtained from UMLS, apart from lexical and morpho-syntactic features (Abacha and Zweigenbaum, 
2011). 
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2.2.4 Hybrid Approaches  
On one hand, rule-based systems tend to provide reliable results with a relatively small amount of 
training data, and the hand-crafted rules are comprehensible for the developers or domain experts, thus 
it is easier to detect and correct errors during error-analysis. However, it is difficult for a rule-based 
system to deal with unfamiliar or erroneous input data, and the hand-crafted rules are usually tailored 
for a specific domain or task, which are not readily reusable. On the other hand, it might be possible 
for an IE system based on statistical methods to cope with problematic data by learning from available 
examples through training. Besides, statistical methods achieve comparable or better performance by 
simply adapting features from the corpus, hence they can be easily adapted to other domains. For 
example, BioTagger-GM was a machine learning tagger, originally developed for the detection of 
gene/protein names in the biology domain (Torii et al., 2009). To extract concepts from clinical 
documents, Torii et al replaced one of its components – BioThesaurus (Liu et al., 2006) with a 
collection of clinical terms extracted from discharge summaries, supplemented the section header as 
an additional feature, adjusted the context window size to derive features by encoding nearby tokens, 
and removed the hand-coded rules for post-processing. Evaluation on the 2010 i2b2/VA Challenge 
indicated its portability to the clinical domain and achieved good performance with 0.890 of F-score. 
However, statistical methods usually require a large amount of training data to create a gold-standard, 
which are typically expensive to obtain. Furthermore, statistical methods can benefit from the 
utilization of the rule-based NLP module as it may capture particular patterns that cannot be well 
handled by machine learning, especially for entities with low frequencies. Therefore in recent years, 
there has been a trend for using hybrid approaches with a combination of statistical methods and rule-
based approaches when designing an IE system for MER. 
 
Entity recognition in the biomedical domain has mainly used rule-based modules in post-processing to 
fix errors produced by the machine learning techniques. For example, Zhou and Su used an HMM 
model as the machine learner in their system to recognize biomedical entities, and employed some 
rule-based methods in post-processing, including named alias resolution, rule construction to handle 
classification errors in nested named entities, expansion of abbreviations and utilization of open and 
closed dictionaries to detect unknown words (Zhou and Su, 2004). The baseline HMM-based learner 
only achieved an F-score of 60.3%, but after post-processing, it boosted to 72.5%. The possible reason 
for the improvement was that the rules could bridge the gap when the system encountered unseen 
words, and handle complex entities better. 
 
Nevertheless, rule-based components were usually prepared to generate additional features in pre-
processing rather than post-processing for machine learning-based systems to allow the systems to 
self-optimize better. For instance, de Bruijn et al applied upper-case/lower-case patterns seen across 
the document and case-folding patterns in sentences as features for the feature space for the machine 
learner (de Bruijn et al., 2011). 
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A hybrid system named Textractor was developed for the 2009 i2b2/VA Challenge (Meystre et al., 
2010), where two modules were based on machine learning algorithms, while other modules 
employed regular expressions, rules, and dictionaries, and another module embedded MMTx. It 
achieved satisfactory performance with F-score of 77%, recall of 72% and precision of 83%, which 
made it one of the top 10 best performing systems in the challenge.  
 
Another hybrid system was established to automatically classify the surgical margin status from 
pathology reports following prostate cancer surgery (D'Avolio et al., 2007). By the preliminary pilot 
analysis of a small subset of reports, heuristics were designed for capturing potential margin 
sentences. With five simple rules based on keyword appearance, it was able to capture positive 
sentences from 780 of 782 reports, with accuracy over than 97%. The extracted sentences were 
tokenized into vectors of lowercase words and then passed to an implementation of an SVM classifier 
to classify to three classes: “positive (involved) margins”, “negative (uninvolved) margins”, and “not-
applicable or definitive”, with an overall accuracy of 97.18%. 
 
Roberts et al compared a lexical look-up method with a statistical method, and to a method which 
combined the two approaches for MER (Roberts et al., 2008a). The lexical look-up method based on 
UMLS had good recall, but poor precision, which was largely due to the ambiguity between domain 
terms and general language words. As much of the ambiguity was caused by a small number of terms, 
the ambiguous terms were filtered with a filter list using simple heuristics to improve precision. The 
SVM classifier trained on lexico-syntactic features alone yielded higher precision, but lower recall 
than the lexical look-up method. When these two approaches were combined, it gained higher recall 
with little loss of precision. The results suggested that they could compensate each other, and attain 
better performance than each on their own. 
 
To extract medication information from the 2009 i2b2/VA Challenge data, Tikk and Solt (Tikk and 
Solt, 2010) first used a rule-based method by creating a custom grammar that combines the benefits of 
using vocabularies and regular expression rules, and the submission ranked fifth in the challenge. 
Then they used CRF models with vocabularies and typical entity patterns taken from the rule-based 
method as one of the features. They found that the standard CRF-based approach did not improve 
upon the rule-based approach with a limited amount of training data. However, when additional 
training data were made available, the approach resulted in considerably better performance.  
 
They concluded that rule-based methods are easier to comprehend with a less time-consuming training 
phase, in favour of iterative trial-and-error development; since feature definition was more 
straightforward and less error-prone, it is more convenient for machine learning approaches to create 
models, and the performance can be improved with less manual effort with these approaches by 
adding more features, compared with cumbersome rule tuning with rule-based methods.  
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Nevertheless, there is also research indicating that rules can contribute to significant improvement 
over machine learning-based systems through post-processing in the clinical domain. 
 
To extract numeric categories  from pathology reports, Martinez and Li applied a two-step process 
(Martinez and Li, 2011). At first, machine learning-based sentence classifiers for each class were built 
to identify the positive sentences, then the numeric values were extracted, and the number closest to 
the median is assigned as output. However, when the target sentence was correctly identified, the 
simple strategy of using the median was not good enough to identify the right number for “Nodes 
positive”. By manual analysis of the sentences, they found that in most cases the number of positive 
nodes is given together with the examined nodes, thus they devised some simple rules to identify the 
number of positive nodes, and achieved significant improvement over the machine learning approach 
alone.  
 
It is noticeable that although the hybrid approaches can have the advantages of both rule-based and 
statistical methods, the limitations from each method can still maintain in hybrid approaches. For 
example, heuristic rules developed based on syntax structures in the training data, may not work as 
expected in the test set, if they cannot cover all possibilities of expressing the information to be 
extracted. 
 
2.3 Negation and Uncertainty Detection 
2.3.1 Negation Detection 
In clinical reports, the presence of a medical term does not indicate the presence of the clinical 
condition represented by that term is certain. In fact, a large portion of clinical findings mentioned in 
the reports (e.g., discharge summaries, radiology reports) are negated. Accurately identifying whether 
these findings are present or absent is critical to extracting pertinent information from the reports and 
indexing them.  
 
In the pathology domain, the narrative reports usually contain negative findings or diagnoses as well 
as positive ones. To detect whether particular findings are negated is of great significance to make a 
proper decision on diagnosis and prognosis. For example, constitutional symptoms such as fever, 
weight loss and night sweats are known to be of prognostic value in non-Hodgkin lymphoma (NHL) 
(Edge et al., 2010; Sobin et al., 2009).  The presence or absence of these symptoms can be used to 
define two categories for each stage of NHL: A (if symptoms absent) and B (if symptoms present) 
(Sobin et al., 2009).  
 
Generally, negation detection includes the detection of negation cues (specific terms to indicate 
negation) and their scope (the text negated by the terms). In the following example, “No evidence of 
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malignancy”, where “No evidence of” is the negation cue and “malignancy” is in the scope negated by 
the cue. 
 
Rule-based approaches can be sub-classified to lexical pattern matching methods and syntax-based 
approaches depend on whether they utilize syntactic information in the texts. 
 
Previous work suggests that a small set of words cover a large portion of negation cues. It is evident 
that “no”, “denies/denied”, “without”, and “not” are the most frequently used terms to indicate the 
absence of clinical observations (Chapman et al., 2001a). Several rule-based approaches that utilized 
lexical pattern matching have been widely applied to the clinical domain.   
 
Negfinder used a Left-to-right Rightmost-derivation parser to detect negations in surgical notes and 
discharge summaries and achieved sensitivity of 95.7% and specificity of 91.8% without extracting 
syntactical structures of sentences and phrases (Mutalik et al., 2001). However, it could not detect 
negated concepts correctly if the negation cue was far away from negated concepts, since it terminated 
a concept list or negation if there are more than three intervening words between concepts or between 
a negating phrase and a concept.  
 
NegEx, a regular expression-based algorithm, which is simple to implement, has shown success in 
detecting negations in discharge summaries with recall of 77.8%, and precision of 84.5% (Chapman et 
al., 2001b). It relied on three types of terms to determine whether a condition is negated, namely 
trigger terms, pseudo-trigger terms, and termination terms. Trigger terms like “no” and “not” indicate 
that the clinical conditions within the scope of the trigger term should be negated. Pseudo-trigger 
terms, such as “not rule out” and “gram-negative”, which appear to indicate negation but identify 
double negatives or modified meanings instead. Termination terms, e.g., “but” and “though”, can 
terminate the scope of the negation before the end of the window. Since it did not take into account 
any syntactic clue to determine the negation scope, it had faced difficulty in determining the scope of 
the negation phrase in some complex cases. Similar to Negfinder, a rigid window might lead to 
omission of some negated UMLS terms in long lists of terms, or when the negation phrase and a term 
were separated with a distance larger than the window size. Thus, the algorithm was likely to only 
negate part of high-level composite concepts. 
 
Without any customization, its application to the pathology domain had lower performance (Mitchell 
et al., 2004), probably because the negation and pseudo-negation phrases that were used by NegEx 
may not adequately cover the spectrum of phrases in pathology reports. It also revealed that failure to 
correctly map the text phrases to UMLS concepts is one major source of errors. 
 
PyConTextNLP was an extension of the NegEx algorithm that included modifications of the scoping 
rules, and more functionality for defining user- and task-specific rules (Chapman et al., 2011a). 
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Instead of a fixed window, the algorithm operated on the whole sentence to get the scope, unless it 
found user-defined conjunctions. 
 
A unique ontology developed for negation is another solution purposed by Elkin et al. They extended 
the work of Mutalik et al (Mutalik et al., 2001) and Chapman et al (Chapman et al., 2001b) by 
performing their study using SNOMED CT and by utilizing a second independently developed 
ontology for negation. The negation ontology contained two sets of terms and their associated rules, 
with one set starting negations and another set stopping the propagation of negations. The system first 
mapped the text in a sentence to SNOMED CT to attain SNOMED CT concepts, and then assigned 
one of the three possible assertion attributes according to the negation ontology. The recall of the 
assignment of negation was 97.2% and the precision was 91.2%. The most common reason for failure 
was the inability of SNOMED CT to represent the negative concepts, as the human reviewer identified 
that 205 of 2028 negative concepts were not mapped by SNOMED CT, revealing that the terminology 
had 88.7% of coverage of the negative concepts. 
 
For complicated negation cases, defining negation scope is still a challenging task. The above 
approaches could perform reliably when a negated concept is close to a negation cue and it can be 
mapped to a controlled terminology (e.g., UMLS, SNOMED CT) , but unsatisfactorily when they are 
separated with multiple words or they fail to be mapped to a controlled terminology. Syntactic 
information is a useful clue to resolve this problem.  
 
NegExpander identified negated UMLS terms by constructing conjunctive phrases to define the 
negation boundaries (Aronow et al., 1999). Conjunctive phrases were referred to a group of noun 
phrases connected with conjunctions such as “and,” “or” and “,”. NegExpander did not take the 
conditional possibility of phrases such as “rule out” into account, hence it could not distinguish from 
uncertainty in some cases. As well, it could not distinguish between pre-UMLS and post-UMLS 
negation phrases inside conjunctive phrases. This might result in incorrectly negated UMLS terms 
preceding the pre-UMLS negation phrases or succeeding the post-UMLS negation phrases inside 
conjunctive phrases, consequently reducing the overall algorithm’s specificity. 
 
A hybrid approach by combining regular expression matching with grammatical parsing has been 
proposed to detect negations (Huang and Lowe, 2007). The results showed that the structured 
grammar rules developed using linguistic principles were more powerful than detecting negated 
concepts at a fixed distance from negation cues. It did not rely on concept mapping to cluster words 
before detecting negations, thus it is more intuitive in understanding a complex sentence, which is 
very helpful to locate the negated phrase in the sentence. One of the limitations was reflected in the 
coverage of the negation grammar, which was not as comprehensive as expected during the test. It 
was also limited by the parsing performance of the NLP parser, especially the errors in noun phrase 
identification. Another limitation was that they only evaluated radiology reports. Radiology reports 
might contain significantly fewer negation phrases frequently used by non-radiology reports. 
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Therefore, it should be further validated on other types of clinical reports. Another approach to detect 
negation is dependency parser-based negation (DepNeg) (Sohn et al., 2012), using dependency parses 
which directly encode thematic roles like subject and object performed quite well and was able to 
identify complicated negations that were wrong in the cTAKES (Savova et al., 2010) by a limited set 
of dependency rules compiled from a small data set.  
 
SynNeg is a negation scoping tool that uses morphological and syntactic information provided by the 
MaltParser (Nivre et al., 2007). It assumes that a negation scope does not cross the boundary of a 
sentence unit (i.e., subject + verb phrase). The MaltParser assigns the ES (logical subject), FS 
(dummy subject) or SS (other subject) and DEPREL (Dependency Relation) tag to a subject of a 
sentence unit. When a cue is found, SynNeg checks the DEPREL tags of either the following token or 
the preceding token from the cue to find a subject DEPREL tag. It also checks the POS tags for 
coordinating conjunction, minor delimiter and subordinating conjunction. Every time one of these 
POS tags is found, the position of the token is stored as a boundary candidate. Once a subject 
DEPREL tag was found, the nearest boundary candidate from the subject DEPREL tag was set as the 
boundary for the scope. 
 
Both lexical pattern matching methods and syntax-based approaches have their merits and limitations 
on negation detection. Tanushi et al compared three different tools: NegEx, PyConTextNLP and 
SynNeg for determining negation scope in Swedish clinical text and achieved similar results with 
around 80% of F-scores (Tanushi et al., 2013). The pros and cons for these tools on negation detection 
were described as follows:  
NegEx was efficient and simple, but it was not able to handle longer or complex sentences, or 
sentences with contradictory statements. PyConTextNLP was possible to improve results if lexical 
phrases that defined the boundaries for the scopes are determined. However, it was also likely to fail 
in some ambiguous cases. SynNeg was more generalizable and easier to port to another domain or 
language by using syntactic information, but its performance was hindered by the syntactic parser to a 
great extent. 
 
There are different opinions on whether rule-based or machine learning-based approaches are more 
suitable for negation detection in the clinical domain. Some studies pointed out those rule-based 
methods outperformed machine learning-based approaches, while other researches suggested that 
machine learning-based systems have better performance than their rule-based counterparts. 
 
Goryachev et al implemented and modified two existing rule-based algorithms: NegEx and 
NegExpander, and created two classification models based on SVM and Naive Bayes (Goryachev et 
al., 2006). All four methods were evaluated on 100 randomly selected outpatient notes, and the results 
revealed that NegEx and NegExpander did slightly better than SVM, and Naive Bayes has the worst 
performance. 
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As part of the assertion task, negation detected by machine learning techniques has been the state of 
the art in the 2010 i2b2/VA Challenge. For example, Patrick et al converted a baseline rule-based 
method to a statistical method trained with CRF, and gained more than 92% of F-score on the 
“absent” category (which stands for negated medical problems) in the task (Patrick et al., 2011). 
 
2.3.2 Uncertainty Detection 
Compared to negation detection, there are fewer studies addressing uncertainty detection. One of the 
possible reasons is that it is harder to determine uncertainty assertions than negations, sometimes even 
for human experts. To produce a freely available resource for research on handling negation and 
uncertainty in biomedical texts, Vincze et al annotated a corpus called the BioScope corpus (Vincze et 
al., 2008). In the study, they found that uncertainty detection was a more difficult task than identifying 
negation because of a higher level of keyword/non-keyword ambiguity. This was confirmed by the 
agreement rates of the human annotations for these two tasks, where the agreement rates for the 
keywords of uncertainty were about 3.4-5.7% lower than those of negation. 
 
The MedLEE system made a distinction between negated and uncertain concepts through encoding 
negated concepts and certainty modifiers (Friedman et al., 1994). It defined five concepts to represent 
certainty information related to the finding: no, low certainty, moderate certainty, high certainty, and 
cannot evaluate, and therefore the words and phrases in the reports relating to this type of information 
would be mapped into one of these concepts. This limitation could greatly facilitate the subsequent 
retrieval of the structured findings in the reports. Since this type of information usually hedged 
information concerning the certainty of the findings in the reports and was basically vague, it was 
thought to be too hard to represent this type of information more precisely in other ways. 
 
Negation and uncertainty detection was one of the emphases of the 2010 i2b2/VA Challenge, named 
as an “assertion classification” task (Uzuner et al., 2011). This task extended traditional negation and 
uncertainty extraction to conditional and hypothetical medical problems, and brought in information 
about the person to whom the medical problem belonged. 
 
Uzuner et al presented two different approaches for the assertion classification task (Uzuner et al., 
2009). One was extension of NegEx algorithm (ENegEx) to cover alter-association assertions; the 
other was a machine learning solution that applied SVM to build a Statistical Assertion Classifier 
(StAC). It turned out that StAC outperformed ENegEx, which benefited the most from a four-word 
context window. 
 
A hybrid system was designed by Clark et al for the task (Clark et al., 2011). To combine machine 
learning algorithms with linguistic knowledge, regular expression-based patterns, and scope enclosure 
rules, they first fed the output from a statistical scope module to a rule-based status module, and input 
the results from that module, as well as other features derived from linguistic knowledge, to a final 
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statistical classifier. They thought this was a feasible way to leverage rule-based and statistical 
techniques, as rule-derived information could weight features automatically with respect to its 
contribution to the overall accuracy and the degree to which the information correlated with other 
features, when it was converted to features as an input to a machine learner. 
 
Their study also revealed another finding that the choice of features was more important than the 
choice of the classifier for this task. Rather than exploring a large number of features, they only 
selected a small number of features based on the analysis of the data and linguistic intuitions. They 
used the same features as input to three machine learning classifiers: a Maximum Entropy classifier, a 
SVM with linear kernel and a CRF classifier, and the results did not differ significantly amongst each 
other. 
 
It can be seen from the above studies that uncertainty detection is commonly accompanied with 
negation detection, probably because both negation and uncertainty indicate the non-factual 
information, which should be distinct from the positive clinical findings or diagnoses. The approaches 
to resolving negation are also applicable to resolve uncertainty in most cases.    
 
2.4 Relation Extraction 
A relation represents the link between two entities. In the general domain, the relations of interest 
usually are quite explicit, for instance, EMPLOYEE_OF, PRODUCT_OF, and LOCATION_OF, 
relations defined in the seventh Message Understanding Conference (MUC-7) (Chinchor, 1998). 
Therefore, pattern-based approaches can work fairly well for this task. In a pattern-based RE system, a 
template or frame is defined to hold relations between two entities, which is a table with slots that can 
be instantiated with the fragments or segments of information extracted from a given document. A set 
of pattern matching rules was used to assign entities to the slots of such templates. However, RE in 
biomedical or clinical domain can be challenging as it needs more domain knowledge to tackle, in 
addition to ambiguity and complexity that embed in the texts.    
 
In the biomedical domain, RE systems usually focus on extracting interactions or relationships 
between biomedical entities. For example, extracting relations between genes and diseases (Chun et 
al., 2006), identifying relations between genes and proteins (Bundschus et al., 2008; Fundel et al., 
2007), determining treatment relations between drugs and diseases (Rosario and Hearst, 2004).  
 
In the clinical domain, the relations to be extracted are relationships that hold between medical 
entities, requiring a lot of domain knowledge as well. For example, the 2010 i2b2/VA Challenge 
proposed a relation classification task, which aimed to assign relation types between medical 
problems, tests, and treatments, including a treatment that improves or worsens a problem, a treatment 
that causes a problem, a treatment that is administered or not administered because of a problem, a test 
revealing a problem, a test conducted to investigate a problem, and a problem that indicates a problem 
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(Uzuner et al., 2011). RE between entities in clinical reports can improve accessibility to the high 
level of information in these reports. 
 
2.4.1 Rule-based Approaches 
Typical approaches to RE in most early work in the clinical domain were usually rule-based and relied 
on full parses, domain-specific grammars, or large domain knowledge bases.  
 
A full syntactic and clinical sub-language parser was used to fill template data structures of medical 
statements in the Linguistic String Project (Sager et al., 1994), which were mapped to a database 
model that incorporated medical facts and the relationships between them.  
 
Both MedLEE (Friedman et al., 1994) and BioMedLEE (Lussier et al., 2006) made use of a semantic 
lexicon and grammar of domain-specific semantic patterns. The patterns encoded potential 
relationships between entities, allowing direct matching of entities and the relationships between them 
in the text.  
 
There were also some systems incorporating large-scale domain-specific knowledge bases. For 
example, MEDSYNDIKATE used a dependency parse of texts and a description logic knowledge 
base re-engineered from existing terminologies to build a rich discourse model of entities and their 
relationships (Hahn et al., 2002). A similar method also adopted by MENELAS, included a full parse, 
a conceptual representation of the text, and a large scale knowledge base (Zweigenbaum et al., 1995). 
 
Rule-based approaches were still considered to be simple and reliable to apply in some recent RE 
tasks.  
 
Halgrim et al used simple heuristic rules to associate each medication name with its related fields 
(Halgrim et al., 2011), which can be processed in three steps: firstly, they identified the closest prior 
and subsequent names for each field; secondly, they linked each field to one of those two names and 
in most cases, usually the prior name unless the distance to the subsequent name was much shorter 
than the one to the prior name by more than two lines; thirdly, they applied a few rules to assemble the 
pairs if more than one field of the same type was linked to the same name.  
 
Nikolova and Angelova presented research work on automatic extraction of relations between medical 
concepts with rule-based methods (Nikolova and Angelova, 2011). Due to a lack of conceptual 
resources with a Bulgarian ontological vocabulary, they formed a terminological dictionary of 
Bulgarian terms, translated them to English and extracted their UMLS definitions, which were 
processed automatically by a semantic parser named RelEx (RelEx Developers, 2007-2014). They 
also applied additional rules, built a set of new relations such as IS-A and AFFECTS and inserted 
them into the conceptual resource. The accuracy of the system was between 81% and 89%. The major 
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source of errors was due to wrong parsing trees from the parser, thus better parses would lead to 
improvement of the system. 
 
Abacha and Zweigenbaum proposed a knowledge and linguistic pattern-based approach for the 
extraction of medical entities and the semantic relations linking them (Abacha and Zweigenbaum, 
2011). Specifically, for every pair of medical entities, they collected the possible relations between the 
semantic types in the UMLS Semantic Network. Then they constructed patterns for each relation type 
and matched them with the sentences to identify the correct relation. They obtained good results in 
precision and F-score compared to other semantic RE approaches, which suggested that such methods 
give good control on the extraction precision by testing and improving manual patterns but with an 
expensive cost needed to attain a good recall. A possible improvement is to integrate such methods in 
hybrid approaches to balance their qualities with that of statistical methods. 
 
2.4.2 Statistical Approaches 
The first effort at applying statistical methods to extraction of relationships from clinical texts was 
made by Roberts et al (Roberts et al., 2008b). They designed and implemented a machine learning-
based system for RE from a clinical corpus annotated with seven types of clinically important 
relationships. There are several important findings from their experiments: 
• Both lexical and syntactic features were assigned to tokens and entity pairs for the SVM 
classifiers prior to classification. For most relation types, the classifier with syntactic features 
outperformed the one with non-syntactic features with a higher macro-averaged F-score by 2-
4%. 
• The system achieved an overall F-score of 72%, only just 3% below the score of human 
inter-annotator agreement, showing that it is possible to extract important clinical 
relationships from free text using supervised machine learning methods, at the level of 
accuracy approaching to that achieved by human annotators. 
• The precision for relation recognition over extracted entities remained close to that over 
gold-standard entities (64% vs. 63%), however, the recall decreased significantly from 76% 
to 40%, resulting in a dramatic drop of F-score by 22%. Apparently, good RE depends on 
accurate MER for an end-to-end RE system. 
 
Patrick and Li classified the relations among six medication entities defined in the 2009 i2b2/VA 
Challenge with a machine learning approach trained with SVM (Patrick and Li, 2010). The features 
that they employed could be an important reference for feature engineering for other tasks in the 
clinical domain, including: 
• Contextual features: words in an optimal window size before and after each entity; words 
between the two entities; words inside of each entity. 
• Semantic features: entity types of each entity; entity types between the two entities. 
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Whereas the features for RE are not limited to the above, more features were also explored in other 
works, such as syntactic features (e.g., POS tags, chunk information, parse trees and dependency paths 
from a parser).  
 
However, it should be also noted that over-inclusion of complex features may harm the performance. 
Jiang and Zhai conducted some experiments to evaluate the effectiveness of different feature 
subspaces for RE (Jiang and Zhai, 2007). They explored three different representations of sentences: 
sequences, syntactic parse trees, and dependency trees, and found that the performance improved only 
slightly by combining the three feature subspaces. Their experiments also showed that over-inclusion 
of complex features may not improve the performance much and hurt the performance instead. They 
concluded that a combination of features of different levels of complexity, coupled with feature 
pruning for particular tasks, can give better performance for RE. 
 
A large amount of research has presented how different features and combinations or representations 
of features affected the performance of a machine learning-based system for RE.  
 
Rink et al developed a state of the art system that automatically extracted relations between medical 
concepts with a supervised machine learning approach (Rink et al., 2011). A single SVM classifier 
and several knowledge resources such as Wikipedia (Wikipedia community, 2001-2014), WordNet 
(Fellbaum, 1998), and General Inquirer (Stone et al., 1966) were used in the system.  
 
They assumed that relations that had similar contexts should also have similar relation types, but 
conventional lexical features like a string of words between the relation arguments was unable to 
directly capture this, as they could not reflect minor lexical variations. To overcome this issue, they 
used a sequence similarity metric known as Levenshtein distance (Levenshtein, 1966) to obtain 
similarity features to indicate the percentage of similar relations of each relation type. They found that 
the RE system benefited mostly from lexical, syntactic, semantic context features and similarity 
features. In addition, the knowledge resources were proved to improve RE performance by providing 
information about whether two entities in the candidate pairs are strongly associated.  
 
Frunza and Inkpen also adopted SVM as a classification algorithm to train models to extract relations 
between diseases, treatments, and tests from clinical notes (Frunza and Inkpen, 2011). The best results 
with 86.15% of overall F-score were obtained by using rich features, including BOW, entity types, 
verb phrases identified by the GENIA tagger (Mitsumori et al., 2006), contextual information attained 
from ConText tool (Chapman et al., 2007a), entities extracted from the training data, semantic vectors 
that captured the distributional semantic correlation between the entities and each relation of interest. 
 
Unlike the traditional BOW representation, Dogan et al represented a relationship between medical 
problems, treatments and tests with a scheme of five distinct context-blocks determined by the 
position of concepts in the text: the introductory, first concept, connective, second concept, and 
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conclusive block (Dogan et al., 2011). They thought this scheme could have better management of the 
word position information, which may be critical in certain relationships. 
 
Taking into account variability in the sentences, Minard et al used different features, including those 
specific to the domain (e.g., entity types), and those similar to the general domain (e.g., the words and 
stems which constitute the entities and the headword of each entity) (Minard et al., 2011). They 
obtained reasonable results with an overall F-score of about 0.70. They believed that the features they 
selected were general enough to be ported to other corpora, with an adaptation of the features to the 
corpora. 
 
A machine learning-based classifier usually performs better on the larger classes than on the smaller 
classes. To recognize the less prevalent classes, one possible solution is augmentation with handcraft 
rules as mentioned above, another way is down-sampling the larger classes. As one of the participants 
of the 2010 i2b2/VA Challenge, de Bruijn et al observed that some of the relationship types were 
much more frequent than others (e.g., negative problem-problem relations were about eight times 
more than positive ones) (de Bruijn et al., 2011). To address the imbalance of the category 
distribution, they down-sampled the training set to a positive/negative ratio between 1:2 and 1:4, 
selected as a development set, which reduced a classifier’s bias towards the majority class. Moreover, 
this down sampling was especially important for the semi-supervised training on the supplied 
unlabelled data, which boosted the system with 0.74% F-score. 
 
2.5 Automatic Structuring 
This automatic structuring of pathology reports presented in the thesis requires nearly all the processes 
to be performed automatically by the system, thus minimizing manual interference. This makes it 
different from the work of Chen et al of semi-automatic structuring of clinical documents (Chen et al., 
2010). In their work, the system used a keyword-based and semantic-driven data matching 
methodology to extract the specific information from the textual clinical documents. When the 
clinician started the matching operation based on the selected keyword, the information matching 
modules applied the matching operations based on the matching profile of the keyword retrieved from 
the matching metadata database. Through the extraction verification interface, clinicians could verify 
and correct the matched information. The extracted data were filled into predefined case-oriented 
templates, which were designed for collecting the necessary information for different diseases or 
research purposes. 
 
Although one of the goals of this project is to facilitate medical informatics in cancer registries, the 
focus is on the detail structured report fields that can provide sufficient information for cancer staging 
rather than inference of the stage factors from the narratives (e.g., T, N, and M stages). Thus, the 
system should be also distinguished from the work of McCowan et al and the medical text extraction 
(MEDTEX) system that targeted on automatic extraction of cancer staging information from medical 
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reports. On the one hand, McCowan et al developed a prototype software system to automatically 
extract cancer staging information from medical reports of lung cancer patients (McCowan et al., 
2007). The system trained SVMs to classify T and N stages’ relevance of each report, and then 
sentences from relevant reports were analyzed by a series of SVM-based or rule-based classifiers 
according to specific contributing factors defined in the staging guidelines. Results from the classifiers 
were post-processed to determine the final T and N stages. The system achieved an overall accuracy 
of 74% for T staging and 87% for N staging. M staging was omitted in the system, thus proper stage 
group information could not be obtained, as it is computed with the combinations of T, N, M staging. 
On the other hand, a symbolic rule-based system named MEDTEX was proposed to extract TNM 
staging factors automatically from free-text pathology reports by subsuming items specified in a 
structured report (Nguyen et al., 2010). SNOMED CT was used as a base ontology to provide the 
semantics and relationships between concepts for subsumption querying. SNOMED CT expressions 
were used to populate a structured report according to the College of American Pathologists’ surgical 
lung resection cancer checklist (CAP, 1991-2014), which could consist of a single concept or a 
combination of concepts post-coordinated by the user according to SNOMED CT’s compositional 
grammar. TNM stages were classified by building logic from relevant structured report items. 
However, the structured report items other than stage were not evaluated due to the lack of readily 
available validation data. 
 
Automatic structuring of medical reports in other clinical sub-domains such as radiology has been 
studied as well, where the issues addressed are likely to be resolved in this project. For example, 
automatic structuring of radiology reports is a difficult task for the following reasons: 
• Automatic structuring requires deep understanding of the domain because it is desirable to 
translate all relevant information in the free text into a structured form. 
• Automatic structuring must deal with ungrammatical writing styles as shorthand and 
telegraphic writing styles are common in radiology reports. Moreover, each subspecialty of 
radiology may have different language models. In addition, there are many stylistic variations 
between radiologists. 
• The vocabulary is large. Large numbers of complex medical terms, proper names, product 
names, abbreviations, and staging codes are used in radiology reports. Hundreds of 
descriptive adjectives are used that are not found in any common electronic medical 
glossaries. 
 
To cope with the issues above, Taira et al (Taira et al., 2001) did not use existing lexical sources such 
as the UMLS to build the specific lexicon for lexical analysis, because these lexical sources do not 
contain a sufficient number of semantic categories to support the statistical parsing and semantic 
interpretation algorithms in their system. In addition, the coverage of descriptive adjectives in the 
radiology domain is not yet adequate. Lexical terms were gathered from two distinct types of sources: 
published sources and actual radiology reports. The terms from the published sources can ensure the 
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generality of the concepts covered by the lexicon; the collection of words and phrases from actual 
radiology reports ensures that most of the string representations for the concepts are included. 
 
Statistical and machine learning methods were used extensively throughout their system, which 
consisted of the following collaborative modules:  
1. The structural analyzer divides the documents into sections and individual sentences within 
the sections. 
2. The lexical analyzer extracts semantic and syntactic features of words with use of a specific 
lexicon. 
3. The parser determines the modifier-head relations between words in a sentence. 
4. The semantic interpreter interprets the links of the parser-generated dependency diagram and 
outputs a set of logical relations. 
5. The frame constructor integrates the individual logical relations into structured frames. 
 
A more recent and similar work to this project has been presented by Coden et al to automatically 
instantiate a knowledge representation model from free-text pathology reports (Coden et al., 2009). 
They introduced Medical Text Analysis System/Pathology (MedTAS/P) system that was based on an 
open-source framework and used NLP principles including machine learning and rules to discover and 
populate elements of the Cancer Disease Knowledge Representation Model (CDKRM). CDKRM is 
like a structured template in this project, storing cancer characteristics and their relations. Each node 
in the model is referred to as a class and each class can have multiple attributes. There are two types 
of classes: leaf classes and container classes. Leaf classes are defined as classes whose attributes are 
only values. The model has five leaf classes to describe cancer characteristics: anatomical site, 
histology, grade value, dimension and stage. Container classes are those whose attributes can be either 
values or other classes. For instance, a tumour class can contain multiple instances of tumour reading 
classes to capture the notion of multiple interpretations of the same tissue sample. 
 
The pipeline of MedTAS/P could be broken into several components: 
1. Ingestion: to extract implicit meaning from the structure of a document. 
2. General NLP: to perform tokenization, sentence boundary detection, POS tagging and 
shallow parsing. 
3. Concept finding: to determine concepts based on the International Classification of Diseases 
for Oncology (ICD-O) (Fritz, 2000) and determine negation. 
4. Cancer-specific annotation: to annotate grade, stage, size, margin, date and tumour blocks. 
5. Relation finding: to populate CDKRM and resolve co-referent relations. 
 
Particularly, the concept recognition is handled by ConceptMapper and ConceptFilter. 
ConceptMapper maps the texts to the ICD-O to create candidate matches. ConceptFilter filters out the 
matches based on a set of rules.  
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Regular expressions are used to discover entities describing dimensions and sizes, dates, number of 
excised and positive lymph nodes and stage. Pattern matching is used to identify instances of the 
grade value class. It also discovers concepts by building machine-learning models. 
 
RelationFinder extracts the relationships between the appropriate leaf classes to populate container 
classes. First, it determines which section should be considered for instantiating a container class. 
Second, certain classes are categorized according to multiple criteria. Third, it identifies co-referent 
instances. Fourth, it determines which instances of leaf classes to be populated to the container 
classes. Fifth, container classes are merged or split according to specific rules. 
 
MedTAS/P achieved F-scores of 0.97–1.0 for most classes such as histologies or anatomical sites, 
0.82–0.93 for primary tumors or lymph nodes, and 0.65 for metastatic tumors. The lower score for 
metastatic tumors is mainly due to two factors:  
• There are relatively few metastatic tumor instances in the reports. 
• Metastatic tumor class contains one more leaf class than primary tumor class. Since the 
correct population of a container class requires all members in the class must match the gold-
standard, the additional leaf class greatly decreases the chance for concordance but increases 
the possibility for disagreement instead. 
 
Except for the limitation mentioned above, another issue is noted in their study. Pathology reports 
have their own conventions and styles, which should be taken into account when adapting other NLP 
tools that originate in the general domain to the pathology domain. Although the grammar for general 
English for the shallow parser had been modified for pathology reports in their study, certain out-of-
vocabulary words were still mislabelled. For instance ‘‘nodes” was labelled as a verb instead of a 
noun in the context of ‘‘lymph nodes”. Such a wrong POS tag can consequently cause the incorrect 
determination of context for a certain term or concept. 
 
2.5.1 Structured Template 
It can be seen from the above literature that there are three feasible ways to construct a template to 
present the extracted information in a structured format: 
1. Predefine case-oriented templates for different diseases according to some standard or 
consensus reporting conventions of the diseases (e.g., the College of American Pathologists’ 
surgical lung resection cancer checklist for MEDTEX (Nguyen et al., 2010)). 
2. Use appropriate frames to bundle all the logical relations that were found in the previous 
processes. Each frame represents knowledge discovery about a specific topic, together with 
descriptions of associated properties. For instance, there were three classes of topics prepared 
for frame construction in Taira et al’s system: abnormal findings, anatomy, and medical 
procedures, each with 11, 4 and 3 types of properties respectively (Taira et al., 2001). 
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3. Build a hierarchical knowledge representation model to store the entities and their relations. 
For example, low level concepts are represented by leaf classes, and high level ones are 
represented by container classes in CDKRM of Coden et al’s work (Coden et al., 2009). 
 
Each way has its own advantages and disadvantages: 
• Predefined case-oriented templates can reveal important pathological features for a specific 
disease, distinct from other diseases, but it requires that a standard consensus for this disease 
is available;  
• Structured frames are ad hoc, based on the logical relations that can be parsed, however, the 
topics or properties they represent may be too general to satisfy a pathologist’s requirements 
for a particular disease;  
• The correlations among each class are very clear and comprehensible in a knowledge 
representation model, as the classes are arranged in a hierarchy, whereas the errors in the leaf 
classes can also propagate to the associated container classes.    
 
Given the considerations above, the author decided that structured templates in this project were 
established based on three structured cancer reporting protocols from the RCPA, where each field 
could be represented by a type of entity, a combination of several types of entity, or relationships 
among the entities, and population of them is separate, thus a decision made on one field would not 
affect decisions on other fields. Specifically, the three protocols are Primary Cutaneous Melanoma 
Structured Reporting Protocol (Scolyer et al., 2010), Colorectal Cancer Structured Reporting Protocol 
(Eckstein et al., 2010) and Tumours of Haematopoietic and Lymphoid Tissue Structured Reporting 
Protocol (Norris et al., 2010). These protocols contain standards and guidelines for the preparation of 
structured reports for these three types of cancer. They contain information from multiple international 
publications and datasets, and they have been developed in consultation with local practicing 
pathologists, oncologists, surgeons, radiologists and interested national bodies. They provide the 
frameworks for the reporting of these three types of cancer, whether as minimum data sets or fully 
comprehensive reports. 
 
2.6 Conclusion 
Diverse and substantial work on information extraction (IE) has been reviewed in this chapter. Four 
main topics are involved: medical entity recognition (MER), negation and uncertainty detection, 
relation extraction (RE) and automatic structuring. Two main streams are proposed for MER, negation 
and uncertainty detection and RE: rule-based approaches and statistical methods.  
 
2.6.1 Medical Entity Recognition 
On the one hand, rule-based approaches tend to provide reliable results with a relatively small amount 
of training data, and the hand-crafted rules ease error-analysis for the developers or domain experts, 
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however, they face difficulty when dealing with unfamiliar or erroneous input data, and the hand-
crafted rules may not be reusable. On the other hand, statistical methods are better at coping with 
problematic data by learning from available examples through training. As well, statistical methods 
can achieve comparable or better performance by simply adjusting features, hence they are portable to 
other domains. However, statistical methods usually require a large and so expensive gold-standard 
for training. Therefore, a better solution is to use hybrid approaches with a combination of statistical 
methods and rule-based approaches when designing an IE system for MER. 
 
2.6.2 Negation and Uncertainty Detection 
Rule-based approaches can be sub-classified into lexical pattern matching methods and syntax-based 
approaches depending on whether they utilize syntactic information in the texts. Lexical pattern 
matching methods are efficient and simple, but they are not able to handle longer or complex 
sentences, or sentences with contradictory statements. Syntax-based approaches are more 
generalizable and easier to port to another domain, but their performance is greatly hindered by the 
limitations of the syntactic parsers. 
 
Since some studies pointed out that rule-based methods outperformed the machine learning-based 
approach, while other research suggested that machine learning-based systems have better 
performance than their rule-based counterparts, both approaches are attempted in this research. 
 
2.6.3 Relation Extraction 
Typical approaches to relationship extraction in most early works in the clinical domain usually were 
rule-based and relied on full parses, domain-specific grammars, or large domain knowledge bases.   
Statistical methods have become more and more popular in recent years. Feature engineering is of 
great importance for a machine learning-based system. Augmentation with handcraft rules and down-
sampling the larger classes are two possible ways to improve the performance for recognizing the less 
prevalent relation types. 
 
2.6.4 Automatic Structuring 
There are three feasible ways to construct a template to present the extracted information in a 
structured format: 
1. Predefine case-oriented templates for different diseases according to some standard or 
consensus reporting conventions of the diseases. 
2. Use appropriate frames to bundle all the logical relations that were found in the previous 
processes. 
3. Build a hierarchical knowledge representation model to store the entities and their relations. 
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Each method has its own advantages and disadvantages. Structured templates in this project were 
drawn from three structured cancer-reporting protocols issued by the RCPA. The population of each 
field in the templates could be a type of entity, a combination of several types of entity, or 
relationships among the entities. 
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Chapter 3 Corpus Analysis 
A detailed corpus analysis was conducted on the three corpora in this study, with the following two 
objectives: 
• To identify lexical and linguistic characteristics in the pathology narratives, and address the 
difficulties or challenges that may be encountered when processing these texts. 
• To assess the level of completeness of the original reports, and propose appropriate strategies 
for their conversion to structured templates. 
 
3.1 Corpus Overview 
The study protocol was approved by Royal Prince Alfred Hospital (RPAH), Sydney, Australia and the 
Royal College of Pathologists of Australia (RCPA). 
 
The melanoma corpus consists of 477 prose pathology reports of primary cutaneous melanomas from 
patients referred to the Sydney Melanoma Unit at the RPAH in 2002; there are 612 free-text colorectal 
cancer pathology reports collected from the RCPA’s members serviced in 2011 which constitute the 
colorectal cancer corpus; the lymphoma corpus is composed of 284 narrative pathology reports of 
lymphomas from patients serviced in the Anatomical Pathology Department at the RPAH from 2004 
to 2008. Most of the reports are from Australia, only 20 free-text colorectal cancer pathology reports 
come from other countries or regions (e.g., Malaysia, Hong Kong, New Zealand, South Africa, 
Namibia, and UAE). They were scanned and optical character recognized (OCR-ed). The melanoma 
corpus and lymphoma corpus were de-identified, while the colorectal cancer corpus was not de-
identified as the personal information was reserved for other projects. 
 
Corpus  No. of training set documents  No. of test set documents  
Melanoma corpus  380  97  
Colorectal cancer corpus  397  215  
Lymphoma corpus  277  57  
Table 3.1 Distribution of training sets and test sets on each corpus. 
 
The three corpora were divided into training sets and test sets by random selection. Table 3.1 outlines 
the distribution of training sets and test sets on each corpus. 
 
The following analyses were all carried out on the training data, thus none of the information from the 
test data would be compromised in the training stage. This ensured the integrity and reliability of the 
system performance in the test stage.  
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3.2 Lexical Analysis 
The lexical analysis was performed on each token in the training data, and the tokenizer used was a 
white space based tokenizer. Each token was separated by white space, unless there is a punctuation 
mark (e.g., full stop (.), comma (,), semicolon (;), and colon (:)) at the start or end of the token, which 
was separated from the token as well. Here is an example:  
There is epidermal invasion (no ulceration), and several foci of papillary dermal invasion (level II, 
depth 0.45mm - block E). 
can be tokenised to 
There is epidermal invasion ( no ulceration ) , and several foci of papillary dermal invasion ( level II , 
depth 0.45mm - block E ) . 
 
The basic token statistics of the three corpora are tabulated in Table 3.2. The melanoma corpus had 
the smallest number of overall tokens (only 71786), and the smallest average count for each note (less 
than 190), and smallest number of unique case sensitive tokens and unique case insensitive tokens, 
which are 4801 and 3783 respectively. The colorectal cancer corpus had the largest number of overall 
tokens (up to 224660), and the largest average count for each note (more than 565), and the largest 
number of unique case sensitive tokens and unique case insensitive tokens, which were 11072 and 
9077 respectively. The statistics of the lymphoma corpus were between the above two corpora. The 
number of overall tokens, average count for each note, number of unique case sensitive tokens, and 
unique case insensitive tokens were 113413, 409.4, 7127 and 5919 respectively. 
 
 Melanoma corpus Colorectal cancer 
corpus  
Lymphoma corpus  
Total No. 71786 224660 113413 
No. of unique case sensitive tokens  4801 11072 7127 
No. of unique case insensitive 
tokens  
3783 9077 5919 
No. of alphabetic words  2263 4351 3513 
No. of non-alphabetic tokens  1520 4726 2406 
Table 3.2 Basic token statistics of each corpus. 
 
The possible reason for these statistics is that the colorectal cancer corpus has the largest number of 
reports and most reports with considerably lengthy texts; the lymphoma corpus had the smallest 
number of reports, but each report was complete without missing contents, and there were more 
sections in some reports than those in the melanoma corpus, although it also had a larger amount of 
reports than the lymphoma corpus, where some of them were incomplete and most of them with 
shorter length texts than those in the lymphoma corpus.  
 
The tokens could be classified into two main categories: alphabetic word and non-alphabetic token. 
Alphabetic words are tokens that only consist of alphabetic letters, while non-alphabetic tokens are 
those which contain digits and punctuation marks other than alphabetic letters. For the melanoma 
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corpus, in the unique case insensitive tokens, there were 2263 tokens of alphabetic words and 1520 
were non-alphabetic tokens; for the colorectal cancer corpus, more than half were non-alphabetic 
tokens, the amount of which was larger than that of alphabetic words with 375; for the lymphoma 
corpus, the amount of alphabetic words exceeded that of non-alphabetic tokens by 1107. 
 
3.2.1 Alphabetic Words 
The alphabetic words were verified against a dictionary, constructed by the union of three lexical 
resources: MOBY, SNOMED CT and UMLS. SNOMED CT and UMLS are two standard 
terminologies, described previously in Chapter 2. MOBY’s thesaurus (Ward, 1996-2000) was released 
as part of the MOBY lexicon project by Grady Ward in June 1996. It contains a single large synonym 
list for each headword and ordered alphabetically. However, it is an American English thesaurus, 
hence it is not able to recognize variant spelling of certain words in Australian English. The dictionary 
comprises 354992 lexical entries from MOBY, 99860 from SNOMED CT, 427578 from UMLS. Not 
only the word itself but also its base form (lemma) is verified against the dictionary, if a match of the 
word cannot be found in the dictionary. Since the workload for manual lemmatization would be very 
heavy, lemmatization is performed automatically by the GENIA tagger (Tsuruoka et al., 2005). 
The frequencies of alphabetic words and the distributions in each lexical resource are listed in Table 
3.3.  
 
Lexical 
resource 
Melanoma corpus Colorectal cancer corpus  Lymphoma corpus  
No. of 
tokens  
No. of 
unique words  
No. of 
tokens  
No. of 
unique words  
No. of 
tokens  
No. of 
unique words  
SNOMED 
CT 
55562 1930 162637 3186 73664 2928 
UMLS 55623 2112 162022 3581 74368 3219 
MOBY 55852 2079 162368 3449 73557 3058 
Any of three 56776 2193 166234 3760 75805  3315 
None of 
three 
120 70 1665 591 1368 198 
Table 3.3 Frequencies of alphabetic words and the distributions in each lexical resource. 
 
The results show that the dictionary captures most of the alphabetic words and tokens in the corpora. 
The highest coverage of tokens from the lexical resources varies between each corpus, which is 77.8% 
from MOBY for the melanoma corpus, 72.4% from SNOMED CT for the colorectal cancer corpus, 
and 65.6% from UMLS for the lymphoma corpus. However, UMLS captures the greatest proportion 
of alphabetic words in each corpus, accounting for 93.3% for the melanoma corpus, 82.3% for the 
colorectal cancer corpus, and 91.6% for the lymphoma corpus, as it is the largest dictionary. 
 
It can be seen from the results that there are more tokens that are general English words in the 
melanoma corpus than the other two corpora, thus MOBY, as a general English lexicon, captures the 
largest ratio of tokens. The lowest coverage of alphabetic words from the dictionary is in the 
colorectal cancer corpus (86.5%) suggesting that there are more unknown words needing to be 
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resolved than in the other two corpora; the dictionary captures the smallest proportion of the tokens in 
the lymphoma corpus (66.8%), indicating that there are considerable proportions of non-alphabetic 
tokens and unknown words in that corpus. 
 
About 97% of the alphabetic words in the melanoma corpus have been recognized in any of three 
lexical resources, with about 3.1% of the words being unknown. There are about 86% of alphabetic 
words in the colorectal cancer corpus identified in any of three lexical resources, leaving 13.6% words 
unknown. At least one match has been found in any of three lexical resources for about 94% of the 
alphabetic words in the lymphoma corpus, with no match for the remaining 5.6% words. 
 
Unknown 
category 
Melanoma corpus Colorectal cancer corpus  Lymphoma corpus  
Correct 
words 
angioplasia, 
guantitation, 
traumatised, 
angiofibroplasia, 
lymphovascular 
albicantia, biopsied, 
oedematous, 
nonperitonealised, 
mesocolonic 
alkomas, angiotropism, 
immunoperoxidases, 
squamoproliferative, 
macrosteatosis 
Abbreviations amm, iescc, ipx, wepc, 
snb 
emr, fhx, trg, lvi, drm bll, dlbcl, nlphl, tblb, tjlb, 
faa 
Shorthand histopath, 
immunohisto, sebk 
revd btw, chemoth, lge, wrk, 
exc 
Misspelling albow, clikical, 
diagosis, dimention, 
kxcision 
absen, abdominoperitinial, 
circumferance, ceacum, 
ccomments 
aaplastic, agessive, 
architectrue, centrablasts, 
concensus, 
Missing 
space 
havepleomorphic, 
macronucleoli, 
midcalf, sqmm 
aminor, 
columnarepithelium, 
furthertests, 
ofextracellular, 
predominantlylymphocytic 
datetime, newbone, 
antibodydescriptionresult, 
lambdapositive 
Named 
entities 
darlinghurst, gosford, 
iml 
albury, alexy, crgh, 
mandard, sswahs 
bayfield, dutcher, 
fuhrmann, ivac, rnsh, 
temno 
Complex pjanchjbiopsy nomx, tubulocribriform, 
tubuloadenoma 
ileoresection 
Table 3.4 Examples of unknown words. 
 
The unknown words were analysed and manually resolved by a medical expert. They can be divided 
into seven categories: correct words, abbreviations, shorthand, misspelling, missing space, named 
entity and complex. Limited coverage of the resources was the main reason that the correct words 
could not be identified by the lexical resources (e.g., “lymphovascular” is a frequently used domain-
specific word that is not recognized by the dictionary), variant spelling (e.g., “nonperitonealised” vs. 
“nonperitonealized”), and lemmatization errors from the tagger (e.g., “biopsied” is lemmatized as               
“biopsie”. Abbreviations and shorthand are words presented in a compact form, deliberately used by 
pathologists under time pressure. Misspelling and missing space can be caused by typing or errors 
from the OCR. Named entities are proper names such as geographic gazetteers (e.g., “darlinghurst” 
and “albury” are two places), names of institutions (e.g., “rnsh” stands for the name of a hospital: 
“Royal North Shore Hospital”), names of people (e.g., “alexy” and “bayfield”), medical named 
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entities (e.g., “temno” is a band of biopsy needle). The complex category is a combination of the 
above categories (e.g., the error of “pjanchjbiopsy” results from misspelling and missing space). Table 
3.4 displays some examples of the unknown words. 
 
The biggest contributions of unknown words are from correct words, abbreviations, misspelling and 
named entities. The method proposed by Patrick et al (Patrick et al., 2010) was applied to misspelling 
correction, which is a combination of a rule-based suggestion generation system and a context-
sensitive ranking algorithm based on word frequencies and trigram probabilities. The results from the 
misspelling corrector were manually verified by the medical expert. Table 3.5 shows some results 
from misspelling correction. The medical expert also tried to resolve words in abbreviations, 
shorthand, missing space, and complex categories as well. 
 
Unknown category Original word Correction 
Misspelling architectrue architecture 
Missing space aminor a minor 
Complex pjanchjbiopsy punch biopsy 
Table 3.5 Examples of misspelling correction. 
 
After misspelling correction and manual verification, the unique unknown word size shrank to 20 for 
the melanoma corpus, 117 for the colorectal cancer corpus, and 25 for the lymphoma corpus. 
 
Melanoma corpus Colorectal cancer corpus  Lymphoma corpus  
Noun Frequency Noun Frequency Noun Frequency 
lesion 945 tumour 4734 cells 1547 
melanoma 902 lymph 2164 procedure 1465 
skin 728 nodes 2064 lymphoma 1289 
specimen 539 margin 1999 node 1188 
margin 448 resection 1951 lymph 1055 
level 445 invasion 1395 t 694 
dermis 361 specimen 1243 cell 612 
sections 359 colon 1188 tissue 581 
tumour 329 bowel 1136 b 578 
invasion 323 adenocarcinoma 1018 specimen 483 
ellipse 314 margins 876 nodes 426 
microscopic 311 fat 868 tumour 384 
mm 295 node 798 nk 383 
cells 295 sections 780 biopsy 358 
thickness, 
excision 
282 surface 645 cd20 355 
component 267 muscularis 623 cd3 286 
report 237 tissue 613 sections 283 
clark 236 length 606 flow 267 
melanocytes 231 propria 602 report 255 
surface, depth 215 mucosa 575 codes 245 
histopathology 198 diameter 573 description, cd5, 
cd10 
240 
Table 3.6 Twenty most common nouns and their frequencies in each corpus. 
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Nouns are one of major elements of a medical entity. The set of nouns in the corpora were identified 
using the GENIA tagger (Tsuruoka et al., 2005) according to their part-of-speech (POS) tags. They 
could be singular, plural and proper nouns, and those converted for anonymization were filtered out 
from the results. Table 3.6 lists the twenty most common nouns and their frequencies in each corpus. 
 
From Table 3.6, we can see that “tumour”, “specimen” and “sections” are frequently used in all three 
corpora, due to the nature of their genre: pathology reports of specific cancers. Different nouns are 
used to represent the major diagnoses in each corpus: “melanoma” for the melanoma corpus, 
“adenocarcinoma” for the colorectal cancer corpus, “lymphoma” for the lymphoma corpus. Various 
nouns are used to describe the usual sites or locations of the tumour(s) or specimen(s) from patients: 
“skin” for the melanoma corpus, “colon” and “bowel” for the colorectal cancer corpus, “lymph”, 
“node” and “nodes” for the lymphoma corpus. There are also some nouns related to the characteristics 
of the corpus. For example, for the melanoma corpus, “ellipse” and “excision” are two main specimen 
types; “melanocytes” is the primary cell type of melanoma. For the colorectal cancer corpus, 
“mucosa” and “muscularis propria” are two distinct layers of the bowel; “length” and “diameter” are 
two frequently used measurements to describe tumour or specimen sizes. For the lymphoma corpus, 
“t”, “b” and “nk” are descriptors of lineage; “cd20”, “cd3”, “cd5”, and “cd10” are biomarkers 
commonly employed in immunohistochemistry tests or flow cytometry.   
 
3.2.2 Non-alphabetic Tokens 
The non-alphabetic tokens are further categorized according to their orthographic features, including 
single punctuation, multiple punctuation, numeric values, dimension, alphanumeric, with slash, with 
hyphen, with apostrophe, with question mark, percentage, and other forms. The descriptions and some 
examples for each category are presented in Table 3.7. 
 
There are various meanings for these tokens. Single and multiple punctuations are usually separators 
or indicators. For example, “.” is the most frequently used for sentence delimitation; “****” separates 
the paragraphs; “+”, “++” and “+++” indicate the severity or intensity. Dimension tokens such as 
“20mm”, “30x7mm” and “3x3x2mm” represent one-, two- and three-dimensional size respectively. 
Alphanumeric tokens like “1a” and “1e” are specimen block identifiers; “cd3” and “ck20” are 
biomarkers; “pn1” represents N staging information. The question mark in the beginning of the token, 
usually stands for “suspicious for” or “maybe”. Nonetheless, other punctuation symbols can have 
polysemous functions in the tokens, such as slash, hyphen, and apostrophe. An initial survey shows 
that there are up to 3 different functions for apostrophe, 7 for slash and 10 for hyphen. Some examples 
are displayed in Table 3.8. Undoubtedly, polysemia of punctuation in the tokens increases the 
difficulty in both tokenisation and disambiguation. Furthermore, the patterns in some categories are of 
great significance for recognizing potential entities (e.g., tokens in dimension category can compose 
entities about specimen or tumour sizes). Therefore, it requires more sophisticated strategies in 
tokenisation, disambiguation and pattern recognition to tackle these tokens. 
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Non-
alphabetical  
token category 
Description Example 
Melanoma 
corpus 
Colorectal cancer 
corpus 
Lymphoma corpus 
Single 
punctuation 
Token is 
punctuation such 
as period, 
comma, colon 
and bracket. 
.; ,; (; ) #; *; @ /; &; % 
Multiple 
punctuation 
Token consists 
of multiple 
punctuations. 
->; ++;… ****; -->; ----------------
---- 
+/-;  +-++ 
Numeric 
values 
Token is a digit 
or decimal 
number. 
27; 3.1 0.3; 1993; 24 16.0; 2000; 23 
Dimension Token describes 
a size or 
dimension value. 
20mm; 
30x7mm; 
3x3x2mm 
1.1mm; 10x10x2mm; 
15cm; 7x6x3; 
80x30mm 
13.8cm; 
45x40x25mm; 
0.2mm 
Alphanumeric Token contains 
both numbers 
and alphabetic 
letters. 
1a; f36; 
hmb45 
1e; 2xdonuts; pn1; 
msh2 
1780g; 2mths; cd3; 
ck20 
With slash Token contains 
slash (/). 
22/02/01; 
3/mm2; 
white/pink 
0/20; 04/08/11; a/prof; 
ascending/transverse 
17/12/2004; 
ae1/ae3; b/g; 
kappa/lambda 
With hyphen Token contains 
hyphen (-). 
1b-1c; -1; ii-
iii; band-like 
01-jan-1999; acps-a; 2-
3mm; chemo-
radiotherapy; well-clear 
15-20cm; b-cell; 
centrocyte-like; 
intra-abdominal; ki-
67; m-00100; cd10- 
With 
apostrophe 
Token contains 
apostrophe ('). 
breslow's; 
o'clock; 
hutchinson's 
carnoy's; crohn's; 
duke's 
burkitt's; bx's; 
hodgkin's; tumour's 
With question 
mark 
Token contains 
question mark 
(?). 
??melanoma; 
?hmf 
?adenoma; ?perforated; 
?ulcer 
??lymphoma; ?malt; 
?transformation 
Percentage Token contains 
digits and %. 
5%; >5% 20%; >10%; <3% 100%; 15-25%; 
~95% 
Other Token cannot be 
categorized 
above. 
20+; h.d.f; 
13.2.01 
03:48pm; 1,2; 1e&1f; 
margins:15mm 
+ve; 5:18; <5mm;  
Table 3.7 Descriptions and some examples for each non-alphabetic token category. 
 
Punctuation Function Example 
Apostrophe Shorthand bx’s 
Of tumour’s 
Term named after someone hodgkin’s 
Slash Or  ascending/transverse 
Divide kappa/lambda 
Ratio 0/20 
Per 3/mm2 
Abbreviation b/g 
Date 17/12/2004 
Mixture ae1/ae3 
Hyphen Identifier 1b-1c 
Range 15-20cm 
Prefix intra-abdominal 
Chapter 3 Corpus Analysis 
43 
 
Joined words well-clear 
Date 01-jan-1999 
Colon (:) acps-a 
Biomarker ki-67 
Code m-00100 
Listing -1 
Negative cd10- 
Table 3.8 Multiple functions and examples of apostrophe, slash and hyphen. 
 
3.3 Language Phenomena in Pathology Reports 
After the detailed lexical analysis, the following language phenomena identified in the pathology 
notes may be barriers to further processing. They are summarized as follows:  
 
Unknown words: Pathology notes contain more unknown words than newswire documents. As 
demonstrated in the previous section, the unknown word rate is very high when only using a general-
purpose dictionary like MOBY. Even with the combination of medical standard terminologies like 
SNOMED CT and UMLS, there are still a considerable number of unknown words. These unknown 
words are an obstacle for the application of dictionary look-up approaches. 
 
Abbreviations: Abbreviations are prevalent in pathology notes. Some abbreviations have standard 
forms and naming conventions, but most of them do not, which makes the expansion of them to full 
terms quite difficult. The abbreviations can be divided into three categories: abbreviation (e.g., 
opening letter initialization and syllabic initialization), acronym (letter capitalisation) and shorthand 
(including end truncation and syllabic contraction). Some examples of abbreviations with their 
expansions are listed in Table 3.9. 
 
Misspellings: Misspellings are mainly caused by typing errors, such as keyboard incompetence; 
another contribution is from non-native English speaking staff, who are more likely to miss syllables, 
substitute syllables and repeat syllables in the words when writing the reports. Most of the 
misspellings can be corrected using a misspelling corrector, but some complex ones also require 
manual verification. 
 
Abbreviation category Original form Expansion 
Abbreviation FHx  family history 
Acronym SNB sentinel node biopsy 
Shorthand btw between 
Table 3.9 Examples of abbreviations with their expansions. 
 
Non-alphabetic tokens: The non-alphabetic tokens make up a great proportion of the overall tokens. 
Some of them may represent special meanings, which should be discriminated from those for layout 
and formatting guidance. As well, punctuation such as hyphen, apostrophe and slash can have 
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multiple functions in different contexts. Disambiguating the tokens with these punctuations and 
capturing the patterns in the tokens is of significant importance in recognizing potential entities 
containing them.   
 
Lexical variants: Lexical variants are usually created by productive morphology and stylistic writing. 
Firstly, staff in the pathology laboratories is from a variety of countries or regions, and they have their 
preferred spelling. Secondly, pathologists tend to create their own ad hoc forms of frequently used 
phrases and sometimes these terms may not follow any naming conventions and can be rarely found 
in the standard terminologies. These created terms are personally idiosyncratic, or represent a local 
community accepted de facto standard. For example, lots of lexical variants are observed in the 
expressions of abdominoperineal resection: abdo peri resection, abdo-perineal resection, AP resection, 
abdomino-perineal resection, abdominoperineal resection, abdominal perineal resection and APR 
(NB. Misspellings like abdo-peritoneal resection, abdominal perineural resection and abdomino-
peritoneal resection are not included).  
 
Complex vocabulary: Pathology notes have more complex vocabulary than the texts in the general 
domain, which is mainly due to the prevalence of abbreviations, unknown words, misspellings, non-
alphabetic tokens and lexical variants. Such complex vocabulary forms a special sub-language in the 
clinical domain. Fully understanding the divergence between this sub-language and the common 
language is critical to adopting suitable natural language processing (NLP) techniques to process the 
notes.   
 
3.4 Completeness Analysis 
One of the main objectives of the project is to help pathologists to validate their reports and improve 
the accuracy and completeness of them. At first, it is necessary to evaluate the quality of the original 
narrative reports, thus, as the most important indicator – completeness was analysed on each corpus to 
achieve this goal.  
 
Completeness is reported below as quantitative measures of adherence to the standards and guidelines 
in the structured reporting protocols (Eckstein et al., 2010; Norris et al., 2010; Scolyer et al., 2010). 
According to the protocols, standards are defined as mandatory fields, reserved for core items 
essential for the clinical management, staging or prognosis of the cancer; guidelines are defined as 
recommended fields, covering items that are not essential for clinical management, staging or 
prognosis of a cancer, but are recommended. The following statistics do not include the measure for 
all standards or guidelines in the protocols because: 
1. Fields that involve personal information were not reported. For example, in Colorectal 
Cancer Structured Reporting Protocol: “G1.01 The patient’s health identifiers should be 
recorded where provided.” and “S1.02 The principal clinician involved in the patient’s care 
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and responsible for investigating the patient must be identified.”, as such information has 
already been removed in de-identification or out of the scope of this study. 
2. Fields without associated information in the original reports were ruled out. For instance, in 
Primary Cutaneous Melanoma Structured Reporting Protocol, for “S5.01 The AJCC 
melanoma tumour–node (pTN) subcategories according to the current AJCC staging system 
must be recorded.”, there is no associated information in the melanoma corpus. 
3. Fields that are recommendations for clinical staff or pathologists to deliver or process the 
specimens rather than record the information about the specimens, which are too complicated 
or ambiguous to compute, were not included, such as in Tumours of Haematopoietic and 
Lymphoid Tissue Structured Reporting Protocol, “S1.05 Where lymphoma is suspected, the 
specimen must be sent immediately, intact and unfixed in a closed sterile container to the 
anatomical pathology laboratory.” 
4. Fields that are not presented in the structured report examples of the protocols were 
excluded. An example is in Primary Cutaneous Melanoma Structured Reporting Protocol, 
“S2.01 The tissue block(s) must be selected to facilitate microscopic assessment of the 
thickest or most suspicious portion of the tumour, and determination of the relationship of the 
tumour to the surgical margins.” 
 
Standards Abbreviation No. of 
documents 
provided 
Percentage 
provided 
S2.02 The specimen must be described. Specimen 
description 
361 95.00% 
S2.03 The specimen dimensions must be 
measured and recorded. 
Specimen 
dimensions 
360 94.74% 
S2.05 The primary lesion must be 
described. 
Primary lesion 312 82.11% 
S2.06 The presence of other lesions must be 
noted, and their features recorded. 
Other lesions 14 3.68% 
S3.01 The diagnosis of primary melanoma 
must be recorded. 
Diagnosis 317 83.42% 
S3.02 The Breslow thickness must be 
recorded. 
Breslow thickness 309 81.32% 
S3.03 The pathology report must indicate 
whether or not the invasive or in situ 
melanoma involves the surgical margins. 
Margin 
involvement 
181 47.63% 
S3.04 The presence or absence of ulceration 
must be reported. 
Ulceration 210 55.26% 
S3.05 The mitotic rate per square millimetre 
of the invasive melanoma must be recorded. 
Mitotic rate 123 33.68% 
S3.06 The presence or absence of 
microsatellites must be recorded. 
Microsatellites 24 6.32% 
S5.02 The pathology report must include a 
field for free text in which the reporting 
pathologist can give overarching case 
comment if required. 
Comment 23 6.05% 
Table 3.10 Completeness measures of standards on the melanoma corpus. 
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Table 3.11 Completeness measures of guidelines on the melanoma corpus. 
 
Melanoma corpus: The completeness measures of standards and guidelines are displayed in Table 
3.10 and Table 3.11 respectively. For standards, the coverage in about half of the fields reaches to 
more than 50%, wherein “S2.02 Specimen description”, and “S2.03 Specimen dimensions” are 
mentioned in most reports (over 94%), while “S2.06 Other lesions”, “S3.06 Microsatellites”, and 
“S5.02 Comment” are seldom referred to (lower than 7%).  
 
Guidelines Abbreviation No. of 
documents 
provided 
Percentage 
provided  
G1.03 The anatomical site of the melanoma 
should be recorded; G1.04 The laterality of the 
melanoma should be recorded. 
Site and 
laterality 
248 65.26% 
G1.05 The clinical diagnosis or differential 
diagnosis should be recorded. 
Clinical 
diagnosis 
170 44.74% 
G1.06 The description of the type of specimen 
should be recorded. 
Specimen type 67 17.63% 
G1.08 The history and timing of lesional 
trauma, biopsy, irritation or treatment with 
topical agent should be recorded. 
Lesional trauma 8 2.11% 
G1.09 A history of previous primary melanoma, 
at this or any other site, should be recorded. 
Previous 
melanoma 
5 1.32% 
G1.10 Evidence of metastatic disease should be 
recorded. 
Metastatic 
disease 
1 0.26% 
G1.12 Other relevant history should be 
recorded. 
Other relevant 
history 
86 22.63% 
G3.02 The pathology report should document 
the distance of invasive and in situ melanoma 
from peripheral and deep margins. 
Margin distance 15 3.95% 
G3.04 The level of invasion (Clark) should be 
recorded. 
Clark level 280 73.68% 
G3.05 The presence or absence of 
lymphovascular invasion should be recorded. 
Lymphovascular 
invasion 
204 53.68% 
G3.06 The distribution and density of tumour-
infiltrating lymphocytes (TILs) should be 
recorded. 
TILs 3 0.79% 
G3.07 The presence or absence of intermediate 
or late regression should be recorded. 
Regression 47 12.37% 
G3.08 The absence or presence and extent of 
desmoplasia (% of invasive component) should 
be recorded. 
Desmoplasia 14 3.68% 
G3.09 The presence or absence of neurotropism 
should be recorded. 
Neurotropism 132 34.74% 
G3.10 Any associated benign melanocytic 
lesion should be recorded. 
Associated 
benign lesion 
112 29.47% 
G3.11 The intra-epidermal growth pattern of the 
melanoma should be recorded. 
Growth pattern 15 3.95% 
G3.12 The subtype of melanoma should be 
recorded. 
Subtype 225 59.21% 
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For guidelines, the coverage in less than a quarter of the fields exceeds 50%, the most frequently 
mentioned field is “G3.04 Clark level” with around 74%, and up to 7 fields are barely described (less 
than 4%), including “G1.08 Lesional trauma”, “G1.09 Previous melanoma”, “G1.10 Metastatic 
disease”, “G3.02 Margin distance”, “G3.06 TILs”, “G3.08 Desmoplasia”, and “G3.11 Growth 
pattern”. 
 
Colorectal cancer corpus: The completeness measures of standards and guidelines are shown in 
Table 3.12 and Table 3.13 respectively. For standards, 15 out of 35 fields have more than 50% 
coverage, which is close to 100% in “S2.04 Specimen length” and “ S2.12 Macroscopic information”, 
but declines to less than 4% in 5 other fields: “S1.04 Presentation”, “S1.06 Distance from anal verge”,  
“S1.09 Local residual cancer”, “S1.10 Adjacent organ involvement” and “S2.11 Mesorectum 
intactness”, wherein only one case stated “S1.09 Local residual cancer”; for guidelines, most fields 
have poor coverage (less than 24%), and “G4.02 KRAS mutation testing” is only stated in two cases. 
 
Lymphoma corpus: The completeness measures of standards and guidelines are tabulated in Table 
3.14 and Table 3.15 respectively. For standards, 75% of fields have more than 50% coverage, and all 
documents describe “S2.04 Specimen size”, while “S2.01 Fluid” has the poorest coverage with 
28.19%; for guidelines, 6 out of 16 fields are referred to in more than 50% of documents, while 
“G5.04 Stage” is only mentioned in 2 documents, “G1.05 Disease spread” and “G1.06 Extent of 
disease” are also rarely mentioned (in 8 and 7 documents respectively). 
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 Standards Abbreviation No. of documents 
provided 
Percentage 
provided 
S1.04 Patient presentation at surgery must be recorded, in particular whether perforation is present. Presentation 11 2.77% 
S1.05 The tumour location must be recorded. Tumour location 288 72.54% 
S1.06 The distance from the anal verge must be recorded (for rectal tumours only). Distance from anal verge 13 3.27% 
S1.07 The type of operation performed must be recorded. Operation type 282 71.03% 
S1.08 If pre-operative radiotherapy has been administered, this must be recorded. Pre-operative radiotherapy 27 6.80% 
S1.09 The surgeon’s opinion on the existence of local residual cancer following the operative 
procedure must be recorded. 
Local residual cancer 1 0.25% 
S1.10 The involvement of adjacent organs must be recorded. Adjacent organ involvement 13 3.27% 
S1.11 The presence of any distant metastases must be recorded. Distant metastases (Clinical) 36 9.07% 
S2.02 The nature and sites of all blocks must be recorded. Blocks 390 98.24% 
S2.03 All regional lymph nodes must be harvested from the specimen and examined histologically. Lymph nodes 233 58.69% 
S2.04 The specimen length must be recorded. Specimen length 396 99.75% 
S2.05 The site of the tumour must be recorded. Tumour site 238 59.95% 
S2.06 The maximum tumour diameter must be recorded. Tumour diameter 383 96.47% 
S2.07 The distance of the tumour to the nearer proximal or distal ‘cut end’ margin must be recorded. Distance  to proximal/distal 
margin 
355 89.42% 
S2.08 The distance of the tumour to the circumferential margin must be recorded. Distance  to circumferential 
margin 
77 19.40% 
S2.09 The presence or absence of tumour perforation must be recorded. Perforation 38 9.57% 
S2.10 For rectal tumours the relationship of the tumour to the anterior peritoneal reflection must be 
recorded. 
Relationship to anterior 
peritoneal reflection 
33 8.31% 
S2.11 For rectal resections the intactness of the mesorectum must be recorded. Mesorectum intactness 12 3.02% 
S2.12 A descriptive or narrative field must be provided to record any macroscopic information that is 
not recorded in the above standards and guidelines, and that would normally form part of the 
macroscopic description. 
Macroscopic information 396 99.75% 
S3.01 The tumour type must be recorded. Tumour type 301 75.82% 
S3.02 The histological grading of the tumour must be recorded. Histological grading 257 64.74% 
S3.03 The maximum degree of local invasion into or through the bowel wall must be recorded. Local invasion 330 83.12% 
S3.04 Involvement of the proximal or distal resection margins (‘cut-end’ margins) by tumour must be 
recorded. If the margin is less than 10 mm, the clearance must be recorded. 
Involvement of 
proximal/distal margin 
202 50.88% 
Chapter 3 Corpus Analysis 
49 
 
S3.05 The status of the nonperitonealised circumferential margin in rectal tumours must be recorded. Status of circumferential 
margin in rectal tumours 
47 11.84% 
S3.06 The status of the nonperitonealised circumferential margin in colon tumours must be recorded. Status of circumferential 
margin in colon tumours 
93 23.43% 
S3.07 Results of lymph node histopathology must be recorded. Lymph node histopathology 333 83.88% 
S3.08 For all tumours, venous and small vessel invasion must be reported and its anatomic location 
specified as mural or extramural. 
Venous and small vessel 
invasion 
298 75.06% 
S3.09 The presence of histologically confirmed distant metastases and their site must be recorded. Distant metastases 
(Microscopic) 
72 18.14% 
S3.10 The presence of any relevant coexistent pathological abnormalities in the bowel must be 
recorded. 
Coexistent pathological 
abnormalities 
224 56.42% 
S3.11 The microscopic residual tumour status must be recorded (i.e., the completeness of resection). Residual tumour 
(Microscopic) 
31 7.81% 
S3.12 The response of the tumour to neoadjuvant treatment must be recorded. Response to neoadjuvant 
treatment 
49 12.34% 
S5.01 The tumour stage and stage grouping must be recorded, incorporating clinical and pathological 
data, based on the TNM staging system of the AJCC Cancer Staging Manual (7th Edition) 
Tumour stage and stage 
grouping 
128 32.24% 
S5.02 The residual tumour status must be recorded according to the AJCC Cancer Staging Manual 
(7th Edition). 
Residual tumour (Synthesis) 63 15.87% 
S5.03 A field for free text or narrative in which the reporting pathologist can give overarching case 
comment must be provided. 
Comment (Synthesis) 140 35.26% 
Table 3.12 Completeness measures of standards on the colorectal cancer corpus. Note that the percentage for S1.06 was computed on documents with rectal tumours. 
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Guidelines Abbreviation No. of 
documents 
provided 
Percentage 
provided 
G1.03 Any additional relevant information should be recorded Clinical information 66 16.62% 
G2.01 Pathologists may be asked to provide tissue samples from fresh specimens for tissue banking or 
research purposes. 
Tissue banking 37 9.32% 
G2.02 Images of the gross specimen showing the overall conformation of the tumour and, especially 
in the case of rectal resections, images showing the relation of the tumour to the resection margins, are 
desirable, and useful for multidisciplinary meetings. 
Specimen imaging 12 3.02% 
G3.01 Involvement of the apical lymph node should be recorded, if required where staging systems 
additional to TNM staging are in use 
Involvement of  apical lymph 
node 
62 15.62% 
G3.02 Perineural invasion should be assessed using routine histology and reported as present or 
absent 
Perineural invasion 176 44.33% 
G3.03 Any additional relevant information should be recorded Microscopic information 221 55.67% 
G4.01 Immunohistochemistry tests should be performed to test mismatch repair deficiency status and 
the results recorded in the pathology report 
Immunohistochemistry tests 52 13.10% 
G4.02 The result of KRAS mutation testing should be recorded KRAS mutation testing 2 0.50% 
G5.01 The “Diagnostic summary” section of the final formatted report should include: 
a. specimen type (S1.01) 
b. tumour site (S2.05) 
c. tumour type (S3.01) 
d. tumour stage (S5.01) 
e. completeness of excision (S5.02) 
Elements of The “Diagnostic 
summary” section 
95 23.93% 
Table 3.13 Completeness measures of guidelines on the colorectal cancer corpus. 
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Standards Abbreviation No. of 
documents 
provided 
Percentage 
provided 
S1.03 The site of biopsy must be recorded. Biopsy site 206 90.75% 
S1.04 The laterality must be recorded. Laterality 184 81.06% 
S2.01 The fluid in which the specimen is 
delivered to the laboratory must be reported. 
Fluid 64 28.19% 
S2.02 Specimen handling or triage must be 
reported. 
Triage 153 67.40% 
S2.03 The specimen type must be reported. Specimen type 134 59.03% 
S2.04 The specimen size must be reported. Specimen size 227 100.00% 
S3.02 The grade (for follicular lymphoma) must 
be reported. 
Grade 65 28.63% 
S4.01 All ancillary studies which have been 
performed, and which are pending, must be 
reported. 
Ancillary studies 121 53.30% 
S4.02 For ancillary studies performed in the 
reporting anatomical pathology laboratory (e.g., 
immunohistochemistry) test results and 
interpretation must be reported in full, including 
all positive, negative and indeterminate results. 
Ancillary study 
results and 
interpretation 
121 53.30% 
S5.01 Lineage must be reported. Lineage 154 67.84% 
S5.02 The WHO disease subtype must be 
recorded. 
WHO disease 
subtype 
221 97.36% 
S5.03 Facility for overall case comment must be 
provided. 
Comment 71 31.28% 
Table 3.14 Completeness measures of standards on the lymphoma corpus. 
 
There are several important findings from the above results: 
1. The completeness of standards is significantly better than that of guidelines, probably 
because standards are compulsory, while guidelines are suggestions, demonstrating clinical 
staff and pathologists usually pay more attention to the former.  
2. Fields with specific conditions may have poor coverage. For example, rectal resection is the 
requisite procedure for recoding “S2.11 Mesorectum intactness”. If the conditions are not 
satisfied, pathologists are prone to ignore them when writing the reports.  
3. The coverage of fields with regard to the presence or absence of findings is also low (e.g., 
“G3.08 Desmoplasia”), since if a finding is absent, pathologists often omit to report it. 
4. The coverage of fields that require co-occurrence of multiple elements is usually poor as 
well. For instance, “G3.02 Margin distance” requires four elements to co-occur in the 
document: the distance of invasive melanoma from peripheral margin, the distance of 
invasive melanoma from deep margin, the distance of in situ melanoma from the peripheral 
margin, and the distance of in situ melanoma from deep margin. However, in most 
documents, only one or some of the elements occur, therefore, they are excluded from the 
valid count. Similarly, “G3.06 TILs” consists of three elements: TILs, the distribution of 
TILs and the density of TILs, but most documents do not present all the elements, resulting 
in the small valid count.  
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5. The possible reason for the low coverage of several fields is that its definition or requirement 
is inconsistent with the facts in the documents. For example, “G3.11 Growth pattern” defines 
the intra-epidermal growth pattern to be recorded; in fact, many documents do refer to cell 
growth patterns, but they may not be intra-epidermal, but located in some layers of the skin 
(e.g., dermis) instead.  
 
Guideline Abbreviation No. of 
documents 
provided 
Percentage 
provided 
G1.03 The reason for the biopsy should be 
recorded. 
Reason for biopsy 25 11.01% 
G1.04 The clinical diagnosis or differential 
diagnosis should be recorded. 
Clinical diagnosis 129 56.83% 
G1.05 Involved sites or pattern of disease 
spread and whether disease is nodal or 
extranodal should be recorded if known. 
Disease spread 8 3.52% 
G1.06 An estimation of stage or extent of 
disease should be given if possible. 
Extent of disease 7 3.08% 
G1.07 All relevant constitutional symptoms 
should be recorded. 
Constitutional 
symptom 
16 7.05% 
G1.09 Any previous lymphoma, leukaemia or 
other relevant haematological disease should 
be recorded. 
Previous relevant 
disease 
64 28.19% 
G1.10 Any previous relevant treatment should 
be recorded; G1.11 Predisposing factors such 
as immunocompromised states 
(immunodeficiency associated 
lymphoproliferative disorders) and 
autoimmune conditions should be recorded; 
G1.12 Predisposing factors such as infective 
agents should be recorded. 
Predisposing 
factors 
27 11.89% 
G3.01 The pattern of infiltration or 
architecture of abnormal cells should be 
reported. 
Architecture 188 82.82% 
G3.02 The size of abnormal cells should be 
reported. 
Cell size  201 88.55% 
G3.03 The cytomorphology of abnormal cells 
should be reported. 
Cytomorphology 119 52.42% 
G3.05 Host cells and tissue reactions should 
be reported. 
Tissue reactions 123 54.19% 
G5.03 The ‘Diagnostic summary’ section of 
the final formatted report should include: 
a. specimen type (S2.03) 
b. tumour site and laterality (S1.03, S1.04) 
c. WHO diagnosis (S5.02) 
d. grade where relevant (S3.02) 
Elements of The 
“Diagnostic 
summary” section 
15 6.61% 
G5.04 Stage should be recorded if known. Stage 2 0.88% 
G5.05 A supplementary report (or equivalent) 
should be added to the pathology report if 
further diagnostic information is subsequently 
obtained. 
Supplementary 
report 
34 14.98% 
Table 3.15 Completeness measures of guidelines on the lymphoma corpus. 
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The issues discussed above should be addressed in the following processes, especially in the 
construction of the structured templates. Although the fields in the structured templates are supposed 
to be based on the standards and guidelines, they also need slight adjustments to the corpora. For 
instance, it is preferable to prepare three fields to depict “G3.06 TILs” in the template: TILs, the 
distribution of TILs and the density of TILs; broaden the scope of “G3.11 Growth pattern” to include 
other cell growth patterns to cut down the loss of useful information embedded in the texts. 
 
3.5 Conclusion 
This chapter presents detailed lexical and completeness analyses of the corpora. 
 
Analyzing the characteristics of tokens is very important since tokens are the foundations for 
constructing more complex structures such as phrases and sentences in the documents. The lexical 
analysis has demonstrated that the texts in pathology notes have specific characteristics which are 
quite different from other genres of texts. For instance, there is extensive use of biomedical terms or 
concepts that can be captured by SNOMED CT and UMLS, and, high frequencies for some nouns 
according to the report types and diseases. The significant language phenomena observed in the 
corpora including abbreviations, unknown words, misspellings, non-alphabetic tokens, lexical variants 
and complex vocabulary indicate the difficulties or challenges that may be encountered when 
processing these texts, which require sophisticated NLP techniques to resolve.  
 
A quantitative completeness analysis has been conducted, and the coverage of most fields is 
unsatisfactory, though certain fields achieve very high coverage. It reveals several issues to be 
addressed in the following processes, especially in the construction of the structured templates, which 
should be slightly adjusted to the corpora.   
 
For these reasons above, the information extraction (IE) task for pathology notes is more complicated 
than that in a general English domain. Using current existing IE systems will not be capable of 
addressing the challenges properly; therefore, novel or appropriate techniques have to be developed to 
deal with them. 
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Chapter 4 Corpus Annotation 
This chapter presents three semantically annotated corpora, namely melanoma corpus, colorectal 
cancer corpus and lymphoma corpus. These corpora are to be used for extracting entities and relations 
in free-text pathology reports. Medical or related entities are annotated in the melanoma corpus and 
colorectal cancer corpus, and relations between them are annotated as well in the lymphoma corpus. 
As far as we know, these corpora are the most specific and detailed cancer corpora prepared for 
automatic conversion to structured reports in the clinical domain. Most of the entities or relations have 
not been well studied previously.  
 
This chapter begins with the overview of some existing annotated corpora, and then follows the 
design of the annotation schema and guidelines, the main annotation process as well as detailing the 
distribution of entity and relations across the corpora. 
 
4.1 Introduction 
4.1.1 Overview of Existing Annotated Corpora 
Many corpora have been designed for information extraction (IE) in the biomedical domain. They 
vary from syntactic annotation (e.g., part-of-speech (POS) tags) to semantic annotation of named 
entities and complex relations between the entities. For example, the GENIA corpus has been widely 
used in a lot of biomedical natural language processing (NLP) research (Kim et al., 2003). It consists 
of 2000 biomedical abstracts extracted from the MEDLINE database, semantically annotated with rich 
biological named entities such as DNA and protein, and up to 47 related biological types defined in 
the GENIA ontology. Apart from semantic information, syntactic information such as POS tags was 
annotated (Tateisi and Tsujii, 2004) with a scheme based on the Penn Treebank corpus (Marcus et al., 
1994). These annotated corpora made a great contribution to promoting the application of machine 
learning techniques in that domain. However, they are not suitable for NLP research in the clinical 
domain, as the materials they used are the biomedical literature, which is a different genre, usually 
well-formatted and with less noise than clinical notes; they focus on biological named entities, which 
are out of the scope of NLP research in the clinical domain.  
 
In the clinical domain, only a few annotated corpora are publicly available. One probable reason is 
lack of access to the data, as hospitals, clinics and other health agencies strictly restrict the access to 
clinical data for researchers outside the associated institutions, given concerns about the possibilities 
of compromising patient privacy and institutional practices (Chapman et al., 2011b). Another reason 
is that the annotations require specific medical knowledge, and the recruitment, training and co-
ordination of annotators also requires significant effort.  
 
Several annotated corpora have been reported for IE in the clinical domain: 
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2010 i2b2/VA Challenge Corpus 
This is composed of 1748 discharge summaries and progress reports received from Partners 
Healthcare, Beth Israel Deaconess Medical Centre, and the University of Pittsburgh Medical Centre. 
Three entity types were annotated: medical problems, tests, and treatments (Uzuner et al., 2011). 
Medical problems were defined as phrases that contain observations made by patients or clinicians 
about the patient’s body or mind that are thought to be abnormal or caused by a disease; treatments 
were defined as phrases that describe procedures, interventions, and substances given to a patient in an 
effort to resolve a medical problem; the definition of tests is phrases that describe procedures, tests, 
and measures that are done to a patient or a body fluid or sample in order to discover, rule out, or find 
more information about a medical problem. They were all loosely based on the associated UMLS 
semantic types such as disease or syndrome, sign or symptom, medical device, clinical drug, 
laboratory procedure, diagnostic procedure and so on, but also included some instances not covered by 
UMLS. 
 
The challenge set three tasks regarding these entities: the concept extraction task focused on the 
extraction of these entities; the assertion classification task was to assign assertion types for medical 
problems, including present, absent, possible, conditional, hypothetical, and not associated with the 
patient; the relation classification task aimed to assign relation types that hold between medical 
problems, tests, and treatments, e.g., treatment improves medical problem, test reveals medical 
problem and medical problem indicates problem. Therefore, the gold-standard data also included 
assertions and relations besides entities. 
 
One of the potential benefits when using the corpus is that each record is de-identified, tokenised and 
broken into sentences, which can save much time on some NLP pre-processes: de-identification, 
tokenization and sentence boundary detection. 
 
ODIE Corpus 
The theme of the 2011 i2b2/VA Challenges was the resolution of coreference in medical records 
(Uzuner et al., 2012). The Ontology Development and Information Extraction (ODIE) corpus is part 
of the data for the challenge. It contained de-identified clinical and pathology reports from Mayo 
Clinic, discharge records, radiology reports, surgical pathology reports, and other reports from the 
University of Pittsburgh Medical Centre. Ten types of entities were annotated: anatomical site, disease 
or syndrome, indicator/reagent/diagnostic aid, laboratory or test result, none, organ or tissue function, 
other, people, procedure, and sign or symptom (Savova et al., 2011). Except for people defined in 
MUC-7 coreference task (Chinchor, 1998), other medical entity types were based on UMLS. “Other” 
and “none” were two special entity types prepared for the task, wherein “other” was assigned for 
entities that cannot be classified as any of the above and “none” served mostly as pronouns that inherit 
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one of entity types through coreference. Apart from the entities, the coreferent or anaphoric relations 
were also annotated between them.  
 
However, the challenge required only entities that participated in anaphoric relations to be annotated. 
Thus, some entities were deliberately ignored for this reason. Moreover, some complex entities were 
also annotated, e.g., nested entities. The nested entities referred to entities with overlapping spans. For 
example, in the sentence “The tumor is 4.0 cm from the distal margin of resection.”, “the distal margin 
of resection” was annotated as “other” and “resection” was annotated as procedure. These entities may 
increase the difficulty for the application of machine learning techniques (e.g., conditional random 
fields), since these techniques assume the entities to be predicted appear in sequence rather than 
nested. To identify such entities, rule-based methods are essential for post-processing. 
   
CDKRM Corpus 
Coden et al developed a detailed manually annotated corpus (Coden et al., 2009) to train and test the 
Medical Text Analysis System/Pathology version (MedTAS/P) for populating the Cancer Disease 
Knowledge Representation Model (CDKRM) from free-text pathology reports,. It consists of 302 
pathology reports of 222 patients who could be assigned ICD-9 CM codes for diagnoses of colon 
cancer, including 153.0, 153.1, 153.2, 153.3, 153.4, 153.7, 153.7, 154.0, and 154.1. They only 
presented some types of entities to be evaluated: anatomical site, histology, grade value, dimension, 
date, gross description, primary tumour, metastatic tumour, and lymph node status. Except for 
anatomical site and histology it was pointed out that they were based on ICD-O, the definitions of 
other entity types were unclear, although their attributes have been interpreted in the descriptions of 
the model. They also annotated coreferences for anatomical site and histology. 
 
According to the results they displayed, most entity types have achieved strong inter-annotator 
agreements, except for positive lymph nodes. They concluded that the corpus was of good quality and 
paved the way for automation. 
 
C311 Corpus 
The C311corpus comprises 311 clinical notes drawn from Royal Prince Alfred Hospital’s Intensive 
Care Service, including admission notes, clinician notes, physiotherapy notes, echocardiogram 
reports, nursing notes, dietary reports and operating theatre reports (Wang, 2009). There were eleven 
entity types derived from the SNOMED CT concept hierarchy (IHTSDO, 2007-2014): abnormality, 
body, finding, health profile, object, observable, occupation, organism, procedure, qualifier, and 
substance. Nested entity was one of the emphases in the corpus. For example, the procedure entity 
“left cavernous carotid aneurysm embolisation” is the outermost entity, contains several inner 
concepts: the qualifier entity “left”, the finding entity “cavernous carotid aneurysm”, the body entity 
“cavernous carotid” and the abnormality entity “aneurysm”. Though it has been pointed out that the 
recognition of nested entities is crucial for other tasks such as coreference resolution, relation 
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extraction, and ontology construction, the evaluation of these entities could be difficult, as they 
resulted in multi-label for a single token. Thus only the outermost entities were evaluated in this work. 
 
MIMIC II Clinical Corpus 
The MIMIC II Clinical Database (Goldberger et al., 2000; Moody and Lehman, 2009) contains 
clinical records for 32,536 subjects. These records include results of laboratory tests, medications, 
ICD-9 diagnoses, admitting notes, and discharge summaries. Each record consists of various data for a 
single subject, such as ICD-9 diagnosis codes, physician's orders, census events (e.g., patient 
admissions and transfers), solution (fluids given to the patient), and chart events (a set of observations, 
e.g., raw measurements come from Intensive Care Unit monitors and other instruments, and 
representative measurements).  
 
Although the database has a great number of records, these records do not suit to this task, as they are 
presented in a semi-structured style, where each instance is listed with an abbreviated subheading.  
 
In summary, these corpora are not suitable for the tasks in this study, for reasons as follows: 
1. Different report types. The 2010 i2b2/VA challenge corpus comprised discharge summaries 
and progress reports; the C311corpus consists of clinical notes from Intensive Care Service; 
MIMIC II clinical corpus is composed of admitting notes and discharge summaries. They are 
distinct genres from pathology notes. 
2. Small sample size. There were only 48 pathology reports and 18 surgical pathology reports in 
the ODIE corpus, which were insufficient for training and testing. 
3. Sections in the reports. There were only two sections in the notes of the ODIE corpus and 
CDKRM corpus: the final diagnosis section and gross description section, which were far 
from the requirements of the structured reporting protocols, where other sections like clinical 
history and microscopic analysis were also required to present in the documents. 
4. Annotated entity types. The advantages of using standard terminologies as reference to 
determine the entity types are evident:  one can save much time on defining the entity types 
to be annotated, because the referring terminologies have explicit definitions for them; it 
eases the application of dictionary look-up approaches and encoding of the entities. For 
example, Wang purposed a lexicon look-up method for medical entity recognition on the 
C311 corpus (Wang, 2009); Coden et al mapped the entities to ICD-O (Coden et al., 2009). 
However, it will not work for this study, as the concept categories provided by standard 
terminologies like UMLS and SNOMED CT are too comprehensive or deficient to be used to 
annotate enough of the text to populate a structured report. For instance, both “3. 01 
Diagnosis” and “G3.08 Desmoplasia” in Primary Cutaneous Melanoma Structured Reporting 
Protocol (Scolyer et al., 2010) belong to “body structure” in SNOMED CT, thus using “body 
structure” as an entity type cannot discriminate them from each other. There is no associated 
category in UMLS or SNOMED CT that can capture information about some standards and 
guidelines in the protocols, e.g., “G3.11 Growth pattern” in Primary Cutaneous Melanoma 
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Structured Reporting Protocol (Scolyer et al., 2010), “S2.02 Blocks” in Colorectal Cancer 
Structured Reporting Protocol (Eckstein et al., 2010) and “G3.02 Cell size” in Tumours of 
Haematopoietic and Lymphoid Tissue Structured Reporting Protocol (Norris et al., 2010) as 
well.  
5. Complicated constructions of some entities. Nested entities were included in the ODIE 
corpus and C311 corpus, and the issues they created have been discussed above.  
6. Accessibility of the corpus. The 2010 i2b2/VA challenge corpus, ODIE corpus, MIMIC II 
clinical corpus and their annotation guidelines are publicly available under data agreements, 
in contrast to the CDKRM corpus and C311 corpus. 
 
Given the above reasons, none of these corpora is suitable for this study, but the annotation workflow 
and guidelines they introduced can provide very useful information in creating the annotation 
workflow and guidelines in this study. 
  
4.1.2 Objective 
Although a number of researchers have achieved some successes with unsupervised machine learning 
algorithms, more practical or sophisticated IE systems rely on annotated data to support learning or 
extraction of rules. Therefore, annotated data are very important for IE in the clinical domain, 
especially for supervised machine learning approaches which require such data to train the machine 
learners. These data are also useful as a gold-standard for evaluation of the IE systems. Creating a 
semantically annotated corpus can enable the performance of the IE system to be fully and 
automatically evaluated, as has been proven in the past i2b2/VA challenges (Uzuner et al., 2012; 
Uzuner et al., 2011). Furthermore, with these data, it is possible to tune an IE system to achieve better 
performance through comparisons across multiple versions of the system. 
 
The aims to create semantically annotated corpora in this study include: 
• To create training data for the application of supervised machine-learning approaches.  
• To prepare test data for evaluation of the components of the IE system. 
• To make use of the training data for tuning the components of the IE system to improve 
performance during development. 
 
4.2 Annotation Schema 
Annotation schemas act as knowledge representation tools regarding semantic categories and their 
specialized lexicon. Chapman et al have indicated that using annotation schema to train annotators 
could significantly increase agreement and decrease variability in annotations (Chapman et al., 2008). 
Hence, before starting the annotation progress, an annotation schema has to be acquired first. 
 
Chapter 4 Corpus Annotation 
59 
 
The goal of the annotation schema is to identify the entities associated with fields in the structured 
reporting protocols, and determine the relationships between particular entities. Annotators can mark 
spans of text with an entity type, such as “De:Size”, “De:Specimen Type” and so on, also mark 
relationships as links between these spans. The entity types and relation types are presented in detail 
in the following sections.  
 
Some researchers tend to develop their schemas based on standard terminologies. For example, for the 
Clinical E-Science Framework (CLEF) project, Roberts et al developed an annotation schema based 
on the UMLS semantic network, with the goal of utilising UMLS vocabularies in the following entity 
recognition task (Roberts et al., 2009). However, the annotation schemas purposed below specify the 
types of entities and relationships to be annotated, without adaption from standard terminologies, but 
are tailored to the structured reporting protocols. Specifically, most of the entity types are derived 
from the protocols, but some of them are defined by referring to published sources related to the 
project (e.g., pathology textbooks, colorectal cancer textbooks) or consulting the clinical staff or 
pathologists; a few of them regarding linguistic information are prepared by computational linguists; 
and, relation types are designed to classify relationships between particular entities. Accordingly, the 
definitions of entities and relations were developed by six computational linguists, a clinician and two 
pathologists. The schemas were developed and refined using an iterative process. 
 
4.2.1 Entity Type 
At first, an initial set of medical entities types was defined in each annotation schema, and new entity 
types were added to the schema if it was necessary to capture additional semantic or linguistic 
information. Most of the types have their own associated fields in the protocols, but some complex 
fields can be separated into more than one related type and ambiguous fields are combined together to 
be represented by the same entity types. Entity types without associated fields in the protocols were 
also created to capture some useful information or facilitate subsequent processes. For example, 
“Li:Lexical Polarity Negative”, “Li:Lexical Polarity Positive” and  “Li:Modality” were created to 
reveal the assertion of an entity; “St:Clinical History Heading”, “St:Specimen Heading”, 
“St:Macroscopic Heading”, “St:Microscopic Heading”, “St:Diagnosis Heading” and “St:Comment 
Heading” were added to represent the section headings in the corpus, which consequently facilitated 
section context detection in the corpus. 
 
There are some generic categories and entities types defined in the three corpora, as well as corpus‐
specific categories and entity types (please refer to Figure 4.1). 
 
Two generic categories Synthesis and Structural are described as follows (definitions for other generic 
categories are tailored to each corpus, which are depicted in the following sub-sections): 
 Synthesis (Sy): to reveal information required inference from the author(s) of the report. 
 Structural (St): to depict the structure of the report. 
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Figure 4.1 Generic and corpus‐specific categories and entities types in the three corpora. En: Entity, 
De: Descriptor, Ma: Margin, Re: Reaction, In: Invasion, Sy: Synthesis, Li: Linguistic, St: Structural, 
Ex: Extent, Met: Metadata, An: Ancillary. 
 
Five generic entities types are defined as (with examples are indicated with underlined texts): 
 
De:Specimen Type – Specimen type captures the surgical procedure or site used to obtain the 
specimen. 
Examples for melanoma corpus: 
• (R) axillary SNB. 
• The biopsy shows lentigo maligna melanoma. 
• An ellipse of skin measuring up to 46mm x 25mm to a depth of 5mm… 
 
Examples for colorectal cancer corpus: 
• Specimen type: Extended right hemicolectomy 
• Right colon: A right hemicolectomy comprising terminal ileum 110x15mm and 
proximal colon 150x35mm. 
 
Examples for lymphoma corpus: 
• Incision biopsy ?lymphoma. 
• Two tan cores 18 and 16mm in length. 
• “Distal gastrectomy + right hemicolectomy”. 
En, De, 
Re, Sy, 
St 
Ma, In 
Melanoma corpus 
Li 
Lymphoma 
corpus 
Colorectal cancer 
corpus 
Ex 
Met An 
 
De:Specimen Type; 
St:Clinical History Heading, 
St:Specimen Heading, 
St:Macroscopic Heading, 
St:Microscopic Heading 
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St:Clinical History Heading / St:Title- Clinical History – Any heading that pertains to the history of 
the patient. 
Examples for melanoma corpus: 
• CLINICAL NOTES 
• Clinical History: 
 
Examples for colorectal cancer corpus: 
• CLINICAL NOTES: 
• CLINICAL HISTORY: AP resection plus transverse colectomy. 
 
Examples for lymphoma corpus: 
• Procedure: Clinical Notes 
• Procedure: CLINICAL DETAILS 
 
St:Macroscopic Heading / St:Title- Macroscopic Description – Any heading that pertains to the 
macroscopic examination. 
Examples for melanoma corpus: 
• MACROSCOPIC 
• MACROSCOPIC EXAMINATION 
• MACROSCOPIC REPORT 
 
Examples for colorectal cancer corpus: 
• SPECIMEN: 1. Labelled - AP resection: 
• MACROSCOPIC: 
• MACROSCOPIC DESCRIPTION.  
 
Examples for lymphoma corpus: 
• Procedure: Macroscopic Description 
 
St:Microscopic Heading / St:Title- Microscopic Description – Any heading that pertains to the 
microscopic examination. 
Examples for melanoma corpus: 
• MICROSCOPIC 
• MICROSCOPIC REPORT 
• MICROSCOPIC EXAMINATION 
 
Examples for colorectal cancer corpus: 
• MICROSCOPIC DESCRIPTION: 
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• MICROSCOPY: Sections of the caecal tumour… 
 
Examples for lymphoma corpus: 
• Procedure: Microscopic Report 
 
The detailed corpus‐specific categories and entity types are described below (with examples are 
indicated with underlined texts). 
 
Melanoma Corpus 
The entities types can be divided into eight main categories. Except two generic categories decribed 
above, others include: 
 Entity (En): to identify the specimen and malignant or benign lesions on it. 
 Descriptor (De): to describe the properties or characteristics of the Entity. 
 Margin (Ma): to indicate whether the excision margins are clear and any descriptive material 
relating to the margins. 
 Reaction (Re): to represent any lymphocytic or inflammatory reaction in the skin. 
 Invasion (In): to illuminate local or distant invasion of the lesions. 
 Linguistic (Li): to mark linguistic information about the above categories (except for 
Margin). 
 
En:Associated Naevus (type) – References to any pre-existing or associated naevus with the 
melanoma.  
• Features suggestive of a pre-existing naevus are seen. 
• The sections show an unusual nodular malignant melanoma associated with a compound 
melanocytic naevus. 
 
En:Primary Lesion – The primary lesion is typically the reason why the report was prepared. It can be 
usually described in various ways, which should be identified during annotation. 
• The lesion is formed by small melanocytic nests… 
• The dermal component consists of nests of moderately atypical naevoid melanocytes. 
• On the surface is a variably pigmented grey nodule measuring 6 x 5 mm with a pale halo. 
 
En:Lesion (other) – Other lesions mentioned in the report. 
• The second lesion (block B) is a benign compound naevus. 
• No pre-existing benign lesion is seen. 
 
En:Satellites – References to any satellite lesion associated with the melanoma. 
• No satellites. 
• Microsatellites are absent. 
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En:Specimen Identifier – The specimen identifier is used to identify the specimen. 
• The specimen consists of an ellipse of skin measuring 40mm x 20mm x 5mm. 
• Sections show a nodular malignant melanoma… 
• 1. The lesion is an acanthotic seborrhoeic keratosis. 
• Specimen A: ?Dysplastic naevus 
 
De:Specimen Type – The manner in which the specimen has been obtained. 
• (R) axillary SNB. 
• The biopsy shows lentigo maligna melanoma. 
• An ellipse of skin measuring up to 46mm x 25mm to a depth of 5mm… 
 
De:Cell Type – Descriptions of the primary cell type. 
• The dominant cell type is epithelioid. 
• Single malignant melanocytes are noted… 
• …composed of large cells with epitheloid and balloon cell features. 
 
De:Cell Growth Pattern – The cell growth pattern contributes to the identification of the sub-type of 
melanoma. 
• The lesion is vertical growth phase … 
• There is an asymmetrical poorly circumscribed proliferation of atypical melanocytes 
arranged in confluent units and nests at the dermal epidermal junction. 
• Very occasional cells show intraepidermal Pagetoid spread. 
 
De:Cosmetic Changes – Changes in appearance to the surrounding area that may be noted in the 
report and may be relevant to the diagnosis or the prognosis. 
• There is a healing scar in the centre of the ellipse. 
• Changed size following trauma. 
• Focal balloon cell change is present. 
 
De:Shape – Descriptions of the entity including colour, border and contour. 
• Centrally there is an irregular mottled brown lesion 20 x 12 mm. 
• A skin ellipse 12 x 6mm with an irregular tan nodule 7mm in greatest diameter with a pale 
centre and irregular outline. 
 
De:Site and Laterality – The body part and side on which the lesion is located. This may also include 
finer locating information such as upper, lower, and mid. 
• Changing lesion central abdo. 
• Specimen labelled “Left upper thigh”. 
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• Irregular pigmented lesion on the back. 
 
De:Size – The sizes of the specimen, the primary lesion and any other lesions or noteworthy entities. 
• The specimen consists of an ellipse of skin measuring 25mm x 15mm x 10mm. 
• Situated on the surface there is a slightly raised grey lesion measuring 12mm in maximum 
extent. 
• An ellipse of skin 15x7 mm bearing a slightly raised pale lesion 5x5mm. 
• An ellipse of skin measuring up to 9mm X 4mm to a depth of 5mm from the nodule on the 
scalp. 
• Specimen comprises a large oval piece of skin 65mm in length, width of 30mm and 
maximum thickness of 13mm. 
 
De:Ulceration (mm)  – References to any ulceration of a lesion and the size should be included if it is 
mentioned. 
• The melanoma is not ulcerated. 
• The tumour shows superficial ulceration. 
• There is some surface ulceration but this is less than 6mm in extent. 
 
De:Dermal Mitoses – Level of dermal mitosis and/or the mitotic rate. 
• Occasional intradermal mitoses are seen, numbering less than 1 per square mm. 
• Mitotic rate is 15 to 18 per mm2. 
• Mitoses are approximately 2 per 10 hpf. 
 
Ma:Excision Clear – Statement that the excision margins are clear or any descriptive material relating 
to the excision margins that doesn’t belong under other Margin types. 
• Excision appears complete. 
• The lines of excision are clear of the lesion. 
 
Ma:Excision Deep – The distance from the lesion to the deep margin. 
• … and a deep margin of 2.3mm. 
• Distance from deep margin = 4.0mm 
 
Ma:Excision In Situ – The distance from the in-situ or junctional component to the lateral margins. 
• The closest peripheral margin to in situ component measures 0.9mm… 
• The in situ component is situated 0.2mm while … 
 
Ma:Excision Invasive – The distance from the dermal component to the lateral margins (default 
category for lateral margins). 
• Closest peripheral margin to invasive component = 1.0mm 
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• The melanoma is excised by a lateral margin of 0.5mm. 
• The invasive component is 2.0mm clear of the nearest margin. 
 
Re:Desmoplasia – References to the presence or absence of desmoplasia. 
• It shows pleomorphic spindled malignant cells with strong S100-positivity permeating the 
dermis, inciting a desmoplastic reaction. 
• Although there is no obvious desmoplasia… 
 
Re:TILS – References to the presence or absence of  tumour infiltrating lymphocytes (TILs). 
• There is a patchy lymphocytic infiltrate around some of the deeper parts of the lesion. 
• Tumour infiltrating lymphocytes (TILS) is seen at the base in block 3 especially in the 
subcutis nodule. 
 
Re:Solar Elastosis – Evidence of skin reaction to the sun. It will make the skin appear leathery and can 
impact on diagnosis and prognosis. 
• No significant solar elastosis is detected. 
• Sections show sun-damaged skin. 
 
Re:Fibrosis – Evidence of reaction in connective tissue or scarring.  
• There is a narrow band of fibrosis between epidermis and the dermal deposit of tumour. 
• Dermis beneath the lesion shows angiofibroplasia indicative of regression… 
 
In:Vascular/Lymphatic – References to any infiltration of the blood vessels and lymphatic system. 
• No lymphatic, vascular or perineural invasion is seen.  
• There is no ulceration or vascular/lymphatic invasion. 
 
In:Neurotropism – References to any neurotropism present or absent. 
• Vascular, lymphatic or perineural invasion is not identified. 
• There is no vascular invasion or neurotropism seen. 
 
In:Breslow Thickness (mm) – Primary tumour thickness. 
• The Breslow thickness is 0.8mm. 
• The depth of invasion (Breslow) is 0.6mm, Clark level 3. 
• Depth 0.55mm, level III. 
 
In: Clark level – The layer of the skin into which the tumour has permeated. 
• The tumour extends to Clark level IV with a Breslow thickness of 3.6mm. 
• There is spread within the epidermis and within the dermis with a lesion contains a thickness 
of 1.4mm. 
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• Breslow thickness is about 1.2mm, Clark level 3. 
 
Li:Lexical Polarity Negative – Lexically bound polarity related to negation. 
• There is no evidence of dermal invasiveness. 
• No perineural or lymphovascular invasion, neurotropism or desmoplasia is identified. 
• Vascular invasion is not noted. 
• The tumour lacks epidermal invasion… 
 
Li:Lexical Polarity Positive – Lexically bound polarity related to confirmation. 
• The biopsy shows lentigo maligna melanoma. 
• The features are consistent with malignant melanoma…  
• Patchy regression is present. 
• A preexisting benign dermal naevus is also noted as in the previous biopsy. 
 
Li:Modality  – Lexically bound modality related to uncertainty. 
• This possibly represents pre-existing dysplastic naevus. 
• The lesion is probably malignant melanoma. 
• This focus may be separate from the main tumour… 
• No definite dermal mitoses are seen. 
 
Li:Mood and Comment Adjuncts – Indication of degree or intensity. 
• There is some dermal scarring, consistent with regression. 
• There is a patchy, moderate lymphocytic infiltrate around the edges of the lesion. 
• There is no significant atypia present. 
 
Li:Temporality – References to any temporal indicator. 
• … the subcutaneous tissue from the previous surgical procedure. 
• There is evidence of both early and late regression. 
 
Sy:Diagnosis – The diagnosis of the lesion within the specimen. 
• The lesion is an invasive superficial spreading malignant melanoma. 
• Sections show an ulcerated Level IV amelanotic melanoma measuring 3.1mm in maximum 
thickness. 
• The section shows nests of basal cell carcinoma. 
 
Sy:Regression – References to any regression within the lesion. 
• There is vascular fibrous tissue up to 3.3mm deep consistent with a zone of late regression. 
• There has been regressive activity and it is mostly complete. 
• The lesion is a partially-regressed level II naevoid malignant melanoma… 
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Sy:Subtype – The histological type and classification of the melanoma. 
• It is of superficial spreading type and is not ulcerated. 
• The central nodule is ulcerated nodular melanoma. 
• Sections show foci of invasive malignant melanoma arising in a Hutchinson's melanotic 
freckle (lentigo maligna). 
 
St:Specimen Heading – Any heading that pertains to the specimen. 
• SPECIMEN 
• NATURE OF SPECIMEN 
• Specimen(s) Received 
 
St:Diagnosis Heading – Any heading pertaining to the diagnostic summary, generally present at the 
end of the report. 
• DIAGNOSIS 
• SUMMARY 
• CONCLUSIONS 
 
St:Comment Heading – Any heading that pertains to comments made by the pathologists. 
• Comment 
• COMMENT 
• Further report 
 
St:Sub Heading – Any miscellaneous subheading that does not fall under the aforementioned 
structural headings. 
• Growth pattern:  
• Lines of Excision: 
• Cytological features: 
 
Colorectal cancer corpus 
The entities types can be broadly classified into nine categories. Apart from two generic categories 
decribed above, others include: 
 Descriptor (De): to describe the specimen, the tumour’s shape, structure, behaviour and 
spatial location. 
 Entity (En): to identify any noteworthy structures composing the specimen or abnormal 
findings regarding to the tumour. 
 Extent (Ex): to indicate the spread of the tumour within the adjacent organs, tissues, 
structures or the body. 
 Invasion (In): to illuminate the malignant involvement caused by the tumour. 
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 Margin (Ma): to provide the distance of the tumour from specified margins or indicate 
whether they are involved by the tumour. 
 Metadata (Met): to mark the staging information of the tumour. 
 Reaction (Re): to reveal the reactive changes due to tumour growth or treatment. 
 
De:Ancillary Studies  – Ancillary modality identifies any supporting tests performed (and their 
findings), usually of diagnostic or prognostic significance.  
• There is no loss of mismatch repair protein expression in tumour cells with 
immunohistochemical stains for MLH1, PMS2, MSH2 and MSH6. 
• In view of the plasmacytoid morphology in part of the tumour, CD138 will be performed and 
neuroendocrine markers CD56, chromogranin and synaptophysin. 
• MIH1 - normal mucosa positive, tumour positive. 
 
De:Specimen Blocks – Specimen block describes how the specimen was sliced into sections for 
testing. An identifier and the composition of each block will be given and the annotation applies to 
each pair of these. 
• Block 1: Proximal margin. 
• Blocks: A-C: terminal ileum lesion.  
• 1I-1L - multiple lymph nodes. 
 
De:Specimen Images  – Specimen image gives information about any imaging of the tumour. 
• Macroscopic Photos - not taken. 
• Mid rectal cancer - T2 on MRI. 
 
De:Specimen Size – Specimen size gives the measured dimension(s) of  the resected colorectal tract. 
• Colon: 340 x 30 mm. 
• With patient details only: A length of large bowel 200mm with attached mesocolon 70mm 
wide. 
• Left colon: A left sided resection measuring 350mm x30mm. 
 
De:Specimen Type – Specimen type captures the surgical procedure or site used to obtain the 
specimen. 
• Specimen type: Extended right hemicolectomy 
• Right colon: A right hemicolectomy comprising terminal ileum 110x15mm and proximal 
colon 150x35mm. 
 
De:Tissue Banking – Tissue banking records whether any tissue, normal or cancerous, has been added 
to a tissue bank for research. 
• Tissue bank specimen: TB1 - A piece of brown tumour 7 x 5 x 3mm. 
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• Tissue Bank 1 - Colon normal: all in TB1. 
 
De:Mesorectal Integrity – The integrity of the mesorectum in the specimen is described as complete, 
nearly complete or incomplete. 
• The mesorectum is complete and indurated measuring up to 70mm in thickness. 
• Mesorectal integrity: Complete. 
 
De:Perforation – Perforation details whether the tumour itself or the colorectal tract adjacent to the 
tumour appears perforated. 
• Perforation: Nil seen. 
• The serosal surface over this tumour appears ragged and ulcerated, possibly representing 
perforation of tumour onto the peritoneal surface. 
• These sections confirm an area of perforation through an ulcerated poorly differentiated 
adenocarcinoma… 
 
De:Serosa Description  – Descriptions of the surrounding serosa (sometimes called “visceral 
peritoneum”). 
• The rest of the serosa is pink and smooth. 
• There is puckering of serosa of the bowel at 50mm from distal resection margin. 
 
De:Tumour Description – Descriptions of the tumour. 
• 80mm from the nearest colonic resection margin there is an annular constricting ulcerated 
hard lesion involving a segment of bowel 30mm long. 
• Appearance - sessile pale pink polypoid tumour 
• 1-2. Sections from the rectum show residual moderately differentiated adenocarcinoma 
composed irregular glands and some nests of pleomorphic cells. 
 
De:Tumour Size – Tumour size gives the measured dimension(s) of a tumour. 
• Size: 53 mm in diameter 
• At the caecum, there is an almost circumferential centrally ulcerated tumour, 40mm in axial 
length and 40mm in width… 
• Within the caecum, immediately inferior to the ileocaecal valve, is a fungating mass 
measuring 45x30x10mm. 
 
De:Peritoneal Reflection – Peritoneal Reflection locates the tumour as completely above, astride, or 
completely below the anterior peritoneal reflection. 
• The tumour extends close to the serosal surface approximately 10mm above the anterior 
peritoneal reflection. 
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• Just below the peritoneal reflection margin mainly posterior there is a large ulcerating 
tumour… 
• Relationship to anterior peritoneal reflection: Astride 
 
De:Tumour Site –Tumour site gives the part of the colorectal tract in which the tumour was located. 
For rectal tumours, tumour site can include a measured distance from the anal verge. 
• At the lower rectum, there is a centrally ulcerated cream tumour… 
• Site of tumour: Right colon. 
• CLINICAL NOTES: Rectal ca 8cm from anal verge. 
 
En:Coexistent Pathology – Relevant coexistent pathological abnormalities, e.g., Polyps (describe type, 
number, etc), Ulcerative colitis (with dysplasia/without dysplasia), Crohn’s disease (with 
dysplasia/without dysplasia). 
• Polyps: Associated tubulovillous adenoma with high grade dysplasia. 
• The specimen shows severe ulcerative colitis of the left colon with a mass associated 
dysplasia arising in the rectum… 
• A non-caseating granuloma has been identified and the appearances are consistent with 
active Crohn`s disease which is much less in the section taken from the terminal ileum. 
 
En:Distant Spread or Metastases  – Metastases identify any distant spread of the cancer. 
• There is a deposit of tumour in the omentum. 
• Distant Spread - present, liver. 
• Metastases (colon/other): Not identified 
 
En:Lymph Nodes – Lymph nodes give the number of lymph nodes identified. 
• LYMPH NODES: 10 lymph nodes identified, 5 of which show evidence of metastatic 
tumour. 
• 16 additional mesenteric lymph nodes are retrieved 3-10mm in greatest dimension. 
• Total number of nodes identified: 25 
 
En:Residual Tumour – Residual Tumour identifies whether any tumour was left as residual by the 
surgical excision. 
• No residual invasive tumour is identified. 
• Residual tumour: R0 
 
Ex:Donut Involvement – Donut involvement refers to the presence of tumour cells within the 
proximal/distant donuts (samples of supposedly normal tissue at the ends of the resection). 
• 2. Distal rectal donut: No tumour identified. 
• 2. Sections show unremarkable donuts of large bowel. No tumour is identified. 
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Ex:Extent – Extent indicates direct spread to adjacent organs, tissues or structures. 
• Other organ invasion: Not present. 
• The tumour extends to the serosal surface and shows focal lymphatic channel permeation 
with extrinsic infiltration into the adherent small bowel, reaching the the small bowel 
mucosa… 
 
Ex:Extramuscular Spread – Extramuscular spread gives the measured distance of spread beyond the 
muscularis propria (in mm). This is often referred to as the tumour having infiltrative margins. 
• Tumour Border: Infiltrative 
• Distance beyond outer edge of muscularis propria: 3.0mm 
 
Ex:Lymph Node Involvement – Lymph nodes involvement reports the number of extracted lymph 
nodes which are shown to be malignantly involved/un involved. 
• Twenty lymph nodes were identified, five of which show evidence of metastatic 
adenocarcinoma.  
• 12 lymph nodes in which no tumour is found. 
• Lymph node status: 7 of 19 lymph nodes show metastatic carcinoma. 
• (Node summary 1/57) 
 
Ex:Serosal Involvement – Serosal involvement identifies whether there is malignant involvement of 
the serosa/outer layer of the colon. 
• The free serosal surface appears clear of tumour. 
• It involves the serosa and infiltrates the adjacent omentum. 
 
In:Depth of Invasion – Depth of  invasion records how far into the colorectal tissue the tumour has 
invaded. This may be reported as a measured distance or as the specific layer of colorectal tissue 
which the tumour reaches (excluding the serosa, see Ex:Serosal Involvement). 
• The tumour infiltrates through the muscularis propria and extends into the subserosa. 
• Depth of invasion: Subserosa (pT3) 
• Sectioning through the tumour reveals depth of invasion is up to 10mm… 
 
In:Perineural Invasion – Perineural invasion describes whether there is malignant involvement of the 
spaces near nerve cells. 
• No peritoneal invasion is identified. 
• Perineural invasion: Present 
 
Chapter 4 Corpus Annotation 
72 
 
In:Venous and Small Vessel Invasion – Small vessel invasion refers to the malignant involvement of 
small vessels including lymphovascular or capillary involvement. Venous invasion refers to the 
malignant involvement of large vessels, including both veins and arteries. 
• No extramural vascular invasion is identified. 
• Lymphovascular invasion: Present. 
• possible small vessel invasion in submucosa. 
• There appears to be a focal tumour invasion of a medium sized vein within perirectal fat. 
 
Ma:Circumferential Margin – Circumferential margin gives the measured distance between the 
tumour and the radial or circumferential margin. Also included is the mesenteric resection margin, 
which is an additional “radial” margin, considered in cancers of particular areas of the colon. 
• …invading into pericolic fat, 0.4mm from the radial margin, without serosal involvement… 
• Tumour extends to 4.4 mm of the non-peritonealised margin. 
• Minimum distance between tumour and circumferential margin: 8mm 
 
Ma:Proximal or Distal Margin – Proximal and distal margins gives the measured distance between the 
tumour and the cut-end margins. 
• Arising in the mid colon is a circumferential tumour 132mm from the proximal resection 
margin, 60mm from the ileocaecal valve and 80mm from the distal resection margin. 
• 35mm from one longitudinal resection margin is an ulcerated lesion 15mm in maximum 
dimension which penetrates into submucosa. 
 
Ma:Clear – Clear indicates that the tumour is clear of its margins, in place of other Margin types if no 
numerical value is given. 
• d. all surgical margins clear. 
• Circumferential margin involved: No 
• Tumour is well clear of longitudinal resection margins. 
 
Met:Anatomic Stage – Anatomic stage represents the extent or severity of the cancer. 
• Pathological stage: ACPS: A2 
• This is a Dukes C colonic carcinoma. 
• AJCC stage I (T1 N0 MX V0 R0) 
 
Met:M Value – M Value identifies whether distant (to other parts of the body) metastasis (M) has 
occurred. 
• T N M: pT3 pN1b pM0 
• Pathological stage: ACPS: Stage D, TMN: pT4b N2b M1b, Stage IIIC 
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Met:N Value – N Value identifies whether cancer cells have spread to nearby (regional) lymph nodes 
(N). 
• STAGE: pT3 N1 
• Pathological stage: ACPS: Stage C, pT4, pN2a 
 
Met:T Value – T Value gives the extent or spread of the tumour (T). 
• AJCC stage 3B (T3 N1 M0). 
• TNM staging pT4a, pN0, pMx. 
 
Re:Desmoplasia and Fibrosis – Desmoplasia identifies whether any fibrous or connective tissue has 
grown as a reaction to tumour growth. Fibrosis identifies any hardening or scarring of tissue as a 
reaction, usually as a healing reaction. 
• The carcinoma is associated with moderate desmoplastic reaction and a mild peritumoural 
chronic inflamatory cell infiltrate. 
• (B) POSTERIOR VAGINAL WALL: PATCHY FIBROSIS, NO TUMOUR IDENTIFIED. 
 
Re:Response to Rx – Response to Rx describes the patient’s response to previous radiotherapy 
treatment. 
• Radiation induced mucosal changes adjacent to residual adenocarcinoma and including distal 
donut. 
• Response to neoadjuvant therapy – moderate 
• …* TRG 2 (Mandard)… 
 
Re:TILS and Peritumoural Lymphocytes – TILS and peritumoural lymphocytes refer to the presence, 
density distribution and severity of lymphocytic response, which are immune reactions to cancer. 
• Intratumoural/peritumoural lymphocytic response - minimal. 
• There are mild numbers of tumour infiltrating lymphocytes… 
• The carcinoma is associated with a moderate peritumoural chronic inflammatory cell 
infiltrate. 
• There is no significant diffuse or nodular Crohn`s-like lymphocytic chronic inflammatory 
infiltrate around the advancing tumour margin. 
 
Sy:Comment – Comment is relevant to the comment fields of the structured template. This includes 
other issues noted by the pathologists. 
• 2.8 Background abnormalities: No 
• Appendix not seen. 
• The colon proximal to the tumour is dilated. 
• The left colon is abnormal, with the greatest abnormality identified in the distal 320mm of 
the specimen. 
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Sy:Histological Grade – Histological grade gives the level of differentiation, or percentage of the 
tumour composed of glandular structures. This maybe reported as a numerical grade. 
• Histological grade: Moderately differentiated. 
• The majority of the tumour is poorly differentiated consisting of ragged clusters… 
• AJCC Stage IIIB (pT3 pN2a G2 R0) 
 
Sy:Histological Type – Histological type identifies the type of cancer the tumour represents. This is 
almost always a form of adenocarcinoma. 
• The tumour is a moderately differentiated adenocarcinoma. 
• Tumour type: Mucinous adenocarcinoma. 
• Tumour type: Signet ring adenocarcinoma. 
 
Sy:Medical History – Previous medical history reported within the request form. This includes 
treatment, past disease, age, etc. 
• CLINICAL NOTES: 60 year old female. 
• No XRT.  
• Past history of breast ca. 
  
St:Ancillary Studies Heading – Any heading that designates the following content is concerned with 
ancillary tests performed and their results. 
• SUPPLEMENTARY REPORT : Ckae1/3 immunostains are unremarkable (block 1G). 
• ANCILLARY STUDIES 
 
St:Synthesis Heading – Same as St:Diagnosis Heading for the melanoma corpus. 
• DIAGNOSIS: 
• SYNOPTIC REPORT: Colorectal carcinoma 
• CONCLUSION: SITE: Caecum. 
 
St:Subheading – Any miscellaneous subheading, which may be further divided into some reportable 
field. Note that it includes specimen identifiers. 
• CONCLUSION: 1. Abdominoperineal resection (post adjuvant chemo-radiotherapy). 
• MICROSCOPIC: SPECIMEN 1. Sections show the tumour to be a moderately differentiated 
mucinous adenocarcinoma. 
• TUMOUR STAGING: AJCC STAGING: T3;N0;MX (STAGE IIA); DUKES STAGE: B. 
• Tumour type/differentiation 
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Lymphoma corpus 
The entities types can be categorized to eight kinds. Except two generic categories described above, 
others are illuminated as follows:  
 Ancillary (An): to illuminate any ancillary study result and interpretation. 
 Descriptor (De): to describe the specimen and the tumour. 
 Entity (En): to identify the specimen and any note-worthy structures composing the 
specimen. 
 Extent (Ex): to indicate the spread of the tumour within the body. 
 Reaction (Re): to reveal the reactive changes due to tumour growth. 
 Linguistic (Li): to mark linguistic information about the above categories (except for 
Ancillary). 
 
An:Biomarker: Indicator that is usually used in immunohistochemistry tests or flow cytometry studies. 
• The atypical lymphoid cells are positive for CD20, CD79a, cyclin D1, CD5 and bcl-2. 
• They are negative for CD3, CD10 and CD23. 
 
An:Immunohistochemistry- Positive: The positive results of the immunohistochemistry tests. 
• Positive - CD20 +++, CD30 + 
• The tumour stains strongly for CD45, CD20 and CD79a. 
 
An:Immunohistochemistry- Negative: The negative results of the immunohistochemistry tests. 
• CD23 – negative 
• Immunohistochemistry shows that the neoplastic cells are CD79a+, CD20+, CD10+, CD23+, 
CD5-, cyclin D1- and CD30-. 
 
An:Immunohistochemistry-Equivocal: The equivocal results of the immunohistochemistry tests. 
• Staining for CD15 is equivocal. 
 
An:Immunohistochemistry-Comment: The free text expressions for interpretive comment of the 
immunohistochemistry tests. 
• The necrotic centre of the nodule also has some cell-outlining staining for CD56 and 
CD45RO. 
• The CD5 staining appears to correlate with the CD3. 
 
An:Flow Cytometry- Positive: The positive results of the flow cytometry studies. 
• Positive for: Kappa, CD19, CD10, CD45, CD38 
 
An:Flow Cytometry- Negative: The negative results of the flow cytometry studies. 
• Negative for : Lambda, CD2, CD3, CD4, CD5, CD8, CD7, CD14, CD16, CD56 
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An:Flow Cytometry- Comment: The free text expressions for interpretive comment of the flow 
cytometry studies. 
• INCREASED CD3+CD4+/CD3+CD8+ T CELL RATIO. 
• NON DIAGNOSTIC FINDINGS. 
 
An:FISH Results: The results of fluorescence in situ hybridization (FISH) tests. 
• The remaining 58% of cells showed a normal diploid MYC signal pattern. 
• nuc ish(MYC x3) 
 
An:Cytogenetics Comment: The free text expressions for interpretive comment of FISH tests. 
• Interphase FISH analysis revealed the presence of an abnormal signal pattern.  
• Three intact MYC fusion signals were observed. 
 
An:IgH Test: The results of polymerase chain reaction (PCR) analysis with immunoglobulin heavy 
chain (IgH) tests. 
• Two MONOCLONAL bands of 104 and 121 bp were detected against a polyclonal 
background. 
• An irregular POLYCLONAL smear was detected. 
 
An:TCRgamma Test: The results of PCR analysis with T-cell receptor gamma chain (TCRgamma) 
tests. 
• Tube 1: A POLYCLONAL smear was detected. 
 
An:PCR Comment: The free text expressions for interpretive comment of PCR analyses. 
• PCR amplification of DNA with primers flanking the region of gene rearrangement. 
• IgH gene rearrangement studies were performed after the method of Brisco et al (1990) Br J 
Haem 75: 163-167 using the LJH and FR3A primer set. 
 
 De:Topography: Specified anatomical site and laterality of biopsy. 
• Tumour (L) cubital fossa 
• Right lower neck lymph nodes. 
• FNAB (R) axilla- suspicions for Hodgkin's Lymphoma 
 
De:Tissue Source: The source of the specimen or tissue. 
• A lymph node 33 x 30 x 18mm. 
• The infiltrate extends into perinodal fat. 
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De:Anatomical Structure: Unspecified anatomical site derived from names of Level 3 codes defined in 
topography axis of ICD-O-3 (WHO - World Health Organization, 1976-2000). 
• “CA stomach”. 
• Cervical lymphadenopathy FNA - atypical cells. 
 
De:Laterality: The laterality of biopsy. 
• “SUPRACLAVICULAR CYST (LEFT)”. 
• Bilateral melanomas mets (R) parotid bed… 
 
De:Specimen Type: Same as De:Specimen Type for melanoma corpus. 
• Incision biopsy ?lymphoma. 
• Two tan cores 18 and 16mm in length. 
• “Distal gastrectomy + right hemicolectomy”. 
 
De:Lineage: Descriptions of the primary cell type. 
• Lymph node, L cubital fossa: Malignant lymphoma, diffuse and follicular, large B cells 
predominating 
• The nodules have a background of mainly T cells… 
 
De:Architecture: The pattern of infiltration or architecture of abnormal cells. 
• Sections show a lymph node with architecture totally effaced by a diffuse proliferation of 
large cells admixed with small lymphocytes and histiocytes. 
• A few lymphoepithelial lesions are present. 
• The nodal portion is follicular in pattern and consistent with grade 2 (of 3, WHO). 
 
De:Cell Size: The size of abnormal cells. 
• The lymph node shows a diffuse infiltrate of malignant large lymphoid cells with a few 
scattered multinucleated cells. 
• Sections show effacement of the nodal architecture by a diffuse infiltrate of small to medium 
sized lymphoid cells. 
 
De:Cytomorphology: Characteristic cytological features of individual tumour cells. 
• Occasional binucleate Reed-Sternberg cells are identified. 
• A few scattered centroblasts are also present. 
 
De:Specimen Size: The measured dimension(s) of specimen(s). 
• Two pieces of pale tissue each 5mm. 
• Fatty tissue 55 x 40 x 15mm in aggregate with multiple enlarged lymph nodes. 
 
Chapter 4 Corpus Annotation 
78 
 
De:Preservative Fluid: The fluid in which the specimen is delivered to the laboratory. 
• “LYMPH NODE RIGHT NECK” (lymph node received fresh). 
• Received in formalin, a small pale tan node 8mm across. 
 
De:Sample Triage: The distribution of biopsy material to different laboratories (internal and/or 
external) and for different investigational modalities. 
• Smears, imprints, tissue for flow cytometry, mollecular biology and frozen section were 
taken. 
 
De:Specimen Blocks:  Same as De:Specimen Blocks for the colorectal cancer corpus. 
• A. Residual of frozen section. 
• B. Remainder of specimen. 
 
De:Tumour Size: Same as De:Tumour Size for the colorectal cancer corpus. 
• Much of this area tumour, at least 80 x 50 x 15mm. 
• Tumour size: - 50mm maximum diameter (macroscopically). 
 
En:Specimen Identifier: Specimen identifier is used to identify the specimen. Unlike En:Specimen 
Identifier for the melanoma corpus, general terms like “specimen” and “sections” are excluded. 
• 1. "Biopsy of liver". 
• 2-5. The (L) axillary sentinel node biopsies show no evidence of melanoma in any of 11 
nodes. 
 
En:Coexistent Pathology: Same as En:Coexistent Pathology for the colorectal cancer corpus. 
• Surface mucosal ulceration is extensive. 
• 2. Gastric (Prepyloric) biopsy- Chronic gastritis. 
 
Ex:Disease Extent: The extent of disease. 
• Pt has generalised lymphadenopathy otherwise well. 
• PET (30.1.06) showed it to be a solitary lesion, and glucose-avid. 
 
Ex:Other Sites of Disease: Indicates involved sites or pattern of disease spread and whether disease is 
nodal or extranodal. 
• The mediastinal mass was 13.8cm dia, involving superior and anterior mediastinum, down to 
the diaphragm. 
• Focal extranodal spread is seen. 
 
Re:Tissue Reaction: Host cells and tissue reactions. 
• There are numerous eosinophils, plasma cells and some macrophages in the background. 
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• There are areas of necrosis. 
 
Li:Lexical Modality: Same as Li:Modality for the melanoma corpus. 
• Incision biopsy ?lymphoma. 
• Small intestine and retroperitoneum - diffuse large B cell malignant lymphoma, probably 
follicular centre cell origin 
 
Li:Lexical Polarity Negative: Same as Li:Lexical Polarity Negative for the melanoma corpus. 
• There is no evidence of dysplasia. 
• Although one resembles a RS cell variant, the morphology overall does not suggest Hodgkin 
lymphoma. 
 
Li:Lexical Polarity Positive: Same as Li:Lexical Polarity Positive for the melanoma corpus. 
• The sections show diffuse malignant lymphoma of large B-cells. 
• Small lymphocytes and eosinophils are also present. 
 
Li:Mood and Comment Adjuncts: Same as Li:Mood and Comment Adjuncts for the melanoma 
corpus. 
• The lymph node shows a diffuse infiltrate of malignant large lymphoid cells with a few 
scattered multinucleated cells. 
 
Li:Temporality: Same as Li:Temporality for the melanoma corpus. 
• The appearances are similar to the previous biopsy. 
• Mass left humerus increasing pain for the past 6-8 weeks. 
 
Sy:Diagnosis: Same as Sy:Diagnosis for the melanoma corpus. 
• Cervical lymph node - Nodular sclerosis Hodgkin lymphoma. 
• Lymph node of neck - T cell-rich, large B cell malignant lymphoma 
• Scapula (acromion) - malignant lymphoma, diffuse large B cell type 
 
Sy:WHO Grade: The grade for follicular lymphoma. 
• 2. Lymph node, site not stated - follicular lymphoma, WHO grade 1. 
• I agree with the diagnosis of follicular lymphoma, grade 1/3, predominantly follicular. 
 
Sy:Medical History: Any previous lymphoma, leukaemia or other relevant haematological disease. 
• NHL 2 years ago. 
• 1998 treated for Hodgkins disease. 
 
Sy:Presentation: Clinical presentation of current relevant disease status. 
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• Presented with bilateral painless cervical lymphadenopathy. 
• 3/12 history, pain. 
 
Sy:Indication for Biopsy: The reason for the biopsy. 
• Axillary lymph node ?recurrence. 
• ?Transformation to high grade. 
 
Sy:Clinical Impression: The clinical diagnosis or differential diagnosis. 
• ?Lymphoma. 
• ?SCC tonsil. 
 
Sy:Constitutional Symptoms:  References to any relevant constitutional symptom. 
• Night sweats, weight loss ?lymphoma 
 
Sy:Predisposing Factors:  Immunocompromised states (immunodeficiency associated 
lymphoproliferative disorders), autoimmune conditions, and infective agents. 
• Longterm HIV +ve. 
• Post CTx. 
 
Sy:Stage: The extent or severity of the lymphoma. 
• ACP substage: C1 
 
Sy:SNOMED RT Codes: SNOMED RT Codes and terms for the diagnosis. 
• M-95903 Lymphoma, NOS 
• T-C4000 Lymph nodes 
 
Sy:Diagnosis Subtype: The sub-classification of lymphoma. 
• ?MALT. 
• The nodular sclerosis subtype is favoured. 
 
Sy:Comment: Comment is relevant to the comment field in “SYNTHESIS” section. 
• Consistent with large B-cell lymphoma, Please see report and comment. 
• Please correlate with clinical and peripheral blood findings. 
 
St:Title- Nature and Specimen Type: Same as St:Specimen Heading for the melanoma corpus. 
• Procedure: Nature and Site of Specimen 
 
St:Title- Summary: Same as St:Diagnosis Heading for the melanoma corpus. 
• Procedure: Summary 
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St:Title-Pathologist Notes: Any heading pertaining to the Pathologist Notes. 
• Procedure: Pathologist Notes - Not for Publication 
 
St:Title- Frozen Section Report: Any heading pertaining to the Frozen Section Report. 
• Procedure: FROZEN SECTION REPORT 
 
St:Title- Supplementary Report: Any heading pertaining to the Supplementary Report 
• Procedure: Supplementary Report 
 
St:Title- Supplementary Summary: Any heading pertaining to the Supplementary Summary. 
• Procedure: Supplementary Summary 
 
St:Title- Special Investigations: Any heading pertaining to the Special Investigations. 
• Procedure: SPECIAL INVESTIGATIONS 
 
 St:Title- Comment:  Same as St:Comment Heading for the melanoma corpus. 
• Procedure: Comment 
 
St:Title-Subheading:  Same as St:Sub Heading for the melanoma corpus. 
• Immunohistochemical profile: 
• SNOMED CODES: 
 
Summary 
It can be seen from the above annotation schemas that the design of the annotation schema for each 
corpus has a number of differences due to the distinguishable standards and guidelines in the protocols. 
For example, In:Clark Level is a medical entity type in the melanoma corpus; De:Peritoneal 
Reflection can only be annotated in the colorectal cancer corpus; De:Cell Size is in the annotation 
schema for the lymphoma corpus. Except for the medical entity types, the annotation schemas for 
melanoma and lymphoma corpora are augmented with Linguistic categories, while the colorectal 
cancer corpus is not, probably because the definition of a medical entity type has implicitly included 
the lexical polarity or modality, mood and comment adjuncts, and temporality (e.g., Ex:Lymph Node 
Involvement, Re:TILS and Peritumoural Lymphocytes, Sy:Medical History). There are some synoptic 
fields present in the colorectal cancer pathology notes, such as “Serosal involvement: Absent” and 
“TILs: MILD”, where the Linguistic category instances are not to be annotated separately from the 
entities. Thus, the computational linguists decided to include lexicons regarding linguistic information 
in the annotations of these entity types, and Linguistic categories are exempted in the schema. 
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However, there are still some common types among the three corpora (e.g., some Structural 
categories). The same category may be presented with different names. For instance, the heading for 
“Diagnostic Summary” section is named as St:Diagnosis Heading, St:Synthesis Heading, St:Title-
Summary in the melanoma corpus, colorectal cancer corpus and lymphoma corpus respectively. 
De:Specimen Type is the only medical entity type that is defined with the same name and same 
description in all three corpora, suggesting that this is a general reporting standard in pathology notes. 
 
4.2.2 Relation Type 
There are 5 relation types in the final annotation schema. The relation annotation schema was targeted 
on the lymphoma corpus. 
 
Relation types were grouped into three border categories: Negate, Result and Spatial Specialization. 
They are described in detailbelow (the examples are highlighted with bold and underlined texts): 
 
Negate 
The Negate relation represents the absence of a clinical or pathological finding and diagnosis. It is 
designed for negation detection in the following progress. Note that only pertinent negations within a 
sentence are annotated. 
• A lower grade [“Sy:WHO Grade”] MALT lymphoma [“Sy:Diagnosis”] is not [“Li:Lexical 
Polarity Negative”] identified. 
• No [“Li:Lexical Polarity Negative”] Helicobacter [“Sy:Predisposing Factors”] or 
malignancy [“Sy:Diagnosis”] seen. 
 
If uncertainty is expressed in the sentence, it should be excluded from the annotation. Here is an 
example: 
• A paraffin block was sent to the Department of Anatomical Pathology, HOSP_NAME, for 
FISH studies to exclude [“Li:Lexical Polarity Negative”] mantle cell lymphoma 
[“Sy:Diagnosis”]. 
In the above example, “exclude” and “mantle cell lymphoma” cannot be annotated as a Negate 
instance. 
 
Result 
The Result relation indicates whether a biomarker is positive, negative or equivocal indicator for an 
ancillary study.  It can be sub-classified into three types: 
 
1. Result-Equivocal 
This relation should be annotated if a biomarker is an equivocal indicator for an ancillary study. 
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• Equivocal [“An:Immunohistochemistry-Equivocal”] - Kappa and lambda light chains 
[“An:Biomarker”], immunoglobulins A, G and M [“An:Biomarker”] . 
• Staining for CD15 [“An:Biomarker”]   is equivocal [“An:Immunohistochemistry-
Equivocal”]. 
 
2. Result-Negative 
This relation should be annotated if a biomarker is a negative indicator for an ancillary study. 
• CD5+ and CD23 [“An:Biomarker”]  – [“An:Immunohistochemistry- Negative”], suggesting 
mantle cell lymphoma on flow cytometry, but cyclin Dl [“An:Biomarker”]  negative 
[“An:Immunohistochemistry- Negative”]. 
• Negative [“An:Immunohistochemistry- Negative”] - CD3 [“An:Biomarker”], CD10 
[“An:Biomarker”], CD56 [“An:Biomarker”], ALK-1[“An:Biomarker”] 
 
3. Result-Positive 
This relation should be annotated if a biomarker is a positive indicator for an ancillary study. Note that 
instances that indicate the intensity of the positivity (e.g., “+++”, “++”, “+”) have precedence over 
others to be connected to the biomarkers. In the following first example, “+++” is connected to 
“CD20”, and “+” is connected to “CD30”, rather than “Positive” to “CD20” or “CD30”. 
• Positive - CD20 [“An:Biomarker”] +++ [“An:Immunohistochemistry- Positive”], CD30 
[“An:Biomarker”] + [“An:Immunohistochemistry- Positive”] 
• Tumour cells are strongly positive [“An:Immunohistochemistry- Positive”] for CD20 
[“An:Biomarker”] & BCL-2 [“An:Biomarker”]. 
 
Spatial Specialization 
This relation depicts the specific laterality of an anatomical site. 
• Right superficial parotidectomy & bilateral [“De:Laterality”] modified radical neck 
[“De:Anatomical Structure”] dissection.  
 
Each relation has particular arguments; in other words, it can only connect certain types of entities 
according to these relations. For example, a Spatial Specialization relation can only exist between a 
De:Anatomical Structure and a De:Laterality entity, whereas up to 11 entity types can be linked to a 
Li:Lexical Polarity Negative for Negate relations. Table 4.1 lists the relationships and their potential 
arguments. 
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Relation 
type 
Argument  #1 type Argument #2 type 
Negate Li:Lexical Polarity Negative De:Architecture, De:Cytomorphology, 
Sy:Diagnosis, Sy:WHO Grade, Sy:Clinical 
Impression, Ex:Other Sites of Disease, 
Sy:Constitutional Symptoms, 
Sy:Predisposing Factors, Re:Tissue 
Reaction, Sy:Diagnosis Subtype, 
En:Coexistent Pathology 
Spatial 
Specialization 
De:Anatomical Structure De:Laterality 
Result-
Positive 
An:Immunohistochemistry- 
Positive, An:Flow Cytometry- 
Positive 
An:Biomarker 
Result-
Negative 
An:Immunohistochemistry- 
Negative, An:Flow Cytometry- 
Negative 
An:Biomarker 
Result-
Equivocal 
An:Immunohistochemistry-
Equivocal 
An:Biomarker 
Table 4.1 Potential arguments for each relation type. 
 
4.3 Methods 
4.3.1 Annotation Tool 
The Visual Annotator (VA) 1 was used as an annotation tool in this study. It is a Python-based 
annotator that supports both entity and relation annotations, which was developed and maintained by 
Health Language Analytics staff members. Figure 4.2 shows a screen shot of the VA working 
environment.  
 
On one hand, Cohen et al indicated that most of the available annotated corpora were difficult to be 
restored or reused as they were stored in non-standard formats (Cohen et al., 2005). On the other hand, 
there are advantages for storing annotation in standoff format, such as optical recoverability and 
reusability.  
 
Therefore, a standoff annotation style was adopted in this study. It stores annotation and raw text 
separately to prevent any loss of the structure information of the original text (Leech, 1993). VA 
stores files in its own “ann” format, which can be converted into other appropriate formats for further 
processing. 
 
Each annotated entity and relation has some associated properties, which can be manually annotated 
or automatically generated by the tool. 
 
An entity has the following properties: 
• Type - The semantic type of the entity. 
                                                     
1 http://www.icims.com.au/VisualAnnotator/ 
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Figure 4.2 The Working environment of the Visual Annotator. 
 
• Extent - The text span of the entity. 
• Text - The string of text in the entity. 
• Id - The internal identifier of the entity.  
 
A relation has attributes as follows: 
• Type - The semantic type of the relation. 
• First Entity Type - The semantic type of the first entity. 
• First Entity Extent - The text span of the first entity. 
• First Entity Text - The string of text in the first entity. 
• Second Entity Type - The semantic type of the second entity. 
• Second Entity Extent - The text span of the second entity. 
• Second Entity Text - The string of text in the second entity. 
• First Argument Id - The internal identifier of the first entity. 
• Second Argument Id - The internal identifier of the second entity. 
 
During annotation, an annotator can annotate an entity by marking a span of text with its semantic 
type, and can also highlight a relation by marking links of two annotated entities. 
 
4.3.2 Annotation Guidelines 
Consistency is critical to the quality of a gold-standard corpus. It is important that each annotation 
must conform to the same standard. A large number of annotation tasks require direct annotation of 
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words in the text that relies on fairly consistent boundary segmentation by the annotators. However 
questions are frequently encountered while annotating a document. For example, should “2mm in 
diameter and 2mm in depth” be annotated as a De:Size instance, or as two instances? Should 
“extending focally onto the ragged serosal surface” be annotated as a In:Depth of Invasion instance or 
a Ex:Serosal Involvement instance? Should “diffuse malignant lymphoma of large and small cells” be 
annotated as a Sy:Diagnosis entity, or as a Sy:Diagnosis entity and a De:Cell Size entity? To ensure 
consistency, a set of guidelines ought to be provided to the annotators. Several issues are described in 
the guidelines: what should and should not be annotated; how to decide the boundary of a particular 
type of instance; how to decide whether two instances should be connected; and some special cases. 
The guidelines should also provide a sequence of steps, an instruction, which annotators should follow 
when annotating a document, in order to minimise errors of omission. 
 
Roberts et al have done an analysis of annotation difference between computational linguists and 
clinicians, which revealed that the computational linguists could find more pronominal co-references 
and verbally signalled relations, while the clinicians could find more relations requiring domain 
knowledge to resolve (Roberts et al., 2007). Hence they believed that a combination of both linguistic 
and medical knowledge were preferable for developing the guidelines. In this study, both 
computational linguists and medical consultants were involved in the guidelines development to 
capture the greatest amount of information. Since the annotation categories cannot be mapped directly 
to an existing lexicon in any controlled vocabulary, sometimes, the guidelines were developed 
according to the text in the corpora, so that they could reflect what actually occurs in the text. 
 
 
Figure 4.3 Annotation guidelines development process. 
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The guidelines were developed in the following processes, including guidelines creation and 
guidelines refinement, as illustrated in Figure 4.3.  
 
Firstly, the computational linguists and medical consultants specify the annotation categories in the 
pathology notes that have been introduced into the annotation schemas. The computational linguists 
also defined a set of linguistic rules to indicate what constituents should be annotated. The 
computational linguists randomly selected a small set of documents from the notes and annotated 
them using these rules. The annotations were analysed where every instance annotated was discussed 
and then more specific rules were compiled and merged into the initial rules. Based on these 
annotations and rules, the initial guidelines were created. 
 
Secondly, the six computational linguists individually annotated another small set of complex 
documents from the notes. They discussed every instance in their annotations with medical 
consultants, and made any change to the guidelines if necessary. A change to the guidelines can be 
either an addition of new rules to the guidelines to represent an unseen example, or modification of 
rules for ambiguous definitions. For instance, if the annotations of a boundary of a certain entity type 
occur inconsistently, a new rule will be added into the guidelines to resolve the ambiguity. After the 
guidelines refinement, the final guidelines were used as the references in the following main 
annotation exercise. 
 
The initial guidelines specified a set of linguistic rules for the annotation convention of the noun 
phrase boundaries, that is, an entity should not cross noun-phrase boundaries. However, based on the 
thorough analysis of the documents, these did not fit for most cases. Thus, more specific rules for 
defining the boundaries of the entity types were presented in the final guidelines (see Table 4.2, 4.3, 
4.4 for more details, wherein an empty boundary specification field suggests that the entity may cross 
the boundary of a noun phrase).  
 
Entity type Protocol standard/guideline Boundary specification 
De:Cell Growth Pattern G3.11  
De:Cell Type   
De:Cosmetic Changes G1.08  
De:Dermal Mitoses S3.05  
De:Shape S2.02  
De:Site and Laterality G1.03  
De:Size S2.03  
De:Specimen Type G1.06  
De:Ulceration S3.04  
En:Associated Naevus (type) G3.10  
En:Lesion (other) S2.06 NP 
En:Primary Lesion S2.05  
En:Satellites S3.06 NP 
En:Specimen Identifier   
In:Breslow Thickness (mm) S3.02  
In:Clark Level G3.04  
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In:Neurotropism G3.09  
In:Vascular/Lymphatic G3.05  
Li:Lexical Polarity Positive   
Li:Lexical Polarity Negative  NP, VP, PP, ADJP 
Li:Modality   
Li:Mood and Comment Adjuncts   
Li:Temporality   
Ma:Excision Clear S3.03  
Ma:Excision Deep G3.02  
Ma:Excision Invasive G3.02  
Ma:Excision In Situ G3.02  
Re:Desmoplasia G3.08 NP 
Re:Fibrosis   
Re:Solar Elastosis   
Re:Tils G3.06  
St:Clinical History Heading   
St:Comment Heading   
St:Diagnosis Heading   
St:Macroscopic Heading  NP 
St:Microscopic Heading  NP 
St:Specimen   
St:Subheading   
Sy:Diagnosis S3.01, G1.05, G1.10  
Sy:Regression G3.07  
Sy:Subtype G3.12  
Table 4.2 Correspondence and boundary specification for entity types in the melanoma corpus. NP: 
noun phrase, VP: verb phrase, PP: prepositional phrase, ADJP: adjective phrase. 
 
Entity type Protocol standard/guideline Boundary specification 
De:Ancillary Studies G4.01, G4.02  
De:Mesorectal Integrity S2.11  
De:Perforation S1.04, S2.09  
De:Peritoneal Reflection S2.10   
De:Serosa Description S2.12  
De:Specimen Blocks S2.02  
De:Specimen Images G2.02  
De:Specimen Size S2.04  
De:Specimen Type S1.07  
De:Tissue Banking G2.01  
De:Tumour Description S2.12  
De:Tumour Site S1.06, S2.05   
De:Tumour Size S2.06  
En:Coexistent Pathology S3.10  
En:Distant Spread or Metastases S1.11, S3.09  
En:Lymph Nodes S2.03  
En:Residual Tumour S1.09, S3.11, S5.02  
Ex:Donut Involvement   
Ex:Extent S1.10  
Ex:Extramuscular Spread S3.03  
Ex:Lymph Node Involvement S3.07, G3.01  
Ex:Serosal Involvement S3.03  
In:Depth of Invasion S3.03  
In:Perineural Invasion G3.02  
In:Venous and Small Vessel Invasion S3.08  
Ma:Circumferential Margin S2.08, S3.05, S3.06  
Ma:Clear S3.04, S3.05, S3.06  
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Ma:Proximal or Distal Margin S2.07, S3.04  
Met:Anatomic Stage S5.01  
Met:M Value S5.01  
Met:N Value S5.01  
Met:T Value S5.01  
Re:Desmoplasia and Fibrosis   
Re:Response to Rx S3.12  
Re:Tils and Peritumoural Lymphocytes   
St:Ancillary Studies Heading   
St:Clinical History Heading  NP 
St:Macroscopic Heading  NP 
St:Microscopic Heading  NP 
St:Subheading   
St:Synthesis Heading   
Sy:Comment S2.12, S5.03, G1.03,  G3.03  
Sy:Histological Grade S3.02  
Sy:Histological Type S3.01  
Sy:Medical History S1.08, G1.03  
Table 4.3 Correspondence and boundary specification for entity types in the colorectal cancer corpus. 
NP: noun phrase. 
 
Entity type Protocol standard/guideline Boundary specification 
An:Biomarker     
An:Cytogenetics Comment S4.02   
An:Fish Results S4.02   
An:Flow Cytometry-Comment S4.02   
An:Flow Cytometry-Negative S4.02 ADJP 
An:Flow Cytometry-Positive S4.02 ADJP 
An:IgH Test S4.01, S4.02   
An:Immunohistochemistry-Comment S4.02   
An:Immunohistochemistry-Equivocal S4.02 NP, ADJP 
An:Immunohistochemistry-Negative S4.02 NP, ADJP 
An:Immunohistochemistry-Positive S4.02   
An:PCR Comment S4.01, S4.02   
An:TCRgamma Test S4.02   
De:Anatomical Structure S1.03   
De:Architecture G3.01   
De:Cell Clonality   ADJP 
De:Cell Size G3.02   
De:Cytomorphology G3.03   
De:Laterality S1.04 NP, ADJP 
De:Lineage S5.01 NP 
De:Other Size     
De:Preservative Fluid S2.01 NP, ADJP 
De:Sample Triage S2.02   
De:Specimen Blocks     
De:Specimen Size S2.04   
De:Specimen Type S2.03 NP 
De:Tissue Source S1.03   
De:Topography S1.03   
De:Tumour Size     
En:Coexistent Pathology     
En:Specimen Identifier     
Ex:Disease Extent G1.05 NP 
Ex:Other Sites of Disease G1.05   
Li:Lexical Modality     
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Li:Lexical Polarity Negative     
Li:Lexical Polarity Positive     
Li:Mood and Comment Adjuncts     
Li:Temporality     
Re:Tissue Reaction G3.05   
St:Title-Clinical History     
St:Title-Comment     
St:Title-Frozen Section Report     
St:Title-Macroscopic Description     
St:Title-Microscopic Description     
St:Title-Nature and Specimen Type     
St:Title-Pathologist Notes     
St:Title-Special Investigations     
St:Title-Subheading     
St:Title-Summary     
St:Title-Supplementary Report     
St:Title-Supplementary Summary     
Sy:Clinical Impression G1.04 NP, ADJP 
Sy:Comment S5.03   
Sy:Constitutional Symptoms G1.07   
Sy:Diagnosis S5.02   
Sy:Diagnosis Subtype S5.02   
Sy:Indication for Biopsy G1.03   
Sy:Medical History G1.09   
Sy:Predisposing Factors G1.10   
Sy:Presentation     
Sy:SNOMED RT Codes     
Sy:Stage G5.04   
Sy:WHO Grade S3.02   
Table 4.4 Correspondence and boundary specification for entity types in the lymphoma corpus. NP: 
noun phrase, ADJP: adjective phrase. 
 
4.3.3 Main Annotation Exercise 
Previous works have reported that the levels of expertise are not the critical factor for annotation 
consistency if explicit guidelines or sufficient training are provided.  
 
Roberts et al have pointed out in their work that much of clinical text can be understood by a non-
clinician armed with a medical dictionary, as it can be exposed by the linguistic constructs of the text, 
although some relationships between entities may require more domain knowledge to understand 
(Roberts et al., 2007).  
  
Patrick et al’s study also indicated that computational linguists can reliably achieve higher consistency 
than pathologists in annotating a large corpus of pathology reports (Patrick and Scolyer, 2008). 
Especially, the consistency of linguists between each other is consistently higher than that between the 
pathologists, or between a linguist and a pathologist. It suggested that once trained to understand the 
linguistic features and extent of pathology concepts, linguists are also capable of annotating pathology 
notes reliably.  
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Therefore, the following annotation process was mainly carried out by an annotation team composed 
of six linguists. They were given a few hours of a training session, focused on the annotation 
instructions and the guidelines before they started to do the main annotation exercise. If difficult cases 
were encountered, they could also turn to medical consultants (clinician and pathologist) for advice. 
 
Double annotation is widely used in an annotation task, where each document is independently 
annotated by two annotators, and the sets of annotations compared for agreements. Agreements from 
the original annotators are accepted into a consensus set, and the third annotator adjudicates on 
differences between the original annotators and resolves them.  Obviously, this method has several 
advantages compared to single annotation, such as reducing the idiosyncrasies of an individual 
annotator and avoiding one-off errors made by a single annotator. Nevertheless, it also requires more 
annotator labour and effort to be devoted to the task. 
 
To address the difficulty of the annotation task, Roberts et al suggested some approaches (Roberts et 
al., 2009), which include:  
• Active learning or mixed initiative approaches can be explored to utilize annotator effort 
most effectively. Since the annotation and system learning stages are integrated in these 
approaches so that except in the early stage, annotators only need to correct and augment the 
annotations that the system has added to a document rather than annotating the whole 
document from scratch. These approaches can reduce the amount of human annotator input 
so that human effort can be concentrated on more difficult cases.  
• Another approach is to adopt a distributed and collaborative annotation framework in which 
the grain size of annotation instances is reduced to a snippet. This approach has many 
advantages, such as smaller annotation grain size indicates smaller levels of effort can be 
exploited and reduces the difficulty for annotators by focusing effort on single-decision types 
over small snippets of text; the annotation of individual instances can be repeated until it 
reaches a satisfactory level of agreement, or they can be eliminated if they turn out to be 
problematic. 
 
Inspired by these approaches, a mixed conveyor method with a two phase validation was purposed to 
accomplish the task. The annotation team was divided into two groups. Each Group had a subset of 
the total categories to annotate. Each team member annotated the documents for those categories 
assigned to them. The team leader reviewed each annotation, as a validator for the development of the 
first gold standards.  There are several benefits of using this method:  
• It requires less time for an annotator to process a document, as each annotator only needs to 
annotate particular information of interests in the document rather than the whole document. 
• It reduces the difficulty for annotation, since annotators can focus effort on the categories 
assigned to them instead of the total categories to make their decisions. 
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• The quality of annotation is reflected by not only the consistency, but also the correct 
application of the guidelines by annotators. Since the validator reviewed the annotations 
strictly followed the guidelines, ensuring the guidelines were applied correctly in most cases. 
 
The annotators conferred and reconciled the differences where possible. Unresolved differences were 
passed to a pathologist to resolve. It is assumed that over 95% consistency was attained at last, as less 
than 5% differences remained unresolved. 
 
4.3.4 Recursive Validation 
The first gold standards were created manually, and thus may still contain minor errors and 
inconsistencies. These errors and inconsistencies can be identified by performing recursive validation 
on the training data with a 100% train and test strategy, which involves using 100% of the training set 
to build a simple model and then test on the same set until no improvement of the performance can be 
made.  
 
With this recursive validation process, more than 80, 2200 and 700 potential errors were detected in 
the training data of the melanoma corpus, colorectal cancer corpus and lymphoma corpus respectively.  
The potential errors can either represent erroneous annotations or weaknesses in the computational 
processing. Erroneous annotations can be text that should not be annotated, omitting what should be 
annotated, assigning an instance with incorrect category and marking an instance with the wrong span. 
The weaknesses in the computational processing can indicate the issues to be addressed in the various 
processes (e.g., features prepared for machine learners). Some error types of entity annotation and 
their corrections are listed in Table 4.5. Each potential error was manually identified if it was an 
erroneous annotation, then it was corrected so that the model would not learn from the incorrect 
examples. This process improved the micro-averaged scores by about 0.3%, 3.1% and 0.4% for the 
melanoma, colorectal cancer and lymphoma corpora respectively. 
 
4.4 Results  
4.4.1 Entity Annotation 
The frequency of annotations for each entity type after recursive validation is detailed in Tables 4.6, 
4.7, 4.8.  
 
There are in total 17470 annotated entities in the melanoma corpus, 3440 are in Linguistic categories 
and 1489 are in Structural categories. Medical entities account for 71.79% of all entities in the corpus. 
The highest frequency medical entities are En:Primary Lesion and Sy:Diagnosis, which account for 
22.73% of medical entities. About 4.73% of medical entities are distributed into 8 rare entity types: 
En:Lesion (other), En:Satellites, In:Neurotropism, Ma:Excision Deep, Ma:Excision In Situ, 
Re:Desmoplasia, Re:Fibrosis, and Re:Solar Elastosis.  
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Table 4.5 Error types of entity annotation and their corrections. 
 
 
Error type Comment for correction Incorrect example Correct example 
Including or 
excluding 
punctuation 
Except for the entailed 
punctuation of an instance 
(e.g., “.” for “En:Specimen 
Identifier” or “Specimen 
Identifier”), “?” 
representing lexical 
modality, punctuation that 
constitute a abbreviation, 
punctuation should be 
excluded from the spans. 
2 [“En:Specimen 
Identifier”]. The sections 
confirm the clinical 
diagnosis of malignant 
melanoma. 
2. [“En:Specimen 
Identifier”] The 
sections confirm the 
clinical diagnosis of 
malignant melanoma. 
Inconsistent 
annotations 
between 
“De:Specimen 
Type” and 
“De:Tumour 
Site” 
Annotate the instances 
according to the local 
context.  If keywords like 
“tumour” and “carcinoma” 
appear in to the local 
context, then the instance 
should be annotated as 
“De:Tumour Site” , 
otherwise, it  should be 
assigned to “De:Specimen 
Type”. 
1. Left colon 
[“De:Tumour Site”]: A 
left sided resection 
measuring 350mm 
x30mm. 
1. Left colon 
[“De:Specimen 
Type”] : A left sided 
resection measuring 
350mm x30mm. 
Inconsistent 
spans for 
instances of 
“Ex:Lymph 
node 
involvement” 
Separate a long span to 
instances of “En:Lymph 
Nodes”  and “Ex:Lymph 
node involvement” 
respectively if it is 
possible. 
Eighteen definite lymph 
nodes are identified, with 
two containing metastatic 
tumour (= 2/18) 
[“Ex:Lymph node 
involvement”]. 
Eighteen definite 
lymph nodes are 
identified 
[“En:Lymph Nodes”], 
with two containing 
metastatic tumour (= 
2/18) [ “Ex:Lymph 
node involvement”]. 
Inconsistent 
spans for 
instances of 
the same type 
Use shorter spans in most 
cases to get more atomic 
instances. 
A16-A18 - Total of nine 
nodes (3 bisected nodes in 
each). A19 - Six lymph 
nodes (one was bisected) 
[“De:Specimen Blocks”]. 
A16-A18 - Total of 
nine nodes (3 bisected 
nodes in each) 
[“De:Specimen 
Blocks”]. 
A19 - Six lymph 
nodes (one was 
bisected) 
[“De:Specimen 
Blocks”]. 
Inconsistent 
annotations 
between 
“Presentation” 
and “ 
Constitutional 
Symptoms” 
Manually corrected by 
medical consultants. 
Lethargy 
[“Sy:Constitutional 
Symptoms ”]. 
Lethargy [“ 
Sy:Presentation”]. 
Nested 
annotations  
Do not annotate an 
instance nested in another 
instance with a longer span 
if it is possible. 
CD3 and CD20 each stain 
a population of small 
lymphocytes [“De:Cell 
Size”][ 
“An:Immunohistochemist
ry-Comment”]. 
CD3 and CD20 each 
stain a population of 
small 
lymphocytes [ 
“An:Immunohistoche
mistry-Comment”]. 
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Table 4.6 Entity frequency for the melanoma corpus. 
 
It is not surprising that the En:Primary Lesion and Sy:Diagnosis are at the top of the most frequent 
medical entity types, as most of the other findings are based on the identification of Primary Lesion; 
Diagnosis is usually the most important issue that should be addressed in a melanoma pathology 
report, and it can appear in any section of a note. 
 
Up to 29807 entities are annotated in total in the colorectal cancer corpus, wherein medical entities 
account for 87.08%, and the remaining 12.92% are in Structural categories. De:Specimen Blocks and 
De:Specimen Type have the highest frequencies, accounting for 20.17% of medical entities. Eight 
entity types have the lowest frequencies (below 0.5% each): De:Mesorectal Integrity, De:Peritoneal 
Reflection,  De:Specimen Images, De:Tissue Banking, En:Residual Tumour, Ex:Donut Involvement, 
Ex:Extramuscular Spread, and Re:Response to Rx. 
 
Most of the documents contain more than one De:Specimen Blocks instance as it is recommended that 
the pathologist should take sufficient blocks (generally at least 4) to fully assess all the necessary 
parameters for staging and prognosis. De:Specimen Type could appear more than once in a document 
as the clinician or pathologist tended to repeat it in different sections. Thus, both these entity types 
have high frequencies in the corpus. 
Entity type Number Proportion Entity type Number Proportion 
De:Cell Growth Pattern 615 3.52% Li:Mood and 
Comment Adjuncts 
931 5.33% 
De:Cell Type 694 3.97% Li:Temporality 167 0.96% 
De:Cosmetic Changes 266 1.52% Ma:Excision Clear 241 1.38% 
De:Dermal Mitoses 364 2.08% Ma:Excision Deep 166 0.95% 
De:Shape 555 3.18% Ma:Excision Invasive 362 2.07% 
De:Site and Laterality 817 4.68% Ma:Excision In Situ 88 0.50% 
De:Size 845 4.84% Re:Desmoplasia 16 0.09% 
De:Specimen Type 627 3.59% Re:Fibrosis 68 0.39% 
De:Ulceration 280 1.60% Re:Solar Elastosis 25 0.14% 
En:Associated Naevus 
(type) 
222 1.27% Re:Tils 212 1.21% 
En:Lesion (other) 57 0.33% St:Clinical History 
Heading 
250 1.43% 
En:Primary Lesion 1612 9.23% St:Comment Heading 28 0.16% 
En:Satellites 24 0.14% St:Diagnosis Heading 258 1.48% 
En:Specimen Identifier 842 4.82% St:Macroscopic 
Heading 
363 2.08% 
In:Breslow Thickness 
(mm) 
508 2.91% St:Microscopic 
Heading 
375 2.15% 
In:Clark Level 742 4.25% St:Specimen 164 0.94% 
In:Neurotropism 149 0.85% St:Subheading 51 0.29% 
In:Vascular/Lymphatic 229 1.31% Sy:Diagnosis 1238 7.09% 
Li:Lexical Polarity 
Positive 
1369 7.84% Sy:Regression 201 1.15% 
Li:Lexical Polarity 
Negative 
676 3.87% Sy:Subtype 476 2.72% 
Li:Modality 297 1.70% Overall 17470  
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Table 4.7 Entity frequency for the colorectal cancer corpus. 
 
The total amount of annotated entities in the lymphoma corpus is 19255, wherein 2553 are in 
Linguistic categories and 1765 are in Structural categories, and the remaining 77.57% are medical 
entities. The most frequently annotated medical entities are An:Biomarker, De:Tissue Source and 
De:Topography, with about 32.23%. There are 211 medical entities distributed sparsely into 15 entity 
types (each has no more than 50 instances), wherein  De:Cell Clonality, Ex:Disease Extent, An:Fish 
Results, An:Flow Cytometry-Negative, An:Flow Cytometry-Positive, An:IgH Test, Sy:Stage and 
An:TCRgamma Test have the lowest frequencies (each with less than 10 occurrences). 
 
Entity type Number Proportion Entity type Number Proportion 
De:Ancillary 
Studies 
272 0.91% In:Perineural Invasion 396 1.33% 
De:Mesorectal 
Integrity 
15 0.05% In:Venous and Small 
Vessel Invasion 
855 2.87% 
De:Perforation 154 0.52% Ma:Circumferential 
Margin 
254 0.85% 
De:Peritoneal 
Reflection 
138 0.46% Ma:Clear 758 2.54% 
De:Serosa 
Description 
212 0.71% Ma:Proximal or Distal 
Margin 
699 2.35% 
De:Specimen 
Blocks 
3343 11.22% Met:Anatomic Stage 291 0.98% 
De:Specimen 
Images 
30 0.10% Met:M Value 257 0.86% 
De:Specimen Size 1585 5.32% Met:N Value 409 1.37% 
De:Specimen Type 1892 6.35% Met:T Value 414 1.39% 
De:Tissue Banking 57 0.19% Re:Desmoplasia and 
Fibrosis 
271 0.91% 
De:Tumour 
Description 
1464 4.91% Re:Response to Rx 106 0.36% 
De:Tumour Site 1446 4.85% Re:Tils and Peritumoural 
Lymphocytes 
389 1.31% 
De:Tumour Size 682 2.29% St:Ancillary Studies 
Heading 
52 0.17% 
En:Coexistent 
Pathology 
1181 3.96% St:Clinical History 
Heading 
378 1.27% 
En:Distant Spread 
or Metastases 
284 0.95% St:Macroscopic Heading 387 1.30% 
En:Lymph Nodes 629 2.11% St:Microscopic Heading 388 1.30% 
En:Residual Tumour 124 0.42% St:Subheading 2121 7.12% 
Ex:Donut 
Involvement 
144 0.48% St:Synthesis Heading 524 1.76% 
Ex:Extent 610 2.05% Sy:Comment 1558 5.23% 
Ex:Extramuscular 
Spread 
197 0.66% Sy:Histological Grade 828 2.78% 
Ex:Lymph Node 
Involvement 
1133 3.80% Sy:Histological Type 998 3.35% 
Ex:Serosal 
Involvement 
392 1.32% Sy:Medical History 206 0.69% 
In:Depth of Invasion 1284 4.31% Overall 29807  
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Entity type Number Proportion Entity type Number Proportion 
An:Biomarker 1928 10.01% Ex:Other Sites of Disease 53 0.28% 
An:Cytogenetics Comment 18 0.09% Li:Lexical Modality 322 1.67% 
An:Fish Results 8 0.04% Li:Lexical Polarity Negative 366 1.90% 
An:Flow Cytometry-
Comment 88 0.46% 
Li:Lexical Polarity 
Positive 1125 5.84% 
An:Flow Cytometry-
Negative 3 0.02% 
Li:Mood and 
Comment 
Adjuncts 
607 3.15% 
An:Flow Cytometry-
Positive 3 0.02% Li:Temporality 133 0.69% 
An:IgH Test 7 0.04% Re:Tissue Reaction 259 1.35% 
An:Immunohistochemistry-
Comment 246 1.28% 
St:Title-Clinical 
History 224 1.16% 
An:Immunohistochemistry-
Equivocal 27 0.14% St:Title-Comment 36 0.19% 
An:Immunohistochemistry-
Negative 284 1.47% 
St:Title-Frozen 
Section Report 39 0.20% 
An:Immunohistochemistry-
Positive 594 3.08% 
St:Title-
Macroscopic 
Description 
223 1.16% 
An:PCR Comment 27 0.14% 
St:Title-
Microscopic 
Description 
226 1.17% 
An:TCRgamma Test 2 0.01% 
St:Title-Nature 
and Specimen 
Type 
123 0.64% 
De:Anatomical Structure 396 2.06% St:Title-Pathologist Notes 83 0.43% 
De:Architecture 472 2.45% St:Title-Special Investigations 47 0.24% 
De:Cell Clonality 1 0.01% St:Title-Subheading 463 2.40% 
De:Cell Size 488 2.53% St:Title-Summary 226 1.17% 
De:Cytomorphology 178 0.92% 
St:Title-
Supplementary 
Report 
38 0.20% 
De:Laterality 18 0.09% 
St:Title-
Supplementary 
Summary 
37 0.19% 
De:Lineage 140 0.73% Sy:Clinical Impression 185 0.96% 
De:Other Size 123 0.64% Sy:Comment 77 0.40% 
De:Preservative Fluid 110 0.57% Sy:Constitutional Symptoms 28 0.15% 
De:Sample Triage 793 4.12% Sy:Diagnosis 1056 5.48% 
De:Specimen Blocks 847 4.40% Sy:Diagnosis Subtype 30 0.16% 
De:Specimen Size 467 2.43% Sy:Indication for Biopsy 28 0.15% 
De:Specimen Type 802 4.17% Sy:Medical History 82 0.43% 
De:Tissue Source 1482 7.70% Sy:Predisposing 60 0.31% 
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Table 4.8 Entity frequency for the lymphoma corpus. 
 
The possible reasons for the high frequencies on An:Biomarker, De:Tissue Source and 
De:Topography are: 
• Biomarkers are requisite for many ancillary studies, especially for immunohistochemistry 
tests; an ancillary study usually involves more than one biomarker. 
• A specimen can consist of different kinds of tissues, the source of which is captured by 
De:Tissue Source. 
• De:Topography represents the anatomical site of a biopsy or operation, which appears 
extensively in Clinical History, Specimen and Summary sections. 
 
The protocol did not explicitly specify what ancillary study should be performed by the pathologist. It 
seems that the pathologist tended to perform more immunohistochemistry tests than other ancillary 
tests (e.g., FISH tests, Flow Cytometry, IgH tests and TCRgamma tests) according to the low 
frequencies on the associated entity types in the corpus. 
 
There are 38592, 163293 and 49799 tokens annotated as entities in the melanoma, colorectal cancer 
and lymphoma corpora respectively, thus the average lengths of entities are 2.21, 5.48 and 2.59 
respectively. It suggests that the pathologists preferred to use longer terms or descriptions to depict 
their findings, procedures or diagnoses in the colorectal cancer corpus. A deeper analysis shows that 
in this corpus, up to 18 entity types have an average length of over 6, wherein those of two types 
(De:Ancillary Studies and De:Tissue Banking) are more than 10.  The colorectal cancer corpus also 
has the largest entity density, which is 72.68%, as the entities of which outnumbered those of other 
two corpora; whereas, the smallest entity density is not in the melanoma corpus (53.76%), but in the 
lymphoma corpus (43.91%) instead. The possible reason is that compared to the lymphoma corpus, 
although the melanoma corpus has smaller amount of tokens annotated as entities, it has much smaller 
amount of tokens in total (71786 vs.113413). A comparison of the entities among the three corpora is 
presented in Table 4.9. 
 
 Melanoma corpus Colorectal cancer corpus  Lymphoma corpus  
No. of tokens  71786 224660 113413 
No. of entity types 41 45 63 
No. of entities 17470 29807 19255 
Average length 2.21 5.48 2.59 
Entity density 53.76% 72.68% 43.91% 
Table 4.9 Comparison of entity densities among the three corpora. 
Factors 
De:Topography 1404 7.29% Sy:Presentation 98 0.51% 
De:Tumour Size 51 0.26% Sy:SNOMED RT Codes 994 5.16% 
En:Coexistent Pathology 160 0.83% Sy:Stage 3 0.02% 
En:Specimen Identifier 675 3.51% Sy:WHO Grade 134 0.70% 
Ex:Disease Extent 8 0.04% overall 19255  
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4.4.2 Relation Annotation 
The relations were annotated after the annotation of entities. Annotators could only mark a 
relationship between two existing entities in the lymphoma corpus. Table 4.10 lists the distribution of 
relation types in the corpus. 
 
Relation type Sentence distance Number Proportion 
0 1 
Negate 318 0 318 14.12% 
Spatial Specialization 12 0 12 0.53% 
Result-Positive 937 10 947 42.05% 
Result-Negative 924 16 940 41.74% 
Result-Equivocal 35 0 35 1.55% 
Overall 2226 26 2252  
Table 4.10 Distribution of relation types and sentence distance between two entities in the lymphoma 
corpus. 
 
The corpus consists of 2252 relations in total, of which 318 are Negate relations and 1922 are Result 
relations. Not all entity types were covered by a relation, as mentioned in the relation schema. There 
are 20 types of entities selected for relation annotation. 
 
Table 4.10 also shows the number of sentence distance for each relation. Among all annotated 
relations, 26 relations are inter-sentential, which is 1.15%, and all inter-sentential relations are from 
Result relations, where each connected entities are located in adjacent sentences. This is probably 
because the annotations of Negate and Spatial Specialization relations could not cross the sentence 
boundaries according to the guidelines. It is assumed that the inter-sentential relations may be harder 
to recognise, due to their longer distances between entities. 
 
4.5 Discussion 
Several exsiting annotated corpora for IE in the clinical domain are not suitable for the tasks in this 
study, mainly due to entity types annotated by using standard terminologies. A preliminary study 
shows that less than half of the concepts in the corpora could be annotated with medical categories 
from SNOMED CT. Thus it is necessary to prepare semantically annotated corpora for this study. 
 
Annotating pathology notes is quite difficult, as it not only needs linguistic knowledge, but also a 
considerable amount of medical knowledge. Explicit annotation guidelines are very important to 
ensure high quality annotation due to the high variability of the medical vocabulary used and personal 
writing styles that pathologists presented in the notes. 
 
There are two kinds of distinguishable opinions for designing an annotation schema. Some advocate 
that to reduce the difficulty of the annotation task, the annotation schema should narrow the scope and 
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simply focus on fewer entities or relations (Roberts et al., 2009). Others argue that to achieve better 
consistency, less ambiguity and greater coverage of the concepts in the corpus, a possible solution is 
to create fine-grained categories by dividing the top categories into smaller classes along the 
terminology’s hierarchy (Wang, 2009). The former strategy may not be possible for an intended 
application, as the entities or relations designed in the schema can be too general to meet the 
requirements of the application. The latter strategy requires the annotators to spend more effort and 
use deeper domain knowledge, consequently increase the difficulty of the annotation task. It is evident 
that appropriate granularity is a crucial factor for designing an annotation schema. 
 
One of the indicators for assessing the quality of the annotation schema in this study is the 
correspondence between the entity types and standards or guidelines in the protocols. The detail 
correspondence for matching the entity types to the standards or guidelines is displayed in Tables 4.2, 
4.3, 4.4. It can be seen that most medical entity types have at least one corresponding standard or 
guideline, suggesting that the annotation schemas have appropriate granularity that can captured most 
of structured template related information without too much ambiguity.   
 
Entity types in the Linguistic and Structural categories cannot be made to correspond with any 
standard or guideline, as these were designed with linguistic knowledge rather than medical 
knowledge from the protocols. There may be several reasons why some medical entity types do not 
have corresponding standard or guideline as well: 
• They represent structured template related information that is not described in the standards 
or guidelines (e.g., Re:Tils and Peritumoural Lymphocytes for the colorectal cancer corpus), 
revealing the deficiency of the protocols. 
• They are critical for the consruction of a structured template (e.g., En:Specimen Identifier for 
the melanoma corpus and lymphoma corpus), although they are not indicated in the standards 
or guidelines. 
• They were designed with the intention to facilitate a distinction from similar entity types. For 
example, for the lymphoma corpus, De:Tumour Size and De:Other Size were designed to 
distinguish the two. 
• Medical consultants thought they may be of clinical significance, but not defined by any 
standard or guideline in the protocols (e.g., De:Cell Type for melanoma corpus). 
 
Likewise, there are some standards or guidelines without associated entity types, possibly because:  
1. These standards or guidelines need combinations of multiple entity types to represent. For 
instance, G5.01 in the Colorectal Cancer Structured Reporting Protocol (Eckstein et al., 
2010) requires a combination of De:Specimen Type, De:Tumour Site, Sy:Histological Type, 
Met:Anatomic Stage, Met:M Value, Met:N Value, Met:T Value and En:Residual Tumour to 
satisfy the conditions.  
2. These standards or guidelines indirectly relate to the entity types in fact. For example, for the 
melanoma corpus, St:Comment Heading does not have direct connection to S5.02 in the 
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Primary Cutaneous Melanoma Structured Reporting Protocol (Scolyer et al., 2010), but the 
recognition is definitely associated with it. 
 
It can be also observed that most of the entity types have a one-to-one match to a standard or guideline 
in the protocol. However, certain entity types can be matched to more than one standard or guideline, 
such as Sy:Diagnosis matched to S3.01, G1.05 and G1.10 in the Primary Cutaneous Melanoma 
Structured Reporting Protocol (Scolyer et al., 2010), and Sy:Comment matched to “S2.12, S5.03, 
G1.03 and G3.03” in the Colorectal Cancer Structured Reporting Protocol (Eckstein et al., 2010), 
implying that the information captured by these entity types can embed extensively in different 
sections in a report; or the goal of  designing these entity types is to represent broader scope of 
involved standards or guidelines. Similarly,  some standards or guidelines have more than one 
matched entity type. For example, G3.02 in the Primary Cutaneous Melanoma Structured Reporting 
Protocol (Scolyer et al., 2010) can match to Ma:Excision Deep, Ma:Excision Invasive and 
Ma:Excision In Situ. As mentioned in the previous chapter, these standards or guidelines require co-
occurrence of multiple elements to be correctly represented, so it is preferable to design multiple 
entity types rather than a single one for them. This can be also due to the over-specific definitions of 
the entity types that cannot cover all the aspects the standards or guidelines may involve. For instance, 
S3.03 in the Colorectal Cancer Structured Reporting Protocol (Eckstein et al., 2010) have three 
matchs: Ex:Extramuscular Spread, Ex:Serosal Involvement, and In:Depth of Invasion. Each of them 
represents one aspect of the standard, as the bowel wall can have several layers: mucosa, submucosa, 
muscularis propria, subserosa and serosa; Ex:Extramuscular Spread and Ex:Serosal Involvement focus 
on muscularis propria and serosa respectively, while In:Depth of Invasion can depict the local 
invasion of all layers except for serosa.  
 
One of the difficulties for the annotation task is the annotation of modifiers. Determining the 
annotation definition for a modifier is not easy as it requires both linguistic and domain knowledge. 
Some modifiers play important roles in constituting medical entities, while others are attributes of 
medical entities, or indicators of the intensity or degree of medical entities. Given the roles the 
modifiers play, there can be two distinct annotations to be made: for the former role, the modifiers 
should be annotated as part of the medical entities; for the latter one, the modifiers should be 
annotated as Li:Mood and Comment Adjuncts  for the melanoma corpus and the lymphoma corpus. 
However, since there are no Linguistic categories in the colorectal cancer corpus, the phrases referring 
to them  should always be annotated as part of the medical entities if they are clinically significant for 
the entities. In the following examples, the modifier small is annotated as a linguistic entity in the first 
example and part of a medical entity in the remaining examples: 
• Occasional small [“Li:Mood and Comment Adjuncts”] foci of TILs suggest early regression. 
• The small polyp identified macroscopically is a moderately dysplastic tubular adenomas 
[“En:Coexistent Pathology”]. 
• Mediastinal mass - Favour small cell B cell lymphoma [“Sy:Diagnosis”], await second 
opinion 
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The annotation of negation or uncertainty phrases is another difficult issue encountered during the 
task.  
 
Since there are no explicit or coherent guidelines released for the annotation of negation phrases at 
present, and one of our research questions is to find out how the annotation of negation phrases can 
affect negation detection, two main strategies were chosen to annotate the negation phrases:  
• For the melanoma and lymphoma corpora, the negation phrases were annotated as Li:Lexical 
Polarity Negative instances. However, there are minor differences for the boundary of this 
Linguistic category in the corpora: in the melanoma corpus, Li:Lexical Polarity Negative 
excludes prepositions, while they can be included in the lymphoma corpus. For example, “no 
evidence of” would be annotated as “no [“Li:Lexical Polarity Negative”] evidence 
[“Li:Lexical Polarity Positive”] of” in the melanoma corpus, but “no evidence of  
[“Li:Lexical Polarity Negative”]” in the lymphoma corpus. 
• For the colorectal cancer corpus, a negation phrase is annotated as part of a medical entity if 
only this entity is negated by the negation phrase in the sentence or the definition of the 
entity has implicitly indicated to include negations; otherwise, if a negation phrase negates 
more than one entity, it should not be annotated. Here are three examples: 
1. 14 lymph nodes are identified and they show no evidence of metastatic tumour 
[“Ex:Lymph Node Involvement”]. The negation phrase “no evidence of” suggests 
that the identified lymph nodes are malignantly uninvolved, thus it is annotated as 
part of an Ex:Lymph Node Involvement  instance. 
2. There is no lymphovascular [“In:Venous and Small Vessel Invasion”] or perineural 
[“In:Perineural Invasion”] invasion. As the negation phrase “no” negates two 
medical entities, it is not annotated. 
3. Extramural venous involvement is not seen [“In:Venous and Small Vessel 
Invasion”]. The negation phrase “not” only negates one entity, hence, it is annotated 
as part of the entity. 
 
Similarly, the strategies for annotating uncertainty phrases are: for melanoma and lymphoma corpora, 
the uncertainty phrases are annotated as Li:Modality or Li:Lexical Modality instances; for the 
colorectal cancer corpus, if only one medical entity is asserted by an uncertainty phrase in the 
sentence or uncertainty can be included in the definition of the entity, the uncertainty phrase should be 
annotated as part of the entity; otherwise, if more than one entity is asserted by the uncertainty phrase, 
it should not be annotated. 
 
The annotation task reveals that pathology reports are distinguishable from other clinical notes. The 
melanoma corpus is compared to discharge summaries from the 2010 i2b2/VA Challenges (Uzuner et 
al., 2011) in the following aspects:  
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1. Section headers. Section headers in a pathology report are more fixed, which can be 
summarized to six types in the melanoma corpus: “Clinical History”, “Specimen”, 
“Macroscopic”, “Microscopic”, “Diagnosis” and “Comment”; section headers in a discharge 
summary are more diverse, including “Chief Complaint”, “Past Medical History”, 
“Discharge Medications”, “Discharge Diagnosis”, etc. 
2. Scope of a medical entity. Annotation guidelines of 2010 i2b2/VA Challenges pointed out 
that “Only complete noun phrases and adjective phrases should be marked”. Nevertheless, 
the scope of an entity in a pathology report can be more flexible. For example, a verb 
“shows” for Li:Lexical Polarity Positive, multiple noun  phrases like “Breslow thickness 
1.6mm” for In:Breslow thickness (mm), a clause or sentence like “mitotic rate is 15 to 18 per 
mm2” for De:Dermal mitoses.  
3. Focus of medical entity types. 2010 i2b2 Challenges mainly focused on three types of 
medical entity: Problem, Test and Treatment. Medical entity types of a pathology report can 
be more specific and detailed. For instance, De:Site and Laterality,  De:Cell Growth Pattern, 
En:Primary Lesion, etc., and there are up to 41 entity types in a melanoma pathology report. 
Thus, it requires more domain and linguistic knowledge, and training to annotate a pathology 
report. 
 
It can be learned from the annotation task that although the annotators for the main annotation process 
were linguists instead of pathologists, they were competent to accomplish the task.  Since most of the 
clinical text can be understood by the linguists and the meaning of most entities can be determined by 
the linguistic constructs of the texts once the linguists are trained, they were able to annotate most 
entities, using their linguistic knowledge rather than medical knowledge. For some difficult cases, 
such as abbreviations or acronyms, they also needed to resolve with medical knowledge. They could 
either look up the dictionaries or textbooks (e.g., NCI Dictionary of Cancer Terms Histology (NCI, 
2008-2014) and Cell Biology: An Introduction to Pathology (Kierszenbaum and Tres, 2011), and 
Colorectal Cancer: Multimodality (Saltz, 2002)) or ask the medical consultants for advice. Since the 
annotators have similar background, their annotations are relatively consistent with the guidelines. 
 
4.6 Conclusion 
This chapter described three semantically annotated corpora: melanoma corpus, colorectal cancer 
corpus and lymphoma corpus, which were annotated with entities and relationships between the 
entities. The annotation process was described, including the design of the annotation schemas and 
guidelines, and main annotation process.  
 
To represent structured templates with related information in the pathology notes, there are up to 29 
and 39 types of medical entities annotated in the melanoma and colorectal cancer corpora 
respectively, 46 types of medical entities and 5 types of relationships annotated in the lymphoma 
corpus. Some Linguistic and Structural categories were added to the schemas as suggested by the 
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computational linguists, resulting in 12, 6 and 17 additional entity types annotated in the melanoma 
corpus, colorectal cancer corpus and lymphoma corpus respectively. The correspondence analysis 
shows that the annotation schemas have appropriate granularity that can capture most of the structured 
template related information without too much ambiguity. 
 
A mixed conveyor method was used to improve the efficiency and reduce the difficulty of the 
annotation task. Linguists carried out the main annotation process, and they were capable of 
accomplishing the task. Furthermore, recursive validation was performed on the first gold standards to 
attain higher consistency among the annotations. 
 
These corpora can be used as resources to support training and evaluating the information extraction 
systems built to extract information from pathology notes. Although the size of each corpus is small, 
owing to limited time and resources, it is believed that their unique annotations with high quality 
make them suitable for future experiments. They can be good supplementary materials to the clinical 
NLP research as well. 
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Chapter 5 Medical Entity Recognition 
5.1 Introduction 
Entity recognition (ER) is one of the key components of an information extraction (IE) system. As 
defined by the Message Understanding Conference-6 (MUC-6) (Grishman and Sundheim, 1996), it is 
a task that automatically locates references of interest in natural languages and classifies them into 
predefined categories. The predefined categories vary in different domains. In the general domain, 
they can be person, location, organization, date and so on; in the biomedical domain, they usually 
refer to proteins, genes, chemicals, etc.; in the clinical domain, they are likely to be disorders, signs or 
symptoms, anatomical sites, medications, and procedures. Moreover, in a particular sub-domain, they 
can be problem-specific. For example, identification of medication information from discharge 
summaries was the main theme of the 2009 i2b2/VA Challenge, where seven categories were defined: 
dosages, modes of administration, frequencies, durations, and reasons for administration (Uzuner et 
al., 2010). In the pathology domain, the predefined categories are more specific and detailed. As most 
categories to be classified are based on medical knowledge, they are named as medical entity types, 
and the task of recognising them is called medical entity recognition (MER). 
 
MER should be discriminated from another similar task – named entity recognition (NER), as NER 
restricts the task to identify rigid designators as defined by Kripke (Kripke, 1980), including proper 
names, certain natural terms like biological species and substances. In the clinical domain, the named 
entities are terms in standard terminologies (e.g. UMLS, SNOMED CT and ICD-9). As mentioned in 
the previous chapter, the medical entities which this study attempts to identify are not restricted to 
them, thus MER can be more complicated than NER. 
 
Medical entities are distributed extensively in the pathology notes according to the statistics of entity 
densities in the previous chapter, hence recognition of these entities provides opportunities to extract 
useful information embedded in the notes so that the information can be used to track the performance 
of pathologists and facilitate communication between the clinical staff and pathologists. MER can also 
improve the efficiency of reading the pathology notes, as the clinical staff or pathologists can identify 
the contents of interest rapidly through the highlighting of the entities. It can ease the data retrieval, 
automatic encoding and indexing by medical informaticians and researchers as well. Moreover, it is 
crucial for more advanced IE tasks such as negation and uncertainty detection, relation extraction, and 
structured output generation.  
 
In the previous chapter, three semantically annotated corpora have been described along with the 
issues of developing training data to support learning of the machine learners and extraction of rules. 
In this chapter, a supervised machine-learning based-approach is developed to recognise medical 
entities from the corpora. Specifically, an MER system using Conditional Random Fields (CRF) and 
integration with various features is presented. This chapter firstly describes the overview of CRF and 
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evaluation methods, and then follows with some pre-processing (e.g., tokenisation, sentence boundary 
detection and proof reading), the descriptions of features, the experimental results and discussion.  
 
5.2 Conditional Random Fields 
Conditional Random Fields (CRF) is a framework for building probabilistic models to segment and 
label sequence data. Given a particular observation sequence, CRF defines a conditional probability 
distribution over label sequences rather than a joint distribution over both label and observation 
sequences. In CRF, models can be trained by learning the conditional distributions between the labels 
and features from the observations, and then they can be used to predict the most likely assignment to 
a new label.  
 
It is a family of discriminative models first proposed by Lafferty et al (Lafferty et al., 2001). Its 
definition is as follows:  
Let X be a random variable over the data, Y be the random variable over a label sequence, G = (V, E) 
be a graph where Y is indexed by the vertices of G, so that 𝑌 = 𝑌𝑣 , 𝑣 ∈ 𝑉. The conditional random 
field (X, Y) is defined as when conditioned on X, the random variables 𝑌𝑣  has the Markov property 
with respect to the graph G: 𝑝(𝑌𝑣 | 𝑋,𝑌𝑤 ,𝑤 ≠ 𝑣) = 𝑝(𝑌𝑣 | 𝑋,𝑌𝑤 ,𝑤 ~𝑣), where w ~ v means that they 
are neighbours in G. 
 
The simplest and important structure of G is a linear chain, which is very close to the nature of the text 
(a sequence of words), where X and Y are assumed to have the same length. The generic input 
sequence is denoted by 𝑥 =  𝑥1 , 𝑥2 ,⋯𝑥𝑛 , and the label sequence is denoted by 𝑦 =  𝑦1 ,𝑦2 ,⋯𝑦𝑛. 
Figure 5.1 presents the graphical structure of linear chain CRF.  
 
Figure 5.1 Graphical structure of linear chain CRF. 
 
CRF (X, Y) is specified by two vectors: vector f stands for local features, and λ is the parameter vector 
learned weight for the feature vector. 
 
The global feature vector F is given by  
𝐹 (𝑦, 𝑥) =  ∑ 𝑓 (𝑦, 𝑥, 𝑖)𝑖  
where i is the current position. 
 
xi-1 xi xi+1 
yi yi+1 yi-1 
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Then the conditional probability of a state sequence given an input sequence in the linear chain CRF is  
𝑝𝜆(𝑌|𝑋) =  exp 𝜆 ∙ 𝐹 (𝑌,𝑋)𝑍𝜆(𝑋)  
where 𝑍𝜆(𝑋) is a normalisation factor of all label sequence, and given by 
𝑍𝜆(𝑋) =  � exp 𝜆
𝑦
∙ 𝐹(𝑦, 𝑥) 
Since 𝑍𝜆(𝑋) does not depend on y, the best label sequence y for input sequence x can be found to 
maximise the following function: 
𝑦� =  arg max
𝑦
𝑝𝜆(𝑦|𝑥) =  arg max
𝑦
 𝜆 ∙ 𝐹(𝑦,𝑥) 
It can be computed with the Viterbi algorithm. 
 
The maximum likelihood principle is applied to estimate the weight vector λ. Given a set of training 
data {(x(1), y(1)), (x(2), y(2)), ⋯ (x(k), y(k)}, the maximum likelihood principle finds its values by 
𝐿𝜆 =  � log𝑝𝜆(𝑦𝑘|𝑥𝑘)
𝑘
=  � [
𝑘
𝜆 ∙ 𝐹(𝑦𝑘 , 𝑥𝑘) − log𝑍𝜆(𝑥𝑘)] 
The optimization can be found by setting the partial derivative with respect to each parameter in λ to 
zero, which is represented as: 
∇𝐿𝜆 =  � [
𝑘
𝐹(𝑦𝑘 , 𝑥𝑘) −  𝐸𝑝𝜆(𝑌|𝑥𝑘)𝐹 (𝑌, 𝑥𝑘)] 
Define the transition matrix M for x at position i: 
𝑀𝑖[𝑦,𝑦′] = exp 𝜆 ∙ 𝑓( 𝑦,𝑦′, 𝑥, 𝑖) 
where y, 𝑦′ are labels. 
 
The expectation 𝐸𝑝𝜆(𝑌| 𝑥)𝐹 (𝑌, 𝑥) can be computed efficiently using a variant of the forward-backward 
algorithm: 
𝐸𝑝𝜆(𝑌| 𝑥)𝐹 (𝑌, 𝑥) =  �𝑝𝜆(𝑦|𝑥)
𝑦
𝐹(𝑦, 𝑥) =  �𝛼𝑖−1(𝑓𝑖 ∗  𝑀𝑖)𝛽𝑖𝑇
𝛼𝑛 ∙  1𝑇
𝑖
 
where * stands for component-wise matrix product, αi and βi are the forward and backward state-cost 
vectors,  denoted by 
𝛼𝑖 =  �𝛼𝑖−1 𝑀𝑖   0 < 𝑖 ≤ 𝑛1    𝑖 = 0   
𝛽𝑖
𝑇 =  �𝑀𝑖+1𝛽𝑖+1𝑇   1 ≤ 𝑖 <  𝑛1        𝑖 = 𝑛  
 
Lafferty et al described two iterative scaling algorithms for CRF training (Lafferty et al., 2001). They 
are very simple and guaranteed to converge, but the convergence is very slow when involving many 
correlated features,  as pointed out in Minka and Malouf’s works (Malouf, 2002; Minka, 2003). 
Conjugate gradient and second-order methods, such as preconditioned conjugate-gradient (Shewchuk, 
1994) and limited-memory quasi-Newton (Nocedal and Wright, 1999) can speed up CRF training. 
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The CRF-based MER systems have achieved the state of art performance without further post-
processing in the past i2b2 challenges (Uzuner et al., 2010; Uzuner et al., 2011), indicating that it is 
one of the best machine learners for MER tasks. 
 
The MER task can be formulated as a sequential labelling task, where each token needs to be assigned 
with a label in a sequence. There were several representations to represent the associations between 
the token and the entity (Shen and Sarkar, 2005). IOB2 notation (Sang and Erik, 2002) is selected to 
represent entities in this task, which has been widely used in other ER tasks. Each token in a sentence 
is represented with one of the B, I, O tags, where tag B shows the current token is at the beginning of 
an entity, I denotes the current token is inside an entity, and O indicates the current token is outside 
any entity. Therefore, for N entity types, there will be 2N +1 BIO tag types in total. The input of a 
CRF learner is a sequence of observed instances, and the output of a CRF learner is a sequence of BIO 
tags. Figure 5.2 displays a BIO representation of a sentence in the melanoma corpus. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 The BIO representation of the sentence: “The appearances are those of in-situ melanoma of 
superficial spreading type.” 
 
5.3 Evaluation Methods 
5.3.1 Evaluation Metrics 
As in an information retrieval system, evaluation metrics such as precision, recall, and F-score are also 
widely employed in an IE system. True positive, false positive, false negative and true negative are 
four important elements for computing these metrics. 
 
True positive (TP): the number of correctly predicted instances by the system. 
False positive (FP): the number of incorrectly predicted instances by the system. 
False negative (FN): the number of incorrectly rejected instances by the system. 
True negative (TN): the number of correctly rejected instances by the system. 
 
Token BIO tag 
The O 
appearances O 
are O 
those O 
of O 
in-situ B-SY:DIAGNOSIS 
melanoma I-SY:DIAGNOSIS 
of O 
superficial B-SY:SUBTYPE 
spreading I-SY:SUBTYPE 
type I-SY:SUBTYPE 
. O 
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The following scoring functions can be calculated by the above elements: 
Precision (P) is the ratio between the number of correctly predicted instances and the total amount of 
instances predicted by the system. It stands for the accuracy of the predictions made by the system. 
𝑃 =  𝑇𝑃
𝑇𝑃 + 𝐹𝑃 
 
Recall (R) is the ratio between the number of correctly predicted instances and the total amount of 
instances. It assesses the coverage of the predictions made by the system. 
𝑅 =  𝑇𝑃
𝑇𝑃 + 𝐹𝑁 
 
F-score (F) is the harmonic mean of precision and recall. Generally, it can be calculated as: 
𝐹𝛽 =  (𝛽2 + 1) × 𝑃 × 𝑅𝛽2 × 𝑃 + 𝑅  
where β gives a weight to precision and recall.  When β > 1, it weights recall higher than precision; β 
< 1, it puts more emphasis on precision than recall; β = 1, equally weights precision and recall. All the 
experiments in this thesis use β = 1, and the F-score, also known as the F1 measure, is calculated as: 
𝐹1 =  2 × 𝑃 × 𝑅𝑃 + 𝑅  
The higher F-score the system attains, the better performance the system achieves. 
 
5.3.2 Cross-validation 
Cross-validation is a model validation technique for assessing the generality of the results of a 
statistical analysis to an independent data set (Stone, 1974). Its main purpose is for researchers to 
estimate how accurately a predictive model will perform in practice. By defining test sets to test the 
model in the training phase, it can limit some problems like over-fitting. 
 
In n-fold cross-validation, the original data set is randomly partitioned into n sub-sets of equal size.  
Of the n sub-sets, a single sub-set is retained for testing the model, and the remaining n − 1 sub-sets 
are used as training data. The process is repeated n times, each time with different subset for testing, 
and then the results from each fold can be averaged to produce a single estimation. Ten-fold cross-
validation was used in most of the experiments in this study. 
 
5.3.3 Matching Criteria 
Traditional evaluation in NER tasks like MUC, used exact match as the standard matching criterion. 
Exact match requires both the boundaries and type of the entity to be in agreement with the gold-
standard. However, in some IE tasks, such as negation detection and relation extraction, the exact 
boundary match for entities is not essential for determining valid instances. 
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By studying some commonly used matching criteria in biomedical NER tasks, Tsai et al suggested 
that it is not necessary to apply exact boundary match in some cases, while left or right boundary 
match may be sufficient (Tsai et al., 2006). In the evaluations of past i2b2 challenges, partial match 
was also considered in the metrics (Uzuner et al., 2010; Uzuner et al., 2011). 
 
In the following evaluation for MER, both exact match and partial match criteria would be applied, 
wherein partial match criteria can be sub-classified into left boundary match, right boundary match 
and sloppy match  (if  the boundary of system prediction overlaps with that of the gold-standard). 
Figure 5.3 displays examples of different matching criteria. 
 
Entity Gold-
standard 
Exact match Left 
boundary 
match 
Right 
boundary 
match 
Sloppy match 
diffuse  B-
SY:DIAGNOS
IS 
B- 
SY:DIAGNOSI
S 
B- 
SY:DIAGNOS
IS 
O O 
malignant I-
SY:SUBTYPE 
I-
SY:SUBTYPE 
I-
SY:SUBTYPE 
O B- 
SY:SUBTYPE 
lymphoma I-
SY:SUBTYPE 
I-
SY:SUBTYPE 
I-
SY:SUBTYPE 
O I- 
SY:SUBTYPE 
of I-
SY:SUBTYPE 
I-
SY:SUBTYPE 
O O O 
large I-
SY:SUBTYPE 
I-
SY:SUBTYPE 
O B- 
SY:SUBTYPE 
O 
B-cells I-
SY:SUBTYPE 
I-
SY:SUBTYPE 
O I- 
SY:SUBTYPE 
O 
Figure 5.3 Examples of exact match, left boundary match, right boundary match and sloppy match. 
 
5.4 Pre-processing 
Like other IE tasks, pre-processing is also required by an MER task. Some typical pre-processing is 
described below. 
 
5.4.1 Sentence Boundary Detection 
Background 
It is important to detect sentence boundaries because other tasks are performed at the sentence level. 
In the general domain, the Wall Street Journal (WSJ) corpus and Brown corpus were typically used as 
the training or evaluation data. For instance, Palmer and Hearst developed a trainable algorithm 
composed of a lexicon with part-of-speech probabilities and a feed-forward neural network, which 
attained 98.5% accuracy on the WSJ corpus (Palmer and Hearst, 1994). Reynar and Ratnaparkhi 
reported that they achieved accuracies of 98.8% on the WSJ corpus and 97.9% on the Brown corpus 
by designing a maximum entropy model based algorithm for sentence boundary detection (Reynar and 
Ratnaparkhi, 1997). In the biomedical or clinical domains, some researchers adopted rule-based 
methods to detect sentences. For example, a rule-based system was developed by Xuan et al using 
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specific dictionaries, and had error rates of below 0.3% on their evaluation (Xuan et al., 2007).  There 
were also some clinical information systems such as Mayo clinical Text Analysis and Knowledge 
Extraction System (cTAKES) (Savova et al., 2010) that made use of third party tools (e.g., Gate2 and 
OpenNLP3) to annotate sentences in clinical documents.  
 
However, it is more difficult to detect the sentence boundaries in pathology notes, compared to those 
well-documented news articles or biomedical reports.  Although most sentences end with period “.” or 
colon “:”, some end without any punctuation; abbreviations or acronyms (e.g., M. – malignant, W.E – 
wide excision), and entailed punctuation of some entities (e.g., “.” for specimen identifiers, “?” 
representing lexical modality), can complicate the detection.  
 
Methods and Results 
Due to the characteristics of the corpora and the advantages of machine learning approaches, a 
sentence boundary detector was built by using the maximum entropy model based algorithm designed 
by Reynar and Ratnaparkhi (Reynar and Ratnaparkhi, 1997), implemented in Python and trained with 
the three corpora. The sentence boundary detector achieved accuracies of 98.77%, 98.86%, and 
99.02% in 10-fold cross-validation experiments on the melanoma, colorectal cancer and lymphoma 
corpora respectively. 
 
5.4.2 Tokenisation 
Background 
The raw texts in a document need to be split into sentences, and then each sentence needs to be 
separated into tokens. This basic task of splitting a sentence into a list of words and other symbols is 
called tokenisation. In the general English domain, most tokens can be separated straightforwardly by 
white space. However, this naïve approach does not suit clinical narratives in some cases, and the 
errors caused by it can propagate severely through a downstream processing pipeline. Punctuation in a 
word can lead to a prominent amount of ambiguity. For example, splitting a hyphen from any word as 
a separate token may break a medical term, a compound word, or a code in a standard terminology. A 
period inside a token but not at the end of the token suggests the token can be a measurement, 
specimen block notation, abbreviation or acronym. This should be identified when performing 
tokenisation. 
 
                                                     
2 http://gate.ac.uk/ 
3 http://opennlp.apache.org/ 
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Methods and Results 
Words were broken initially at white space and punctuation symbols. After analysing the performance 
of the white space tokeniser, a set of rules was added, with special attention to separating punctuation 
symbols from words. They are described as follows (note: examples are separated by semicolon “;”): 
• Separate period “.” at the end of a word from the word (e.g., Malignant polyp .; I . Anterior ( 
R ) forearm). 
• Do not separate period “.” from a word if it is a measurement, specimen block notation, 
abbreviation or acronym (e.g., 4.5cm; W.E; 1.1). 
• Separate hyphen “-” and “+” at the end of a word from an alphanumeric word (e.g., CD3 +; 
CD5 -), but not a numeric word (e.g., 20+; 2+). 
• Do not separate a hyphen “-” inside a word from the word if it is not at the end of the word 
(e.g., non-peritonealised; 1-2; B-cell; M-95913; BCL-2). 
• Separate a question mark “?” at the beginning of a word from the word (e.g., ? lymphoma; ? 
MM). 
• Do not separate numbers and letters (e.g., 3mm; CD3). 
• Do not separate some consecutive punctuation (e.g., 1., 2.; ++). 
 
5.4.3 Proof Reading 
After tokenisation, each token is passed through the proof reading process. The main purpose of this 
process is to verify the token, identify the lexical resource of the token, and standardise the token. 
Besides three lexical resources: SNOMED CT (SCT), UMLS and Moby, which were introduced in 
Chapter 2 and 3, there are two other resources used in this process: abbreviation and misspelling 
lexicons. They were generated from the previous clinical notes (such as notes in the C311 corpus).  
The abbreviation lexicon contains about 1480 abbreviations or acronyms with their expansions, while 
the misspelling lexicon consists of over 75000 misspelt words and their correct spelling. Figure 5.4 
illustrates the proof reading process. 
1. First, the misspelling lexicon is used to verify whether the token is misspelt or not. If it is a 
misspelling, its correct spelling will be returned from the misspelling lexicon. Meanwhile, 
every word in the correct form of the token will be passed through the following steps. 
2. The token is checked as to whether it belongs to the abbreviation lexicon. If it does, this 
abbreviation or acronym will be expanded to its full name. If it doesn’t, it will be moved to 
the next step. 
3. In the following steps, the token is checked against the other three lexical resources 
respectively. If it is an entry in these resources, then it will be tagged as “moby”, “umls” and 
“sct” accordingly and exported. 
4. If the token does not belong to any of the resources mentioned above, it is passed to manual 
verification.  
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5. All the results from the above steps are subsequently manually verified by the medical 
consultants, and then they are stored in a correction dictionary, expansion dictionary, moby 
dictionary and medical dictionary respectively. 
 
Note that this process is only performed on single tokens, thus it cannot handle some complicated 
errors like missing letters and an extra white space (e.g., “fib nopurulent” should be 
“fibrinopurulent”). The frequency of these errors is not high in a single document, but for the whole 
corpus, it may be time-consuming to resolve them manually. Although a few of these errors have been 
found by the author and added to the correction dictionary, it is assumed that there are still some that 
require an additional process to identify. 
 
 
Figure 5.4 Proof reading process. 
 
It is also worth metioning that the expansions for ambiguous abbreviations were based on the 
frequencies of the full forms occurred in the corpora; that is, the most frequent full form would be 
selected as the result. For some complex cases, the expansions were determined by medical 
consultants. 
 
The proof reading process resulted in four types of dictionary, and the number of entries in the 
dictionaries for each corpus is presented in Table 5.1. 
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Dictionary Melanoma corpus Colorectal cancer corpus  Lymphoma corpus  
Correction 34 332 39 
Expansion 67 148 243 
Moby 2890 4815 4024 
Medical 189 476 437 
Table 5.1 Entries in the four dictionaries for each corpus. 
 
5.4.4 Part-of-speech Tagging and Shallow Parsing 
Background 
Part-of-speech (POS) tagging is the process of identifying a word in a text as corresponding to a 
particular part of speech. Shallow parsing, also called chunking is a process to identify phrases from 
constituent POS tagged tokens. For example, an adjective sequence followed by a noun can compose 
a noun phrase. Thus POS tagging is usually requisite for shallow parsing, which was recognised in 
1994 in a preliminary investigation on mapping clinical terms to SNOMED III (Sager et al., 1994).  
The identification of noun phrases was a crucial factor for MER with dictionary lookup methods. It is, 
for example, one of the essential processes in MetaMap (Aronson, 2001). However, POS taggers for 
general purposes usually do not perform well in the clinical domain because the lexical characteristics 
of clinical documents are considerably different from those of articles in the general domain, which 
are often used as the training data for these taggers. This was addressed by Huang et al, using a 
statistical parser trained with a corpus in the general domain integrated with the UMLS Specialist 
Lexicon (Huang et al., 2005). They found that the integration with the UMLS Specialist Lexicon 
could boost precision and recall of the system by about 5% and 6% respectively.  
 
Methods and Results 
Likewise, the annotation guidelines presented in the previous chapter indicate that some entity types 
cannot cross the boundary of certain kinds of phrase, such as noun phrases and adjectival phrases. The 
identification of these phrases can contribute to the boundary detection in the MER task.  The GENIA 
tagger is a robust POS tagger based on a cyclic dependency network with maximum entropy with 
inequality constraints, trained not only on the WSJ corpus, but also on the GENIA corpus and the 
PennBioIE corpus (Tsuruoka et al., 2005). The tagger has worked well on various types of biomedical 
documents. It achieved an accuracy of 98.49% on the GENIA corpus, and 91.2% on 332 abstracts of 
biomedical papers. Thus, it was adopted to perform POS tagging and shallow parsing in this sub-task. 
The results of POS tagging and shallow parsing on a sentence from the tagger are displayed in Table 
5.2. 
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5.4.5 Lemmatisation 
Background 
Lemmatisation is a morphological transformation process that changes a given word with different 
inflected forms into the canonical form or lemma of the word, so that different morphological variants 
of a word can be analysed as a single item. By reducing the total number of distinct words in the text, 
it decreases the complexity of processing the text. 
 
Stemming is closely related to lemmatisation, with a similar goal to map different forms of a word to a 
single form.  It normalizes the morphological variants of a word into the same form, a stem, by 
stripping off the suffix of a word. Since it does not aim to generate a naturally occurring canonical 
form of a word, it often results in incorrect conflation of semantically distinct terms (Fuller and Zobel, 
1998). For example, “excisions” and “excisional” would all be stemmed to “excision” by the Porter 
stemmer (Porter, 2006), while a lemmatiser would normalize into distinct base forms: “excision” and 
“excisional”. A lemmatiser can yield the canonical form of “larger” as “large”, while a stemmer 
cannot. Although most stemming algorithms are usually easier to implement and run faster, they fail 
to discriminate between words with different meanings depending on POS, as they don’t consider 
knowledge of the context of the words. Compared to the truncated ambiguous stems, there are more 
advantages shown by lemmas in document clustering and information extraction (Korenius et al., 
2004; Liu et al., 2011). 
 
Methods and Results 
Lemmatization may involve other processes such as understanding the context and determining the 
POS of a word in a sentence, thus a good POS tagger can also bring benefits to lemmatization. To be 
consistent with the results of POS tagging and shallow parsing, the GENIA tagger was used as a 
lemmatiser as well. Table 5.2 also presents some outputs of lemmatisation from the tagger. 
 
Token Lemma POS tag Chunk tag 
The The  DT  B-NP 
appearances appearance  NNS  I-NP 
are be  VBP  B-VP 
those those  DT B-NP 
of of  IN B-PP 
in-situ in-situ  FW B-NP 
melanoma melanoma  NN I-NP 
of of  IN B-PP 
superficial superficial  JJ B-NP 
spreading spread  VBG I-NP 
type type  NN I-NP 
. .  . O 
Table 5.2 Results of lemmatisation, POS tagging and shallow parsing on a sentence: “The 
appearances are those of in-situ melanoma of superficial spreading type.” from the GENIA tagger. 
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5.4.6 Section Context Detection 
Standard section headings are encouraged by health providers to write well-structured medical records 
(Fagan et al., 2003; Nieman et al., 2006). Accurate identification of section headings is critical for the 
detection of section contexts, which is a key step towards further automated or semi-automated 
clinical language processing. For instance, the diagnoses appearing in the “Clinical History” section 
are the clinical impressions or differential diagnoses provided by clinicians, while in the 
“Microscopic” or “Diagnosis Summary” sections, they are final diagnoses made by pathologists. 
 
Several studies have addressed this issue.  For instance, a pre-processor integrated into MedLee was 
able to recognise some common section headings in clinical records (Friedman et al., 1994), and it 
could achieve 92.0% precision and 91.0% recall in the evaluation conducted by Wang et al (Wang et 
al., 2010). Many methods purposed by other researchers are also based on rules. Meystre and Haug 
first implemented a regular expression section detector based on the heading morphology to analyse 
200 cardiovascular records, and then augmented it with the section headings extracted from their 
whole corpus to improve their section detector (Meystre and Haug, 2005). Although they could obtain 
100% precision and recall on the test set, the sample size was very small with only 20 records. Some 
researchers also purposed more sophisticated rule-based approaches to cope with this issue. For 
example, by applying post-processing, e.g. matching training data to UMLS concepts, correcting 
misspelling headings and removing stop words, SecTag started with the heading morphology, and 
finally obtained 95.6% precision and 99.0% recall on test records (Denny et al., 2009). Compared to 
those rule-based systems relying on more time-consuming and labour-intensive effort, statistical 
models have an apparent advantage that automatically learns from the predefined feature sets and 
labels the unseen data. A supervised machine learning approach was adopted by Guiasu and Shenitzer 
to identify section headings (Guiasu and Shenitzer, 1985). 
 
5.4.6.1 Section Heading Detection 
Section terminologies like Logical Observation Identifiers Names and Codes (LOINC) (LOINC 
Committee, 1994-2014) can facilitate Health Level 7 Clinical Document Architecture to provide a 
framework to represent and exchange clinical notes (Dolin et al., 2001). An hierarchical section 
header terminology developed by Denny et al, has also been utilised in SecTag as a reference 
terminology (Denny et al., 2008). However, these terminologies did not fit for this sub-task. As 
mentioned in the previous chapter, the section headers in pathology notes are distinct from other 
clinical documents (e.g. history and physical examination records, progress notes), which these 
terminologies were designed for.  A preliminary study using rules in Meystre and Haug’s work 
(Meystre and Haug, 2005) for this sub-task attained unsatisfactory results (lower than 80% accuracy). 
A CRF-based approach trained with annotated data, was adopted instead. 
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Feature Engineering 
The preliminary study has shown that the surface heading lexicon is not enough for high quality 
learning, as there are many lexical variants for some section headings, especially the subheadings. To 
capture more characteristics of the headings, other features are studied, including the contextual 
window, lower case of word, standardisation, orthography, and bigram. 
 
Contextual window: According to the analysis of the heading annotations, most of the headings are 
presented in a single line, which end with a new line separator; some headings are followed by 
punctuation like a colon “:” and hyphen “-”. Hence, the new line separator and the punctuation might 
be effective learning features in the contextual window, also known as “bag-of-word” models. 
Different sizes of contextual windows have been tried on the corpora, and the optimal size for each 
corpus is different:  seven for the melanoma corpus, nine for the colorectal cancer corpus and five for 
the lymphoma corpus. 
 
Lower case of word: Lower case of the word is used to normalize the orthographic variants of the 
word. For example, “CLINICAL NOTES” and “Clinical Notes” can be normalized to “clinical notes”. 
 
Standardisation: Standardisation refers to misspelling correction and expansion of abbreviations. 
Specific lists for correcting the misspelt or abbreviated words inside the heading strings were 
generated manually through the analysis of the heading annotations. Note that there are no misspelt or 
abbreviated words found on the heading annotations in the lymphoma corpus. 
 
Orthography: The rendition of words can be captured by the orthographic feature, which is a feature 
to indicate whether the predicates about the orthography of a word exist. Table 5.3 presents the 
predicates used in the experiments. 
 
Predicate Description Example 
IsUppercase Is the token in uppercase? CLINICAL; SPECIMEN 
IsTitlecase Does the token have initial capital? Diagnosis; Immunoperoxidase 
IsLowercase Is the token in lowercase? results; tumour 
HasHyphen Does the token contain any hyphen “-”? 1-2.; 1-3 
IsHyphen Is the token a hyphen? - 
IsSlash Is the token a slash? / 
IsColon Is the token a colon “:”? : 
IsBracket Is the token a round bracket “(” or “)”? ( ; ) 
IsDigit Is the token a digit? 1; 4 
HasPunctuation Does the token contain any other punctuation? T.N.M; ypT.N.M 
IsPunctuation Is the token punctuation except for those above? & ; . 
IsAlphanumeric Is the token an alphanumeric word? pTNM 
Table 5.3 Predicates used for representing the orthographic features (examples from section heading 
instances). Note: examples are separated by semicolon “;”. 
 
Bigram: A bigram is every sequence of two adjacent elements in a text. In this study, it refers to the 
combination of two words in original form or standardised form: if the word is an entry in the lists for 
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standardisation, the standardised form of the word is used; otherwise, the original form of the word is 
adopted. 
 
Results and Discussion 
The 10-fold cross-validation experiments were performed, and the performances were evaluated by 
the evaluation metrics mentioned above. The scores from those experiments are presented in Tables 
5.4, 5.5 and 5.6 with corresponding feature sets. From these tables, it is clear that the best feature sets 
vary between each corpus:  
• For the melanoma corpus – seven-word contextual window, bag of lower case of word, and 
orthography.  
• For the colorectal cancer corpus – nine-word contextual window, bag of lower case of word, 
standardisation, orthography and bigram. 
• For the lymphoma corpus – five-word contextual window, lower case of word, and bag of 
orthography. 
 
Model # Feature Precision Recall F-score 
M1 seven-word contextual window 98.80% 93.96% 96.32% 
M2 M1+ bag of lower case of word 98.81% 95.16% 96.96% 
M3 M2 + orthography 99.09% 95.37% 97.19% 
Table 5.4 Scores for section heading detection experiments on the melanoma corpus. 
  
Model # Feature Precision Recall F-score 
M1 nine -word contextual window 94.42% 85.27% 89.61% 
M2 M1+ bag of lower case of word 94.11% 86.81% 90.31% 
M3 M2 + standardisation 93.97% 87.01% 90.36% 
M4 M3 + orthography 94.20% 88.10% 91.05% 
M5 M4 + bigram 95.16% 88.78% 91.86% 
Table 5.5 Scores for section heading detection experiments on the colorectal cancer corpus. 
 
Model # Feature Precision Recall F-score 
M1 five-word contextual window 99.76% 96.09% 97.89% 
M2 M1+ lower case of word 99.77% 96.37% 98.04% 
M3 M2 + bag of orthography 99.31% 97.17% 98.22% 
Table 5.6 Scores for section heading detection experiments on the lymphoma corpus. 
 
The baseline models performed best on the lymphoma corpus (97.89% F-score), and worst on the 
colorectal cancer corpus (89.61% F-score); the final models using the best feature sets also attained 
the best performance on the lymphoma corpus (98.22% F-score), and lowest F-score of 91.86% on the 
colorectal cancer corpus; performances on the melanoma corpus are close to those on the lymphoma 
corpus, which was 96.32% obtained with baseline model and improved to 97.12% with final model.  
 
For the melanoma corpus, the F-score of the model was improved slightly by 0.64% by introducing 
bag of lower case of word; for the colorectal cancer corpus, the bigram feature made the most 
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contribution to boost the F-score by 0.81%, while a considerable improvement could be contributed 
by bag of lower case words and orthography; a relatively small gain (0.33%) was achieved by feature 
engineering on the lymphoma corpus. 
 
Tables 5.7, 5.8 and 5.9 show the performance of each heading with the best models on each corpus. It 
can be seen from these tables that the lowest F-scores are on some rare headings, such as 
“St:Comment Heading” in the melanoma corpus and  “St:Ancillary Studies Heading” in the colorectal 
cancer corpus. Subheadings also have relatively low F-scores due to their abundant lexical variants. 
The 100% F-scores achieved by most headings on the lymphoma corpus are due to their limited 
lexical variability (each with only one or two variants). 
 
Heading Number Precision Recall F-score 
St:Clinical History Heading 250 99.60% 98.80% 99.20% 
St:Comment Heading 28 76.92% 35.71% 48.78% 
St:Diagnosis Heading 258 99.61% 98.06% 98.83% 
St:Macroscopic Heading 363 99.16% 97.80% 98.47% 
St:Microscopic Heading 375 99.18% 97.33% 98.25% 
St:Specimen 164 98.73% 95.12% 96.89% 
St:Subheading 51 100.00% 66.67% 80.00% 
Overall 1489 99.09% 95.37% 97.19% 
Table 5.7 Performance of each heading with the best model on the melanoma corpus. 
 
Heading Number Precision Recall F-score 
St:Ancillary Studies Heading 52 80.95% 65.38% 72.34% 
St:Clinical History Heading 378 99.73% 98.68% 99.20% 
St:Macroscopic Heading 387 97.64% 96.38% 97.01% 
St:Microscopic Heading 388 98.96% 97.94% 98.45% 
St:Subheading 2121 92.34% 83.03% 87.44% 
St:Synthesis Heading 524 98.81% 94.85% 96.79% 
Overall 3850 95.16% 88.78% 91.86% 
Table 5.8 Performance of each heading with the best model on the colorectal cancer corpus. 
 
Heading Number Precision Recall F-score 
Title-Clinical History 224 100.00% 100.00% 100.00% 
Title-Comment 36 100.00% 100.00% 100.00% 
Title-Frozen Section Report 39 100.00% 100.00% 100.00% 
Title-Macroscopic Description 223 100.00% 100.00% 100.00% 
Title-Microscopic Description 226 100.00% 100.00% 100.00% 
Title-Nature And Specimen Type 123 100.00% 100.00% 100.00% 
Title-Pathologist Notes 83 100.00% 100.00% 100.00% 
Title-Special Investigations 47 100.00% 100.00% 100.00% 
Title-Subheading 463 97.18% 89.20% 93.02% 
Title-Summary 226 100.00% 100.00% 100.00% 
Title-Supplementary Report 38 100.00% 100.00% 100.00% 
Title-Supplementary Summary 37 100.00% 100.00% 100.00% 
Overall 1765 99.31% 97.17% 98.22% 
Table 5.9 Performance of each heading with the best model on the lymphoma corpus. 
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Through error analysis, the possible reasons for false negatives include: 
• Unseen headings in the test set, e.g., “REQUEST FORM [“St:Clinical History Heading”]” 
and “ADDENDUM [“St:Comment Heading”]” in the melanoma corpus,  “SYNTHESIS 
AND OVERVIEW [“St:Synthesis Heading”]” and “GROSS [“St:Macroscopic Heading”]” in 
the colorectal cancer corpus,  “Architecturally [“St:Title-Subheading”]” and 
“Cytomorphology [“St:Title-Subheading”]” in the lymphoma corpus. 
• Some long span instances exceed the contextual window size, e.g., “Dr X agrees with our 
diagnosis and his report is as follow [“St:Comment Heading”]” in the melanoma corpus, 
“The tumour cells show the following immunohistochemical staining pattern [“St:Title-
Subheading”]” in the lymphoma corpus. 
 
The following reasons brought not only some false negatives, but also several false positives: 
• Polysemous usage of some instances. For example, in the colorectal cancer corpus, 
“SUPPLEMENTARY REPORT” can be a St:Ancillary Studies Heading if the following 
contents are regarding ancillary studies; otherwise, it would be a St:Subheading.  
“Macroscopic Description” at the beginning of a separate section should be regarded as a 
St:Macroscopic Heading ; whereas, when it is under the “Diagnostic Summary” section, it 
should be classified as St:Subheading. 
• Ambiguity of annotations. In the annotation schema of the colorectal cancer corpus, some 
subheadings can be annotated as part of the entity if they only contain a single reportable 
field, e.g. “LYMPH NODES: 2/15 show metastatic adenocarcinoma [“Ex:Lymph Node 
Involvement”].”; else, they should be annotated as St:Subheading, if they can be further 
divided into multiple reportable fields, e.g. “LYMPH NODES [“St:Subheading”]: Nineteen 
(19) lymph nodes identified [“En:Lymph Nodes”], all of which show reactive changes 
[“Ex:Lymph Node Involvement”].” 
 
Note that the results of the identification of subheadings is not be further used in the section context 
detection. 
 
Compared to other existing heading detectors, e.g. MedLee (92.0% precision and 91.0% recall) and 
SecTag (95.6% precision and 99.0% recall), a similar or higher precision can be achieved by the 
present section heading detectors, except the recall is lower in the colorectal cancer corpus. The 
possible reasons for the lower recall is that subheadings including specimen identifiers increases the 
difficulty for detection due to their indistinguishable morphology and orthography; the larger number 
of variants for subheadings (about 350) make it difficult for the machine learner to learn and predict. 
The ratio between training set and test set in SecTag is 33.8:1, but is 9:1 in this study, hence the 
present detector models are encouragingly more successful. 
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5.4.6.2 Section Context Assignment 
Based on the results from the above section heading detectors, the second stage of section context 
detection is to find the text span between each heading and assign a section context for the text span. 
For example, the text span between “St:Macroscopic Heading” and “St:Microscopic Heading” should 
be assigned a section context of “MACROSCOPIC”.  
 
If a particular section heading is missing in the record, assign a section context for a text span 
according to the frequent sequences of heading appearances. For instance, in the melanoma corpus, 
headings usually appear in this order: St:Clinical History Heading,  St:Macroscopic Heading, 
“St:Microscopic Heading”,  and  “St:Diagnosis Heading”. When a St:Clinical History Heading is 
omitted in a report, but St:Macroscopic Heading appears in the first place, it implies the text span 
preceding the St:Macroscopic Heading has a section context of  “CLINICAL HISTORY”.   
 
If multiple section headings are missing in the record, or in a poorer written report, no heading 
appears in it, specific rules are applied to resolve the problem: 
1. Count the amount of newline separators and special combinations punctuation as section 
separators (e.g., “.,” and “,,” in the colorectal cancer corpus) and divide the texts in the 
document into several potential sections. 
2. Try to assign section contexts according to the frequent sequences of heading appearance as 
mentioned above. 
3. If the last step fails, assign a section context for the potential section arbitrarily based on the 
significance and frequency analysis of other well-organised reports. For example, in the 
colorectal cancer corpus, if a poorly written report has three potential sections, they can be 
assigned section contexts in this order: “MICROSCOPIC”, “MACROSCOPIC” and 
“DIAGNOSIS”; if there are two sections in it, “MICROSCOPIC” and “MACROSCOPIC” 
will be assigned to them respectively. 
 
Finally, three section contexts are shared by the three corpora: “CLINICAL HISTORY”, 
“MACROSCOPIC” and “MICROSCOPIC”; there are two common section contexts for the 
melanoma corpus and lymphoma corpus: “SPECIMEN” and  “COMMENT”; section contexts for the 
“Diagnostic Summary” section have different notations, which are “DIAGNOSIS” for the melanoma 
corpus, “CONCLUSION” and “SYNOPTIC” for the colorectal cancer corpus, “SUMMARY” for the 
lymphoma corpus; the colorectal cancer corpus has one more section context “ANCILLARY”; the 
lymphoma corpus has five more section contexts:  “FROZEN SECTION”,  “PATHOLOGIST 
NOTES”, “SPECIAL INVESTIGATIONS”, “SUPPLEMENTARY REPORT” and  
“SUPPLEMENTARY SUMMARY”. The main difference between “CONCLUSION” and 
“SYNOPTIC” is whether the following contents contain synoptic fields: if synoptic fields are present, 
the section context is assigned as “SYNOPTIC”; otherwise, it is assigned as “CONCLUSION”. 
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5.4.7 Ring-fenced Tagging 
Background 
Some chunks of a text may be of medical significance, like scores and measurements, or contain 
useful linguistic patterns, which have been dissembled in the above tokenisation. This requires an 
additional process of detection. 
 
A simple way to resolve this issue is to employ regular expressions. However, there are several 
disadvantages of this method: while more rules are developed to capture new patterns, it is more 
difficult to handle the rules as any change of them may create the risk of losing previously recognised 
patterns or introducing some false positives; besides, it also requires exhaustive knowledge about 
regular expressions and a considerable amount of time to modify the rules.  
 
A more efficient way is to automate the learning process to capture patterns. Patrick and Sabbagh 
developed a pattern-matching engine consisting of a trainable finite state automaton (FSA) as a 
solution (Patrick and Sabbagh, 2011). The trainable FSA can dynamically learn from training 
examples with high accuracy and efficient computational time.  Additionally, the cascaded approach 
and removal of irrelevant words enhances the power of generalization of the engine and the active 
learning process increases the speed of the engine.  
 
Methods and Results 
Two lists of training patterns are prepared for the engine. One is the basic pattern file and the other is 
the complex pattern file. Both have the same format, with two columns, where the first one is the tag 
type and the second one is the text example. The training examples are then generalized by the FSA so 
that the engine can capture other similar forms of these patterns. Table 5.10 lists some training 
examples in a basic pattern file and complex pattern file. 
 
Basic pattern file Complex pattern file 
Tag  type Pattern Tag  type Pattern 
Digit 2; 1.16; 10; 110 Volume 20x14x9mm; 1.5x0.5x1.0 cm 
mm mm Area 140x30mm; 40 mm x 35 mm 
cm  cm Measurement 50mm; 5.5cm 
x x   
Table 5.10 Some training examples in a basic pattern file and complex pattern file. Note: examples are 
separated by semicolon “;”. 
 
The results from the engine for a particular chunk of a text can be either the tag type defined in the 
training pattern list or the default output. The default output of the engine can have 22 semantic 
categories, e.g. “Date”, “Time”, “Range”, “two word slash”, “two word hyphen”, etc. The default 
output for some chunks of text is presented in Table 5.11. 
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Semantic category Chunk of text 
Date 28/05/02 
Range 1-2 
two word slash SPECIMEN/CLINICAL 
two word hyphen in-situ 
two word apostrophe Hutchinson’s 
Complexdigit 10/19 
Operator < 
Punctuation , 
Plainword component 
Table 5.11 Default output for some chunks of text from the ring-fenced engine. 
 
5.5 Methods 
5.5.1 Overview of the System 
A supervised machine learning approach is used for the Medical Entity Recognition (MER) System to 
identify medical entities in the free texts. To facilitate the learning and prediction of the machine 
learner, data should be converted into features so that the learner can distinguish them from each 
other. Features should represent the characteristics and empirical distribution of the training data. 
Furthermore, they should encode the most significant aspects of the data for the testing. In a CRF-
based system, the generation of features is a crucial factor for the success of the system. 
 
There are two stages involved in the feature generation process. The first stage is feature extraction, 
which is to extract potentially useful features from the corpus. However,  not all the features extracted 
can be applied to the models, as some of them may be less informative or redundant, and will 
introduce noise and slow down the training process. Thus, the second stage, feature selection, is 
required to carefully remove the irrelevant features. 
 
A detailed description of the features used in the MER task is presented as follows. The aims are to 
extract various features that can capture useful information about the entities, and then determine the 
optimal configuration of feature sets to yield the best performance. To discover the best feature sets, a 
selective incremental method was used: each feature was added progressively to identify its 
contribution to the model; if the performance of the model benefited from a feature, then this feature 
would be retained, else, it would be dropped. 
 
5.5.2 Feature Sets 
Features are descriptors of characteristic attributes of tokens prepared for the task. The features are 
usually represented in a vector string, which can be a Boolean, numeric or nominal value. For 
example, a Boolean feature assigned with “T” if the current token is in lowercase, else “F”; a nominal 
feature that represents the lemma of the token. 
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Various features have been experimented with in previous works, such as lexical features, contextual 
features and semantic features. The feature sets used in the MER experiments consist of lexical 
features, semantic features, contextual features, orthographic features, morphological features and 
syntactic features. They are not only focused on the identification of entity boundaries but also the 
classification of entity types. 
 
Contextual Features 
Contextual window: Tokens surrounding the target token provide useful contexts for predicting the 
entity type, as they are incorporated into the classifier to reveal the linguistic patterns of the entity 
type. Typically, a contextual window is used to represent this context feature, which is a sliding 
window around the target token. The Larger the window size, the more context information it can 
provide to the classifier. A nine-word contextual window was used in the following experiments, that 
is, four tokens preceding the target token and four tokens succeeding the target token. 
 
Section context: The regional context information can be captured by a contextual window, but it 
cannot represent the global context information. Section context is a feature to represent the global 
context information, as the distribution of the entity types vary between each section. Tables 5.12, 
5.13 and 5.14 show the details of each medical entity type present in the section with the highest 
frequency of the corpora. Figures 5.5, 5.6 and 5.7 present the proportion of medical entities held by 
each main section. Note that Linguistic categories and associated types of specimen identifiers are 
excluded, as it is assumed that they are insensitive to section context. 
  
Entity type Section context Number Proportion 
De:Cell Growth Pattern MICROSCOPIC 584 93.6% 
De:Cell Type MICROSCOPIC 659 94.8% 
De:Cosmetic Changes CLINICAL HISTORY 35 13.2% 
De:Dermal Mitoses MICROSCOPIC 355 97.3% 
De:Shape MACROSCOPIC 403 72.2% 
De:Site and Laterality CLINICAL HISTORY 272 29.6% 
De:Size MACROSCOPIC 801 92.5% 
De:Specimen Type MACROSCOPIC 437 66.1% 
De:Ulceration MICROSCOPIC 244 87.1% 
En:Associated Naevus (type) MICROSCOPIC 153 68.3% 
En:Lesion (other) MICROSCOPIC 36 64.3% 
En:Primary Lesion MICROSCOPIC 952 58.0% 
En:Satellites MICROSCOPIC 24 100.0% 
In:Breslow Thickness (mm) MICROSCOPIC 340 65.9% 
In:Clark Level MICROSCOPIC 553 74.2% 
In:Neurotropism MICROSCOPIC 144 96.6% 
In:Vascular/Lymphatic MICROSCOPIC 219 95.6% 
Ma:Excision Clear MICROSCOPIC 165 67.9% 
Ma:Excision Deep MICROSCOPIC 152 91.0% 
Ma:Excision Invasive MICROSCOPIC 285 78.3% 
Ma:Excision In Situ MICROSCOPIC 74 83.1% 
Re:Desmoplasia MICROSCOPIC 16 100.0% 
Re:Fibrosis MICROSCOPIC 65 95.6% 
Re:Solar Elastosis MICROSCOPIC 23 92.0% 
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Re:Tils MICROSCOPIC 209 98.6% 
Sy:Diagnosis MICROSCOPIC 668 51.5% 
Sy:Regression MICROSCOPIC 173 86.1% 
Sy:Subtype MICROSCOPIC 301 61.7% 
Table 5.12 Numbers of medical entities present in the sections with the highest frequency in the 
melanoma corpus. 
 
Table 5.13 Numbers of medical entities present in the sections with the highest frequency in the 
colorectal cancer corpus. 
 
 
Entity type Section context Number Proportion 
De:Ancillary Studies ANCILLARY 178 63.8% 
De:Mesorectal Integrity MACROSCOPIC 12 80.0% 
De:Perforation MICROSCOPIC, MACROSCOPIC 41 26.6% 
De:Peritoneal Reflection MACROSCOPIC 125 90.6% 
De:Serosa Description MACROSCOPIC 165 77.8% 
De:Specimen Blocks MACROSCOPIC 3335 98.9% 
De:Specimen Images MACROSCOPIC 16 53.3% 
De:Specimen Size MACROSCOPIC 1551 97.7% 
De:Specimen Type MACROSCOPIC 794 41.9% 
De:Tissue Banking MACROSCOPIC 58 100.0% 
De:Tumour Description MICROSCOPIC 780 53.2% 
De:Tumour Site CONCLUSION 363 25.1% 
De:Tumour Size MACROSCOPIC 443 65.0% 
En:Coexistent Pathology MICROSCOPIC 470 39.7% 
En:Distant Spread or Metastases MICROSCOPIC 98 34.3% 
En:Lymph Nodes MACROSCOPIC 307 48.7% 
En:Residual Tumour CONCLUSION 61 49.2% 
Ex:Donut Involvement MICROSCOPIC 64 43.8% 
Ex:Extent MACROSCOPIC 210 34.4% 
Ex:Extramuscular Spread SYNOPTIC 112 56.9% 
Ex:Lymph Node Involvement MICROSCOPIC 479 42.2% 
Ex:Serosal Involvement SYNOPTIC 137 34.9% 
In:Depth of Invasion MICROSCOPIC 443 34.5% 
In:Perineural Invasion MICROSCOPIC 181 45.5% 
In:Venous and Small Vessel 
Invasion 
MICROSCOPIC 406 47.4% 
Ma:Circumferential Margin MACROSCOPIC 90 35.3% 
Ma:Clear MICROSCOPIC 335 43.9% 
Ma:Proximal or Distal Margin MACROSCOPIC 509 72.8% 
Met:Anatomic Stage CONCLUSION 164 56.4% 
Met:M Value CONCLUSION 176 68.5% 
Met:N Value CONCLUSION 247 60.4% 
Met:T Value CONCLUSION 164 56.4% 
Re:Desmoplasia and Fibrosis MICROSCOPIC 221 81.5% 
Re:Response to Rx MICROSCOPIC 69 64.5% 
Re:Tils and Peritumoural 
Lymphocytes 
SYNOPTIC 215 55.3% 
Sy:Comment MACROSCOPIC 821 52.7% 
Sy:Histological Grade CONCLUSION 366 44.1% 
Sy:Histological Type CONCLUSION 414 41.5% 
Sy:Medical History CLINICAL HISTORY 110 53.1% 
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Table 5.14 Numbers of medical entities present in the sections with the highest frequency in the 
lymphoma corpus. 
 
From Figures 5.5, 5.6 and 5.7, it can be seen that “MACROSCOPIC” and “MICROSCOPIC” hold 
most of the entities, while a considerable number of entities located in the section contexts stand for 
the “Diagnostic Summary” section (e.g., “DIAGNOSIS” in the melanoma corpus) and “CLINICAL 
HISTORY”, and other sections account for a small proportion of the entities (e.g., “ANCILLARY” in 
the colorectal cancer corpus).  
Entity type Section context Number Proportion 
An:Biomarker MICROSCOPIC 1748 90.50% 
An:Cytogenetics Comment SUPPLEMENTARY REPORT 16 88.90% 
An:Fish Results SUPPLEMENTARY REPORT 7 87.50% 
An:Flow Cytometry-Comment SPECIAL 71 77.20% 
An:Flow Cytometry-Negative SUPPLEMENTARY REPORT 3 100.00% 
An:Flow Cytometry-Positive SUPPLEMENTARY REPORT 3 100.00% 
An:IgH Test SUPPLEMENTARY REPORT 7 100.00% 
An:Immunohistochemistry-Comment MICROSCOPIC 226 90.40% 
An:Immunohistochemistry-Equivocal MICROSCOPIC 24 88.90% 
An:Immunohistochemistry-Negative MICROSCOPIC 248 87.30% 
An:Immunohistochemistry-Positive MICROSCOPIC 537 90.40% 
An:PCR Comment SUPPLEMENTARY REPORT 27 96.40% 
An:TCRgamma Test SUPPLEMENTARY REPORT 2 100.00% 
De:Anatomical Structure MICROSCOPIC 93 23.50% 
De:Architecture MICROSCOPIC 446 94.50% 
De:Cell Clonality SUPPLEMENTARY REPORT 1 100.00% 
De:Cell Size MICROSCOPIC 466 95.50% 
De:Cytomorphology MICROSCOPIC 168 94.40% 
De:Laterality CLINICAL HISTORY 6 33.30% 
De:Lineage MICROSCOPIC 120 85.70% 
De:Other Size MACROSCOPIC 103 83.70% 
De:Preservative Fluid MACROSCOPIC 77 70.00% 
De:Sample Triage MACROSCOPIC 538 67.80% 
De:Specimen Blocks MACROSCOPIC 847 100.00% 
De:Specimen Size MACROSCOPIC 462 98.90% 
De:Specimen Type MACROSCOPIC 200 24.90% 
De:Tissue Source MICROSCOPIC 771 52.00% 
De:Topography MACROSCOPIC 374 26.60% 
De:Tumour Size MACROSCOPIC 35 68.60% 
En:Coexistent Pathology MICROSCOPIC 111 68.90% 
Ex:Disease Extent CLINICAL HISTORY 7 87.50% 
Ex:Other Sites of Disease MICROSCOPIC 34 64.20% 
Re:Tissue Reaction MICROSCOPIC 245 94.60% 
Sy:Clinical Impression CLINICAL HISTORY 159 85.90% 
Sy:Comment SUMMARY 43 55.80% 
Sy:Constitutional Symptoms CLINICAL HISTORY 28 100.00% 
Sy:Diagnosis MICROSCOPIC 530 50.20% 
Sy:Diagnosis Subtype MICROSCOPIC 18 60.00% 
Sy:Indication for Biopsy CLINICAL HISTORY 26 92.90% 
Sy:Medical History CLINICAL HISTORY 78 95.10% 
Sy:Predisposing Factors CLINICAL HISTORY 35 58.30% 
Sy:Presentation CLINICAL HISTORY 86 87.80% 
Sy:SNOMED RT Codes SUMMARY 859 86.40% 
Sy:Stage SUMMARY 2 66.70% 
Sy:WHO Grade MICROSCOPIC 78 58.20% 
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Figure 5.5 Proportions of medical entities contained in each main section of the melanoma corpus. 
 
 
Figure 5.6 Proportions of medical entities contained in each main section of the colorectal cancer 
corpus. 
 
 
Figure 5.7 Proportions of medical entities contained in each main section of the lymphoma corpus. 
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Lexical Features 
Lowercase of token: Every token in the training data can be used as a feature, since the frequency of 
the token is of significance to determine the entity type. To increase the recall, each token is converted 
to lowercase. 
 
Lemma: By applying lemmatisation to a token, different morphological variants of a token can be 
normalized to its canonical form. 
 
Correction of misspelling: Spelling errors detected in the proof reading process should be replaced 
by their correct forms stored in the correction dictionaries. 
 
Expansion of abbreviations and acronyms: Similarly, abbreviations and acronyms identified in the 
proof reading process should be expanded to their full forms based on the abbreviation dictionaries. 
 
Bigram: This feature refers to that in feature engineering for detecting section headings. It is assumed 
that some combination of two words compose phrases that are likely to be medical terms. Thus, it can 
be an informative supplement for the lexical information about certain entity types. Table 5.15 lists 
the ten most common bigrams and their frequencies in each corpus. The Bigram “of/the” frequently 
appears in the corpora, with second highest frequency in each corpus. Several of them are probably 
medical glossaries: “malignant/melanoma”, “clark/level”,  “lymph/nodes”,  “resection/margin”, 
“muscularis/propria”, “lymph/node”, “malignant/lymphoma”, “t/cells”,  “snomed/codes”,  
“flow/cytometry” and  “microscopic/report”. 
 
Melanoma corpus Colorectal cancer corpus  Lymphoma corpus  
Bigram Frequenc
y 
Bigram Frequenc
y 
Bigram Frequenc
y 
malignant/melano
ma 
601 lymph/nodes 1736 lymph/node 844 
of/the 591 of/the 1696 of/the 445 
there/is 543 the/tumour 1193 malignant/lympho
ma 
279 
the/lesion 391 there/is 1125 cell/lymphoma 266 
of/skin 371 resection/margin 987 t/cells 258 
clark/level 349 from/the 945 lymph/nodes 252 
consists/of 256 of/tumour 701 snomed/codes 246 
ellipse/of 253 up/to 649 flow/cytometry 241 
from/the 249 muscularis/propri
a 
601 1/m 235 
the/specimen 
is/a 
247 is/a 584 microscopic/report 226 
Table 5.15 Ten most common bigrams and their frequencies in each corpus. 
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Morphological Features 
Morphological information has been proven to be a good clue for recognising named entities in the 
biomedical domain. For example, Wang et al carried out some experiments, which showed that the 
performance of the NER system was greatly enhanced with prefix and suffix information, as this 
information can help a machine learner to predict whether an unseen token is an entity or not (Wang et 
al., 2008). 
 
In the clinical domain, there are a large number of entities derived from Latin or Greek roots, and their 
affixes suggest special meanings. For instance, -omy suggests a surgical procedure, -oma indicates an 
abnormal structure, ade- implies or relates to a gland, cyt- associates with cell. These affixes do 
provide helpful hints for determining the entity types. The prefix and suffix features are focused on 
the characters of each word that begins and ends with respectively. A different number of characters 
from either the start or end of each alphabetic word were extracted as features. Affixes of length from 
two to four characters were used in the preliminary experiments. It turned out that the optimal sizes of 
affixes were 3 in most cases, except that of suffixes in the melanoma corpus was 2 instead. The ten 
most frequent suffixes and prefixes for the alphabetic tokens in each corpus are presented in Tables 
5.16 and 5.17 respectively. 
 
Melanoma corpus Colorectal cancer corpus  Lymphoma corpus  
Suffix Frequency Suffix Frequency Suffix Frequency 
he 3025 ion 6808 ure 1802 
on 2361 our 4964 ion 1698 
al 2161 ing 4119 lls 1448 
nt 1571 ted 2862 oma 1410 
ed 1562 ent 2630 ing 1407 
ng 1478 tal 2509 ent 1290 
nd 1434 des 2405 ode 1238 
re 1392 mph 2262 ive 1131 
in 1231 gin 2023 mph 1088 
es 1115 oma 1991 ith 1081 
Table 5.16 Ten most frequent suffixes for the alphabetic tokens in each corpus. 
 
Melanoma corpus Colorectal cancer corpus  Lymphoma corpus  
Prefix Frequency Prefix Frequency Prefix Frequency 
the 3683 tum 4941 lym 3168 
and 1234 lym 3286 cel 2141 
mel 1210 nod 3221 nod 2017 
les 928 mar 3165 pro 1886 
wit 763 inv 2608 wit 1171 
are 660 wit 2461 lar 816 
mal 614 res 2320 sho 681 
ski 612 pro 2133 sma 675 
der 585 col 1978 spe 661 
inv 559 per 1880 sec 641 
Table 5.17 Ten most frequent prefixes for the alphabetic tokens in each corpus. 
 
Chapter 5 Medical Entity Recognition 
129 
 
From Tables 5.16 and 5.17, the common frequent suffixes for the three corpora are “ion” or “on”, 
“ing” or “ng”, “ted” or “ed”, “ent” or “nt”, while “wit” is the most common frequent prefix. A detailed 
analysis reveals that this is likely because of the extensive use of past tense or gerund of verbs (e.g. 
“noted”, “ulcerated”, “measuring”, “infiltrating”, “extending”), nouns end with “ion” or “ent” (e.g. 
“component”, “involvement”, “resection”, “description”, “invasion”, “lesion”, “section”, “portion”), 
adjectives end with “ent” (e.g. “present”, “consistent”), prepositions “with” and “within” in the notes. 
 
Semantic Features 
Three kinds of semantic features are prepared: lexical resource, medical category, and ring-fenced tag. 
 
Lexical resource: From the above proof reading process, the resource dictionaries are the references 
for determining the source of a token. The possible values for this feature are “moby”, “umls”, “sct” 
and “O” (the default value if the token is not an entry in the resource dictionaries). 
 
Medical category: The medical category is one of the top categories of SNOMED CT, obtained by 
parsing the text to identify concepts of SNOMED CT using the TTSCT service (Patrick et al., 2007b), 
which was developed to detect SNOMED CT concepts in free texts and to annotate them with clinical 
reference terms. Note that in some cases, TTSCT can return more than one category as results; only 
the first order category is selected as the feature to reduce the complexity of the representation of the 
feature. 
 
Ring-fenced tag: This is an internal semantic feature, attained from the pattern-matching engine 
mentioned above by providing training examples to the trainable FSA.  
 
Syntactic Features 
This feature set includes POS tag and chunk. 
 
POS tag: This feature is able to generalise some tokens in an entity with relatively low frequency by 
representing them with a set of POS tags. Although it is low level syntactic information, it can help 
the machine learner to acquire the grammatical constructs of the entities and consequently, affect the 
determination of the boundaries of the entities, which has been proven in some biomedical NER 
systems, e.g. in Zhou and Su’s system (Zhou and Su, 2004). 
 
Chunk: This feature results from shallow parsing by the GENIA tagger described above. It is also 
used as a clue to determine the boundary of an entity. 
 
Orthographic Features 
This feature set consists of the orthography, full word class and brief word class. 
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Orthography: This feature aims to capture the rendition of words, with the same description 
illuminated above. Most of the predicates are retained, but some of them (e.g., “IsColon” and 
“IsBracket”) have been discarded after testing. More examples from some medical entities are 
displayed in Table 5.18. 
 
Predicate Example 
IsUppercase BOWEL; RM 
IsTitlecase Smears;  Sigmoid  
IsLowercase flow; resection 
HasHyphen Non-Hodgkin; MLH-1 
IsHyphen - 
IsSlash / 
IsDigit 20; 21 
HasPunctuation 0.5mm; 0.8 
IsPunctuation (; : 
IsAlphanumeric CD10; 20mm 
Table 5.18 Orthography feature with examples from some medical entities. Note: examples are 
separated by semicolon “;”. 
 
Full word class: To generalize the expression of the words, a feature named “full word class”, similar 
to that in Collins’s work (Collins, 2002), is used. It represents a token by replacing capital letters with 
“A”, lowercase letters with “a”, digits with “0”, and all other characters with “_”. 
 
Brief word class: Like the full word class, the brief word class is also a generalized representation of 
the words. It collapses consecutive identical characters into one.  
 
Table 5.19 presents the full word class and brief word class features for some tokens. 
 
Token Full word class Brief word class 
right aaaaa a 
COLON AAAAA A 
Large Aaaaa Aa 
70mm 00aa 0a 
4bp 0aa 0a 
,  _  _ 
CD20 AA00 A0 
1A 0A 0A 
30 00 0 
M-95903 A_00000 A_0 
B-cell A _aaaa A_a 
immunoblast-like aaaaaaaaaaa_aaaa a_a 
CD79a AA00a A0a 
Table 5.19 Full word class and brief word class features for some tokens. 
 
Table 5.20 summarizes the feature sets used in the experiments, with all features generated for 
predicting the label of token t at position i in an input sequence. 
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Feature Representation 
Contextual window ti-4, ti-3, ti-2, ti-1, ti, ti+1, ti+2, ti+3, ti+4 
Section context Context(ti-4), Context(ti-3), Context(ti-2), Context(ti-1), Context(ti), 
Context(ti+1), Context(ti+2), Context(ti+3), Context(ti+4) 
Lowercase of token Lower(ti-4), Lower(ti-3),  Lower(ti-2), Lower(ti-1), Lower(ti), Lower(ti+1), 
Lower(ti+2), Lower(ti+3), Lower(ti+4) 
Lemma Lemma(ti-4), Lemma(ti-3), Lemma(ti-2), Lemma(ti-1), Lemma(ti), Lemma(ti+1), 
Lemma(ti+2), Lemma(ti+3), Lemma(ti+4) 
Correction of 
misspelling 
Correction(ti-4), Correction(ti-3), Correction(ti-2), Correction(ti-1), 
Correction(ti), Correction(ti+1), Correction(ti+2), Correction(ti+3), 
Correction(ti+4),  
Expansion of 
abbreviations and 
acronyms 
Expansion(ti-4), Expansion(ti-3), Expansion(ti-2), Expansion(ti-1), 
Expansion(ti), Expansion(ti+1), Expansion(ti+2), Expansion(ti+3), 
Expansion(ti+4) 
Bigram ti-4/ti-3, ti-3/ti-2, ti-2/ti-1, ti-1/ti, ti/ti+1, ti+1/ti+2, ti+2/ti+3, ti+3/ ti+4 
Prefix Prefix(ti-4), Prefix(ti-3), Prefix(ti-2), Prefix(ti-1), Prefix(ti), Prefix(ti+1), 
Prefix(ti+2), Prefix(ti+3), Prefix(ti+4) 
Suffix Suffix(ti-4), Suffix(ti-3), Suffix(ti-2), Suffix(ti-1), Suffix(ti), Suffix(ti+1), Suffix(ti+2), 
Suffix(ti+4) 
Lexical resource Resource(ti-4), Resource(ti-3), Resource(ti-2), Resource(ti-1), Resource(ti), 
Resource(ti+1), Resource(ti+2), Resource(ti+3), Resource(ti+4) 
Medical category Category(ti-4), Category(ti-3), Category(ti-2), Category(ti-1), Category(ti), 
Category(ti+1), Category(ti+2), Category(ti+3), Category(ti+4) 
Ring-fenced tag Tag(ti-4), Tag(ti-3), Tag(ti-2), Tag(ti-1), Tag(ti), Tag(ti+1), Tag(ti+2), Tag(ti+3), 
Tag(ti+4) 
POS tag POS(ti-4), POS(ti-3), POS(ti-2), POS(ti-1), POS(ti), POS(ti+1), POS(ti+2), 
POS(ti+3), POS(ti+4) 
Chunk Chunk(ti-4), Chunk(ti-3), Chunk(ti-2), Chunk(ti-1), Chunk(ti), Chunk(ti+1), 
Chunk(ti+2), Chunk(ti+3), Chunk(ti+4) 
Orthography Orthography(ti-4), Orthography(ti-3), Orthography(ti-2), Orthography(ti-1), 
Orthography(ti), Orthography(ti+1), Orthography(ti+2), Orthography(ti+3), 
Orthography(ti+4) 
Full word class Full(ti-4), Full(ti-3), Full(ti-2), Full(ti-1), Full(ti), Full(ti+1), Full(ti+2), Full(ti+3), 
Full(ti+4) 
Brief word class Brief(ti-4), Brief(ti-3), Brief(ti-2), Brief(ti-1), Brief(ti), Brief(ti+1), Brief(ti+2), 
Brief(ti+3), Brief(ti+4) 
Table 5.20 Features generated for token t at position i used in the experiments. 
 
It is noteworthy that the strategies for the identification of specimen identifiers vary between each 
corpus due to different definitions in the annotation schemas. Specimen identifiers are identified as 
subheadings in the colorectal cancer corpus, which have been discussed in the section on heading 
detection. They are recognised with other entities in the same model in the melanoma corpus, which 
are presented in the next section. They are detected in a separate model in the lymphoma corpus. 
Several experiments were performed for specimen identifier detection in the lymphoma corpus. The 
best model attained a high F-score of up to 99.04%, by using a combination of the features: five-word 
contextual window, bag of lowercase of token, bag of orthography, ring-fenced tag and bigram. 
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5.5.3 Experiment Setting 
The toolkit used for applying CRF in this task is CRF++4, currently one of the fastest and stable CRF 
toolkits, which is based on the algorithms proposed by Sha and Pereira, and Lafferty et al (Lafferty et 
al., 2001; Sha and Pereira, 2003). It provides a simple way to manage feature extraction. The input 
data file should be in a spread sheet-like format that each column is a potential feature such as the 
token itself and the POS of the token, except that the last column is the annotation category. It is 
necessary to specify a feature template to train a model, which indicates the combination of features 
customized by a user to train the model. Thus the user can combine features easily by modifying the 
template rather than changing the training data. The test data file has the same format as in the training 
data, and the results generated by the model are presented in a results file, with an additional column 
next to the last column in the test data file. This eases the evaluation, as there are existing evaluation 
scripts (e.g., the evaluation script for CoNLL 2000 shared task5) that can compute scores from the 
results file.  
 
The experiments were carried out with 10-fold cross-validation, and each fold was stratified on a 
document level, and used the default parameter configuration of the toolkit. The standard evaluation 
metrics: Precision, Recall and F-score were used to measure the performance. The evaluation scripts 
were adapted from those provided by the JNLPBA 2004 shared task6. 
 
5.6 Results and Discussion 
Baseline models were built using only the bag-of-word feature from the training corpora. A contextual 
window size of nine was used in all experiments. Further experimental analysis of the contribution of 
each feature was conducted by progressively adding features to the system. Note that only the 
combinations of features that improve the system performance are presented below. 
 
5.6.1 System Performance on Melanoma Corpus 
Table 5.21 shows the contribution of features to the system performance on the melanoma corpus. The 
baseline model achieved 78.95% F-score. The lexical feature set was the most effective, and improved 
the model by 3.72%, whereas the lowercase of tokens contributed 2.59%. Semantic and morphological 
feature sets yielded moderate improvements by 0.82% and 0.57% respectively.  Minimal 
improvements were made by adding the syntactic feature set and the section context with 0.16% and 
0.07%. 
 
 
 
                                                     
4 http://crfpp.googlecode.com/svn/trunk/doc/index.html 
5 http://www.cnts.ua.ac.be/conll2000/chunking/ 
6 http://www.nactem.ac.uk/tsujii/GENIA/ERtask/report.html 
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Model # Features Precision Recall F-score 
1 Nine-word contextual window 85.79% 73.12% 78.95% 
2 M1 + Lowercase of tokens 86.49% 77.12% 81.54%* 
3 M2 + Lemma 86.46% 78.21% 82.13% 
4 M3 + POS 86.12% 78.64% 82.21% 
5 M4 + Chunk 86.07% 78.82% 82.29% 
6 M5 + Medical category 86.35% 79.62% 82.85% 
7 M6 + Expansions of abbreviations and acronyms 86.38% 79.64% 82.87% 
8 M7 + Correction of misspelling 86.51% 80.16% 83.22% 
9 M8 + Ring-fencing tag 86.41% 80.75% 83.48% 
10 M9 + Suffixes 86.41% 81.15% 83.70% 
11 M10 + Bag of prefixes 86.55% 81.69% 84.05% 
12 M11 + Section context 86.63% 81.75% 84.12% 
13 M12 + Bigram 87.11% 81.65% 84.29% 
Table 5.21 Contribution of features to the system performance on the melanoma corpus. Scores 
marked with * suggests significant contribution within 95% confidence interval. 
 
Entity type Number Precision Recall F-score 
De:Cell Growth Pattern 615 71.06% 62.28% 66.38% 
De:Cell Type 694 73.08% 71.18% 72.12% 
De:Cosmetic Changes 266 67.76% 38.72% 49.28% 
De:Dermal Mitoses 364 82.82% 80.77% 81.78% 
De:Shape 555 76.69% 67.57% 71.84% 
De:Site and Laterality 817 89.51% 82.50% 85.86% 
De:Size 845 91.87% 88.28% 90.04% 
De:Specimen Type 627 92.25% 83.57% 87.70% 
De:Ulceration 280 93.12% 91.79% 92.45% 
En:Associated Naevus (type) 222 70.59% 64.86% 67.61% 
En:Lesion (other) 57 71.43% 8.77% 15.62% 
En:Primary Lesion 1612 88.20% 90.45% 89.31% 
En:Satellites 24 89.47% 70.83% 79.07% 
En:Specimen Identifier 842 97.13% 88.36% 92.54% 
In:Breslow Thickness (mm) 508 86.23% 85.04% 85.63% 
In:Clark Level 742 88.52% 85.18% 86.81% 
In:Neurotropism 149 97.93% 95.30% 96.60% 
In:Vascular/Lymphatic 229 96.44% 94.76% 95.59% 
Li:Lexical Polarity Positive 1369 95.31% 92.11% 93.68% 
Li:Lexical Polarity  Negative 676 96.60% 92.46% 94.48% 
Li:Modality 297 90.00% 84.85% 87.35% 
Li:Mood and Comment Adjuncts 931 77.84% 70.57% 74.03% 
Li:Temporality 167 89.74% 62.87% 73.94% 
Ma:Excision Clear 241 88.65% 84.23% 86.38% 
Ma:Excision Deep 166 80.69% 70.48% 75.24% 
Ma:Excision Invasive 362 64.51% 63.26% 63.88% 
Ma:Excision In Situ 88 51.16% 25.00% 33.59% 
Re:Desmoplasia 16 100.00% 50.00% 66.67% 
Re:Fibrosis 68 80.36% 66.18% 72.58% 
Re:Solar Elastosis 25 76.47% 52.00% 61.90% 
Re:Tils 212 86.67% 85.85% 86.26% 
Sy:Diagnosis 1238 92.86% 89.34% 91.07% 
Sy:Regression 201 81.12% 79.10% 80.10% 
Sy:Subtype 476 91.16% 88.87% 90.00% 
Overall 15981 87.11% 81.65% 84.29% 
Table 5.22 Performance of the best model by entity types on the melanoma corpus. 
 
Chapter 5 Medical Entity Recognition 
134 
 
Table 5.22 displays the performance of the best model by entity types. From Table 5.22, most of the 
entity types attained F-scores of over 60%, whereas F-scores on seven medical entity types and two 
Linguistic categories were equal to or higher than 90%.  However, there was poor performance on 
some medical entity types: De:Cosmetic Changes, En:Lesion (other) and Ma:Excision In Situ. Lexical 
variability is one of the possible reasons for this. Over 56% of the De:Cosmetic Changes instances 
only appear once in the corpus, making it difficult for the machine learner to learn from the training 
data, thus greatly decreasing the recall. Ambiguity is another possible reason for the low F-score. For 
example, “lesion” is a common word used by both En:Lesion (other) and En:Primary Lesion. The 
correct determination of the entity type is not only based on the local context, but also the global 
context of the whole document. For instance, if a primary lesion has been described in other 
specimens, the “lesion” appears in the specimen is likely to be a En:Lesion (other). Similarly, there 
are many similarities between Ma:Excision In Situ and Ma:Excision Invasive: the same words and 
same linguistic construction of the instances.  Here are two examples: 
• The in situ component is 1.4mm from the closest lateral resection margin. 
• The tumour appears completely excised being 1.6mm from the closest lateral resection 
margin. 
The first example is a Ma:Excision In Situ instance, while the second one is a Ma:Excision Invasive 
instance, as it can be inferred from the local context of the first instance “in situ component”, and no 
such context can be detected for the second example. However, it is quite difficult to achieve the 
correct inference in some cases, as the average length of the Ma:Excision In Situ entities is over seven 
tokens, the local context may locate outside the contextual window. It is also more difficult if the 
context is situated in other sentences. For example, in these sentences:  
Superficial spreading melanoma extends to one lateral surgical margin. It is 2.5mm clear of 
the other edge. Invasive melanoma has a cutaneous clearance of 3.5mm and a deep clearance 
of over 8mm. 
where the contexts that infer the entity type of the instance “2.5mm clear of the other edge” are “one 
lateral surgical margin” and “Invasive melanoma”, are located in the previous and next sentences. 
Thus the machine learner would misclassify the instance to Ma:Excision Invasive, as the classification 
is at the sentence-level and Ma:Excision Invasive is the default category for lateral margins. 
 
5.6.2 System Performance on Colorectal Cancer Corpus 
The system performance on the colorectal cancer corpus according to the contribution of features is 
displayed in Table 5.23. The outcome of the experiments shows that the model achieved an 
improvement of about 2% on F-score by applying the lexical feature set, while semantic, 
morphological and syntactic feature sets also brought some gains by 0.86%, 0.65% and 0.51%. 
Orthographic features and section context improved the model slightly by 0.17% and 0.02%. 
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Model 
#  
Features  Precision  Recall  F-score  
1 Nine-word contextual window  77.96% 70.71% 74.16% 
2 M1 + Lowercase of tokens  78.58% 72.27% 75.29% 
3 M2  + Lemma  78.58% 72.55% 75.44% 
4 M3  + Bag of POS 78.80% 73.30% 75.95% 
5 M4 + Medical category  78.84% 73.70% 76.18% 
6 M5+ Lexical resource  78.80% 73.80% 76.22% 
7 M6 + Bag of expansions of abbreviations and acronyms  78.84% 73.89% 76.28% 
8 M7  + Bag of  ring-fencing tag  79.23% 74.65% 76.87% 
9 M8  + Orthography  79.25% 74.94% 77.04% 
10 M9  + Suffixes  79.34% 75.34% 77.29% 
11 M10 + Bag of  prefixes  79.66% 75.81% 77.69% 
12 M11 + Section context  79.59% 75.91% 77.71% 
13 M12 + Bigram 80.58% 76.33% 78.40% 
Table 5.23 System performance on the colorectal cancer corpus according to the contribution of 
features. 
 
The scores for the best model by entity types are presented in Table 5.24. From Table 5.24, most 
entity types achieved good performance with over 60% F-scores. The best performance is on eight 
entity types with F-scores of higher than 90%, while the worst performance is on five entity types: 
De:Mesorectal Integrity, De:Specimen Images, En:Coexistent Pathology, Re:Desmoplasia and 
Fibrosis and  Re:Response to Rx, whose F-scores did not reach 60%. The poor performances on 
De:Mesorectal Integrity and De:Specimen Images were probably due to lack of sufficient training 
samples. A detailed error analysis on En:Coexistent Pathology shows that there were several possible 
reasons for the poor performance: 
 
Entity type Number Precision Recall F-score 
De:Ancillary Studies 272 76.49% 70.59% 73.42% 
De:Mesorectal Integrity 15 83.33% 33.33% 47.62% 
De:Perforation 154 78.50% 54.55% 64.37% 
De:Peritoneal Reflection 138 81.54% 76.81% 79.10% 
De:Serosa Description 212 73.45% 61.32% 66.84% 
De:Specimen Blocks 3343 89.00% 88.33% 88.67% 
De:Specimen Images 30 100.00% 30.00% 46.15% 
De:Specimen Size 1585 79.82% 78.36% 79.08% 
De:Specimen Type 1892 85.91% 81.87% 83.84% 
De:Tissue Banking 57 100.00% 87.72% 93.46% 
De:Tumour Description 1464 73.25% 68.65% 70.87% 
De:Tumour Site 1446 81.60% 76.07% 78.74% 
De:Tumour Size 682 80.34% 75.51% 77.85% 
En:Coexistent Pathology 1181 56.39% 54.95% 55.66% 
En:Distant spread or Metastases 284 69.86% 51.41% 59.23% 
En:Lymph Nodes 629 82.30% 76.15% 79.11% 
En:Residual Tumour 124 85.19% 55.65% 67.32% 
Ex:Donut Involvement 144 72.07% 55.56% 62.75% 
Ex:Extent 610 68.43% 55.08% 61.04% 
Ex:Extramuscular Spread 197 95.24% 81.22% 87.67% 
Ex:Lymph Node Involvement 1133 77.26% 77.05% 77.15% 
Ex:Serosal Involvement 392 79.60% 70.66% 74.86% 
In:Depth of Invasion 1284 69.45% 69.24% 69.34% 
In:Perineural Invasion 396 95.26% 91.41% 93.30% 
Chapter 5 Medical Entity Recognition 
136 
 
In:Venous and Small Vessel Invasion 855 88.26% 85.26% 86.73% 
Ma:Circumferential Margin 254 68.66% 58.66% 63.27% 
Ma:Clear 758 84.68% 83.11% 83.89% 
Ma:Proximal or Distal Margin 699 82.62% 79.54% 81.05% 
Met:Anatomic Stage 291 95.45% 86.60% 90.81% 
Met:M Value 257 98.39% 94.94% 96.63% 
Met:N Value 409 97.95% 93.64% 95.75% 
Met:T Value 414 95.93% 91.06% 93.43% 
Re:Desmoplasia and Fibrosis 271 60.00% 45.39% 51.68% 
Re:Response to Rx 106 65.31% 30.19% 41.29% 
Re:TILS and Peritumoural Lymphocytes 389 90.62% 86.89% 88.71% 
Sy:Comment 1558 60.43% 62.64% 61.52% 
Sy:Histological Grade 828 96.03% 93.60% 94.80% 
Sy:Histological Type 998 92.87% 88.78% 90.78% 
Sy:Medical History 206 79.07% 49.51% 60.90% 
Overall 25957 80.58% 76.33% 78.40% 
Table 5.24 Scores for the best model by entity types on the colorectal cancer corpus. 
 
1. The machine learner could not detect the boundary correctly occasionally as the there are no 
specific requirements for its boundary in the annotation schema. In the annotations, there 
were various grammatical structures for En:Coexistent Pathology: a noun phrase (e.g., 
“villous adenoma”), multiple noun phrases connected by a preposition (e.g., “tubulovillous 
adenoma with high grade dysplasia”),  a verb phrase and a noun phrase connected by a 
proposition (e.g., “arising within a moderately dysplastic tubulovillous adenoma”), a clause 
(e.g., “overlying adenoma seen in some of the sections”), a sentence (e.g., “Two polyps are 
identified within the ascending colon 7 and 12mm”), etc. Therefore, it was too difficult for 
the machine learner to learn from these structures and predict the potential instances as well. 
2. The machine learner would be confused with other entity types in some case (e.g., 
Sy:Comment). The annotation schema defined that if a coexistent pathological abnormality is 
absent, it should be annotated as SY: COMMENT instead. For example, in the following 
sentence:  
These sections show changes of diverticular disease with no evidence of 
diverticulitis. 
the first instance is a En:Coexistent Pathology, while the second one is a Sy:Comment 
instance. However, as negation phrases like “no evidence of” were not designed to be 
annotated separately in the schema, the machine learner could not classify the second 
instance correctly.  
3. Ambiguity is another possible reason. For example, if a tumour is a polypoid lesion, the 
machine learner would usually misclassify it to En:Coexistent Pathology, as “polyp” is a 
familiar coexistent pathological abnormality. An example is presented below: 
The gold-standard is 
Located 130mm from the distal resection margin [“Ma:Proximal or Distal Margin”] 
is a pedunculated polyp [“De:Tumour Description”] measuring 25x25x25mm 
[“De:Tumour Size”].  
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The system prediction is 
Located 130mm from the distal resection margin is a pedunculated polyp measuring 
25x25x25mm [“En:Coexistent Pathology”].  
 
Likewise, the above reasons also caused most of the classification errors on Re:Desmoplasia and 
Fibrosis and Re:Response to Rx, such as the incorrect  boundary detection.  The similar grammatical 
structures among Re:Desmoplasia and Fibrosis, Sy:Comment and En:Coexistent Pathology can 
confuse the learning of the machine learner in some cases. For instance, it tagged the following 
example: “OTHER FINDINGS: The appendix is fibrosed consistent with either old ischemia or 
previous inflammation” as Sy:Comment, while the correct type should be Re:Desmoplasia and 
Fibrosis.  The machine learner could not discriminate the instances from Re:Desmoplasia and Fibrosis 
and Re:Response to Rx sometimes, if  desmoplasia or fibrosis are the responses to the treatment. For 
example, the instance “extensive fibrosis suggesting at least moderate response to therapy” would be 
misclassified as Re:Desmoplasia and Fibrosis, but the correct assignment should be Re:Response to 
Rx instead, as the fibrosis is a manifestation of the response to the therapy.  
 
5.6.3 System Performance on Lymphoma Corpus 
Table 5.25 presents the system performance on the lymphoma corpus with the contribution of 
features. The performance of the baseline model was improved significantly by 3.3% by considering 
the lexical feature set, whereas a prominent improvement (2.40%) was made by introducing lowercase 
of tokens. Furthermore, a considerable improvement was contributed by the semantic feature set 
(nearly 2.83% gain), wherein more of the gain was achieved by the bag of ring-fencing tag (1.87%), 
as well as the section context feature (1.66% improvement). A relatively small gain (0.55%) was 
achieved by integrating the syntactic feature set, and orthographic and morphological features only 
accounted for minimal improvements of 0.13% and 0.16%. 
 
Model # Features Precision  Recall  F-score  
1 Nine-word contextual window 84.91% 69.66% 76.53% 
2 M1 + Lowercase of tokens 85.33% 73.43% 78.93%* 
3 M2  + Lemma 85.16% 74.74% 79.61% 
4 M3  + POS 85.20% 75.68% 80.16% 
5 M4 + Medical category 85.44% 76.49% 80.72% 
6 M5+ Lexical resource 85.79% 76.93% 81.12% 
7 M6 + Correction of misspelling 85.61% 77.47% 81.34% 
8 M7  + Bag of  ring-fencing tag 85.65% 80.90% 83.21%* 
9 M8  + Suffixes 85.64% 81.11% 83.31% 
10 M9  + Bag of prefixes 85.81% 81.07% 83.37% 
11 M10 + Section context 87.49% 82.71% 85.03%* 
12 M11 + Brief word class 87.52% 82.93% 85.16% 
Table 5.25 System performance on the lymphoma corpus with the contribution of features. Scores 
marked with * suggest significant contribution within 95% confidence interval. 
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Entity type Number Precision Recall F-score 
An:Biomarker 1928 93.07% 94.09% 93.58% 
An:Cytogenetics Comment 18 40.00% 11.11% 17.39% 
An:Fish Results 8 0.00% 0.00% 0.00% 
An:Flow Cytometry-Comment 88 86.30% 71.59% 78.26% 
An:Flow Cytometry-Negative 3 0.00% 0.00% 0.00% 
An:Flow Cytometry-Positive 3 0.00% 0.00% 0.00% 
An:IgH Test 7 50.00% 28.57% 36.36% 
An:Immunohistochemistry-Comment 246 50.24% 42.68% 46.15% 
An:Immunohistochemistry-Equivocal 27 86.96% 74.07% 80.00% 
An:Immunohistochemistry-Negative 284 96.45% 95.77 96.11% 
An:Immunohistochemistry-Positive 594 93.54% 92.59% 93.06% 
An:PCR Comment 27 96.00% 88.89% 92.31% 
An:TCRgamma Test 2 0.00% 0.00% 0.00% 
De:Anatomical Structure 396 80.45% 72.73% 76.39% 
De:Architecture 472 77.48% 72.88% 75.11% 
De:Cell Clonality 1 0.00% 0.00% 0.00% 
De:Cell Size 488 90.12% 89.75% 89.94% 
De:Cytomorphology 178 86.16% 76.97% 81.31% 
De:Laterality 18 0.00% 0.00% 0.00% 
De:Lineage 140 83.90% 70.71% 76.74% 
De:Other Size 123 56.94% 33.33% 42.05% 
De:Preservative Fluid 110 94.39% 91.82% 93.09% 
De:Sample Triage 793 92.43% 87.77% 90.04% 
De:Specimen Blocks 847 94.02% 90.91% 92.44% 
De:Specimen Size 467 81.38% 86.08% 83.66% 
De:Specimen Type 802 91.23% 89.53% 90.37% 
De:Tissue Source 1482 87.91% 81.92% 84.81% 
De:Topography 1404 83.04% 79.84% 81.41% 
De:Tumour Size 51 23.53% 7.84% 11.76% 
En:Coexistent Pathology 160 83.61% 63.75% 72.34% 
Ex:Disease Extent 8 100.00% 12.50% 22.22% 
Ex:Other Sites of Disease 53 50.00% 22.64% 31.17% 
Li:Lexical Modality 322 84.64% 70.19% 76.74% 
Li:Lexical Polarity Negative 366 85.63% 79.78% 82.60% 
Li:Lexical Polarity Positive 1125 87.45% 89.78% 88.60% 
Li:Mood and Comment Adjuncts 607 81.77% 77.59% 79.63% 
Li:Temporality 133 81.11% 54.89% 65.47% 
Re:Tissue Reaction 259 78.88% 70.66% 74.54% 
Sy:Clinical Impression 185 81.92% 78.38% 80.11% 
Sy:Comment 77 90.28% 84.42% 87.25% 
Sy:Constitutional Symptoms 28 81.82% 32.14% 46.15% 
Sy:Diagnosis 1056 85.62% 84.00% 84.80% 
Sy:Diagnosis Subtype 30 70.00% 23.33% 35.00% 
Sy:Indication for Biopsy 28 75.00% 21.43% 33.33% 
Sy:Medical History 82 69.44% 60.98% 64.94% 
Sy:Predisposing Factors 60 68.57% 40.00% 50.53% 
Sy:Presentation 98 71.23% 53.06% 60.82% 
Sy:SNOMED RT Codes 994 99.40% 99.30% 99.35% 
Sy:Stage 3 0.00% 0.00% 0.00% 
Sy:WHO Grade 134 87.31% 87.31% 87.31% 
Overall 16815 87.52% 82.93% 85.16% 
Table 5.26 Performance of each entity type attained by the best model on lymphoma corpus. 
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Table 5.26 shows the performance of each entity type attained by the best model. From Table 5.26, 
although the overall micro-averaged F-score was up to 85.16%, and nine medical entity types obtained 
F-scores exceeding 90%, unsatisfactory results were presented on a considerable number of entity 
types, some with extremely low F- score (0%).  The dramatic loss of the F-scores on these types was 
mostly caused by insufficient training examples, e.g., there is only one De:Cell Clonality instance and 
two An:TCRgamma Test instances in the training data. Besides the small sample size, massive lexical 
variants are another possible reason for the drop of F-score, e.g., there are 39 lexical variants of 
Ex:Other Sites of Disease in total, wherein 30 of them have a frequency of one, so it is difficult for the 
machine learner to learn from the training data effectively. Abbreviation seems to be a challenge for 
recognising Predisposing Factors.  More than half of the Sy:Predisposing Factors instances consist of 
abbreviations or acronyms, such as chemo, CTx, and HIV +ve. It is believed that classifying 
abbreviations is harder than classifying full terms in the biomedical domain. Ambiguity also causes 
most of the classification errors on De:Other Size and De:Tumour Size. In this example: “The nodule 
ranges in size between 3 and 6mm”, the gold-standard is De:Tumour Size as the “nodule” appears to 
be a tumour in this example. Nevertheless, “nodule” can represent other entities in different cases, 
such as a specimen or a coexistent pathological abnormality, and the associated entity types of the size 
should be De:Specimen Size and De:Other Size. Hence, it requires deep insight into the whole 
document to correctly identify these instances, and additional features need to be considered. Except 
for lexical variability, the long span of the instances is likely to be a problem for identifying 
An:Immunohistochemistry-Comment.  The gold-standard of this example: “CD3, CD5 and CD 43 
label moderate numbers of apparently small cells throughout the specimen” is 
An:Immunohistochemistry-Comment. However, as its span exceeds the nine-word contextual 
window, the machine learner could not identify it correctly and tagged it as follows:  
CD3 [“An:Biomarker”], CD5 [“An:Biomarker”] and CD43 [“An:Biomarker”] label 
moderate numbers [“Li:Mood and Comment Adjuncts”] of apparently small cells [“De:Cell 
Size”] throughout the specimen. 
 
5.6.4 Discussion on Three Corpora 
Although all features or their combinations with contextual windows (except for the bigram feature) 
depicted in Section 5.5.2 were attempted in feature engineering (which resulted in 32 models prepared 
for each corpus), not every one of them was effective on each corpus. Some only worked on two 
corpora or one corpus. The full word class feature was not helpful, which was discarded during feature 
engineering. Table 5.27 tabulates these common beneficial features across the three corpora, and 
specific features which were useful for two corpora or one corpus. Consequently, there were 19, 19 
and 20 models discarded during feature engineering for the melanoma, colorectal cancer and 
lymphoma corpora respectively. 
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Beneficial feature Corpus 
Contextual window Melanoma, colorectal cancer, 
lymphoma 
Section context Melanoma, colorectal cancer, 
lymphoma 
Lowercase of token Melanoma, colorectal cancer, 
lymphoma 
Lemma Melanoma, colorectal cancer, 
lymphoma 
Correction of misspelling Melanoma, lymphoma 
Expansion of abbreviations and acronyms/Bag of 
expansions of abbreviations and acronyms 
Melanoma, colorectal cancer 
Bigram Melanoma, lymphoma 
Bag of  prefixes Melanoma, colorectal cancer, 
lymphoma 
Suffixes Melanoma, colorectal cancer, 
lymphoma 
Lexical resource Colorectal cancer, lymphoma 
Medical category Melanoma, colorectal cancer, 
lymphoma 
Ring-fenced tag/Bag of  ring-fencing tag Melanoma, colorectal cancer, 
lymphoma 
POS tag/Bag of POS Melanoma, colorectal cancer, 
lymphoma 
Chunk Melanoma 
Orthography Colorectal cancer 
Brief word class Lymphoma 
Table 5.27 Beneficial features and their contribution to the corpora. 
 
It can be seen from the results that the scores of the baseline models are relatively high (all over 74%), 
which indicates that contextual and lexical information is very useful for recognising medical entities. 
The best feature configurations yielded prominent gains on F-scores from 4.24% to 6.84%. Most of 
the gains were brought by some common features: lowercase of tokens, lemma, POS tag (or bag of 
POS tag), medical category, ring-fenced tag (or bag of ring-fenced tags), suffixes, bag of prefixes, and 
section context. 
 
The lowercase of tokens feature normalize the orthographic variants of a token, which is a good 
supplement for the basic lexical information, the token itself, and significantly increased both 
precision and recall. Given the larger proportions of unique case insensitive tokens in the token 
collection overall held by the melanoma and lymphoma corpora, the models of these two corpora 
benefited more from this feature. Lemma is another lexical feature that normalizes the morphological 
variants of a token, and POS tag is a simple syntactic feature to generalise the representation of the 
tokens. They both increased the recall to some extent. It is likely that the improvement they achieved 
was hindered by the accuracy of GENIA tagger on the texts. For example, the GENIA tagger assigned 
“VBG” as a POS tag for “Advancing” in this sentence “Advancing edge of tumour: Circumscribed.”, 
but the correct tag should be “JJ” instead.   
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It was observed that a great number of the entities have very low frequency (some may have only one) 
so that the machine learner was unable to learn from the insufficient training examples. The medical 
categories generated by the TTSCT service utilising the SNOMED CT lexicon and the semantic tags 
provided by the ring-fenced tagging engine, were able to compensate for the drop of recall caused by 
unseen data in the test subset of each fold to some degree. The semantic knowledge provided by these 
features can benefit both the determination of the presence of an entity and the classification of the 
entity type. As the lymphoma corpus has a moderate number of tag types assigned in the basic pattern 
file (about 40) prepared for the ring-fenced tagging engine, the engine was likely to perform better on 
this corpus, which consequently led to a bigger gain on the system performance.  Affix features 
boosted the F-scores by 0.16-0.65%, as the generalizability of the affixes in some entities may 
increase the recall. Note that bag of prefixes seems to be more informative than prefixes by combining 
prefixes with contextual windows. Given the different distribution of entities in the sections, section 
context was added to determine the presence of an entity. It was more powerful on the lymphoma 
corpus than on other corpora, probably because there are more types of section contexts in this corpus.  
 
The orthographic features were supposed to be able to capture the capitalised information in 
abbreviations or acronyms and generalise tokens that contain numeric or punctuation in measurements 
and named entities such as “0.5mm” and “CD10”. But they were not as effective as expected, and 
only yielded very small gains in the colorectal cancer and lymphoma corpora (both less than 0.2%). 
This suggests that the pathologists might not follow consistent formation conventions and used the 
orthography of words arbitrarily when writing the reports, especially for melanoma pathology notes. It 
is observed that several notes were written in all uppercase format, and some uppercase words were 
intentionally used by the pathologists for emphasis in the sentences (e.g., “Sections show a 
MALIGNANT MELANOMA of superficial spreading type.”). This arbitrary variation of orthography 
could introduce noise in the learning of the models. 
 
The syntactic feature chunk only worked on the melanoma corpus, yet with a minor improvement of 
0.08% F-score, probably because of the specific boundary requirements of several entities (accounting 
for about 8.65% of total instances). 
 
Surprisingly, the lexical feature correction of misspelling did not work on the colorectal cancer 
corpus, although it has more entries in the correction dictionary compared to the other two corpora. 
This is possibly due to the defects in the proof reading process: during proof reading, the correction 
was assigned for a misspelling according to the most frequent context it occurred in the corpus, thus 
only one form of correction would be considered for a misspelling even if there were other alternative 
forms of correction given in different contexts; moreover, some misspellings might not be identified 
during the process. Similarly, the lexical feature expansion of abbreviations and acronyms diminished 
the performance on the lymphoma corpus, probabaly due to erroneous expansion of ambiguous 
abbreviations. The bigram feature also had adverse effect on the lymphoma corpus, which was 
probably because of the relative lower frequencies of common bigrams in this corpus. It can be seen 
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from Table 5.15 that except for the bigram “lymph/node”, the frequencies of other bigrams were 
significantly lower than those in the other two corpora. 
 
The effectiveness of the semantic feature lexical resource seemed to be related to the ratio between 
the number of entries in the medical dictionary and that in Moby dictionary; it was more effective on 
the corpus with bigger ratio. For example, by using this feature, the lymphoma corpus had more gain 
on the F-score than the colorectal cancer corpus (0.40% vs. 0.04%), owing to its larger ratio (1:9.21 
vs. 1:10.12). If this ratio is too small, the feature would be disadvantageous for the system 
performance instead. The application of this feature to the model on the melanoma corpus performed 
worse. 
 
From Table 5.22, 5.24 and 5.26, there is a consistent gap between precision and recall, where the 
recall is 4.25 ~ 5.46% less than precision. The better performance is usually on the entity types with 
high frequency, such as Sy:Diagnosis in the melanoma corpus, Sy:Histological Type in the colorectal 
cancer corpus and An:Biomarker in the lymphoma corpus. This suggests that a sufficient training 
sample is a crucial factor in achieving both high precision and recall. However, besides the training 
sample size, consistent expressions of the instances are also important for the classification. For 
example, though the amount of De:Tissue Banking instances is relatively small, it still obtained very 
high F-score of 93.46% as its training data always contain lexical items like “tissue bank”, “tissue 
banking”, “TB”, etc. Another example is Sy:SNOMED RT Codes.  All of its instances follow a 
pattern: Code ID + Code name, such as “M-95903 Malignant lymphoma, NOS” and “T-C4480 Aortic 
lymph node”. Such consistent expressions improve both learning and prediction by the models. 
  
From the above analyses of each corpus, there are several common reasons accounting for the poorer 
performance on some entity types. Abundant lexical variants are the major one leading to low recall. 
Many variants have a frequency of only one. Though generalised information provided by certain 
features such as POS tag, suffixes, and bag of prefixes can partially cure this problem, there is still a 
lack of lexical information for the classification. Utilisation of the semantic feature sets like medical 
category and ring-fenced tag has shown its advantages in tackling this problem, but these resources 
are not exhaustive, and they may not cover the personally idiosyncratic writing styles of different 
pathologists in the notes. Ambiguity is another possible reason for the low F-scores. It manifests as 
similar use of the lexicons or grammatical structures, which can confuse the classification of the 
machine learner. More complicated contextual information involving the adjacent sentences may be 
helpful to solve this problem. The problems caused by the long span of instances may be a defect of 
CRF++, which restricts the maximal value of contextual window size to be nine. Using other machine 
learning algorithms (e.g., Support Vector Machines (SVM)) can be considered as a possible solution 
for this problem.  
 
 
 
Chapter 5 Medical Entity Recognition 
143 
 
 Melanoma corpus Colorectal cancer corpus Lymphoma corpus 
Matchin
g 
Criteria 
Precisio
n 
Recall F-
score 
Precisio
n 
Recall F-
score 
Precisio
n 
Recall F-
score 
Exact 
match 
87.11% 81.65
% 
84.29
% 
80.58% 76.33
% 
78.40
% 
87.52% 82.93
% 
85.16
% 
Left 
boundar
y match 
89.82% 84.19
% 
86.91
% 
85.53% 81.02
% 
83.21
% 
89.82% 85.11
% 
87.40
% 
Right 
boundar
y match 
91.49% 85.75
% 
88.53
% 
86.37% 81.81
% 
84.03
% 
90.00% 85.28
% 
87.58
% 
Sloppy 
match 
97.78% 91.65
% 
94.62
% 
98.85% 93.63
% 
96.17
% 
96.93% 91.85
% 
94.32
% 
Table 5.28 Partial match performance on the three corpora. 
 
Table 5.28 lists the partial match performance on the three corpora. As suggested by the above 
analyses, many errors occurred at the boundary of the entities, and resulted in the poor performance of 
these entities. In the colorectal cancer corpus, the partial matching F-scores are significantly higher 
than that of the exact match by about 4.8%, 5.6% and 17.8% of the left boundary match, right 
boundary match and sloppy match respectively, which outperformed those in other corpora. This 
indicates that the system performance was hindered by the quality of the detection of entity 
boundaries to a greater extent in this corpus. This is possibly because: 
• The average length of the entities is longer in this corpus than those in other corpora (more 
than twice).  
• Some synoptic fields present in the corpus. As discussed in the section heading detection, 
they were annotated as part of the entities or subheadings in the gold-standard according to 
the amount of reportable fields they contained instead of linguistic structures. 
Hence, the detection of entity boundaries seems to be a more difficult issue for the machine learner on 
this corpus.  
 
Likewise, the smaller gaps between the F-scores of partial matches and exact match in the lymphoma 
corpus, implies that the misclassification of entity type is more likely to account for the classification 
errors. This is probably because the total entity types have larger numbers in this corpus than those in 
other corpora, and the machine learner is more confused when making decisions on entity types.  Note 
that the inconsistent annotations of the entity boundary can also cause some faults on boundary 
detection. 
 
5.6.5 Limitations 
The overall results are promising, with micro-averaged F-scores ranging from 78.4% to 85.16%. 
Nonetheless, there are still some notable limitations in the experiments: 
1. Additional features can be introduced into the models. For example, features that represent 
more complicated contextual information may remedy the ambiguity problem. The second 
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order category from TTSCT can also be considered as another medical category feature to 
enrich the semantic feature set. 
2. Although nearly all other features were tried in combination with the contextual window to 
boost the system performance, the same nine window size was applied to them. This cannot 
rule out the possibility that the combination with different window sizes may yield better 
performance. 
3. One of the disadvantages of using CRF is that CRF is likely to bias to the majority entity 
types in the classification, especially when ambiguous expressions occur in the minority 
counterparts. The voting or stacking strategies for aggregating the results from different 
machine leaning classifiers might be applied to resolve this issue (Dzeroski and Zenko, 2004; 
Wang and Patrick, 2009). 
 
5.7 Conclusion 
A supervised machine learning-based approach is proposed to recognise medical entities in the 
corpora. The spans of most entity types are smaller than nine, thus CRF-based models were able to 
capture a significant portion of the entity boundaries by using contextual information. The application 
of rich feature sets provides useful clues for the classification of entity types. By feature engineering, 
the best feature configurations were attained, which yielded prominent gains on F-scores from 4.24% 
to 6.84%. Several common beneficial features were identified, which can be helpful for other MER 
tasks using similar approaches.  
 
The error analyses show that lexical variability and ambiguity are two main causes accounting for the 
poorer performance on some entity types. The limitation of the machine learning method can also 
result in some mistakes on the entities with a relatively long span. Future work will involve improving 
the performance of the boundary detection (e.g., using other machine learning algorithms), and 
classification of entity types (such as introducing additional features).  
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Chapter 6  Negation and Uncertainty Detection 
6.1 Introduction 
In the clinical domain, when a particular term appears in a patient record, it does not mean the clinical 
finding or condition it represents occurs in the patient, or the procedure it refers to has been performed 
on the patient. Actually, nearly half of all symptoms, diagnoses, and findings in clinical reports are 
estimated to be negative or uncertain (Chapman et al., 2001a). Without discrimination between the 
negative or uncertain information and the positive in an information retrieval and information 
extraction (IE) system, the reliability of the extracted information is diminished and this causes 
redundancy when indexing. For example, in the sentence: “CV - Ischemia ASA, lisinopril Pump no 
evidence of failure”, the clinical finding “failure” is negated, which suggests that it can be ruled out 
for the patient. In another example: “Possible aspiration pneumonia”, the clinical condition “aspiration 
pneumonia” is uncertain, which indicates that the patient may have it, but is not confirmed to have it. 
Negation and uncertainty detection was also part of the assertion classification task in the 2010 
i2b2/VA Challenge, which was to determine what the clinical note asserts the medical problem to be 
based on and the context in which it is used (Uzuner et al., 2011) . 
 
In pathology notes, negative or uncertain findings or diagnoses also appear frequently. To find out 
whether a finding is present, absent or uncertain is critical to making the correct diagnosis and 
prognosis for the patient. The presence or absence of a particular disease can influence the clinical 
management of the patient. For example, the treatment can be different for Hodgkin’s lymphoma and 
non-Hodgkin’s lymphoma. According to the protocols, there are several fields explicitly indicating 
that pathologists should record the findings whether they are present or not, such as “S3.04 
Ulceration” in Primary Cutaneous Melanoma Structured Reporting Protocol (Scolyer et al., 2010). 
Thus, negation and uncertainty detection is an important component in the study and definitely can 
affect the final output for these fields in the structured templates. 
 
In the previous chapter, potential medical entities have been identified by the medical entity 
recognition (MER) system, as well as Linguistic categories for the melanoma corpus and the 
lymphoma corpus. The study presented in this chapter focuses on the detection of absent and uncertain 
assertions for a selection of these entities.  It begins with an overview of current methodologies for 
negation and uncertainty detection, and is then followed by a case study on the lymphoma corpus 
where three different approaches are experimented with, and the preferable method for the other two 
corpora. The associated results and discussions for these methods on the three corpora are presented as 
well. 
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6.2 Case Study on Lymphoma Corpus  
A case study on the lymphoma corpus was carried out to find out a suitable method to be implemented 
for this project. Another objective of the case study is to discuss the advantages and disadvantages of 
different methods for negation detection on narrative pathology reports. 
 
The lymphoma corpus was chosen ahead of the other corpora, because:  
• It has the smallest number of training documents, thus it was likely to be less labour and time 
consuming for the annotation and evaluation of the gold-standards. 
• It has a medium amount of tokens and entities, but the largest number of entity types 
amongst the corpora, hence it might be more representative than the other two corpora. 
 
Besides the 227 reports mentioned in the previous chapters as a training set, an additional 57 reports 
were collected as a test set. 
  
6.2.1 Negation Detection 
In this study, only pertinent negations within a sentence are considered as valid instances. The 
pertinent negations indicate “completely absent”, while partial negations such as “probably not” and 
“unlikely” were excluded. Normal or abnormal findings and test results, and related comments also 
were not considered. In the following sentence: 
The absence of CD15 expression [“An:Immunohistochemistry-Comment”] and the cellular 
arrangement of the large atypical cells [“De:Cell Size”] is much more in favour of 
[“Li:Lexical Modality”] a diffuse large B-cell lymphoma [“Sy:Diagnosis”]. 
“absence of CD15 expression” is a comment made by the pathologist based on the 
immunohistochemistry test results, thus it was not considered as negation. Negative prefixes or 
suffixes are also not considered, because they are often semantically ambiguous or they are part of an 
entity, e.g., “non-Hodgkin’s malignant lymphoma” can represent several sub-types of malignant 
lymphoma, except for Hodgkin’s lymphoma.  
 
Motivated by the approaches mentioned above, three different methods were applied in this study to 
detect negation. Given a medical entity in a sentence, the methods seek to determine whether the 
entity is negated.  
 
The processing components shown in Figure 6.1 include: 
1. The MER system introduced in the previous chapter which annotates the medical entities and 
instances of Li:Lexical Polarity Negative in the test set. Not all types of entities were utilised, 
the selection of particular entity types was based on their definitions in the annotation 
schema, their associated fields in the protocol, and thorough analysis on the training data. 
The selected entity types were Sy:Clinical Impression, Ex:Other Sites of Disease, 
Sy:Constitutional Symptoms, Sy:Predisposing Factors, De:Architecture, 
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De:Cytomorphology, Re:Tissue Reaction, Sy:WHO Grade, En:Coexistent Pathology, 
Sy:Diagnosis and Sy:Diagnosis Subtype. 
2. Different methods are applied to detect negated medical entities.  
3. The results from the negation detection module are filtered by identification of pseudo-
negations. 
4. The final output is evaluated and compared to the performances of the other methods. 
 
Figure 6.1 Processing components for negation detection on the lymphoma corpus. 
 
Lexicon-based Approach 
NegEx defined three types of terms: trigger terms, pseudo-trigger terms, and termination terms 
(Chapman et al., 2001b). Trigger terms are some negation phrases, also known as the negation cues; 
pseudo-trigger terms are phrases that indicate double negatives or modified meanings; termination 
terms are used to restrict the scope of the negation. 
 
Similar to NegEx, trigger and termination terms were also adopted in this method. The instances of 
Li:Lexical Polarity Negative in the training data were used as trigger terms, and divided into three 
groups according to their positions relative to a medical entity: Group 1- the instance precedes a 
medical entity, Group 2 - the instance succeeds a medical entity, Group 3 - any of the above positions. 
Besides some specific words, particular punctuation was also considered as termination cues. Note 
that the termination punctuation varied between different section contexts. These terms or cues and 
some examples are compiled in Table 6.1. From Table 6.1, it can be seen that there are only four 
lexical entries of trigger terms the same as those used in NegEx: “no”, “no evidence of”, “not”, and 
“without”. 
 
There are some differences between this approach and NegEx: 
• In this approach, “not” is defined as a trigger term that can either precede or succeed a 
medical entity. 
• Termination cues include specific punctuation. 
• The negation scope is not constrained in a fixed context window. 
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Type of 
term/cue 
Sub-category Example 
Trigger term Group 1 devoid of, no features of, no morphological evidence of, not 
sufficient to, lacking, without, exclude, lack, no definite evidence 
of, none, rather than, no convincing evidence of, no evidence of, 
no 
Group 2 absent,  not a feature 
Group 3 not 
Termination 
cue 
Termination 
term 
but, which, though, although, however, so, whether,  involved by, 
based on 
Termination 
punctuation 
“CLINICAL HISTORY” and “SPECIMEN”: , | ; | ( | ) | -> 
“SUMMARY” and “SUPPLEMENTARY SUMMARY”: ( | ) | - 
Other section contexts: ( | ) 
Table 6.1 Trigger terms and termination cues for negation detection in the lymphoma corpus. Note: 
word examples are separated by comma “,”; punctuation examples are separated by pipe “|”. 
 
This rule-based method can be summarized in three steps, and is illustrated in Figure 6.2:  
1. Find out whether there is at least one termination cue between the trigger term and the 
medical entity. If there is, filter out the entity. 
2. Validate the position of the trigger term to the entity. If it is not the same as defined in the 
associated group, filter out the trigger term. 
3. If there are multiple trigger terms, repeat the above two steps; if the trigger term is not 
filtered out, yield “absent” as the output. 
 
 
Figure 6.2 Workflow of the lexicon-based approach for negation detection on the lymphoma corpus. 
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Syntax-based Approach 
The Stanford parser (Klein and Manning, 2003) is a well-known probabilistic natural language parser 
that computes the grammatical structure of new sentences based on knowledge of language gained 
from hand-parsed sentences. It can provide both phrase structure trees and Stanford dependencies as 
output. The usages of the output were different in a variety of syntax-based approaches for negation 
detection. In Huang et al’s work,  the parse tree output was utilised for the deriviation of a negation 
grammar (Huang and Lowe, 2007). Firstly, they constructed grammar rules from the parse trees, and 
then translated these rules into a structural rule to extract negated phrases: the classification of 
negations were firstly based on the syntactical category of negation signals, and further based on 
phrase patterns to locate negated phrases.  DepNeg used several types of negation patterns based on 
dependency paths, which were computed from the dependency parse (Sohn et al., 2012). The negation 
patterns included:  
• Negated Verbs – if a particular verb is negated, the whole verb phrase is negated as well, 
including the objects or complements of the verb. 
• Negative Verbs – Particular verbs indicate exclusion of the direct object of the verbs.  
• Negative Prepositions – Particular prepositions negate the object of the prepositions. 
• Negated Nouns – Certain determiners negate the nouns they modify. 
• Negative Adjectives – Certain adjectives negate the nouns they modify. 
• Conjunction Expansion – A general rule can be applied to every other pattern to allow 
conjunctions or lists of the targets above.  
 
The medical entities were identified in a named entity recognition module in DepNeg, which 
resembles the methods developed in this study. Therefore, the syntax-based approach prepared in this 
study also uses the dependency paths from the parser to extract the rules.  
 
A set of grammatical relations was drawn from the Stanford dependencies (de Marneffe et al., 2006), 
which are all binary relations that hold between a governor and a dependent. 
• Adverbial modifier (advmod): An adverbial modifier of a word. 
• Adjectival modifier (amod): An adjectival modifier of a noun phrase. 
• Appositional modifier (appos): An appositional modifier of a noun phrase. 
• Conjunct (conj): The relation between two elements connected by a coordinating 
conjunction.  
• Dependent (dep): When the parser is unable to determine a more precise relation between 
two words, it assigns this label to the words. 
• Determiner (det): The relation between the head of a noun phrase and its determiner. 
• Direct object (dobj): A noun phrase which is the accusative object of a verb. 
• Infinitival modifier:  An infinitive that serves to modify a noun phrase. 
• Negation modifier (neg): The relation between a negation word and the word it modifies. 
• Noun compound modifier (nn): Any noun that serves to modify the head noun. 
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• Nominal subject (nsubj): A noun phrase which is the syntactic subject of a clause. 
• Passive nominal subject (nsubjpass): A noun phrase which is the syntactic subject of a 
passive clause. 
• Participial modifier (partmod): A participial verb form that serves to modify a noun phrase or 
sentence. 
• Object of a preposition (pobj): The head of a noun phrase following the preposition or the 
adverbs “here” and “there”. 
• Prepositional modifier (prep): Any prepositional phrase that serves to modify a verb, 
adjective, noun, or another preposition. 
• Relative clause modifier (rcmod): A relative clause modifying a noun phrase. 
• Open clausal complement (xcomp): A clausal complement without its own subject, and is 
determined by an external subject. 
 
In the collapsed representation, dependencies involving prepositions and conjuncts are collapsed to 
get direct dependencies between content words. Conjuncts involve conjunctions “and” and “or” are 
collapsed as “conj_and” and “conj_or”. Several variant conjunctions for “and not": “but not”, “instead 
of”, “rather than”, and “but rather” are collapsed as “conj_negcc”. Prepositional modifiers regarding 
prepositions “of”, “without “, and “such as” are collapsed as “prep_of”, “prep_without” and 
“prep_such_as” respectively. 
 
Firstly, the dependency path between a medical entity and a Li:Lexical Polarity Negative instance can 
be computed from the result between the head words of the entity and the instance as two nodes in the 
dependency parse of the sentence. Figure 6.3 displays an example of dependency parse of the 
sentence: “No necrosis is identified.” 
 
Figure 6.3 Dependency parse of the sentence: “No necrosis is identified.” 
 
The dependency path between “No” and “necrosis” is  
det (necrosis-2, No-1) 
where “1” and “2” are the positions of “No” and “necrosis” in the sentence respectively. 
 
Several rules were designed according to the dependency path based on manual analysis of the gold-
standards in the training data. Other words except for the headwords in the path are called linkage 
words. The length of the dependency path is calculated as follows: if two nodes are connected directly 
with a grammatical relation, the length is zero; if two nodes are connected indirectly with two 
nsubjpass 
auxpass 
No necrosis 
 
is identified . 
det 
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grammatical relations and one linkage word, the length is one; if two nodes are connected indirectly 
with three grammatical relations and two linkage words, the length is two, etc. Figure 6.4 divides the 
rules into several categories according to the length of the dependency path, grammatical relations, the 
role of the headwords and linkage words, and the prerequisite conditions. 
 
In total, seven negation patterns could be derived from the combinations of the rules: 
Pattern 1: Rule #1 
Pattern 2: Rule #3 
Pattern 3: Rule #5 
Pattern 4: Rule #2 / Rule #4 / Rule #6 + Rule #7 / Rule #9 / Rule #11 
Pattern 5: Rule #2 / Rule #4 / Rule #6 + Rule #8 + Rule #13 
Pattern 6: Rule #2 / Rule #4 / Rule #6 + Rule #10 + Rule #14 
Pattern 7: Rule #2 / Rule #4 / Rule #6 + Rule #12 + Rule #15 
Note that for Pattern 6, grammatical relation “dep” cannot co-occur in Rule #10 and Rule #14. It is 
presumed that “dep” occurs once in Rule #10 or Rule #14, which may be due to a rare grammatical 
construction or an unresolved long distance dependency; whereas “dep” occurs both in Rule #10 and 
Rule #14, which is more likely because of an error from the parser. 
 
Examples for each pattern are presented in graphical form as follows. 
 
Pattern 1: Rule #1 
 
Pattern 2: Rule #3 
 
 
No significant histological abnormality . 
det 
The sections show mainly partly crushed lymphoid tissue devoid of follicles . 
prep_of 
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Rule  Length of  
the path  
Grammatical 
relation 
(abbreviation)  
The role of the headword 
of  the “Lexical Polarity 
Negative” instance  
The role of the first 
linkage 
word in the path 
The role of the 
second linkage 
word in the path 
The role of the 
headword of   the 
medical entity 
The order of appearance in 
the output  from the parser  
Condition  
#1  0  GR 1  governor  N/A  N/A  dependent  N/S  N/A  
#2  1  GR 1  governor  dependent  N/A  N/A  N/S  N/A  
#3  0  GR 2  dependent  N/A  N/A  governor  N/S  N/A  
#4  1  GR 2  dependent  governor  N/A  N/A  N/S  N/A  
#5  0  GR 3  N/A  N/A  N/A  dependent  N/S  N/A  
#6  1  GR 3  N/A  dependent  N/A  N/A  N/S  N/A  
#7  1  GR 4  N/A  governor  N/A  dependent  Proceeding the match rule in 
the condition  
Match one of the rules 
in #2, # 4 and #6  
#8  2  GR 4  N/A  governor  dependent  N/A  Proceeding the match rule in 
the condition  
Match one of the rules 
in #2, # 4 and #6  
#9  1  GR 5  N/A  governor/ dependent  N/A  dependent/ governor  Succeeding the match rule in 
the condition  
Match one of the rules 
in #2, # 4 and #6  
#10  2  GR 5  N/A  governor/ dependent  dependent/ 
governor  
N/A  Succeeding the match rule in 
the condition  
Match one of the rules 
in #2, # 4 and #6  
#11  1  “nsubj”  N/A  dependent  N/A  governor  Succeeding the match rule in 
the condition  
Match one of the rules 
in #2, # 4 and #6  
#12  2  “ccomp”  N/A  dependent  governor  N/A  Succeeding the match rule in 
the condition  
Match one of the rules 
in #2, # 4 and #6  
#13  2  GR 6  N/A  N/A  governor  dependent  Proceeding the match rule in 
the condition of  #8, 
succeeding #8  
Match # 8  
#14  2  GR 6  N/A  N/A  governor  dependent  Succeeding the match rule in 
the condition of #10  
Match #10  
#15  2  GR 6  N/A  N/A  governor  dependent  Proceeding #12  Match # 12  
Figure 6.4 Rules for constructing negation patterns. N/S: Not specified; N/A: Not applicable; GR 1: “dobj”, “prep_of”, “nsubj”, “pobj”, “dep” and “partmod”; GR  2: “det”, 
“neg”, “advmod”, “nn” and “amod”; GR 3: “conj_negcc” and “prep_without”; GR 4: “nsubjpass”, “nsubj” and “nn”; GR 5: “appos”, “dobj”, “prep_of”,  “conj_and”,  “nn”, 
“conj_or”, “infmod”, “prep”, “xcomp”, “amod” and “dep”; GR 6: “nn”, “prep_such_as”, “pobj”, “nsubj”, “conj_or”, “nsubjpass”, “dobj”, “prep_of”, “rcmod” and “dep”. 
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Pattern 3: Rule #5 
 
Pattern 4: Rule #4 + Rule #9 
 
Pattern 5: Rule #4 + Rule #8 + Rule #13 
 
Pattern 6: Rule #4 + Rule #10 + Rule #14 
 
Pattern 7: Rule #4 + Rule #12 + Rule #15 
No Reed-Sternberg cells are seen and no reactive eosinophils or plasma cells are seen . 
nsubjpass 
nsubjpass 
det 
The tumour has a diffuse pattern, the larger cells not showing a proliferation centre picture . 
neg dobj 
nn 
A lower  grade MALT not lymphoma is identified . 
neg nsubj 
ccomp 
No evidence  malignancy of in lymph nodes . 
prep_of det 
 
conj_negcc 
The immunophenotype and flow cytometry (see below) results indicate follicle centre cell differentiation and are more 
suggestive of a follicular lymphoma rather than small cell/chronic lymphocytic lymphoma . 
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This method consists of the following processes: 
1. Find the headwords. For a medical entity, its headword is the head noun if it is a noun phrase; 
else, its headword is the last word of the entity. For a Li:Lexical Polarity Negative instance, 
the first word of the instance (e.g., “no” for “no evidence of”, “not” for “not”) is the 
headword. 
2. Compute the path. The dependency path between the headwords of the Li:Lexical Polarity 
Negative instance and the medical entity is computed as described above. To reduce the 
complexity of the rules, only paths with length not larger than two are considered. Note that a 
special case exists:  if the Li:Lexical Polarity Negative instance is “rather than” or “without”, 
and the headword of the entity is a dependent with a grammatical relation of “conj_negcc” or 
“prep_without”, the associated governor can be any word in the sentence, and the path is 
computed from the results between it and the headword of the entity. 
3. Match the patterns. Evaluate whether the path matches the patterns as described above. If the 
length of the path is zero and it matches one of the patterns in Patterns 1 to 3, the entity is 
negated; if the length of the path is one and it matches Pattern 4, the entity is negated; if the 
length of the path is two and it matches one of the patterns in Patterns 5 to 7, the entity is 
negated. 
 
Machine Learning-based Approach 
Uzuner et al had argued that in the Statistical Assertion Classifier (StAC), contextual features could 
capture the information necessary for assertion classification, and syntactic information could make 
some contribution as well (Uzuner et al., 2009). Similar to their work, a machine learning-based 
approach applying a support vector machine (SVM) was built in this study for negation detection. 
However, the approach was different from their work, employing a pair-wise method instead, as 
Li:Lexical Polarity Negative instances were annotated in the training data, besides medical entities. 
Specifically, an instance of Li:Lexical Polarity Negative (the first concept) and a medical entity (the 
second concept) were paired and then passed into a SVM classifier to classify the negation 
relationships between them. Positive pairs were created for each pair with negation in a sentence, and 
negative pairs were created for each pair without negation in a sentence.  
 
Besides contextual and syntax features, the SVM classifier was armed with other features, including 
semantic features, lexical features, grammatical features and positional features. 
 
Contextual features: Four-word contextual window of each concept. 
The contextual window size was determined by preliminary experiments on the training data. 
The optimal size found was four. 
 
Grammatical features: Headwords of each concept. 
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Headwords of each concept are determined as described above. These features are general 
representatives for the concepts even if they consist of different lexicons. For example, the 
headword of the first concept can generalise two different Li:Lexical Polarity Negative 
instances “no definite evidence of” and “no convincing evidence of” to the same feature 
value: “no”; the headword of the second concept can yield the same feature value 
“lymphoma” for two Diagnosis entities “large B-cell lymphoma” and “classical Hodgkin 
lymphoma”. 
 
Syntax features: a) The grammatical relations of the shortest dependency path between the 
headwords of two concepts; b) The length of the shortest dependency path between the headwords of 
two concepts; c) Part-of -speech (POS) tags of the tokens between the two concepts. 
The shortest dependency path between the headwords of two concepts can be computed as 
follows: First, compute the path between the root and the headword of each concept (path to 
root); compare the path to root for each concept, and the ones with least common nodes are 
selected from others; the selected paths to root are merged together into the shortest 
dependency path between two concepts. 
In the syntax-based approach, grammatical relations are used to extract rules to construct 
negation patterns; with a), the classifier can automatically learn from the grammatical 
relations prepared for the model, and predict the unseen data based on probability. 
For b), since most of the lengths of the shortest dependency paths for the positive pairs in the 
training data are not larger than two, assign the value for the feature as “C1” if the length is 
zero or one; “C2” if it is two; “F” if it is larger than two; “O” if the shortest dependency path 
cannot be found. 
 
Semantic features: Annotation types of each concept. 
 
Lexical features: a) Words inside each concept; b) Lowercase of words inside each concept; c) 
Tokens between the two concepts. 
Tokens between the two concepts may contain termination cues; this feature provides an 
opportunity for the classifier to learn from these cues. 
 
Positional features: a) Token distance between the two concepts; b) The order of appearance for the 
two concepts. 
For a), as the average token distance for all positive pairs in the training data is smaller than 
one, so assign the feature value as “C” if the token distance between the two concepts is not 
larger than one; else, assign the feature value as “F”. 
For b), if the second concept is preceding the first concept, assign the feature value as “P”; 
else, assign the feature value as “S”. As indicated in the lexicon-based approach, there are 
some patterns for the positions of particular trigger terms relative to a medical entity.  
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From the above features, it can be seen that several of them are adapted from the similar ideas in the 
two rule-based approaches. This is motivated by Patrick et al’s work that converted a baseline rule-
based method to a statistical approach based on the same idea for assertion classification, which 
produced better performance (Patrick et al., 2011). 
 
Pseudo-negation Detection 
A special module was implemented with regular expressions to handle pseudo-negations in sentences. 
They are triggered by some pseudo-negation phrases (e.g., “not possible”, “not likely”, “to exclude”). 
If a match is found, the related positive output from the negation detection module will be ruled out. 
 
Evaluation Methods 
All approaches were evaluated using single train-test cycles. The toolkit used for applying SVM in the 
machine learning-based approach is LIBSVM (Chang and Lin, 2011). Ten-fold cross-validation 
experiments were also carried out for this approach on the training set, and each fold was stratified at 
a document level, and used the default configuration for most parameters, except that parameter “cost” 
was set to 100, and “gamma” was set to 0.025.  
 
The performances of the three methods on the training set were measured by the standard Precision, 
Recall and F-score. To compare the results to the work of Mitchell et al (Mitchell et al., 2004), three 
metrics were adopted to measure the performances of the three methods on the test set: strict, lenient 
and average metrics (Douthat, 1998). Strict metrics only consider exact match of the system 
predictions and gold-standards when they have the same boundaries; lenient metrics also consider 
partial match when they have any overlap of the boundaries; average metrics are the mean of the two 
above metrics. They are computed by true positive (TP), false positive (FP), false negative (FN) and 
partial positive (PP) as follows: 
Strict Precision (SP) = TP/(TP+FP+½PP) 
Strict Recall (SR) = TP/(TP+FN+½PP) 
Strict F-score (SF) = 2*SP*SR/(SP+SR) 
Lenient Precision (LP) = (TP+½PP)/(TP+FP+½PP) 
Lenient Recall (LR) = (TP+½PP)/(TP+FN+½PP) 
Lenient F-score (LF) = 2*LP*LR/(LP+LR) 
Average Precision (AP) = (SP + LP)/2 
Average Precision (AR) = (SR + LR)/2  
Average F-score (AF) = 2*AP*AR/(AP+AR) 
 
Results 
Table 6.2 shows the contribution of features to the machine learning-based approach on the training 
set. 
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The section contexts were classified to four categories: Macroscopic (referring to 
“MACROSCOPIC”), Microscopic (referring to “MICROSCOPIC”), Summary (including 
“SUMMARY” and “SUPPLEMENTARY SUMMARY”), and Other (composed of “CLINICAL 
HISTORY”, “SPECIMEN”, “FROZEN SECTION REPORT” and “SUPPLEMENTARY REPORT”). 
 
Table 6.2 Contribution of features to the machine learning-based approach on the lymphoma training 
set (evaluated with the strict metric). 
 
Table 6.3 Performance metrics across report sections for negation detection for the three methods on 
the lymphoma training set (evaluated with the strict metric). 
 
Table 6.3 displays the results for the three methods by section and overall on the lymphoma training 
set, using the strict metric. From Table 6.3, the highest F-score of 98.90% was achieved by the syntax-
based approach. The best performance for most sections varied from each method: the highest F-score 
of 99.38% for the “Microscopic” section was attained by the syntax-based approach; the highest F-
Model  
# 
Feature  Precision  Recall  F-score  
1  Words inside each concept + annotation types of each 
concept                              
84.78%  89.31%  86.98%  
2  M1 + Four-word contextual window of each concept  83.64%  99.69%  90.96%  
3  M2 + Lowercase of words inside each concept 84.04%  99.37%  91.07%  
4  M3 + Token distance between the two concepts 89.66%  98.11%  93.69%  
5  M4 + Headwords of each concept 89.43%  98.43%  93.71%  
6  M5 + The order of appearance for the two concepts 90.67%  97.80%  94.10%  
7  M6 + Tokens between the two concepts 92.60%  98.43%  95.43%  
8  M7 + The grammatical relations of the shortest 
dependency path between the headwords of two 
concepts 
93.18%  98.74%  95.88%  
9  M8 + The length of the shortest dependency path 
between the headwords of two concepts 
94.28%  98.43%  96.31%  
10  M9 + POS tags of the tokens between the two 
concepts 
95.41%  98.11%  96.74%  
Method Section Number Precision  Recall  F-score  
Lexicon-based approach Macroscopic 4 100.00% 100.00% 100.00% 
Microscopic 242 97.57% 99.59% 98.57% 
Summary 54 100.00% 98.15% 99.07% 
Other 18 94.74% 100.00% 97.30% 
Overall 318 97.83% 99.37% 98.60% 
Syntax-based approach Macroscopic 4 100.00% 100.00% 100.00% 
Microscopic 242 99.59% 99.17% 99.38% 
Summary 54 98.11% 96.30% 97.20% 
Other 18 94.74% 100.00% 97.30% 
Overall 318 99.05% 98.74% 98.90% 
Machine learning-based approach (10-fold cross-
validation) 
Macroscopic 4 100.00% 100.00% 100.00% 
Microscopic 242 95.97% 98.35% 97.14% 
Summary 54 100.00% 100.00% 100.00% 
Other 18 76.19% 88.89% 82.05% 
Overall 318 95.41% 98.11% 96.74% 
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score of 100.00% for the “Summary” section was attained by the machine learning-based approach; 
the lexicon-based approach and syntax-based approach had the same performance for other sections 
with 97.30%  F-score; no difference occurred on the performances of “Macroscopic” section with the 
three methods, all with 100.00% F-score. 
 
The system performances across sections for the three methods on the test set are presented in Table 
6.4. The overall micro-averaged F-scores decreased by 14.18 to 20.28%. The machine learning-based 
approach performed well on the Microscopic section, with 84.85% F-score; the syntax-based approach 
performed well within the Summary and other sections, with 100% and 61.54% F-scores respectively. 
 
As shown in Table 6.5, the majority of errors on the test set can be attributed to MER. Note that the 
errors were categorized to incorrect MER in priority, hence it cannot rule out the possibility that some 
errors might be actually be due to mistakes from both MER and negation detection. 
 
Discussion 
From Table 6.2, the baseline model achieved 86.98% F-score. Contextual feature set yielded the 
biggest gain, and improved the model by 3.98%. Meanwhile, moderate improvements are contributed 
by the positional feature token distance between the two concepts and the lexical feature tokens 
between the two concepts (with 2.62% and 1.33% gain respectively). Three syntax features and the 
positional feature the order of appearance for the two concepts yielded some gains ranging from 
0.39% to 0.45% respectively.  Minimal improvements were made by adding the lexical feature 
lowercase of words inside each concept and headwords of each concept with 0.11% and 0.02%.  
 
The results are consistent with those from the evaluation on StAC (Uzuner et al., 2009), which 
indicated that the contextual features were very effective at improving the model. Syntax features 
could correct some false positives when a Li:Lexical Polarity Negative instance occurs within the 
four-word window but does not in fact negate a medical entity. For example, in the sentence “The 
colonic wall is not involved by lymphoma.”, “involved” is negated by “not” but not “lymphoma”. 
Note that the syntax features in this study are different from those in StAC:  
• StAC utilised the output of the Link Grammar Parser (LGP) (Sleator and Temperley, 1991), 
while Stanford parser was used to generate the dependency parse. 
• StAC focused on the verbs preceding and succeeding the entity, while this was not 
emphasized in this study, as the training data for StAC were discharge summaries, which 
were pathology reports in this study; verbs were less frequently appearing in pathology 
reports,  and they would be omitted in some cases, e.g., in this sentence “2. Lymph node, in 
transit sentinel - no evidence of malignancy.”  
• Unlike StAC, a few features that motivated by the rule-based approach (e.g., the positional 
feature token distance between the two concepts and the lexical feature tokens between the 
two concepts) were also adopted, which yield more gains than the syntax feature set. 
Chapter 6 Negation and Uncertainty Detection 
159 
 
 
 
 
 
 
Method Section TP FP FN PP SP SR SF LP LR LF AP AR AF 
Lexicon-based approach Macroscopic 1 0 1 0 100.00% 50.00% 66.67% 100.00% 50.00% 66.67% 100.00% 50.00% 66.67% 
Microscopic 53 3 15 8 88.33% 73.61% 80.30% 95.00% 79.17% 86.36% 91.67% 76.39% 83.33% 
Summary 10 1 0 0 90.91% 100.00% 95.24% 90.91% 100.00% 95.24% 90.91% 100.00% 95.24% 
Other 4 2 4 0 66.67% 50.00% 57.14% 66.67% 50.00% 57.14% 66.67% 50.00% 57.14% 
Overall 68 6 20 8 87.18% 73.91% 80.00% 92.31% 78.26% 84.71% 89.74% 76.09% 82.35% 
Syntax-based approach Macroscopic 1 0 1 0 100.00% 50.00% 66.67% 100.00% 50.00% 66.67% 100.00% 50.00% 66.67% 
Microscopic 46 2 23 7 90.20% 63.89% 74.80% 96.08% 68.06% 79.67% 93.14% 65.97% 77.24% 
Summary 10 0 0 0 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
Other 4 1 4 0 80.00% 50.00% 61.54% 80.00% 50.00% 61.54% 80.00% 50.00% 61.54% 
Overall 61 3 28 7 91.04% 66.30% 76.73% 95.52% 69.57% 80.50% 93.28% 67.93% 78.62% 
Machine learning-based 
approach 
Macroscopic 1 0 1 0 100.00% 50.00% 66.67% 100.00% 50.00% 66.67% 100.00% 50.00% 66.67% 
Microscopic 54 2 14 8 90.00% 75.00% 81.82% 96.67% 80.56% 87.88% 93.33% 77.78% 84.85% 
Summary 10 3 0 0 76.92% 100.00% 86.96% 76.92% 100.00% 86.96% 76.92% 100.00% 86.96% 
Other 4 2 4 0 66.67% 50.00% 57.14% 66.67% 50.00% 57.14% 66.67% 50.00% 57.14% 
Overall 69 7 19 8 86.25% 75.00% 80.23% 91.25% 79.35% 84.88% 88.75% 77.17% 82.56% 
Table 6.4 Test set performance metrics across report sections for the three evaluation methods (Strict, Lenient and Average) for the lymphoma corpus. 
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• StAC restricted ±2 link window on the features, while there was no such restriction in this 
study. 
 
It can be seen from Table 6.4 that the best performance on the lymphoma test set was on the Summary 
section. This is possibly because of the better grammatical structure in the Summary section.  This 
section was present in almost every report, often in a well-structured and formalized format. This is 
also the main reason for the best performance in this section with the syntax-based approach (100% F-
score), as the syntax-based approach relied on the output from the parser and the performance of the 
parser was hindered by the linguistic constructions of the input. Accurate parsing output can be 
generated due to the simple linguistic constructions in this section. The best performance for the 
Microscopic section was obtained by the machine learning-based approach, which indicates one of the 
advantages of using this method when the amount of training samples are sufficient: the training 
examples in the Microscopic section had the largest proportion (about 76%), that allowed the machine 
learner to learn more effectively, which led to more accurate prediction on the test set with the lowest 
drop from the training set result, compared to those in other sections. 
 
Method Total 
errors 
Error from MER Error from 
negation 
detection 
“Lexical Polarity 
Negative” 
Other entity 
type 
Both 
Lexicon-based 
approach 
26 7 6 11 2 
Syntax-based 
approach 
31 6 6 11 8 
Machine learning-
based approach 
26 7 6 10 3 
Table 6.5 Summary of errors from medical entity recognition and negation detection on the lymphoma 
test set. 
 
Table 6.5 shows that errors from negation detection directly accounted for about 8.7% to 25.8% of 
total errors depending on the method. The reasons for those errors with the syntax-based approach are 
mainly due to the poor parsing results from the parsers, where the rules do not work as expected if 
parse trees are problematic. For example, given the input “No vasculitis [“En:Coexistent Pathology”] 
with fibrinoid necrosis  or leucocytoclastic debris, granulomas [“Re:Tissue Reaction”] or necrosis 
[“Re:Tissue Reaction”] are seen”,  the parser  attached  the noun phase “leucocytoclastic debris” to the 
incorrect location in the parse tree (see Figure 6.5). Consequently, the entities “granulomas” and 
“necrosis” could not be identified as negated concepts. This suggests that such errors can be amended 
by using a domain-specific parser or a parser trained with medical corpora to improve the parsing 
performance.  
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Figure 6.5 The incorrect parse tree of the text example as generated by the Stanford parser. 
 
It is known that medical narratives often prefer to be presented in compact expressions, and therefore 
noun and prepositional phrases are more frequently used in a long sentence rather than complex verb 
structures or short sentences as in the general domain, and in some cases, they may be irregular 
grammatical structures. Errors from the other two methods are probably because of the abnormal 
structures presented in the notes. Here is an example: 
NO EVIDENCE OF [“Li:Lexical Polarity Negative”] METASTATIC MELANOMA IN 11 
LYMPH NODES, 
SMALL LYMPHOCYTIC NON-HODGKINS LYMPHOMA [“Sy:Diagnosis”], 
Gene rearrangement studies pending, Please see report. 
 
The instance of “SMALL LYMPHOCYTIC NON-HODGKINS LYMPHOMA” should not be tagged 
as negated in the above. However, due to the irregular grammatical structure of the sentence, it is too 
difficult for the negation detection module to generate a correct output. In fact, in regular grammatical 
structures, this sentence can be divided into four sentences:   “NO EVIDENCE OF METASTATIC 
MELANOMA IN 11 LYMPH NODES.”, “SMALL LYMPHOCYTIC NON-HODGKINS 
LYMPHOMA.”, “Gene rearrangement studies pending.” and “Please see report.”; or some 
conjunctions like “and”, “but” could be supplemented  in the sentence for grammatical correction. 
 
Similar work has been done by Mitchell et al on detecting and annotating UMLS concepts as well as 
annotating negation based on the NegEx algorithm (Mitchell et al., 2004). They reported that the 
overall precision and recall under average conditions were about 64% and 55% respectively, which 
are about 25.7% and 21.1% lower than the results obtained from the lexicon-based approach in this 
study. This is probably because the lexicon-based approach modified from NegEx has been adapted 
for this corpus. For example, the negation and pseudo-negation phrases were extracted from the 
training data. Except for some terms, particular punctuation for each section was also introduced as 
termination cues to improve the precision. Nevertheless, the comparisons are also subject to some 
notable differences between the Mitchell et al’s work and this study: 
1. The materials for evaluation.  The previous work used surgical pathology reports; this study 
selected pathology reports of a specific disease (lymphoma). 
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2. The development of gold-standards. The Mitchell work used a modified Delphi technique to 
achieve consensus among the panel and pathologists participating in the manual annotation. 
This study only used a single pass panel and linguists were involved for manual annotation. 
3. The test sample size. The previous work had a larger test sample size with 311 entities; our 
study only had 96 entities for testing. 
4. The semantic types.  The semantic types chosen by the previous work were up to 35 from 
five semantic categories relevant to surgical pathology reports in UMLS; this study defined 
11 specific semantic types based on the protocol. 
5. The methods for concept recognition. The previous work performed dictionary look-up to the 
NLM Knowledge Source Server, and matched phrases against the UMLS, therefore each 
extracted entity was a UMLS concept. This study used a supervised machine learning-based 
approach to extract medical entities, hence the extracted entities might not be UMLS 
concepts. 
6. The results for the Comment section.  The results for most sections reported in this study 
correspond to the previous work, e.g., Macroscopic vs. Gross Description, Microscopic vs. 
Microscopic Description, and Summary vs. Final Diagnosis. However, the results for the 
Comment section were not presented in this study, since all the contents in the Comment 
section are required to populate the structured templates instead of each entity type as in 
other parts of the project, and no entity was annotated in this section according to the 
annotation schema.  
 
Tables 6.3 and 6.4 show that the syntax-based approach had the best overall performance on the 
training set but the poorest on the test set, in contrast to the machine learning-based approach. This is 
likely to be because: in the test set, there were unforeseen structures in the sentences which the rules 
or patterns designed for syntax-based approach cannot handle properly though they worked well on 
the training set. The model generated by the machine learning-based approach predicted the test data 
with features not only captured from the training set but also from the test set, which made it less 
vulnerable to the unforeseen structures. Nevertheless, the performance of the lexicon-based approach 
was more stable: on the training set, it only lagged behind the syntax-based approach by 0.3% F-score. 
On the test set, there was also a very small gap between the overall F-score and that of the machine 
learning-based approach of 0.21%.  
 
The run time for applying each method is distinct: least for the lexicon-based approach, most for the 
machine learning-based approach and between the two for the syntax-based approach (see Table 6.6). 
Moreover, there is a prominent gap between the lexicon-based approach and the other two methods. It 
seems that the length of the sentence is a crucial factor in effecting the run time for applying the 
lexicon-based approach, while the number of medical entities in the sentence is more likely to effect 
the run time for the other two methods. The following two sentences were used for the comparisons 
shown in Table 6.6. 
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Input 1: No [“Li:Lexical Polarity Negative”] necrosis [“Re:Tissue Reaction”] or Reed-Sternberg 
cells [“De:Cytomorphology”] seen. 
Input 2: Intraepithelial lymphocytes appear generally increased, however classic 
lymphoepithelial lesions [“De:Architecture”] are not [“Li:Lexical Polarity Negative”] identified 
[“Li:Lexical Polarity Positive”] (cytokeratin, CD3 and CD20 immunohistochemical stains). 
 
Method Input 1 Input 2 
Lexicon-based approach 0.0007s 0.0250s 
Syntax-based approach 12.35s 8.44s 
Machine learning-based approach 14.74s 13.90s 
Table 6.6 Run time for applying each method to the examples. s: seconds. 
 
Considering the above factors and the simplicity of the lexicon-based approach to implement and tune 
to another corpus, it was adopted for the other two corpora to detect negation.  
 
6.2.2 Uncertainty Detection  
As described previously, uncertainty detection is more challenging than negation detection, for several 
reasons: 
• The phrases or keywords indicating uncertainty are vaguer. For example, “unlikely” appears 
to be the antonym of “likely” and can be a candidate for a negation cue; in fact, it could be 
reclassified to uncertainty, as it indicates the lower possibility than “likely”. 
• Punctuation suggests uncertainty. Not only certain words, but also punctuation can be 
considered as an uncertainty cue. For instance, question mark(s) “?” and “??” frequently 
appear in “CLINICAL HISTORY” and “SPECIMEN”.  
• Uncertainty can be expressed explicitly or implicitly.  An explicit expression like “suspicions 
for Hodgkin's Lymphoma” is easy to understand, while an implicit expression such as “The 
main differential diagnosis is between a T-cell rich large B-cell non-Hodgkin lymphoma and 
a nodular lymphocyte predominant Hodgkin lymphoma” requires inference from the domain 
knowledge to comprehend. 
 
It is thus preferable to employ a rule-based method to resolve this issue. As natural language parsers 
like the Stanford parser cannot generate correct output when parsing some cases if it contains 
punctuation as an uncertainty cue, the rule-based method tends to be lexicon-based instead of syntax-
based.  
 
The lexicon-based approach designed to detect uncertainty is similar to that for negation detection. It 
also defines trigger terms and termination cues. The trigger terms refer to Li:Lexical Modality 
instances in the training data, and are categorized into three groups depending on their position 
relative to a medical entity: Group 1 – only preceding a medical entity; Group 2 – only succeeding a 
medical entity; Group 3 – any of the above positions. Termination cues include terms that suggest 
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cause, experiencer or transition, and particular punctuation. Table 6.7 shows some examples. Trigger 
terms in Group 1 and Group 3 outnumber those in Group 2, suggesting that the uncertainty phrases 
usually appear before the entity they assert in the notes; the positions of terms in Group 3 are more 
flexible, which makes determination for their scope more difficult. If there is more than one trigger 
term, the closest one to the entity is selected as the best candidate. 
 
Type of 
term/cue 
Sub-category Example 
Trigger 
terms 
Group 1 probable, highly suspicious for, highly suspicious of, suspicious of, 
suspicious for, possibly, probably, perhaps, slightly favour, 
wondered about, wonder about, fit best for, more suggestive of, 
more in favour of, more in keeping with, possibilities, definite, 
definitive, possibility 
Group 2 cannot be excluded 
Group 3 certain, certainly, maybe, suspicious, whether, less likely, unlikely, 
convincing, likely, may, more likely, most likely, probable, 
possible, difficult to identify, reluctant, uncertain, ? | ?? 
Termination 
cues 
Termination 
term 
but, which, though, although, however, so, from 
Termination 
punctuation 
“CLINICAL HISTORY” and “SPECIMEN”: , | ; | ( | ) | -> 
Other section contexts: ( | ) 
Table 6.7 Trigger terms and termination cues for uncertainty detection on the lymphoma corpus. Note: 
word examples are separated by comma “,”; punctuation examples are separated by pipe “|”. 
 
The determination of the scope is distinguishable from that for negation detection. First, the text span 
between the trigger term and the entity is checked whether it contains any termination cue; then the 
following rules are applied to it:  
If the token distance from the entity to the trigger term is not larger than four, the entity is assigned in 
the scope;  
Else, it will be validated against these patterns:  
The trigger term has a comparative modifier, such as “more suggestive of” and “more in 
favour of”, and “than” appears in the text span;  
The trigger term succeeds the entity and there is a conjunction in the text span.  
If it has one of these patterns, the entity is included in the scope. 
 
The lexicon-based approach can work well for explicit expressions, but cannot handle the implicit 
ones properly. An additional module that resembles the one for pseudo-negation detection was 
designed to cope with this problem. It was implemented with regular expressions to represent some 
patterns, which are described as follows: 
Pattern 1: <n word> < diagnosis> <n word> <between/includes> <n word> <entity 1> <n 
word> <and> <n word> < entity 2> <n word>. 
Pattern 2: <n word> < diagnosis> <n word> < includes> <n word> <entity 1> <n word> <but> 
< n word >.  
Pattern 3: <n word> < entity 1> <n word> < however> < n word> < against this> < n word >.  
Pattern 4: <n word> <differential diagnosis> < n word> < entity 1> < n word >. 
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Pattern 5: <n word> <more> < n word> <than> < n word> < entity 1> < n word >. 
Pattern 6: <n word> <favour/favours> <n word> < entity 1> <n word> <over> <n word> < 
entity 2> <n word>. 
Pattern 7: <n word> <either/ any Li:Lexical Polarity Positive instance > <n word> < entity 1> 
<n word> <or> <n word> < entity 2> <n word>. 
Pattern 8: <n word> < entity 1> <n word> <favoured over> <n word> < entity 2> <n word>. 
Where n stands for the number of tokens, without any restriction and can be 0. The entities in each 
pattern are assigned uncertainty. The pseudo-negations mentioned above would also be considered as 
candidates of the results. 
 
Unlike the representation for negation that is quite clear that “absent” or “no” can be used to represent 
it, the ambiguous use of “possible”, which was suggested in the assertion annotation guidelines of the 
2010 i2b2/VA Challenge (i2b2, 2010a), cannot reveal the degree of certainty. Similar to MedLEE that 
used different certainty modifiers to indicate the degree of certainty, a standard dictionary was used to 
map each trigger term to four categories: “cannot exclude”, “possible”, “probable” and “definite”, 
which stand for low certainty, low to moderate certainty, moderate to high certainty and high 
certainty, respectively. For example, “cannot be excluded” is mapped to “cannot exclude”, “?” is 
standardized to “possible”, “more suggestive of” is represented with “probable” and “certainly” is 
replaced with “definite”. 
 
The results for uncertainty detection on the lymphoma training set and test set are shown in Table 6.8. 
The uncertainty detection module attained very good performance on the training set with micro-
averaged F-score over 97%, but dropped dramatically to about 67% on the test set. Two categories 
“cannot exclude” and “definite” could not be assessed fairly, due to lack of training and test examples. 
 
Uncertaint
y type 
Training set Test set 
Numbe
r 
Precisio
n 
Recall F-score Numbe
r 
Precisio
n 
Recall F-score 
cannot 
exclude 
1 50.00% 100.00
% 
66.67% 0 0.00% 0.00% 0.00% 
definite 2 100.00% 100.00
% 
100.00
% 
0 0.00% 0.00% 0.00% 
possible 264 98.48% 98.48% 98.48% 62 77.55% 61.29
% 
68.47
% 
probable 30 96.55% 93.33% 94.92% 9 80.00% 44.44
% 
57.14
% 
Overall 297 97.98% 97.65% 97.81% 71 77.78% 59.15
% 
67.20
% 
Table 6.8 Results for uncertainty detection on the lymphoma training set and test set. 
 
Error analysis shows that the errors on the training set can be categorized to: 
• The fixed four-token window size may omit some entities far from the trigger term. Although 
in most cases, the entity asserted by the trigger term locates very close to the term, there are 
still some cases like “A high grade [“Sy:WHO Grade”] lymphoma of follicle centre cell 
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origin [“Sy:Diagnosis”] is also possible [“Li:Lexical Modality”] but considered less likely 
[“Li:Lexical Modality”].” where the entity “high grade” is situated distant from the trigger 
term “possible”. 
• The closest trigger term is not always the best candidate that asserts the entity. For example, 
in this sentence: 
Although the subtype is difficult to discern a nodular sclerosis Hodgkin's lymphoma 
[“Sy:Diagnosis”] or perhaps [“Li:Lexical Modality”]   a lymphocyte depleted type 
[“Sy:Diagnosis Subtype”] would be the two most likely [“Li:Lexical Modality”].  
the closest trigger term to the entity “lymphocyte depleted type” is “perhaps”, but the best 
candidate is “most likely”. 
 
There were 36 errors identified in the results on the test set, where errors in the MER accounted for 
most of them. Specifically, 8 were from incorrect recognition of Li:Lexical Modality instances, 16 
were caused by misclassification of medical entities. The false positive recognition of both Li:Lexical 
Modality instances and medical entities led to 5 errors, and 7 errors owing to mistakes in the module. 
The main reason for the mistakes in the module was the incompetence of the uncertainty pattern. For 
instance, Pattern 7 relied on the appearance of the lexicon “either” or any Li:Lexical Polarity Positive 
instance, while in this sentence:  
The appearance of the lymph nodes [“De:Tissue Source”] and the skin [“De:Tissue Source”] 
infiltrate is of small lymphocytic lymphoma [“Sy:Diagnosis”] or involvement by chronic 
lymphocytic leukaemia [“Sy:Diagnosis”]. 
where “suggestive” was omitted by the author between “is” and “of” so that the uncertainty for the 
entities “small lymphocytic lymphoma” and “involvement by chronic lymphocytic leukaemia” cannot 
be detected.  
 
The ambiguous usage of slash “/” can also cause some problems. Slash “/” can function as 
“separator”, e.g., in this sentence: 
 (L) para-aortic lymph node [“De:Topography”] / core bx [“De:Specimen Type”] - 
MALIGNANT LYMPHOMA [“Sy:Diagnosis”]. 
 It can couple two entities, e.g., small lymphocytic lymphoma (SLL) and chronic lymphocytic 
leukaemia (CLL) are usually coupled together and expressed as: “SLL/CLL”. It can stand for “per” in 
a measurement unit, such as “14/mm2”. In this sentence “Low-grade [“Sy:WHO Grade”] follicular 
lymphoma [“Sy:Diagnosis”] / small cleaved lymphoma [“Sy:Diagnosis”].”, “/” stands for “or”. 
However, due to the ambiguity “/” may bring, it was not considered in the patterns. 
 
The higher error rate of uncertainty detection compared to negation detection with the same method 
on the test set did suggest that uncertainty detection is more difficult to handle than negation 
detection. This is probably because: 
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• The lexical variants of trigger terms for uncertainty outnumbered that for negation. 
Additionally, many of them had an ad-hoc position that made their relationships with other 
lexical items more difficult to detect. 
• The expressions of uncertainty were more diverse, hence predefined rules or patterns failed 
more often to correctly process. 
• The sub-classification of uncertainty into four categories also increased the difficulty of 
resolving this issue. 
 
Nevertheless, the good performance achieved by this method on the training set, and the simplicity it 
manifests, implies that it can be applied to the other two corpora as well.  
 
6.3 Negation and Uncertainty Detection in the Other Two Corpora 
As discussed above, the methods for negation and uncertainty detection on the other two corpora were 
also lexicon-based, but because of the idiosyncrasies or characterises of the corpora and the associated 
annotation schemas, the approach needs to be fine-tuned for each corpus. 
 
6.3.1 Melanoma Corpus 
The annotation schema for the melanoma corpus is similar to that for the lymphoma corpus, thus the 
main adjustment of the method for negation detection was to modify the entries of the trigger terms 
and termination cues, which are displayed in Table 6.9.  Several medical entity types were involved: 
De:Ulceration, In:Vascular/Lymphatic, In:Neurotropism, En:Satellites, En:Associated naevus (type), 
Re:Desmoplasia, Sy:Diagnosis, Sy:Subtype, De:Cell Growth Pattern, En:Lesion (other), Re:TILs, and 
Sy:Regression.  
 
Type of 
term/cue 
Sub-category Example 
Trigger term Group 1 no, nor, exclude, lack, rule out, non, neither, lacks, failure, 
precludes, obscures, rather than, obscure, without 
Group 2 not at all, nil, absent 
Group 3 not, unremarkable 
Termination 
cue 
Termination term but, which, though, although, with, however, there is, so, it is, 
due to, this, and the, in the 
Termination 
punctuation 
“CLINICAL HISTORY” and “SPECIMEN”: , | ; | ( | )  
“DIAGNOSIS”: ) | \n 
Table 6.9 Trigger terms and termination cues for negation detection on the melanoma corpus. Note: 
word examples are separated by comma “,”; punctuation examples are separated by pipe “|”. “\n”: 
newline character. 
 
Another adjustment was the utilisation of the Li:Lexical Polarity Positive instances to derive the 
negation rules. A detailed analysis on the corpus shows that a Li:Lexical Polarity  Negative instance 
frequently occurs in the company of  a Li:Lexical Polarity Positive instance, thus it is presumed that 
the utilisation of the Li:Lexical Polarity Positive instances can facilitate the detection.  
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The primary idea was similar to that presented in Patrick et al’s work that the assertion of a medical 
entity was usually determined by the closest specific lexicon (e.g., “absent” lexicons, “possible” 
lexicons) (Patrick et al., 2011). The specific lexicon data were referred to Li:Lexical Polarity Negative  
and  Li:Lexical Polarity Positive instances (“negative”  and “positive” instances)  in this study. For 
example, in this sentence “Mitoses are infrequent [“De:Dermal Mitoses”] and vascular space invasion 
[“In:Vascular/Lymphatic”] is not [“Li:Lexical Polarity  Negative”] identified [“Li:Lexical Polarity 
Positive”].”, “not” is the closest lexical polarity instance to the entity “vascular space invasion”, thus 
the assertion of the entity is “absent”.  
 
The initial processes resemble steps 1 and 2 in the lexicon-based approach for the lymphoma corpus. 
The additional procedures are: 
• Firstly, compute the token distances between an entity and each lexical polarity instance in 
the sentence, and sort them in ascending order. 
• In most cases, let “negative” instances take precedence over “positive” ones: if a “negative” 
instance exists in the sentence and its position is valid, it can assert the entity no matter if it is 
the closest lexical polarity instance. For example, in this sentence: 
There is no [“Li:Lexical Polarity  Negative”] evidence [“Li:Lexical Polarity 
Positive”] of regression [“Sy:Regression”]. 
although “no” locates farther  than “evidence” to the entity “regression”, the entity is asserted 
by “no”.  Likewise, “no” also negates the entity “perineural invasion” in the sentence: 
There is no [“Li:Lexical Polarity  Negative”] lymphovascular or perineural invasion 
[“In:Vascular/Lymphatic”] identified [“Li:Lexical Polarity Positive”]. 
If multiple “negative” instances occur, the closest one accounts for the assertion, e.g., in this 
sentence: 
No [“Li:Lexical Polarity Negative”] ulceration [“De:Ulceration”] is noted 
[“Li:Lexical Polarity Positive”] and no [“Li:Lexical Polarity Negative”] vascular 
invasion [“In:Vascular/Lymphatic”] is seen. 
the entity “ulceration” is negated by the first “negative” instance “No” and “vascular 
invasion” is negated by the second one “no”. 
 
However, there are some exceptions: 
• If the negative” instance in Group 1 or Group 3, and the closest “positive” instance is 
“suggestive of”, “evident”, or “appears”, the entity is asserted by the closest “positive” 
instance. An example is presented below: 
Although there is no [“Li:Lexical Polarity Negative”] obvious desmoplasia 
[“Re:Desmoplasia”] , this growth pattern is suggestive of [“Li:Lexical Polarity 
Positive”] a desmoplastic melanoma [“Sy:Diagnosis”].  
• If the “negative” instance is “non”, it can only assert the adjacent succeeding word, which is 
“ulcerating” in this example: 
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The melanoma [“Sy:Diagnosis”] measures 3mm across [“De:Size”] and is non 
[“Li:Lexical Polarity Negative”] -ulcerating [“De:Ulceration”]. 
 
The pseudo-negation detection module is also similar to that for the lymphoma corpus, and focused on 
detecting pseudo-negation phrases such as “probably not” and “to rule out”. 
 
Uncertainty detection for the melanoma corpus also adopted the same module as for the lymphoma 
corpus, excluding the utilization of regular expressions to capture uncertainty patterns. A detailed 
manual analysis on the corpus shows that most of the expressions of uncertainty are quite explicit and 
uncertainty patterns prepared for the lymphoma corpus cannot fit the melanoma corpus. Table 6.10 
presents the adapted trigger terms and termination cues for the corpus. Compared to the trigger terms 
for uncertainty detection in the lymphoma corpus, there are more terms identified in this corpus, many 
of which can be categorized to Group 2. In addition, the positions of question mark (?) and question 
marks (??) are more stable, which only occur before a medical entity.  
 
Type of 
term/cue 
Sub-category Example 
Trigger 
term 
Group 1 probable, possibly, possible, probably, definite, convincing, 
possibility, suspicious for, suspicious of, if, whether, susp for, raise 
the possibility, most probably, cannot exclude, cannot determine 
? | ?? 
Group 2 cannot be excluded, cannot be completely ruled out, could not be 
entirely excluded, cannot be totally excluded, cannot be guaranteed, 
cannot be entirely excluded, cannot be determined, cannot be 
confidently excluded 
Group 3 may, likely, suspicious, presumably, borderline, unequivocally, 
uncertain, query, only just marginally, not absolutely certain, most 
likely, maybe, alternatively 
Termination 
cue 
Termination 
term 
but, which, though, although, however, so, with, and 
Termination 
punctuation 
“CLINICAL HISTORY” and “SPECIMEN”: , | ; | ( | )  
“DIAGNOSIS”: ( | ) | \n 
Other section contexts: , 
Table 6.10 Trigger terms and termination cues for uncertainty detection in the melanoma corpus. 
Note: word examples are separated by comma “,”; punctuation examples are separated by pipe “|”. 
“\n”: newline character. 
 
6.3.2 Colorectal Cancer Corpus 
Besides negation and uncertainty as in the other two corpora, there is another assertion that needs to 
be discriminated in this corpus: inapplicability, which is similar to the “cannot evaluate” category in 
MedLEE. As the annotation schema for the colorectal cancer corpus is different from those of the 
other two corpora, where no Linguistic category is available, a specific rule-based module named 
Negation/Uncertainty/Inapplicability (NUI) Detector was introduced to resolve this issue. 
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The input could be a medical entity or the sentence where the entity is located in a document. The 
related medical entity types are: De:Perforation, Ex:Serosal Involvement, In:Perineural Invasion, 
De:Tissue Banking, De:Specimen Images, Re:TILS and Peritumoural Lymphocytes, En:Distant 
Spread or Metastases and In:Venous and Small Vessel Invasion. 
 
Type of 
term 
Sub-category Example 
Trigger 
term 
Negation Group 1: without, nor, none, no, benign, negative, unremarkable,  
neither, clear of, short of, free of, free from, no evidence of , not 
sufficient for, not, negative for, clearance, rather than, non-involved, 
without evidence of, spares, absence of. 
Group 2: not, uninvolved, absent, nil, benign, negative, 
unremarkable, tumour free, no, none, clear. 
Uncertainty alternatively, uncertain, equivocal, maybe, query, whether, if, 
possibility, possible, possibly, may, seems, susp, presumably, 
suspicious, likely, convincing, probably, probable, suspicion, 
certain, unequivocally, definite, definitive, ? | ?? 
Inapplicability Not applicable: not applicable, n/a, na. 
Unknown: not known, nil known, unknown, cannot be assessed, not 
given, not supplied, not assessed. 
Pseudo-
trigger term 
Pseudo- 
negation 
not applicable, not known, nil known, not through, not given, not 
supplied, no special type, no special-type, not otherwise specified, 
not assessed. 
Termination 
term 
-- but, although, though, despite, however, identified, there is. 
For preceding scope: and. 
For succeeding scope: which, further. 
Table 6.11 Three types of terms and examples for the colorectal cancer corpus.  Note that some 
negation phrases (e.g., not, benign, negative) occur in both groups, suggesting that they can precede or 
succeed the scope. 
 
Similar to ConText (Chapman et al., 2007b), the module also relied on three types of terms to yield 
the output: trigger terms, pseudo-trigger terms, and termination terms. Trigger terms, as the cues, 
included negation phrases, uncertainty phrases and inapplicability phrases. Through a combination of 
manual scanning and semi-automated learning, 28 negation phrases, 26 modality phrases and 10 
inapplicability phrases were identified respectively. These negation phrases could be divided into two 
groups according to their positions to the scope (Group 1: preceding the scope, Group 2: succeeding 
the scope) and inapplicability phrases were classified to two categories (Not applicable and 
Unknown). Pseudo-trigger terms particularly referred to pseudo-negation phrases, which contained a 
negation phrase but did not indicate negation of a medical entity. The text span between the trigger 
term and the entity (if the input is an entity), or the start or end of the sentence (if the input is a 
sentence) was called the potential scope. If the input was an entity, then the potential scope was 
limited to the instance; else, the potential scope was extended to the whole sentence, unless a 
termination term occurred.  A termination term like “but” could terminate the potential scope before 
the end of the sentence. The termination terms were augmented with additional phrases depending on 
the positions of the potential scope to the trigger term.  A similar approach to the one suggested in 
NegExpander (Aronow et al., 1999), was used to determine the scope by detecting conjunctions like 
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“and”, “or”, and “,”, instead of a fixed five-word window size employed in ConText. These terms 
with examples are shown in Table 6.11. 
 
 
Figure 6.6 Workflow of Negation/Uncertainty/Inapplicability Detector.  
 
The workflow of the module is illustrated in Figure 6.6, which includes the following processes: 
1. Pre-process. The input is passed through the pre-processing engine to remove all punctuation 
and extra white spaces, and converted to lowercase.  
2. Detect negation.  
1) Pseudo-negation phrases are filtered out from the input.  
2) Negation phrases are searched by a string match algorithm, and then the longest 
candidate is selected to be the cue. For example, in the sentence: 
“No evidence of vascular [“In:Venous and Small Vessel Invasion”], lymphatic 
[“In:Venous and Small Vessel Invasion”] or perineural [“In:Perineural Invasion”] 
invasion is seen. 
                      “no evidence of” is the cue rather than “no”.  
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3) The GENIA tagger is used to identify noun phrases, adjective phrases and prepositional 
phrases in the potential scope. If there is no conjunction, then only the adjacent noun 
phrase proceeds the negation phrase (for Group 1 entries), and the adjacent noun phrase, 
adjectival phrase or prepositional phrase succeeds the negation phrase (for Group 2 
entries) should be considered to be in the scope; else, the scope would be propagated to 
the conjunctive phrases as well.  
4) To verify the validity, specific keywords and rules are applied to validate the cue and the 
scope.  
For example, a general rule is to check whether a termination cue occurs in the potential 
scope; if it occurs, the cue and the scope are verified as invalid. Except for termination 
terms described above, termination cues also include some punctuation, e.g., “: | - | ” | ;”  
for “CONCLUSION”, “SYNOPTIC”  and “” | ;” for other sections.  Specific rules were 
designed according to entity types. For instance, several keywords were defined as valid 
scope for En:Distant Spread or Metastases, such as “deposit”, “spread” and 
“metastases”; if the scope does not contain one of these keywords, it will be filtered out 
as invalid output. This rule can filter some false positives, e.g., in this entity “deposit of 
tumour is present in mesenteric fat, with no residual vascular or lymph node architecture 
- considered an extranodal deposit (pN1c).”, as the scope “residual vascular or lymph 
node architecture” does not consist of  any of the keywords, the cue “no” and the scope 
are considered invalid. More examples are presented in Table 6.12.  If both the cue and 
the scope are valid, it skips the following steps, and yields the output “absent”. 
 
Table 6.12 Examples of valid and invalid negations. Bold texts: the cue, Italic texts: the scope, 
Underscore texts: the entity. 
 
3. Detect uncertainty. Uncertainty phrases are searched by a string matching algorithm, and the 
matched entry is selected to be the cue. Next, a standard dictionary is used to map the cue to 
a standardized representation, which becomes the output.  
Validity Example 
Valid 1. no obvious lymphovascular invasion [“In:Venous and Small Vessel Invasion”] 
2. tumour infiltrating lymphocytes are not a feature [“Re:TILS and Peritumoural 
lymphocytes”] 
Invalid 1. Tumour cells involve the subserosal layer (blocks 7 and 8), and block 8 shows some 
microscopic involvement of the peritoneal surface [“Ex:Serosal Involvement”], without 
obvious ulceration [“De:Serosa Description”]. 
2. POORLY DIFFERENTIATED (HIGH GRADE) ADENOCARCINOMA WITH 
AREAS OF SIGNET RING DIFFERENTIATION AND FOCAL MUCINOUS 
DIFFERENTIATION, EXTENDING THROUGH COLON WALL TO ABUT THE 
SEROSAL SURFACE, EXTENDING TO THE LUMINAL SURFACE OF ADHERENT 
SMALL BOWEL, EXTENDING INTO ADHERENT ABDOMINAL WALL, 
INVOLVING OMENTUM, WITH VASCULAR AND LYMPHATIC INVASION 
[“In:Venous and Small Vessel Invasion”], CLEAR OF THE RESECTION MARGINS 
EXAMINED [“Ma:Clear”].  
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4. Detect inapplicability. Inapplicability phrases are searched by a string matching algorithm. If 
an entry is found, the output is set to be “not applicable” (if it belongs to the “Not applicable” 
sub-category) or “unknown” (if it belongs to the “Unknown” sub-category).  
If the output cannot be determined from the above processes, then “present” is assigned as the output. 
  
6.4 Results and Discussion 
The negation and uncertainty detection modules have to be combined together to determine the 
assertion for a medical entity.  The combination of both modules for the colorectal cancer corpus has 
been described in the previous section. For the other two corpora, it is computed as follows: 
1. If negation cannot be detected in the input, but “positive” instance(s) are found in the 
sentence, and uncertainty is detected as well, then the final output is set to be the output from 
uncertainty detection module. 
2. If negation is detected in the input, the final output is “absent”. 
3. If uncertainty is detected in the input, the final output is the standardization of the uncertainty 
phrase. 
4. If both negation and uncertainty cannot be detected in the input, the final output is “present”. 
 
6.4.1 Lymphoma Corpus 
The combination of both modules yielded the following results for the lexicon-based method on the 
lymphoma training and test sets (see Table 6.13).  
 
Category Training set Test set 
Number Precision Recall F-score Number Precision Recall F-score 
absent 318 97.83% 99.37% 98.60% 96 83.95% 70.83% 76.84% 
cannot 
exclude 
1 50.00% 100.00% 66.67% 0 0.00% 0.00% 0.00% 
definite 2 100.00% 100.00% 100.00% 0 0.00% 0.00% 0.00% 
possible 264 98.48% 98.48% 98.48% 62 77.08% 59.68% 67.27% 
present 2001 99.70% 99.45% 99.57% 543 81.04% 74.77% 77.78% 
probable 30 96.55% 93.33% 94.92% 9 80.00% 44.44% 57.14% 
Overall 2616 99.27% 99.27% 99.27% 710 81.10% 72.54% 76.58% 
Table 6.13 Results for combination of negation and uncertainty detection modules on the lymphoma 
training and test sets. 
 
It can be seen that there was a dramatic drop for the micro-averaged F-score by about 22.7% of the 
test set compared to training set. False positives and false negatives from “present” contributed to 
most of the errors, where most of them were caused by incorrect MER. Error analysis on the training 
set shows that some complicated cases require additional inference from the texts. For example, in the 
sentence: 
I am reluctant [“Li:Lexical Modality”] to diagnose mantle cell lymphoma [“Sy:Diagnosis”] 
in the absence of cyclin Dl [“An:Immunohistochemistry-Comment”] and t(11;14) without 
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[“Li:Lexical Polarity Negative”] any strong morphological suggestion of [“Li:Lexical 
Polarity Positive”] MCL [“Sy:Diagnosis”]. 
the entity “MCL” was misclassified to “absent”,  and regarded “without” as the negation cue.  
Coreference resolution may be a helpful solution, as “MCL” co-referred to “mantle cell lymphoma”, 
which was correctly identified as “possible”.  
 
6.4.2 Melanoma Corpus 
Results for combining both modules on the training and test sets are shown in Table 6.14. 
 
Category Training set Test set 
Number Precision Recall F-score Number Precision Recall F-score 
absent 723 98.49% 99.45% 98.97% 160 97.42% 94.38% 95.87% 
cannot 
exclude 
11 90.91% 90.91% 90.91% 3 100.00% 66.67% 80.00% 
definite 1 100.00% 100.00% 100.00% 0 0.00% 0.00% 0.00% 
possible 210 97.17% 98.10% 97.63% 65 90.48% 87.69% 89.06% 
present 2746 99.82% 99.45% 99.64% 696 90.23% 90.23% 90.23% 
probable 25 96.15% 100.00% 98.04% 6 80.00% 66.67% 72.73% 
Overall 3716 99.35% 99.35% 99.35% 930 91.42% 90.54% 90.98% 
Table 6.14 Results for combining negation and uncertainty detection modules on the melanoma 
training and test sets. 
 
From Table 6.14, the micro-averaged F-score decreased mildly from 99.35% to 90.98% on the test set. 
Most of the errors occurred in “present” due to incorrect MERs. There were 30 errors identified for 
negation or uncertainty, wherein 7 of them were due to the defects of the modules, and the rest were 
caused by poor MER performance. The defects of the modules include: 
• The fixed window size for uncertainty detection can lead to the omission of some distant 
entities, e.g., the assertion “probable “ of the entity “regression” in the sentence: 
Features were regarded as most probably [“Li:Modality”] representing [“Li:Lexical 
Polarity Positive”] a malignant melanoma [“Sy:Diagnosis”] with superficial dermal 
invasion [“In:Clark Level”] and regression [“Sy:Regression”]. 
was not detected as it was nine tokens away from the uncertainty phrase “most probably”. 
• The scope involving prepositions were very difficult to tackle in some cases. Consider the 
following sentences: 
Sentence 1: “There is Pagetoid infiltration [“De:Cell Growth Pattern”] of the 
overlying-epidermis without [“Li:Lexical Polarity  Negative”] epidermal ulceration 
[“De:Ulceration”], and an adjacent in-situ melanoma [“Sy:Diagnosis”]  of 
superficial spreading type [“Sy:Subtype”].” 
Sentence 2: “The latter cells do not [“Li:Lexical Polarity Negative”] show 
[“Li:Lexical Polarity Positive”] the same mitotic activity [“De:Dermal Mitoses”] 
evident [“Li:Lexical Polarity Positive”] in the superficial portion of the tumour 
Chapter 6 Negation and Uncertainty Detection 
175 
 
[“En:Primary Lesion”] but they are most probably [“Li:Modality”]  also portion 
[“En:Primary Lesion”] of the malignant melanoma [“Sy:Diagnosis”].” 
Where both the entities “in-situ melanoma” and “superficial spreading type” are negated by 
“without”, while “portion” is asserted by “most probably”, but not “malignant melanoma” 
itself. A simple lexicon-based algorithm has difficulty in determining the scope like these.  
The global context information would have to be taken into account to solve this problem.  
 
Error analysis on the training set further revealed some weaknesses of the modules: 
• The categorization of the trigger terms according to their positions in the training set does not 
cover all the possibilities of location in the test set. For instance, “cannot be excluded” was 
usually situated succeeding the entity; hence it was grouped to the Group 2 trigger terms. 
However, there were also exceptions like: 
In view of the evidence [“Li:Lexical Polarity Positive”] of extensive [“Li:Mood and 
Comment Adjuncts”] dermal regression [“Sy:Regression”], the possibility 
[“Li:Modality”] cannot be excluded [“Li:Modality”] that the melanoma 
[“Sy:Diagnosis”] , before [“Li:Temporality”] regression [“Sy:Regression”] , may 
[“Li:Modality”] have involved the superficial reticular dermis. 
where it occurred before the entity “melanoma”, as its position was not matched to that in  
Group 2, it was ruled out by the uncertainty detection module. 
• As addressed by Chapman et al, a simple lexicon-based algorithm could not handle complex 
cases which needed syntactic cues to resolve (Chapman et al., 2001a). Here is an example: 
 It is of superficial spreading type [“Sy:Subtype”] and is not [“Li:Lexical Polarity  
Negative”] ulcerated [“De:Ulceration”] . 
where the entity “superficial spreading type” was misclassified as “absent”. 
• It seemed that explicit expressions of negation and uncertainty were harder to detect than 
implicit ones. In the following example: 
In view of the lack [“Li:Lexical Polarity Negative”] of a well developed [“Li:Mood 
and Comment Adjuncts”] junctional component [“En:Primary Lesion”], it is 
probably [“Li:Modality”] best classified [“Li:Lexical Polarity Positive”] as nodular 
[“Sy:Subtype”] melanoma [“Sy:Diagnosis”] in this material, although in this site 
acral lentiginous type [“Sy:Subtype”]  is also considered. 
The correct assertion of the entity “acral lentiginous type” was “possible”, whereas, there 
was no lexical nor syntactic information to indicate it, thus the uncertainty module failed to 
detect it. This issue requires domain knowledge to resolve. 
 
6.4.3 Colorectal Cancer Corpus 
Table 6.15 shows the performance of the NUI Detector on the training and test sets. 
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Category Training set Test set 
Number Precision Recall F-score Number Precision Recall F-score 
absent 1509 99.80% 99.93% 99.87% 770 91.32% 87.40% 89.32% 
cannot 
exclude 
4 100.00% 100.00% 100.00% 4 100.00% 75.00% 85.71% 
definite 1 100.00% 100.00% 100.00% 3 66.67% 66.67% 66.67% 
not 
applicable 
6 100.00% 100.00% 100.00% 0 0.00% 0.00% 0.00% 
possible 22 91.67% 100.00% 95.65% 10 50.00% 40.00% 44.44% 
present 974 99.90% 99.18% 99.54% 423 81.12% 72.10% 76.35% 
probable 20 86.96% 100.00% 93.02% 13 75.00% 69.23% 72.00% 
unknown 13 100.00% 100.00% 100.00% 1 0.00% 0.00% 0.00% 
Overall 2549 99.65% 99.65% 99.65% 1224 87.45% 81.37% 84.30% 
Table 6.15 Performance for Negation/Uncertainty/Inapplicability Detector on the colorectal cancer 
training and test sets. 
 
From Table 6.15, the micro-averaged F-score for the test set declined by about 15.4% against the 
training set. The incorrect MER results for the entities in both “absent” and “present” were still the 
main reason for the drop of F-score. There were up to 180 errors in negation, uncertainty or 
inapplicability, wherein only 7 were created directly by the detector. These errors include: 
• The efficiency of the lexicon-based approach was precluded by the limited predefined trigger 
terms. The trigger terms were obtained mainly based on the analysis of training data. They 
were not exhaustive, thus unseen terms in the test set could not be captured. For example, in 
the sentence: 
The possibility of vascular space invasion could not be excluded in the submucosa. 
where uncertainty phrase “could not be excluded” was not predefined in the trigger term 
lexicons, hence the detector omitted it.   
• The determination of the scope involving preposition “of” has proven to be difficult in the 
melanoma corpus, while the scope involving the preposition “with” was also problematic. 
The preposition “with” was defined as a terminator for the detector, which satisfied most 
cases, whereas, in this sentence: 
These may represent discontinuous spread, venous invasion [“In:Venous and Small 
Vessel Invasion”] with extravascular spread [“In:Venous and Small Vessel 
Invasion”] or totally replaced nodes (TD ). 
The asserted scope for “may” should be extended to the end of the sentence where “with” 
was not a correct terminator. 
• The sequence for applying different detection modules can bring some problems. For 
example, the detector stated that negation detection takes precedence over uncertainty 
detection, which yielded the false output “absent” for the following In:Venous and Small 
Vessel Invasion entity: “Focal possible but not definite lymphovascular invasion is seen”. 
 
Additional deficiencies in the NUI detector were discovered through error analysis on the training set: 
• The uncertainty trigger terms were not categorized according to their positions to the entities, 
which led to some false positives. For example, in the sentence: 
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Focal perineural invasion is seen [“In:Perineural Invasion”], and a focus of probable 
extramural lymphovascular invasion is identified [“In:Venous and Small Vessel 
Invasion”]. 
the uncertainty phrase “probable” only asserted the noun phrase “extramural lymphovascular 
invasion”, but not “Focal perineural invasion”. 
• The keywords and rules used to validate the cue and the scope could not work well in some 
cases. For instance, in this En:Distant spread or Metastases entity: “more suggestive of 
consistent with this being a metastatic deposit rather than synchronous tumour”, since the 
keywords list for the valid scope contained both “deposit” and  “tumour”, thus the detector 
could not verify the cue “rather than” and the scope “synchronous tumour” to be invalid. 
• Another defect of the detector may be due to irregular grammatical structures of the text. 
Here is an example: “Perforated, likely secondary.”, which was more likely to be a 
combination of several phrases rather than a regular sentence.  The module could not handle 
these correctly.  
 
6.4.4 Discussion of the Three Corpora 
The evaluation performed on the training sets was to validate the competence of the rules. The high F-
scores achieved by the lexicon-based method on the training sets indicate that the extracted rules were 
competent to cover most negation patterns in the corpora. 
 
It can be seen from the above results that the method performed best on the melanoma test set, and 
worst on the lymphoma test set. The probable reasons for this are: 
• The MER system had achieved encouraging performance on the recognition of associated 
Linguistic categories: Li:Lexical Polarity Positive, Li:Lexical Polarity Negative and  
Li:Modality, with 93.68%, 94.48% and 87.35%  F-scores respectively in the 10-fold cross-
validation experiments on the melanoma train set , which were significantly better than the 
counterparts on the lymphoma train set, which were 88.60%, 82.60%  and 76.74% 
respectively.  
• The performance of the recognition of most entity types by the MER system to be utilized for 
evaluation was also better in the 10-fold cross-validation experiments on the melanoma train 
set than on the lymphoma train set. Note that there are three entity types in the lymphoma 
train set: Sy:Constitutional Symptoms, Sy:Diagnosis Subtype and Ex:Other Sites of Disease 
which had attained F-scores of below 50%, while only one entity type: En:Lesion (other) in 
the melanoma corpus had achieved a very low F-score (15.62%) in the 10-fold cross-
validation experiments. 
Although the evaluation of the MER system on the test sets was not carried out, presumably, the 
performace would be similar to that in the 10-fold cross-validation experiments on the training sets. 
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Another reason for best performance attained on the the melanoma test set is that the melanoma 
corpus had the largest ratio between training set and test set (close to 4:1), which suggests that there 
would be more potential patterns and lexical information to be extracted for the rules in the training 
set. 
 
The relatively poorer performance on the colorectal cancer test set also indicated that the utilization of 
associated linguistic categories could bring some advantages for negation and uncertainty detection. 
They could facilitate the acquisition of the trigger terms. The MER system would be able to identify 
them in unseen data by using the model trained on the training data. The ratio between training set and 
test set was smallest (about 2:1) in the colorectal cancer corpus, which could also hinder the extraction 
of rules or patterns to a great extent. 
 
In addition, the reason for the poorest performance of uncertainty detection on the the lymphoma 
corpus lies in the fact that the accurate diagnosis of lymphoma is usually more difficult to be made by 
pathologists, thus the reports could contain more hedging information, which can be expressed in 
various forms, making it hard to capture the uncertainty patterns from the limited examples available 
in the training set. 
 
Most of the errors on the test sets resulted from incorrect MER, accounting for 92.3%, 76.7% and 
96.1% of the total errors in the lymphoma, melanoma and colorectal corpora respectively.  
 
Nevertheless, the analysis of the errors types for the lexicon-based detection modules includes: 
• Although most of the uncertainty trigger terms were very close to the asserted entities 
(usually within four-word window size), there were also some entities distant from these 
terms, thus the fixed window size for uncertainty detection would omit these entities.  
• The lack of a positional cluster of the trigger terms would lead to some false positives; 
however a sloppy cluster would also bring some false negatives. 
• It was not possible to determine the correct scope involving particular prepositions (e.g., 
“of”, “with”). 
• It could not handle some complicated cases which needed syntactic cues or additional 
inference of the texts to resolve. 
• Insufficient predefined trigger terms could affect the performance of the method. 
• Current heuristic integration of different detection modules could also cause some problems. 
• It had difficulty when facing implicit expressions of negation and uncertainty or irregular 
grammatical structures of the text. 
 
Accordingly, some feasible improvements can be made to the method: 
• A more flexible window size can be considered to determine the scope for uncertainty. 
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• A thorough analysis of the trigger terms, which is not only based on their positions relative to 
the entities, but also some conditions (e.g., whether a trigger term can be in the company of 
another trigger term). 
• Resolving coreference or introducing syntactic cues would enable the method to cope with 
more complicated cases. 
• Considering domain knowledge or global context information may be helpful to correctly 
determine the scope containing prepositional phrases or detect negation and uncertainty from 
implicit expressions. 
• More lexical items could be considered to enrich the predefined trigger term lists. 
• A more comprehensive integration of different detection modules to avoid some problems 
caused by weak integration.  
 
6.5 Conclusion 
The goal of negation and uncertainty detection on the corpora is to determine the assertion of the 
presence or absence of specific medical entities. In the case study of the lymphoma corpus, three 
different methods were experimented with: the lexicon-based approach was a rule-based method, 
modified from a known negation detection algorithm NegEx, relying on trigger terms and termination 
cues. The syntax-based approach was also a rule-based method, where the rules and negation patterns 
were designed according to the dependency output from the Stanford Parser. The machine learning-
based approach used an SVM classifier to build models with a number of features.  The syntax-based 
approach had the best overall performance on the training set, while the machine learning-based 
approach performed best on the test set. However, both of them were at the cost of very long run 
times. The lexicon-based approach was simple and efficient, and yielded more stable performance, 
thus it was preferable for the other two corpora. Given the challenges and characteristics of the 
corpora, a rule-based approach was created for uncertainty detection. The poorer performance for 
uncertainty detection suggests that uncertainty detection is much more difficult to handle than 
negation detection.  The main adjustment for lexicon-based approaches applied to the other two 
corpora was to modify the entries of the trigger terms, pseudo-trigger terms and termination cues. 
There were also specific adaptations for each corpus. For example, the utilisation of the Li:Lexical 
Polarity Positive instances to derive the negation rules in the melanoma corpus, while specific 
keywords and rules were applied to validate the cue and the scope in the colorectal cancer corpus. 
  
The good performances on the training sets are consistent with the finding of  Mutalik et al’s work 
that the language used in the medical domain is more restricted, so negation and uncertainty should be 
presented in much more direct and straightforward way in the texts (Mutalik et al., 2001).  
 
Moreover, although the materials in this study are pathology reports of specific tumour streams, it still 
has some generalizability: 
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• The lexicon-based approach highlights the importance of adaptation to the corpus, which can 
boost the system performance markedly. 
• Apparently, the negation rules and patterns purposed for the syntax-based approach can be 
reused to detect negation in other pathology notes, as they are not associated with semantic 
information. 
• Since the methodology, classification strategies and algorithms adopted in the machine 
learning-based approach are general, they can be easily adapted for other negation detection 
tasks on clinical notes. 
 
Though incorrect MER accounted for most of the errors on the test sets, error analyses that focused on 
the error types of the lexicon-based detection modules, reveals other problems, such as incorrect 
determination of the scope caused by the fixed window size for uncertainty detection, a sloppy cluster 
of the trigger terms and integration of different detection modules, difficulty in determining the 
correct scope involving particular prepositions, and restriction from insufficient samples of trigger 
terms. There are several possible solutions to improve them: utilization of more flexible window size, 
thorough clustering of the trigger terms, coreference resolution, introduction of syntactic cues, domain 
knowledge or global context information, additional lexical items considered as trigger terms, and 
more comprehensive integration of different detection modules. 
 
The output from these modules was stored to populate values for associated fields in the structured 
templates, which will be described in Chapter 8 in detail. 
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Chapter 7  Relation Extraction 
7.1 Introduction 
Information extraction (IE) is a process to extract relevant information from unstructured text. As one 
of the major components in an IE system, entity recognition had been the focus in the early stage of 
IE. With the development of more and more complex IE systems, the significance of Relation 
Extraction (RE) was realized by more and more researchers. Extracting relations among entities is an 
efficient way to utilize the recognised entities so that the implicit connection among them can be 
revealed. It can help the users of the IE system to better understand the facts or events of interest 
without interpretation of irrelevant contexts.  
 
In the clinical domain, RE is very important as not only medical entities themselves but also how they 
are related to each other are also of clinical significance. In the following sentences from Relation 
Annotation Guidelines of 2010 i2b2/VA Challenge (i2b2, 2010c): 
Sentence 1: She has an elevated cholesterol [“Problem”] controlled with Zocor [“Treatment”]. 
Sentence 2: Penicillin [“Treatment”] causes rash [“Problem”]. 
Only recognizing the Treatment entities “Zocor” and “Penicillin”, and the Problem entities “an 
elevated cholesterol” and “rash” from the examples does tell the differences between how “Zocor” 
affects “an elevated cholesterol” and how “Penicillin” is related to “rash”. But with RE from the 
examples, they can be discriminated from each other: “Zocor” cures “an elevated cholesterol, while 
“Penicillin” causes “rash”. 
 
In the pathology domain, RE is also very important. Without RE, it is impossible to identify some 
crucial facts embedded in the texts, e.g., CD20, CD79a, CD10 and CD30 are the positive biomarkers 
in the following example, and CD3, cytokeratin and S100 are the negative biomarkers in the second 
example. 
Example 1: On immunohistochemical stains the cells show diffuse strong membranous staining 
[“An:Immunohistochemistry-Positive”] for CD20 [“An:Biomarker”], CD79a [“An:Biomarker”] and 
CD10 [“An:Biomarker”] with moderate widespread membrane staining [“An:Immunohistochemistry-
Positive”] for CD30 [“An:Biomarker”]. 
Example 2: The cells are negative [“An:Immunohistochemistry-Negative”] for CD3 
[“An:Biomarker”], cytokeratin [“An:Biomarker”] and S100 [“An:Biomarker”]. 
 
Unlike other natural language processing (NLP) tasks, such as medical entity recognition, RE requires 
deeper analysis of the sentences because relationships often correspond to the grammatical structures 
of the sentences. In the above examples, the prepositional phrases composed of the preposition “for” 
and biomarkers modify the nouns “staining” or the adjective “negative”. 
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The relation types are usually determined by the entity types involved. The involved entities are called 
the arguments of a relation. In the first example, “strong membranous staining” is the first argument of 
the Result-Positive relation, and “CD20” is the second argument of the relation; “negative” is the first 
argument of the Result- Negative relation, and “CD3” is the second argument of the relation. Only 
particular entity types can be connected with relations, which has been discussed in detail in Chapter 
4. 
 
In this chapter, an RE system for extracting relations from the lymphoma corpus is proposed. 
Specifically, the task attempts to identify relationships between eight types of medical entities and 
classify four relation types that occur amongst them. A rule-based approach was applied to classify 
Spatial Specialization relation, while a supervised machine learning-based approach was adopted to 
identify Result-Positive, Result- Negative and Result-Equivocal relations.  
 
The rest of the chapter is organised as follows: firstly, it provides an overview of the mechanisms of 
Support Vector Machines (SVM), and then presents the classification strategy, system architecture 
and two proposed approaches. The Results and Discussion section illuminates the system performance 
and error analysis. 
 
7.2 Support Vector Machines 
Support Vector Machines (SVM) is a discriminative machine learning method that is based on the 
structural risk minimisation principle for binary classification. The basic idea is to find a decision 
hyper-plane to separate positive and negative examples by maximising the distance to the support 
vectors from each category.  
 
Given k training examples (𝑥𝑖 ,𝑦𝑖), 𝑖 = 1,⋯, k, where each example has input data D (𝑥𝑖 ∈  𝑅𝐷), and a 
category label with one of two values (𝑦𝑖 ∈ {−1, 1}). All hyper-planes in 𝑅𝐷can be parameterized by a 
vector (w) and a constant (b): 
𝑤 ∙ 𝑥 + 𝑏 = 0 
 
A canonical hyper-plane can be defined to separate the data from the hyper-plane by a distance of at 
least 1 (at least one example on both categories has a distance of exactly 1). It should satisfy 
𝑤 ∙ 𝑥𝑖 + 𝑏 ≥ +1, when 𝑦𝑖 = +1 
𝑤 ∙ 𝑥𝑖 + 𝑏 ≤ −1, when 𝑦𝑖 = −1 
 
All such hyper-planes have a functional distance ≥ 1. For a given hyper-plane (w, b), all pairs  {𝜆𝑤, 𝜆𝑏} where 𝜆 ∈ 𝑅+, define the exact same hyper-plane, but each can have a different functional 
distance to a given data point. The magnitude of w should be normalized to obtain the geometric 
distance from the hyper-plane to a data point by calculating 
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𝑦𝑖  (𝑥𝑖 ∙ 𝑤 + 𝑏) 
‖𝑤‖
 ≥  1
‖𝑤‖
 
 
Intuitively, the hyper-plane is preferred to maximize the geometric distance to the closest data points 
(see Figure 7.1). 
 
 
 
 
 
Lagrange multiplier  𝛼 is applied to minimizing ‖𝑤‖ (Burges, 1998), and the problem is transformed 
into: 
Minimize  𝑊(𝛼) =  −∑ 𝛼𝑖 +  12𝑘𝑖=1 ∑ ∑ 𝛼𝑖𝛼𝑗𝑦𝑖𝑦𝑗𝑘𝑗=1𝑘𝑖=1 (𝑥𝑖 ∙ 𝑥𝑗) 
                                        subject to  ∑ 𝛼𝑖𝑦𝑖 = 0𝑘𝑖=1 , 0 ≤ 𝛼𝑖 ≤ 𝐶 (∀𝑖) 
where α is the vector of k non-negative Lagrange multipliers to be determined, and C is a trade-off  
parameter between maximization of margin and minimization of error. Higher C weights more on 
classifying the training data correctly, while lower C results in a more flexible hyper-plane to 
minimize the margin error for each example (Alpaydin, 2004). 
 
From the derivation of these equations, the optimal hyper-plane can be written as: 
𝑤 =  �𝛼𝑖
𝑖
𝑦𝑖𝑥𝑖 
where w is a linear combination of the training examples. 
 
According to the Karush-Kuhn-Tucker conditions, it shows that 
𝛼𝑖 (𝑦𝑖  (𝑤 ∙ 𝑥𝑖 + 𝑏 ) − 1) = 0  (∀𝑖) 
𝑤 ∙ 𝑥 + 𝑏 = +1 
 
𝑤 ∙ 𝑥 + 𝑏 = −1 
 
𝑤 ∙ 𝑥 + 𝑏 = 0 
 
2
‖𝑤‖
 
𝑥1 𝑥2 
𝑥3 
Figure 7.1 Support Vector Machines separate positive and negative examples. Note: 𝑥1,𝑥2 and 𝑥3 
are support vectors. 
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Which suggests that when the functional distance of an example is greater than 1 (𝑦𝑖  (𝑥𝑖 ∙ 𝑤 + 𝑏 ) >1), then 𝛼𝑖 = 0. Thus the training examples for 𝛼𝑖 > 0 are named support vectors, which are the only 
examples needed to define and find the optimal hyper-plane. Given any positive and negative support 
vector, 𝑥𝑝 and 𝑥𝑛, it yields: 
𝑤 ∙ 𝑥𝑝 + 𝑏 = +1 
𝑤 ∙ 𝑥𝑛 + 𝑏 = −1 
The constant b can be calculated by 
𝑏 = − 12 (𝑤 ∙ 𝑥𝑝 + 𝑤 ∙ 𝑥𝑛) 
The dual form of the SVM reduces to the following optimization problem: 
Maximize  𝑊(𝛼) = ∑ 𝛼𝑖 −  12 ∑ ∑ 𝛼𝑖𝛼𝑗𝑦𝑖𝑦𝑗𝑘𝑗=1𝑘𝑖=1 (𝑥𝑖 ∙ 𝑥𝑗)𝑘𝑖=1  
                                          subject to  𝛼𝑖  ≥ 0, 𝑖 = 1,⋯ , 𝑘  and ∑ 𝛼𝑖𝑦𝑖 = 0𝑘𝑖=1  
 
When the input data are noisy, they are not easily separable. Cortes and Vapnik suggested a modified 
maximum margin idea to allow for mislabelled examples, which was known as the Soft Margin 
method (Cortes and Vapnik, 1995). It chooses a hyper-plane to split the examples as clearly as 
possible, by maximizing the distance to the nearest cleanly split examples. It introduces non-negative 
slack variables 𝜀𝑖, which measure the degree of misclassification: 
𝑦𝑖  (𝑤 ∙ 𝑥𝑖 − 𝑏 ) ≥ 1 − 𝜀𝑖 , 1 ≤ 𝑖 ≤ 𝑘 
 
The optimization problem becomes a trade-off between a large margin and a small error penalty, 
which is  
                                                       Minimize  1
2
 ‖𝑤‖2 + 𝐶 ∑ 𝜀𝑖𝑘𝑖=1  
subject to  𝑦𝑖  (𝑤 ∙ 𝑥𝑖 − 𝑏 ) ≥ 1 − 𝜀𝑖, 𝜀𝑖  ≥ 0 
if the function penalizing non-zero 𝜀𝑖 is linear.  
 
By introducing Lagrange multipliers α and β as done above, the problem becomes: 
𝑎𝑟𝑔 min
𝑤,𝑏,𝜀 max𝛼,𝛽 �12 ‖𝑤‖2 + 𝐶� 𝜀𝑖𝑘𝑖=1 −� 𝛼𝑖[𝑦𝑖  (𝑤 ∙ 𝑥𝑖 − 𝑏 ) − 1 + 𝜀𝑖] −� 𝛽𝑖𝜀𝑖𝑘𝑖=1𝑘𝑖=1 � 
where 𝛼𝑖 ,𝛽𝑖  ≥ 0. 
 
A linear classifier cannot separate data sets like those displayed in Figure 7.2, non-linear classifiers 
may resolve this issue (Hofmann et al., 2008). In non-linear classifiers, every dot product is replaced 
by a non-linear kernel function, so that the original input space can be transformed to higher 
dimensional space to find the optimal hyper-plane. For example, the data in Figure 7.2 can be 
separated by a non-linear classifier by transforming to a higher dimensional space in Figure 7.3. 
 
There are several popular kernel functions, which are depicted below: 
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Figure 7.2 Data sets cannot be separated by a linear classifier. 
 
Figure 7.3 Higher dimensional space transformed from the original input space. 
 
Linear Kernel 
This is the simplest kernel that is used in a linear classifier, which is defined as 
𝐾�𝑥𝑖 , 𝑥𝑗� =  𝑥𝑖 ∙ 𝑥𝑗 
 
It can attain high accuracy if the data are linearly separable. It costs much less training time than non-
linear kernels, especially when handling a very large number of features or training samples.  
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Polynomial Kernel 
The polynomial kernel represents the similarity of training examples in a feature space over 
polynomials of the original variables, allowing learning of non-linear models. It is defined as 
𝐾�𝑥𝑖 , 𝑥𝑗� =  �𝑥𝑖 ∙ 𝑥𝑗 + 1�𝑑 
where d is the degree of the kernel, which stands for the dimensionality of the feature space that the 
kernel transforms the data to.  
 
Radial Basis Function 
The Radial Basis Function (RBF) is defined as 
𝐾�𝑥𝑖 , 𝑥𝑗� = exp (−𝛾�𝑥𝑖 − 𝑥𝑗�2) 
 
This kernel turns the hyper-plane into a Gaussian bell function. 𝛾 is related to the kernel width; a 
larger value for 𝛾 suggests the function is more specific to the training data, while a smaller value 
makes the function more generalised. 
 
In summary, SVM has several advantages on classification tasks: 
• The formulation of results in a global quadratic optimisation problem, which can be solved 
by interior point methods. 
• The solution is obtained as a set of relevant support vectors, which lie on the boundary so 
that they can summarise the information to separate the data. 
• The support vectors can be sparse, which is very useful for learning of the model, especially 
when only very small amount of training data are available. 
• It can handle high dimensional feature spaces, which facilitate the integration of various 
features with it. 
• The kernel functions provide several common model architectures, so that users can employ 
them in the classification tasks. 
  
7.3 Relation Extraction System 
7.3.1 Classification Strategy 
In the following sections, a pair-wise method will be proposed to extract binary relationships between 
entities. Two entities e1 and e2 can be paired as (e1, e2), which can be instances of  De:Anatomical 
Structure, De:Laterality, An:Immunohistochemistry-Positive, An:Flow Cytometry-Positive, 
An:Immunohistochemistry-Negative, An:Flow Cytometry- Negative, An:Immunohistochemistry-
Equivocal or  An:Biomarker. They can be connected via relations (rel), which can be one of the 
predefined relationships: Spatial Specialization, Result-Positive, Result-Negative and Result-
Equivocal. 
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The RE task is formulated as a pair-wise classification task, which aims to classify every pair of 
entities (e1, e2) to the possible relation type rel between them or None if there is no relationship 
between them. Note that the order of appearance of arguments is not considered to affect a relation, 
e.g., if there is a Result-Positive relationship between e1 and e2, it makes no difference on whether e1 
occurs before or after e2. But the order of argument types is confined to the annotation schema, e.g., 
the first argument of Result-Positive should be an An:Immunohistochemistry- Positive or An:Flow 
Cytometry- Positive entity, and the second argument should be an An:Biomarker entity. 
 
Figure 7.4 Three sentences with 9 entities and 3 relations hold between them. 
 
To employ SVM for classification, both positive and negative examples are needed to be prepared. 
These examples are restricted within a ±1 sentence window. For example, the sentence in Figure 7.4 
shows, there are three entities in each sentence. Three relations hold between them, namely Result-
Positive, Result-Negative and Result-Equivocal. There are sixteen combinations of the entity pairs in 
total, wherein six are positive examples and ten are negative examples. These examples are listed in 
Table 7.1. 
 
As mentioned in Chapter 2, there are two main streams for RE: rule-based approaches and statistical 
methods. Rule-based approaches are considered to be simple and reliable with limited amount of 
training data; machine learning-based approaches mainly focus on the feature pruning based on 
various levels of linguistic processing on the text. Given the sample size of different relation types in 
bcl2 - 
positive CD79a - CD20, 
positive negative 
CD21, positivity CD23 - equivocal 
small and large cells 
small cells, large cells 
Sentence 1: 
Sentence 3: 
Sentence 2: 
Result-Positive 
Result-Positive 
Result-Positive 
Result- Negative 
Result- Equivocal 
Result- Equivocal 
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the training data, a rule-based method is applied to extract Spatial Specialization relations, while a 
machine learning-based approach is used to extract other relations. 
 
First entity  Position of first 
entity 
Second entity  Position of second 
entity 
Relation type 
positive Sentence 1 CD20 Sentence 1 Result-Positive 
positive Sentence 1 CD79a Sentence 1 Result-Positive 
positive Sentence 1 bcl2 Sentence 2 None 
positive Sentence 2 CD20 Sentence 1 None 
positive Sentence 2 CD79a Sentence 1 None 
positive Sentence 2 bcl2 Sentence 2 Result-Positive 
positive Sentence 2 CD21 Sentence 3 None 
positive Sentence 2 CD23 Sentence 3 None 
negative Sentence 2 bcl2 Sentence 2 Result-Negative 
negative Sentence 2 CD21 Sentence 1 None 
negative Sentence 2 CD23 Sentence 1 None 
negative Sentence 2 CD20 Sentence 1 None 
negative Sentence 2 CD79a Sentence 1 None 
equivocal Sentence 3 bcl2 Sentence 2 None 
equivocal Sentence 3 CD21 Sentence 3 Result-
Equivocal 
equivocal Sentence 3 CD23 Sentence 3 Result-
Equivocal 
Table 7.1 Entity pairs generated with their relation types in the sentences displayed in Figure 7.4. 
 
7.3.2 System Architecture 
The RE system architecture is illustrated in Figure 7.5. 
 
 
 
 
Figure 7.5 Architecture of the relation extraction system. 
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From Figure 7.5, first, the input data are passed to the pre-processing engine, which includes most of 
the pre-processes described in Chapter 5: sentence boundary detection, tokenisation, proofreading, 
part-of-speech (POS) tagging and shallow parsing.  
 
The Entity Pair Generator generates the entity pairs according to the annotation schema. Note that for 
Spatial Specialization relation, only entities are paired; for other relations, the relation types 
connecting the entities are also included in the pairs to facilitate the learning of the statistical model. 
If it is to extract Spatial Specialization relation, a rule-based module will handle it; else, it will pass 
through to the subsequent procedures. 
 
The Stanford parser (Klein and Manning, 2003) is used to perform dependency parses on the 
sentences, and the results are stored for further analysis. The feature generator prepares five features 
sets generated from the pre-processed texts and the dependency parse output for every entity pair. The 
SVM classifier classifies the relation type between each entity pair and yields the output. 
 
7.3.3 Rule-based Module 
Simple heuristic rules were applied in the module, which consists of three steps and is illustrated in 
Figure 7.6:  
 
 
Figure 7.6 Workflow of the rule-based module in the relation extraction system. 
 
1. Check whether the paired entities are in the same sentence. If they are not, they will be 
filtered out. 
2. Check whether they are separated by particular punctuation or combination of punctuation 
(comma “,”, semicolon “;”, and arrow “->”). If they are, they will be filtered out. 
3. Check whether they are inside a three-word window. If they are not, they will be filtered out. 
If they are not filtered in the above processes, they will be linked with a Spatial Specialization 
relation.    
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7.3.4 Feature Sets 
Various features were prepared for the SVM classifier, which can be categorised into five broader 
feature sets. They are a lexical feature set, semantic feature set, contextual feature set, syntactic 
feature set, and positional feature set, which are described in detail below.  
 
Contextual Feature Set 
Contextual window of the paired entities: As indicated in Giuliano’work (Giuliano et al., 2006), 
words surrounding the target entities often provide strong clues for RE. A ±4 token window of each 
entity in the pair was adopted in the task, which was determined by running some preliminary 
experiments on the training data.  Given the entity at the  ith position in the sentence, this feature 
captured the tokens found in the (i-1)th, (i-2)th, (i-3)th, (i-4)th, (i+1)th, (i+2)th, (i+3)th and (i+4)th 
positions in the sentence. It treats each token at the above positions as an individual feature.  ±1, ±2, 
and ±3 token windows are subsumed by the ±4 token window, such that any text string occurring in 
the smaller windows can be captured by the larger window as well. 
 
Lexical Feature Set 
To characterise the lexical nature of the local context of the involved entities, this feature set contains 
important lexical information about the entities or the text span between the entities. 
 
Tokens inside each entity in the pair: Every token in the entities is used as a feature to represent the 
frequency of particular lexical items that make up the relations. 
 
Lowercase of tokens inside each entity in the pair: The tokens are converted to lowercase in order 
to attain a higher recall. 
 
Tokens between the paired entities: Helpful clues can be embedded in the tokens between the two 
entities.  
• Some prepositions or verbs that express a state of being are indicators for the connected 
relation. For instance, the preposition “with” in the following sentence: 
They have strong staining [“An:Immunohistochemistry-Positive”] with fascin 
[“An:Biomarker”], and also with CD15 [“An:Biomarker”] and weaker 
[“An:Immunohistochemistry-Positive”] with CD30 [“An:Biomarker”]. 
       indicates the Result-Positive relation between “strong staining” and “fascin”.  
Another example is the verb “is” as the 3rd person singular present tense to connect “CD15” 
with “equivocal”, in the sentence: 
Staining for CD15 [“An:Biomarker”] is equivocal [“An:Immunohistochemistry-
Equivocal”].  
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• Several punctuations provide hints for the construction of relations. For example, colon “:” is 
a strong hint for the connection of Result-Negative relation between “Negative” and “CD30” 
in the sentence: 
 Negative [“An:Immunohistochemistry-Negative”]: CD30 [“An:Biomarker”]. 
 
Semantic Feature Set 
Entity types of each entity in the pair:  This feature explicitly indicates the argument types that 
comprise the associated relation type. 
 
Entity types between the paired entities: The types of entity between the entities can function as an 
indicator to link two entities that are distant from each other or terminate the propagation of the 
relation span. For example, in the sentences below: 
Positive [“An:Immunohistochemistry-Positive”] : CD20 [“An:Biomarker”], CD79a 
[“An:Biomarker”], CD23 [“An:Biomarker”], CD43[“An:Biomarker”] 
Negative [“An:Immunohistochemistry-Negative”] : CD5 [“An:Biomarker”], 
CD3[“An:Biomarker”], cyclin D1 [“An:Biomarker”], CD30 [“An:Biomarker”], CD10 
[“An:Biomarker”] 
Although the distance from “Positive” to “CD23” and “CD43” exceeds ±4 token window, they can 
still be linked together, as there is only one unique entity type between them: An:Biomarker, 
suggesting that the span of the Result-Positive relation can be extended to the two An:Biomarker 
entities even if they are distant from “Positive”. In contrast, the An:Immunohistochemistry-Negative 
entity “Negative” can terminate the span of the Result-Positive relation to subsume the succeeding 
An:Biomarker entities: “CD5”, “CD3”, “cyclin D1”, “CD30” and “CD10”. 
 
Syntactic Feature Set 
POS tags of each entity in the pair: These are the generalised representations of the paired entities, 
such as “JJ” for “Negative”, “SYM” for “++”, “NN” for “CD3” and “JJ NN” for “positive staining”. 
 
Shortest dependency path: To compute the shortest dependency path between the paired entities, 
first, the headwords of the entities need to be identified, which were determined as follows:  
• For entity types of An:Immunohistochemistry-Positive and An:Flow Cytometry-Positive, 
two lists of specific lexicons are prepared, which are displayed in Table 7.2. A string match 
is used to search the lexicons in the text of the entity according to the order in the lists, and 
the matched entry becomes the headword of the entity; if no match can be found, the first 
token is the headword of the entity. 
• For An:Biomarker entities, the last token of the entity is the headword of the entity. 
• For other types of entity, the first token is supposed to be the headword of the entity. 
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List # Lexicon 
1 positively, positive, positivity 
2 strongly, moderately, weakly, weaker, strong, moderate, weak 
Table 7.2 Lists of lexicons for searching headwords of Immunohistochemistry-Positive and Flow 
Cytometry-Positive entities. 
 
The shortest dependency path between the headwords of the entities can be computed as described in 
the previous chapter. Here are some examples to demonstrate the computation in graphical form: 
 
Example 1:  
The shortest dependency path is:  
prep_for (positive-6, CD15-8) 
 
Example 2:  
 
The shortest dependency path is:  
nn (cells-6, CD10-4) 
amod (cells-6, positive-5) 
 
Example 3:  
The shortest dependency path is:  
amod (stains-3, negative-2) 
appos (CD21-19, CD1a-17) 
dep (stains-3, CD21-19) 
 
Small numbers of CD10 positive are present. cells 
amod 
nn 
stains Further  S-100, HMB-45, MPO, EMA, myogenin, desmin, CD1a, 
amod 
CD21 negative 
appos 
dep 
The atypical population stains strongly and CD30. positive for CD15 
prep_for 
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Example 4:  
The shortest dependency path is:  
amod (stains-1, Negative- 0) 
nsubj (include-2, stains-1) 
dobj (include-2, CD5-3) 
appos (CD5-3, bcl-6-12) 
 
Example 5:  
The shortest dependency path is:  
amod (proliferative-3, Ki-67-2) 
amod (index-4, proliferative-3) 
nsubj (high-7, index-4) 
prep_with (high-7, %-11) 
prep_of (%-11, nuclei-13) 
vmod (nuclei-13, staining-14) 
advmod (staining-14, positively-15) 
 
As the lengths of the shortest dependency paths for the positive pairs in the training data are not larger 
than three in most cases, so assign the value for the feature as “C1” if the length is zero or one; “C2” if 
it is two or three; “F” if it is larger than three; “O” if the shortest dependency path cannot be found. 
 
 
stains Negative include CD5, bcl-6, 
lysozyme, TdT, CK, CD99, synaptophysin and CD56. 
cyclin D-1, CD10, CD138, 
appos 
dobj amod nsubj 
The Ki-67 proliferative index is extremely high with approximately 95 
of nuclei staining positively. 
% 
amod amod prep_with 
prep_of 
nsubj 
vmod advmod 
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Feature set Feature Abbreviation Value 
Contextual 
feature set 
 
Contextual window of the first 
entity 
BFW_FOUR_1 
AFW_FOUR_1 
-4 window: 
atypical|lymphoid|cells|a
re 
+4 window: 
for|CD3,|CD4,|CD45RO 
Contextual window of the 
second entity 
BFW_FOUR_2 
AFW_FOUR_2 
-4 window: 
are|positive|for|CD3, 
+4 window: 
,|CD45RO|but|are 
Lexical 
feature set 
Tokens inside the first entity C1_TOKENS positive 
Tokens inside the second 
entity 
C2_TOKENS CD4 
Lowercase of tokens inside the 
first entity 
C1_TOKENS_LOW positive 
Lowercase of tokens inside the 
second entity 
C2_TOKENS_LOW cd4 
Tokens between the entities BTW_TOKEN for|CD3, 
Semantic 
feature set 
Entity types of the first entity C1_CLASS Immunohistochemistry-
Positive 
Entity types of the second 
entity 
C2_CLASS Biomarker 
Entity types between the 
paired entities 
BTW_TYPE Biomarker 
Syntactic 
feature set 
POS tags of the first entity C1_POS JJ 
POS tags of the second entity C2_POS NN 
Shortest dependency path DEP_LEN C2 
Positional 
feature set 
Token distance between the 
paired entities 
TOKEN_DIS C1 
Sentence distance between the 
paired entities 
SEN_DIS 0 
The order of appearance for 
the paired entities 
POSITION S 
Table 7.3 Examples of features prepared for the entity pair (positive, CD4) in the sentence: “The 
atypical lymphoid cells are positive for CD3, CD4, CD45RO but are negative for CD20, CD8 and 
CD30.”. Note: multiple values are separated by pipe “|”. 
 
Positional Feature Set 
Token distance between the paired entities: This refers to the distance between the paired entities 
along a token path. 
The average token distance for all positive pairs in the training data is smaller than four. There are 
three possible values to be assigned to this feature: “C1” if the token distance between the paired 
entities is not larger than two; “C2” if it is three or four; “F” if it is over four. 
 
Sentence distance between the paired entities: This is a numeric value that was computed by the 
difference of the numbers of sentences between entities in the pair. Its possible values are 0 and 1. 
 
The order of appearance for the paired entities: It seems that there is a pattern for the order of 
appearance for the entities with particular lexicons in the pair. If the first entity contains or consists of 
sign(s) such as “++”, “-“ and “1+”, then it usually succeeds the second entity; if the first entity has an 
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initial capital , e.g., “Positive” and “Negative”, then  it usually precedes the second entity. The feature 
value is assigned as “P” if the second entity is preceding the first entity; else, it is assigned as “S”. 
 
Examples of the above features are presented in Table 7.3. 
 
7.3.5 Vector Representation 
To represent a relation, a binary feature vector is created by using the extracted features. Each feature 
has a unique index associated with it, which is stored in a feature index file. Table 7.4 displays part of 
the data extracted from the file for the above examples. Given a relation instance R, assign the index 
value with 1 if the associated feature is active, thus the feature vector representation for it is: 
R = (index_1:1, index_2:1, ⋯, index_n:1) 
where n is the total number of  active features. 
 
According to Table 7.4, the feature vector representation of the examples in Table 7.3 is: 
R = (17:1 19:1 21:1 22:1 23:1 35:1 36:1 37:1 38:1 40:1 84:1 116:1 133:1 140:1 163:1 164:1 165:1 
176:1 179:1 183:1 199:1 473:1 499:1 721:1 722:1 2722:1 3520:1) 
  
Feature Value Index 
C2_CLASS Biomarker 17 
TOKEN_DIS C1 19 
C2_POS NN 21 
C1_POS JJ 22 
BTW_TYPE Biomarker 23 
C1_TOKENS positive 35 
C1_TOKENS_LOW positive 36 
C1_CLASS Immunohistochemistry-Positive 37 
POSITION S 38 
SEN_DIS 0 40 
AFW_FOUR_2 , 84 
BFW_FOUR_1 cells 116 
BFW_FOUR_2 for 133 
DEP_LEN C2 140 
BFW_FOUR_2 CD3, 163 
AFW_FOUR_2 are 164 
BFW_FOUR_1 are 165 
AFW_FOUR_1 for 176 
BTW_TOKEN for 179 
BTW_TOKEN CD3 183 
AFW_FOUR_1 CD3, 199 
BFW_FOUR_1 lymphoid 473 
BFW_FOUR_1 atypical 499 
C2_TOKENS CD4 721 
C2_TOKENS_LOW cd4 722 
AFW_FOUR_2 but 2722 
AFW_FOUR_2 CD45RO 3520 
                     Table 7.4 Associated indices for the examples in Table 7.3. 
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7.4 Results and Discussion 
7.4.1 Experimental Settings 
The RE system was evaluated on the lymphoma corpus that was described in Chapter 3 and 4. The 
rule-based module was run on the corpus to evaluate the coverage of the rules. The experiments for 
evaluating the SVM classifier were carried out as follows: 
First, the corpus was pre-processed, and positive and negative examples were generated from it. A 
relation can cross a sentence boundary, and a ±1 sentence window was used to generate entity pairs, 
as in the analysis described in Chapter 4 where the entities holding relations appear within the same 
sentence or the adjacent sentences. An over-sized window is not necessary and harmful for the 
classifier, since it will lead to the dramatic increase of negative examples, which can result in the bias 
of the classifier towards them, slow down the training speed, and even impair the quality of the 
learning of the model.  
 
All experiments for evaluating the SVM classifier were conducted with 10-fold cross-validation, and 
each fold was stratified on a document level instead of instance level. As pointed out by Sætre et al 
(Sætre et al., 2007), it is likely for an RE system to gain an artificial boost of performance by 
evaluation at the instance level, since one sentence may generate many similar features for multiple 
entity pairs within it, which will be used in both the training and testing stage, however, it is supposed 
that the test set should remain to be unseen in the training stage. Therefore, it is preferable to evaluate 
the RE system at a document level to prevent the instances of the test data overlapping with those of 
the training data. 
 
The Multiclass SVM implementation of LIBSVM (Chang and Lin, 2011) was used in the 
experiments. To compare the effects of different kernels on the classifier, the performance of three 
popular kernels: linear, polynomial and RBF kernels were evaluated. A grid search method (Hsu et al., 
2010) was used with 10-fold cross-validation to find the optimal values of parameters C and  𝛾. The 
parameter d for polynomial kernel is set to be 2. 
 
The system performance is measured by the standard evaluation metrics: Precision, Recall and F-
score. 
 
7.4.2 System Performance 
7.4.2.1 Rule-based Module 
The 100% F-score obtained in the experiments suggests that the rules worked well, but it is likely to 
be limited by the small sample size (only 12 samples). More samples are needed to test it in future 
work. 
 
Chapter 7 Relation Extraction 
197 
 
7.4.2.2 SVM Classifier 
Feature Contribution 
The contribution of each individual feature to the model is reported in Table 7.5. A baseline model 
was built using the lexical feature tokens inside each entity in the pair and the semantic feature entity 
types of each entity in the pair. Feature engineering was conducted by progressively adding features to 
the classifier using the RBF kernel. The best feature configuration was obtained by using all the 
features described in Section 7.3.4. The best model achieved precision with 96.70%, recall with 
97.66% and F-score with 97.18%, which outperformed the baseline model by F-score of about 45.5%. 
 
Model 
# 
Features Precision Recall F-score 
1 Tokens inside each entity in the pair + Entity types of 
each entity in the pair 
63.65% 43.55% 51.71% 
2 M1 + Contextual window of the paired entities 82.10% 95.68% 88.37%* 
3 M2 +  Token distance between the paired entities 88.84% 94.02% 91.35% 
4 M3 + Sentence distance between the paired entities 92.77% 97.40% 95.03%* 
5 M4 + Lowercase of tokens inside each entity in the pair 92.96% 97.55% 95.20% 
6 M5 + Entity types between the paired entities 95.24% 97.76% 96.48% 
7 M6 + The order of appearance for the paired entities  95.73% 97.92% 96.81% 
8 M7 + Tokens between the paired entities 96.06% 97.71% 96.88% 
9 M8 + Shortest dependency path 96.60% 97.71% 97.15% 
10 M9 + POS tags of each entity in the pair 96.70% 97.66% 97.18% 
Table 7.5 Contribution of each individual feature to the model. Score marked with * suggests 
significant contribution within 95% confidence interval. 
 
The baseline features showed their power on gaining a relatively high precision (63.65%), as the 
major lexical information for connecting the entities could be captured by the lexical feature: tokens 
inside each entity in the pair, and the primary semantic information were revealed by the semantic 
feature: entity types of each entity in the pair. These two features integrated with each other, and 
defined the basic linguistic construct of a potential relation. Entity types restricted the semantic types 
of the arguments in the relations, since only certain types of argument can hold a particular relation 
according to the annotation schema. The lexical variability is relatively low in some entity types, 
which can assist the classifier to recognise the relations with them. For example, the 
An:Immunohistochemistry-Negative entities always contain the word “negative” or sign “-”. 
 
The contextual feature contextual window of the paired entities is the most effective feature, which 
boosted the system by about 36.7% F-score, especially improved the recall by about 52.1%. It is 
consistent with the finding that a relation between two entities is generally correlated with the words 
surrounding the entities. The local contextual information about the entities was well-preserved in the 
contextual window feature, which could compensate for the weaknesses of the baseline features to a 
great extent, especially on the loss of recall. 
 
The positional feature set yielded a moderate gain on the system with a total of about 7% F-score, 
wherein token distance and sentence distance made the biggest contribution with 2.98% and 3.68% 
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gains on F-score. The positional feature token distance mainly improved the precision by ruling out 
some entity pairs where the entities are distant from each other; sentence distance improved both the 
precision and recall, which corrected some mistakes made by using the token distance feature, e.g., 
some positive entity pairs within the same sentence, though with relative long token distance. 
 
The semantic feature entity types between the paired entities were also very effective, and increased 
the F-score by 1.28%. It remedied part of the defects caused by introducing contextual window and 
token distance features. 
 
The syntactic feature set and the remaining lexical features only improved the overall F-score slightly 
by 0.3% and 0.24% respectively.  
 
The remaining lexical features only yielded small gains, probably because of their redundancy with 
several other features. For example, if the original text of an An:Immunohistochemistry-Positive 
instance is in lowercase (e.g., “positive”) or consisting of punctuation (e.g., “++”), the value for the 
lexical feature lowercase of tokens inside each entity in the pair is the same as that for tokens inside 
each entity in the pair. Likewise, if the token distance between the entities is no more than four, then 
the lexical feature tokens between the paired entities can be replaced by the contextual window 
feature. 
 
Since the shallow and dependency parsing results were not reliable, the errors generated in syntactic 
pre-processes will propagate to the associated feature generation and account for the limited 
improvement by the syntactic feature set. One of the prominent issues is that the POS tag for an 
An:Immunohistochemistry-Negative instance “-” is “HYPH” provided by the GENIA tagger 
(Tsuruoka et al., 2005), and the Stanford parser usually treats it as colon “:” , thus it will be ignored in 
the dependency parse output.  It was likely that the parser would fail on the long distance 
dependencies as well.  For instance, in the parse tree of the sentence:  
Immunohistochemical stains show positive staining [“An:Immunohistochemistry-Positive”] 
of the large atypical cells with CD30 [“An:Biomarker”] (on repeated stain), fascin 
[“An:Biomarker”] and to a lesser extent with CD15 [“An:Biomarker”].  
the prepositional phrase “with CD15” was attached incorrectly by the parser to modify the noun 
“extent” (see Figure 7.7).  Consequently, the parser generated an incorrect dependency output for the 
sentence, and the shortest dependency path between “CD15” and “positive staining” could not be 
computed from this result. Another problem is that due to missing verbs or prepositions in the 
sentences, the parser fails to parse the sentences correctly. Here is an example: 
CD20, CD79a - positive small and large cells 
Without the verb “are” and preposition “in”, “CD20” and “CD79a” cannot be linked to “positive” via 
an explicit grammatical relation (see Figure 7.8 (a)). By revising the sentence as  
CD20 and CD79a are positive in small and large cells 
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Figure 7.7 Parse tree of the sentence: “Immunohistochemical stains show positive staining of the large atypical cells with CD30 (on repeated stain), fascin 
and to a lesser extent with CD15.” 
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(a) 
 
(b) 
Figure 7.8 Dependency parse of the original sentence: “CD20, CD79a - positive small and large cells” 
and revised sentence “CD20 and CD79a are positive in small and large cells”. 
 
the parser can yield correct dependency output for the sentence, where “CD20” and “CD79a” are 
linked to “positive” via “nsubj” (see Figure 7.8 (b)). 
 
It is notable that this phenomenon is common in the corpus. It is necessary to adopt a parser trained on 
such ungrammatical texts in this domain, in order to fully utilise the syntactic structure information 
embedded in the texts. However, it requires much additional effort to develop or train such a domain-
specific parser. 
 
Unsurprisingly, the syntactic feature: shortest dependency path only contributes a slight boost of the 
system performance. In addition to the above reasons, the possible causes include:  
Most dependency paths for the positive entity pairs are quite short, and the paired entities are probably 
located several tokens away, thus these short distance dependencies can be implicitly represented by 
some other features, e.g., the contextual window or token distance features. Therefore, the major 
effectiveness of the shortest dependency path feature should reflect on handling the longer distance 
dependencies. Nevertheless, as discussed above, the parser is more error-prone when coping with 
longer distance dependencies. Moreover, the dependency parse is performed at sentence level, so that 
for longer distance dependencies that cross sentence boundaries, the parser will fail to generate the 
dependency output for these cases. 
CD20, 
amod 
CD79a - positive small and large cells 
dep 
conj_and 
amod 
amod num 
CD20 CD79a  positive small and large cells 
cop 
are and 
amod amod 
conj_and 
conj_and 
nsubj 
nsubj prep_in 
in 
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Other features have been introduced to the model, such as lemmas and chunks of the paired entities, 
but they only introduced noise and decreased the overall F-score. This is possibly due to: 
• They may represent some overlapping features. For example, lemmas of the paired entities 
are equivalent to tokens inside each entity in the pair if the tokens are in their canonical 
forms. According to the analysis on the training corpus, the morphological variants of lexical 
items inside the entities are very limited, thus lemmas of the paired entities can be replaced 
by tokens inside each entity in the pair in most cases. 
• There may be unreliable results from the pre-processing. As mentioned above, there may be 
errors in the shallow parsing results provided by GENIA tagger. Hence using chunks of the 
paired entities as a feature with incorrect values may bring more harm rather than benefit for 
the learning of the model. 
 
Performances of Individual Relation Type 
The individual relation type performances obtained from the best model above are listed in Table 7.6. 
 
Relation type Number Precision Recall F-score 
Result-Equivocal 35 85.37% 100.00% 92.11% 
Result-Negative 940 98.72% 98.19% 98.45% 
Result-Positive 947 95.23% 97.04% 96.13% 
Overall 1922 96.70% 97.66% 97.18% 
                          Table 7.6 Performance for each individual relation type. 
 
From Table 7.6, it can be seen that the micro-averaged F-score is over 97%, indicating that the 
features are sufficient to identify most of the relations. Result-Negative achieved the best performance 
with 98.45% F-score; Result-Positive attained the second highest F-score with 96.13%; the classifier 
performed worst on Result-Equivocal, with 92.11% F-score. The possible reasons for this are: 
1. The sample size of Result-Equivocal instances (35 instances) is very small, and it is known 
that insufficient sample size can hinder the performance of a statistical classifier. 
2. One of the constituent entity types for Result-Positive: An:Immunohistochemistry-Positive 
has more lexical variants than that of the counterpart for Result-Negative 
(An:Immunohistochemistry-Negative), the ratio being approximately 10:1. The 
An:Immunohistochemistry-Positive instances can be morphological variants of “positive”, 
such as “positively” and “positivity”; phrases referring to the intensity of positivity, e.g., 
“strong”, “moderately”,  and “weaker”;  a combination of punctuation or numerals to indicate 
the intensity of positivity, such as “+” and  “2+”. It also has more syntactic variants, e.g., the 
POS tags, including “JJ”, “NN”, “RB”, “JJR”, “SYM”, etc. The concurrence of different 
variants in the same sentences can also increase the difficulty for determination of the 
relation. For example, in this sentence: 
“Positive [“An:Immunohistochemistry-Positive”] : CD30 [“An:Biomarker”] +++ 
[“An:Immunohistochemistry-Positive”], Ki67 [“An:Biomarker”] (5% nuclei)” 
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there are two An:Immunohistochemistry-Positive instances: “Positive” and “+++”,  where  
“Positive” should be connected to “Ki67”, while “+++”should be linked to “CD30”.  
This phenomenon often occurs in the Result-Positive instances, but does not exist in the 
Result-Negative ones. All of the above factors lead to greater variety in the linguistic patterns 
to determine the Result-Positive relations.  
 
Error Analysis 
Error analysis shows that most of the errors (about 67%) are probably due to the weaknesses of the 
features, while incorrect results from the pre-processing accounts for 28% of the errors. 
 
Although the features have shown their advantages on recognising most of the relations, they still 
have weaknesses in several cases: 
1. The possible values for token distance were determined based on the averaged count of the 
positive pairs in the corpus, which are not suitable for some cases. For example, it restricted 
the recognition of Result-Positive relations between the An:Immunohistochemistry-Positive 
entity “Positive” and some distant An:Biomarker entities (“CD45”, “CD138”, “CD30” and 
“CD3”) in this sentence: 
   Positive [“An:Immunohistochemistry-Positive”] - CD20 [“An:Biomarker”] and 
CD79a [“An:Biomarker”] (only a proportion of the large cells stain with each 
antibody), CD45 [“An:Biomarker”] (most cells), CD138 [“An:Biomarker”], EMA 
[“An:Biomarker”] (strong [“An:Immunohistochemistry-Positive”] and diffuse), 
CD30 [“An:Biomarker”] (moderate numbers of cells), Human Herpes Virus 8 
[“An:Biomarker”] (HHV8 [“An:Biomarker”], strong staining 
[“An:Immunohistochemistry-Positive”]), CD3 [“An:Biomarker”] (scattered small 
lymphocytes).   
   The argument for using four-tokens as a close distance also caused some misclassifications 
of the paired entities located at this distance. For instance, it brought a false Result-Positive 
relation between the An:Biomarker entity “CD30” and the An:Immunohistochemistry-
Positive entity “positive” in this sentence: 
   The cells stain strongly [“An:Immunohistochemistry-Positive”] for CD30 
[“An:Biomarker”], are also positive [“An:Immunohistochemistry-Positive”] for 
CD15 [“An:Biomarker”], but are negative [“An:Immunohistochemistry-
Negative”] for CD20 [“An:Biomarker”]. 
2. The initiative for utilizing entity types between the paired entities was to try to extend or 
shrink the relation span through learning the possible entity types between the entities in 
positive pairs. However, this may allow some invalid constructions of the relations. For 
example, invalid Result-Positive relations were constructed among the An:Biomarker 
entities “CD10”, “CD20”, “CD79a”, “bcl-2”  and  the second An:Immunohistochemistry-
Positive entity “positive”, as well as  those among the An:Biomarker entities “CD3”, 
“CD43” and the first An:Immunohistochemistry-Positive entity “positive”, in the sentence: 
Chapter 7 Relation Extraction 
203 
 
   Immunoperoxidase staining of these cells is positive [“An:Immunohistochemistry-
Positive”] for CD10 [“An:Biomarker”], CD20 [“An:Biomarker”], CD79a 
[“An:Biomarker”] and bcl-2 [“An:Biomarker”] with CD3 [“An:Biomarker”], 
CD43 [“An:Biomarker”] positive [“An:Immunohistochemistry-Positive”] T cells 
mainly in the interfollicular regions. 
   as one of the frequent entity types between the entities in positive pairs is An:Biomarker.  
It also precluded some valid connections of the entities. For instance, the connection of 
“bcl2” and “negative” was excluded in the sentence: 
bcl2 [“An:Biomarker”] - positive [“An:Immunohistochemistry-Positive”] small 
cells, negative [“An:Immunohistochemistry-Negative”] large cells 
since an An:Immunohistochemistry-Positive entity “positive” occurred between them. 
3. The tokens between the paired entities feature did not consider the implicit meaning of 
particular tokens, hence it failed to rule out some invalid relations. For example, the invalid 
Result-Negative relation between “CD21” and “negative” should be ruled out from the 
sentence: 
   Immunohistochemical stains show the large cells to be positive 
[“An:Immunohistochemistry-Positive”] for CD20 [“An:Biomarker”], CD79a 
[“An:Biomarker”], kappa [“An:Biomarker”], BCL-2 [“An:Biomarker”], BCL-6 
[“An:Biomarker”] (scattered nuclei) and CD21 [“An:Biomarker”] (patchy 
cytoplasmic staining); and negative [“An:Immunohistochemistry-Negative”] for 
CD5 [“An:Biomarker”], lambda [“An:Biomarker”], CD10 [“An:Biomarker”] and 
CD30 [“An:Biomarker”]. 
   considering the occurrence of the punctuation  semicolon “;”.  This suggests that it needs 
discrimination from particular tokens. However, to obtain such particular lexicons requires 
additional effort not only in the investigation of the positive pairs but also negative pairs in 
the corpus. 
4. The goal of using dependency paths as a feature is to identify some paired entities that may 
locate far along a token path but close along a dependency path. It classified the dependency 
path lengths of zero and one to the same category “C1”, which may lead to some problems 
on classifying the entity pairs with short dependency distance. In the following example: 
   Despite the negative [“An:Immunohistochemistry-Negative”] CD23 
[“An:Biomarker”], and strong [“An:Immunohistochemistry-Positive”] CD20 
[“An:Biomarker”] on flow cytometry and immunohistochemistry, I favour an 
atypical chronic lymphocytic leukaemia (or small lymphocytic lymphoma), 
morphologically, and in view of the strong [“An:Immunohistochemistry-
Positive”] CD5 [“An:Biomarker”] staining on immunoperoxidase stains.  
   the dependency path between “CD23” and the first An:Immunohistochemistry-Positive entity 
“strong” can be computed by  
conj_and (CD23-3, CD20-7) 
amod (CD20-7, strong-6) 
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where the length is one. 
But the dependency path between “CD20” and “negative” can be computed by 
amod (CD23-3, negative-2) 
conj_and (CD23-3, CD20-7) 
where the length is also one. 
Thus, the classifier produced an incorrect Result-Positive relation between “CD23” and 
“strong”, as well as an invalid Result-Negative relation between “CD20” and “negative”. 
 
The main defect of the pre-processing was incorrect results from sentence boundary detection, which 
affects the following dependency parse, and the effectiveness of the sentence distance feature. For 
example, the following sentence:  
The negative [“An:Immunohistochemistry-Negative”] CD23 [“An:Biomarker”] on 
immunostaining and flow cytometry does not support CLL/SLL and the negative 
[“An:Immunohistochemistry-Negative”] CD10 [“An:Biomarker”] and BCL6 [“An:Biomarker”] 
does not support a follicular lymphoma.  
was incorrectly divided into two sentences by the sentence boundary detector:  
The negative CD23 on immunostaining and flow cytometry does not support CLL/SLL and the 
negative” and “CD10 and BCL6 does not support a follicular lymphoma.  
which caused the omission of the Result-Negative relations among “CD10”, “BCL6” and the second 
An:Immunohistochemistry-Negative entity “negative”, because a Result-Negative relation seldom 
crossed sentence boundaries.  
 
Likewise, the sentence boundary detector could not recognize that the following text is composed of 
two sentences: 
Larger cells -CD30 [“An:Biomarker”], CD15 [“An:Biomarker”], Fascin [“An:Biomarker”] 
positive [“An:Immunohistochemistry-Positive”] 
EMA [“An:Biomarker”], ALK1 [“An:Biomarker”], LCA [“An:Biomarker”], CD3 
[“An:Biomarker”], CD20 [“An:Biomarker”] negative [“An:Immunohistochemistry-Negative”] 
Consequently, a false Result-Positive relation was defined between “EMA” and “positive” by the 
classifier. 
 
Another issue is about the difficulty of dependency parsing to correctly parse some ungrammatical 
sentences. Here is an example: 
CD5 [“An:Biomarker”] - Scattered small cells positive [“An:Immunohistochemistry-Positive”] 
consistent with reactive T-cells. 
 
As it seems to be a combination of several phrases rather than a sentence, the parser yielded erroneous 
results for it. From Figure 7.9, there are several mistakes in the parse tree:  
• The POS tag for “Scattered” should be “JJ” rather than “VBN”; 
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• The chunk tag for “Scattered small cells positive consistent with reactive T-cells” should be 
“S” instead of “VP”; 
• The adjective “consistent” and the prepositional phrase “with reactive T-cells” were attached 
to the wrong place. 
 
 
 
 
As discussed above, the parser was not trained with pathology notes, thus it was unable to parse this 
ungrammatical sentence correctly.  
 
The classifier also could not handle entity pairs situated in the sentences in irregular structures. For 
example, the classifier was confused by the sentence: 
 CD5 [“An:Biomarker”] + [“An:Immunohistochemistry-Positive”] and CD23 [“An:Biomarker”] 
- [“An:Immunohistochemistry-Negative”], suggesting mantle cell lymphoma on flow cytometry, 
but cyclin Dl [“An:Biomarker”] negative [“An:Immunohistochemistry-Negative”].  
Due to the misuse of the verb “suggesting” and omission of the verb “is” or the form “suggest” being 
used instead.  
 
Comparison of Kernels 
The comparative results among different kernels employed in the classifier are displayed in Figures 
7.10, 7.11 and 7.12.  
 
From Figure 7.10, 7.11 and 7.12, the polynomial kernels achieved significantly better overall F-score 
on model 1, probably due to the higher recall on the model; the gaps between each kernel was 
narrowed by increasing features, and remained stable for models 4 ~10.  
 
The better performance attained by the polynomial kernel on model 1, suggests that there is a positive 
influence on the system performance by mapping the original feature space into a higher dimensional 
Figure 7.9 Parse tree of the sentence: “CD5 - Scattered small cells positive consistent with 
reactive T-cells.” 
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feature space, especially with a limited feature size. But this influence will be reduced with features 
added to the model. 
 
 
                 Figure 7.10 F-scores of three kernels on each language model. 
                  
 
                 Figure 7.11 Precisions of three kernels on each language model. 
                     
It seems that the contribution of the features to the models was also affected by the kernels. The 
positional feature token distance yielded prominent larger gain on the precision of model 3 with the 
polynomial kernel, while the contextual window improved the recall to a less extent of model 2 with 
the linear kernel. This is possibly because in the models there were data that are not linearly separable, 
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and a non-linear kernel like the polynomial kernel was more suitable to separate them, as it increased 
the flexibility of the classifier; the RBF kernel could extend the feature space into an infinite number 
of dimensions, while the polynomial kernel could create combinations of features. 
 
 
                    Figure 7.12 Recalls of three kernels on each language model. 
                     
There are different opinions on kernel selection in SVM. On the one hand, some researchers advocate 
that the linear kernel should be considered initially, as it has a simpler training algorithm that saves 
more time during training and scales well with the number of training examples (Bishop, 2007; Hastie 
et al., 2001); it has only one parameter to be tuned, that can prevent over-fitting to the training data, 
which the RBF and polynomial kernels may lead to with a small sample size. On the other hand, in 
many applications, SVM classifiers armed with non-linear kernels could provide better accuracy 
(Cristianini and Shawe-Taylor, 2000). In a simulation study done by Way et al, the polynomial kernel 
was more vulnerable to overtraining with large feature sets, and the RBF kernel was better than or 
comparable to the polynomial kernel under most conditions (Way et al., 2010). In this study, given the 
medium sample size and feature size, the RBF kernel was selected at first.  
 
According to Figure 7.10, with a considerable amount of features, there was no significant difference 
between the performances of each kernel, which suggests that the choice of kernels has limited 
influence on the system with medium sample size when sufficient features were provided. 
 
General Applicability 
The relative value of various types of features has been demonstrated in this study, and researchers 
can use these features as a baseline for the development of more complex models in the future. 
Furthermore, the system performance was accomplished by using simple models and SVM, a classical 
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machine learning algorithm, therefore the system is likely to be durable and reusable and can be 
readily modified to meet different requirements for other clinical relation extraction tasks. 
 
7.4.2.3 Limitations 
Note that although the experiments have shown very good performance, there are also some issues 
addressed by them: 
1. Incorrect results from the pre-processing, includes errors from sentence boundary detection 
and dependency parsing. To overcome this problem, it requires a more sophisticated sentence 
boundary detector and parser trained on the domain.  
2. There are defects in feature extraction and construction.  For example, there should be further 
consideration on particular tokens for the tokens between the paired entities feature; the 
categorization of the dependency path length may be too ambiguous, which needs to be tuned 
for short dependency distances. 
3. The sample size for the rule-based module was too small so that the module could not be 
properly evaluated in the experiments. 
4. There are disadvantages in the feature selection method. In this study, a “bottom-up” method 
(Whitney, 1971) was used, where features were progressively added to an initial empty 
feature set to find the best configuration. Its counterpart is the “top-down” method, where 
features are gradually removed from an initial full feature set to obtain the best feature set. 
Both the methods suffer from the nesting effect that features once added cannot be removed 
or once removed would not be re-considered. This can be overcome by the stepwise feature 
selection (Sahiner et al., 2000) and sequential forward floating search (Pudil et al., 1994) 
methods. Better still would be an investigation into the inter-relationships between the 
features so that the particular structures they are exploiting are clearly identified and 
redundancies between features removed. 
 
7.5 Conclusion 
This chapter presents a relation extraction system to extract four relations from the lymphoma corpus, 
including a rule-based module and a SVM classifier. Simple heuristic rules were applied in the rule-
based module, while several useful features were prepared for the SVM classifier. The system has 
achieved very good performance, with 100% F-score obtained by the rule-based module and 97.18% 
micro-averaged F-score attained by the SVM classifier. The contextual, positional and semantic 
features were identified as the most effective features.  
 
Error analysis shows that weaknesses of the features and incorrect results from the pre-processing 
were the main reasons for the loss of precision and recall. The small sample size for testing and the 
disadvantages of the feature selection method were also addressed in the evaluation of the system. 
Future work can be focused on adopting a more sophisticated sentence boundary detector and domain-
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specific parser, improving feature extraction and construction, and using other methods for feature 
selection.  
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Chapter 8  Structured Output Generation 
8.1 Introduction 
Many information extraction (IE) shared tasks only focused on one aspect: extracting relevant 
information from unstructured text, but neglected the subsequent task: transforming the extracted 
information into structured data. Although they might have specifications for the output formats (in a 
structured or semi-structured style), the goal of proposing these specifications was to ease the 
evaluations of the extracted information rather than facilitate the users to access or understand them. 
For example, in the concept extraction task of 2010 i2b2/VA Challenge (i2b2, 2010b), the organizer 
required the system output should be a plain text file that contains entries in the form: 
“c= concept text  offset || t=concept type” 
So that the evaluation scripts could run on the system output and compute the system performance. 
 
Unlike these tasks, this study also emphasizes the importance of structured representation of the 
extracted information, so as to represent the information in a straightforward way that the users can 
understand and utilize easily and efficiently.  
 
The targeted users of the system in this study are pathologists and clinical staff, although they did not 
participate in the validation of the system directly at present.  Without a proper structured 
representation of the extracted information, they may be reluctant to use it; or worse, the inappropriate 
representation may affect the efficiency to make clinical decisions, and consequently diminish the 
quality of the clinical management of the patients.  
 
Note that the structured representation in this work refers to the population of structured templates 
instead of structured generation of codes, thus it is distinguishable from other systems, e.g., MedLEE 
(Friedman et al., 2004) and cTAKES (Garla et al., 2011), which aimed to encode medical concepts in 
clinical documents. 
 
The structured representation process includes construction of predefined templates and population of 
the templates, which will be described in this chapter. The rest of the chapter is organised as follows: 
firstly, it depicts the design of the predefined templates, and then presents the detailed mapping 
strategies and a particular sub-system for populating these templates.  The results section illustrates 
the performances evaluated on the sub-system and those evaluated on the full system by assembling 
all components together. 
 
8.2 Design of Structured Templates 
As mentioned in Chapter 2, the structured templates were established based on three associated 
structured cancer reporting protocols from the Royal College of Pathologists of Australasia (RCPA). 
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Moreover, they were slightly modified for the corpora according to the detailed analyses presented in 
Chapter 3. 
 
The reason for using structured templates rather than utilizing clinical entities identified in Chapter 4 
directly is: 
Most clinical entities are defined based on the standards and guidelines from the structured protocols, 
which are suitable to be repoted in structured checklists. The strucutred protocols are designed 
accoding to the disease and what has to eb reproted about the disease. This information varies from 
one disease to another so no single list of clinical entities can be defiend for use across all protocols. 
According to the practice of clinical and pathology staff, a good structured pathology report should be 
formatted to provide information clearly and unambiguously to the treating doctors, and should be 
organised with their use of the report in mind. In this sense, the report differs from the structured 
checklist, which is organised with the pathologists’ workflow as a priority.  
 
Therefore, the aim of designing structured templates is to systematically report cancer diseases, 
making it easier for treating doctors to understand the reports. 
 
8.2.1 Structured Template of the Melanoma Corpus 
The structured template of the melanoma corpus is displayed in Table 8.1. From this table, almost 
each section context can be mapped to its associated section in the template, except for “SPECIMEN”. 
“SPECIMEN” was finally decided to correlate with “CLINICAL HISTORY”, as they seemed to be 
complementary with each other: the reporting items were similar; when the contents in one of them 
were missing, those of the other could function as a replacement or supplement.  
 
Major differences in the template from the sample template provided in Primary Cutaneous Melanoma 
Structured Reporting Protocol (Scolyer et al., 2010) include: 
1. Item “Comment” in the “CLINICAL” section was replaced with another item “Description”, 
with a broader scope to cover the contents in “CLINICAL HISTORY” and “SPECIMEN”. 
2. The default unit for item “Mitotic rate” is “per mm2” in the protocol.  However, units like 
“per HPF (High Power Field)”, “per 5 HPFs” are also frequently used by pathologists in the 
corpus. A study indicates that the number of mitoses in a one square millimetre area is equal 
to the count in approximately 5 full HPFs with an Olympus BH2 microscope at ×400 
magnification (Scolyer et al., 2003). It suggests that without knowledge of which brand of 
the microscope or the magnification the pathologist used, the arbitrary conversion of the 
count in HPFs to the number in one square millimetre may be inappropriate. Therefore, it 
was decided to present the units aside from the numeric values to obtain flexible 
representation of this field in the template. 
3. A supplementary field was prepared to report the presence or absence of  tumour infiltrating 
lymphocytes (TILs) in the template, given the analysis on the corpus that pathologists do not 
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always record the distribution and density of TILs, but only whether TILs were present or not 
in some cases; the presence or absence of TILs is also of prognostic significance. For 
example, in a recent study of melanoma, absent TILs could predict sentinel lymph node 
positivity (Taylor et al., 2007). 
4. Item “Int. / late regression” in “MICROSCOPIC” section was replaced with “Regression”, as  
• Regression can be categorised into three stages: early, intermediate and late. 
• The focus on intermediate and late stage may omit the importance of characteristics 
of the regression. For example, one study of thin melanomas showed that past 
regression adversely affected survival in patients, while active regression without 
fibrotic area did not have significant influence on it (Sondergaard and Hou-Jensen, 
1985). 
5. Item “Intraepidermal growth” was substituted with “Cell growth”. Researchers pointed out 
that in the radial growth phase, the melanoma tends to grow within the epidermis along the 
lines or radii of a circle and does not form any expansive nest or nodule, which does not 
indicate any metastatic potential (Guerry et al., 1993); in a vertical growth phase, the 
melanoma extends vertically into the underlying dermis, where melanoma cells form 
expansive and coalescent nests and nodules, which shows metastatic potential with possible 
invasion into dermal lymphatic and vascular channels (Oliveira Filho et al., 2003). Only 
reporting the cell growth patterns within the epidermis may neglect the abnormal ones in 
other skin layers, e.g., dermis. 
 
8.2.2 Structured Template of the Colorectal Cancer Corpus 
Table 8.2 illuminates the structured template designed for the colorectal cancer corpus. From this 
table, each section context can be mapped to its associated section in the template, wherein 
“CONCLUSION” was associated with “Diagnostic Summary” section, while “SYNOPTIC” was 
relevant to “SYNTHESIS” section, considering the potential advantages of utilizing the synoptic 
fields presented in “SYNOPTIC”.  
 
There are several notable variations from the sample template provided in the Colorectal Cancer 
Structured Reporting Protocol (Eckstein et al., 2010): 
1. In the sample template, only a type of operation should be considered as a value for item 
“Specimen type” (the original name “Type” was thought to be ambiguous, hence “Specimen 
type” was used instead). However, the analysis of the corpus revealed that the site of 
operation was also used by pathologists to imply the surgical resection of it, thus it was also 
considered as a possible value in the structured template. 
 
Chapter 8 Structured Output Generation 
213 
 
Template section Template item Section context Possible value 
Diagnostic Summary Summary 
 
“DIAGNOSIS” Contents in associated section context(s) 
Comment 
 
“COMMENT” Contents in associated section context(s) 
Supporting 
Information 
 
CLINICAL Description 
 
“CLINICAL HISTORY”, 
“SPECIMEN” 
Contents in associated section context(s) 
Site and laterality Anatomical site  
Clinical diagnosis 
 
Diagnosis made by the clinician; for negative diagnosis: “no” + the diagnosis; 
for uncertain diagnosis: an entry in the uncertainty standard dictionary + the 
diagnosis 
Specimen type Surgical procedure, biopsy type  
Prev. Rx / Trauma 
 
Cosmetic change indicating 
trauma/treatment ( and history or timing if applicable) 
Previous melanoma Present, absent, an entry in the uncertainty standard dictionary 
Distant metastasis Present, absent, an entry in the uncertainty standard dictionary 
Other medical 
history 
History of the current lesion 
MACROSCOPIC Description 
 
“MACROSCOPIC” Contents in associated section context(s) 
Size of specimen Measurement of the specimen dimensions 
Other lesions Present, absent, an entry in the uncertainty standard dictionary 
MICROSCOPIC 
 
Description 
 
“MICROSCOPIC” Contents in associated section context(s) 
Diagnosis 
 
Diagnosis made by the pathologist; for negative diagnosis: “no” + the 
diagnosis; for uncertain diagnosis: an entry in the uncertainty standard 
dictionary + the diagnosis 
Tumour thickness Breslow thickness of the tumour 
Excision margins: 
Invasive 
 
Numeric value - Distance of invasive melanoma from peripheral margin (and 
“clear” if the margin is uninvolved by the melanoma) 
Excision margins: 
In-situ 
 
Numeric value - Distance of  in-situ melanoma from peripheral margin (and 
“clear” if the margin is uninvolved by the melanoma) 
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Excision margins: 
Deep 
 
Numeric value - Distance of  the melanoma from deep margin (and “clear” if 
the margin is uninvolved by the melanoma) 
Ulceration (mm 
diam) 
 
Present (and measurement of the ulceration if applicable), absent, an entry in 
the uncertainty standard dictionary 
Mitotic rate Mitotic rate of the melanoma 
Microsatellites Present, absent, an entry in the uncertainty standard dictionary 
Level of invasion 
(Clark) 
Classification of Clark level 
Lymphovascular 
invasion 
Present, absent, an entry in the uncertainty standard dictionary 
TILs Present, absent, an entry in the uncertainty standard dictionary 
TILs: Distribution Phrase referring to the distribution of TILs 
TILs: Density Phrase referring to the density of TILs 
Regression 
 
Present (and stage or characteristic 
if  applicable), absent, an entry in the uncertainty standard dictionary 
Desmoplasia Present, absent, an entry in the uncertainty standard dictionary 
Neurotropism Present, absent, an entry in the uncertainty standard dictionary 
Assoc. benign 
naevus 
Type of  associated naevus, present, absent 
Cell growth 
 
Cell growth pattern of the melanoma 
Subtype Sub-classification of the melanoma; for negative subtype: “no” + the subtype; 
for uncertain subtype: an entry in the uncertainty standard dictionary + the 
subtype 
Table 8.1 Structured template of the melanoma corpus. The default possible value is “N/A” (not applicable). 
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Template section Template item Section context Possible value 
Diagnostic Summary 
 
Summary “CONCLUSION” Contents in associated section context(s) 
Comment Texts relating to other issues noted during the pathology reporting in associated 
section context(s) 
Supporting 
Information 
 
CLINICAL 
 
Site “CLINICAL 
HISTORY” 
The part of the colorectal tract where the tumour was found by the clinician 
Other sites of 
disease 
Relevant coexistent pathological abnormality 
Medical history Previous medical history of the patient  
MACROSCOPIC 
 
Specimen type “MACROSCOPIC” Surgical procedure or site 
Tissue banking Yes, no 
Specimen images Yes, no 
Specimen length Numeric value - Measured length of resected colorectal tract 
Tumour site The part of the colorectal tract where the tumour was located  found by the 
pathologist 
Peritoneal 
reflection 
Astride, above, below 
Mesorectal 
integrity 
Complete, nearly complete, incomplete 
Tumour size Numeric value - Measurement of the maximum dimension of a tumour 
Extramuscular 
spread 
The measured distance of spread beyond the muscularis propria (in mm), the status 
of tumour border/margin (e.g., “infiltrative”, “pushing”) 
Tumour 
description 
Description of the tumour  
Overlying serosa Description of the surrounding serosa 
Perforation Present, absent, an entry in the uncertainty standard dictionary 
Margins: 
Proximal 
Numeric value - The measured distance between the tumour and the proximal 
margin in macroscopic examination (and “clear” if the margin is uninvolved by the 
tumour) 
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Margins: Distal Numeric value - The measured distance between the tumour and the distal margin in 
macroscopic examination (and “clear” if the margin is uninvolved by the tumour) 
Margins: Radial Numeric value - The measured distance between the tumour and the radial or 
circumferential margin in macroscopic examination (and “clear” if the margin is 
uninvolved by the tumour) 
Lymph nodes Numeric value - The total number of lymph nodes identified in macroscopic 
examination 
Metastases  Present, absent, an entry in the uncertainty standard dictionary 
Blocks selected Description of how the specimen was sliced into sections for testing 
Comment Texts relating to other issues noted during the pathology reporting in macroscopic 
examination 
MICROSCOPIC 
 
Histological type 
(WHO) 
“MICROSCOPIC” The histological type of cancer the tumour represents 
Histological 
grade 
The level of differentiation of the tumour 
Depth of 
invasion 
The depth that the tumour has invaded into the colorectal tissue  
Serosal 
involvement 
Present, absent, an entry in the uncertainty standard dictionary 
Small vessel 
invasion 
Present, absent, an entry in the uncertainty standard dictionary 
Venous invasion Present, absent, modality, an entry in the uncertainty standard dictionary 
Perineural 
invasion 
Present, absent, modality, an entry in the uncertainty standard dictionary 
TILs Present, absent, an entry in the uncertainty standard dictionary (and sub-
classification of the lymphocytic response, phrase referring to 
density/distribution/degree if applicable), texts refers to other  lymphocytic 
responses 
Margins: 
Proximal 
Numeric value - The measured distance between the tumour and the proximal 
margin in microscopic examination (and “clear” if the margin is uninvolved by the 
tumour) 
Margins: Distal Numeric value - The measured distance between the tumour and the distal margin in 
microscopic examination (and “clear” if the margin is uninvolved by the tumour) 
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Margins: Radial Numeric value - The measured distance between the tumour and the radial or 
circumferential margin  in microscopic examination (and “clear” if the margin is 
uninvolved by the tumour) 
Lymph nodes Numeric value - The total number of lymph nodes in microscopic examination 
Number involved Numeric value - The number of extracted lymph nodes which are shown to be 
malignantly involved 
Distant spread Present, absent, an entry in the uncertainty standard dictionary 
Response to Rx Reaction to treatment 
Comment Texts relating to other issues noted during the pathology in microscopic examination 
ANCILLARY 
STUDIES 
Description  “ANCILLARY” Supporting tests performed (and their findings) 
SYNTHESIS 
 
TNM stage: T “CONCLUSION”, 
“SYNOPTIC” 
T value  
TNM stage: N N value  
TNM stage: M M value  
Stage group Pathological stage grouping for colorectal cancer 
Residual tumour 
(R) 
R status, description of whether any tumour was left as residual 
Comment “SYNOPTIC” Texts relating to other issues noted during the pathology reporting in associated 
section context(s) 
Table 8.2 Structured template of the colorectal cancer corpus. The default possible value is “N/A” (not applicable). 
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2. The possible value for item “Tumour size” was referred to the maximum dimension of a 
tumour instead of the maximum diameter of a tumour, as it was stated in the latest 
Macroscopic Cut-Up Manual for Colorectal tumour from RCPA (RCPA, 2013-2014), 
although it was traditionally defined as the greatest linear diameter by macroscopic 
examination (Miller et al., 1985); the pathologists might not indicate which dimension of the 
tumour was measured, such as “size: 40mm”, “75x50mm” and “38mm from proximal to 
distal”. 
3. There was no specification about the value for item “Extramuscular spread” in the protocol. 
By seeking advice from the medical consultants, it was decided that the possible value for 
this item can be the measured distance of tumour spread beyond the muscularis propria or the 
tumour border configuration, as extramuscular spread is often present when the tumour has 
an infiltrative border; the tumour border configuration represents an important 
histomorphological prognostic indicator. As indicated in Koelzer’s work, infiltrative tumour 
border is associated with poor survival outcome and early disease recurrence of colorectal 
cancer patients; a “pushing” tumour border frequently occurs in colorectal cancer cases with 
low risk for nodal and distant metastasis (Koelzer and Lugli, 2014). 
4. Not only the T stages were considered as possible values for item “Depth of invasion”, but 
also the narratives about the definitions of the stages were also taken into account. For 
example, our system can be draw a conclusion that the maximum degree of local invasion is 
pT2 from the texts “extending into but not through muscularis propria” and pT3 from the 
texts “tumour extends to the full thickness of the muscularis propria into the mesocolon” 
(Edge et al., 2010). 
5. There was also no specification about the value for item “TILs” in the protocol. But given the 
experience of the same item in the structured template of the melanoma corpus, it was 
assumed that the presence or absence of TILs, density, distribution and degree of the TILs 
should be reported if applicable. However, the coverage of this item in the colorectal cancer 
corpus was broader than that in the structured template of the melanoma corpus, which 
represented the lymphoid host response to the tumour. Based on the analysis of the corpus, it 
can be classified to four categories: TILs, peritumoural lymphocytes, Crohn’s-like reaction 
and other. TILs was defined as at least four unequivocal intraepithelial lymphocytes found in 
a single ×40 field on haematoxylin and eosin-stained slides (Michael-Robinson et al., 2001); 
peritumoural lymphocytes were considered to be present as a cap or mantle of chronic 
inflammatory cells at the deepest point of invasive tumour border (Bosman et al., 2010); 
Crohn’s-like reaction was based on the finding that three or more nodular lymphoid 
aggregates deep to the advancing tumour margin within a single ×4 field (Graham and 
Appelman, 1990); the other category includes other lymphocytic reaction responses that 
cannot be classified to the categories above. The possible values for “TILs” should include 
the category of the lymphoid host response if applicable as each has its own prognostic 
impacts on colorectal cancer patients (Ogino et al., 2009).   
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6. Items “Margins: Other” and “Margins: Donuts” were removed from the sample template, as 
they were not described in the protocol, thus it was hard to define them based on the 
protocol; there were few instances about “Margins: Other” in the corpus; donuts from 
stapling devices do not need to be examined histologically if the tumour is more than 3 cm 
from the cut end of the main specimen (Cross et al., 1989). 
7. Item “TNM stage” was divided into “TNM stage: T”, “TNM stage: N” and “TNM stage: M”, 
in order to gain a better granularity for the field, and ease the evaluation. 
8. Besides the pathologic stages defined in the American Joint Committee on Cancer (AJCC) 
Cancer Staging Manual, stages defined in other staging systems were also considered to be 
populated for the item “Stage group”, such as Australian Clinico-Pathological Staging 
(ACPS) and  Dukes classification, if they were available in the reports. 
9. The AJCC Cancer Staging Manual (Edge et al., 2010) defined three R codes: R0, R1 and R2 
to represent the residual tumour status. But if they cannot be found in a report, the 
descriptions regarding them would also be considered as the possible values for item 
“Residual tumour (R)”. 
 
8.2.3 Structured template of the Lymphoma Corpus 
The structured template of the lymphoma corpus is presented in Table 8.3. From this table most 
sections of the template have their own associated section contexts, except that:  
• “SUPPLEMENTARY REPORT” was recognized as a frequently occurring supplementary 
section context if the related information about the fields in the primary section contexts were 
missing, or the reports lacked the primary section contexts. 
• Both “SPECIMEN” and “MACROSCOPIC” were mapped to the “SPECIMEN” section, as 
they were categorized to the same chapter in Tumours of Haematopoietic and Lymphoid 
Tissue Structured Reporting Protocol (Norris et al., 2010): “Specimen handling and 
macroscopic findings”; both of them contained information about how to handle the 
specimen and gross examination of the specimen.  
• “IMMUNOPHENOTYPING”, “CYTOGENETICS” and “MOLECULAR” sections have up 
to three associated section contexts, as the locations of the results and interpretations of these 
ancillary studies were unstable: sometimes they might be recorded with other microscopic 
findings in “MICROSCOPIC”; in some cases, they were recorded separately in 
“SUPPLEMENTARY REPORT” or “SPECIAL INVESTIGATIONS”; otherwise, they were 
recorded in multiple section contexts, especially for some complex cases. 
• “SUPPLEMENTARY SUMMARY” was integrated with “SUMMARY” to represent 
“SYNTHESIS”, as a supplement for the primary diagnosis summary.  
 
Most items were almost the same as those in the sample template provided in the protocol, except for 
some fields: 
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Template section Template item Section context Possible value 
Diagnostic Summary 
 
Summary “SUMMARY”, 
“SUPPLEMENTARY 
SUMMARY” 
Contents in associated section context(s) 
Comment “COMMENT” Contents in associated section context(s) 
Supporting 
Information 
 
CLINICAL 
 
Site and laterality “CLINICAL HISTORY”, 
“SUPPLEMENTARY 
REPORT” 
 
Anatomical site 
Presentation Clinical presentation of the disease 
Indication for biopsy Primary diagnosis, staging, relapse, assessment of 
transformation, the failure of another biopsy 
Clinical impression Clinical diagnosis or differential diagnosis 
Disease extent Solitary, localised, generalised 
Other sites of disease Present, absent, an entry in the uncertainty standard dictionary 
Const. symptoms Constitutional symptom 
Medical history Previous relevant disease 
Predisposing factors Previous relevant treatment, immunodeficiency–associated 
lymphoproliferative disorder, autoimmune disorder, infective 
agent 
SPECIMEN 
 
Specimen type “SPECIMEN”,  
“MACROSCOPIC”, 
“SUPPLEMENTARY 
REPORT” 
Surgical procedure, biopsy type 
Size Measurement of the specimen dimensions 
Received in Fresh, formalin, saline 
Triage Frozen section, imprints, cytology, flow cytometry, paraffin 
section, cytogenetics, molecular laboratory, microbiology 
laboratory, tissue bank, electron microscopy and macroscopic 
photography 
Description Contents in associated section context(s) 
MICROSCOPIC Pattern of infiltration “MICROSCOPIC”, 
“SUPPLEMENTARY 
REPORT” 
Diffuse, follicular, marginal zone, mantle zone, interstitial, 
perivascular, nodular, superficial, deep, angiocentric, 
lymphoepithelial lesions, proliferation centres 
Cell size Small, medium, large, mixed, indeterminate 
Cytomorphology Pleomorphic, hyperlobate, anaplastic, clear cell, giant cell, 
spindle cell, signet ring cell, blastic, indeterminate, 
centroblastic, centrocytic, immunoblastic, plasmacytic, 
lymphoplasmacytic, lymphoplasmacytoid, prolymphocytic, 
paraimmunoblastic, plasmablastic, monocytoid, centrocyte-like, 
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popcorn cell, reed-sternberg cell-like 
Tissue reactions Host cell or tissue reaction 
Grade Grade 1, 2, 3, low grade, high grade 
Description Contents in associated section context(s) 
IMMUNOPHENOTYPING 
 
Immunohistochemistry: 
Positive for 
“MICROSCOPIC”, 
“SUPPLEMENTARY 
REPORT”, “SPECIAL 
INVESTIGATIONS” 
Biomarker 
Immunohistochemistry: 
Negative for 
Biomarker 
Immunohistochemistry: 
Equivocal for 
Biomarker 
Immunohistochemistry: 
Comment 
Interpretive comment of immunohistochemistry tests 
Flow cytometry: 
Positive for 
Biomarker 
Flow cytometry: 
Negative for 
Biomarker 
Flow cytometry: 
Comment 
Interpretive comment of flow cytometry tests 
CYTOGENETICS 
 
FISH Result of FISH tests 
Cytogenetics:  Comment Interpretive comment of FISH tests 
MOLECULAR 
 
PCR: IgH Result of PCR analysis with IgH tests 
PCR: TCRgamma Result of PCR analysis with TCRgamma tests 
PCR: Comment Interpretive comment of PCR analyses 
SYNTHESIS Lineage “SUMMARY”, 
“SUPPLEMENTARY 
SUMMARY” 
B-cell, T-cell, NK-cell, NK/T-cell, histiocytic, dendritic cell, 
myeloid, Hodgkin-like 
Clonality Monoclonal, polyclonal 
Diagnosis (WHO) WHO category of lymphoma or leukaemia (includes subtype or 
grade if applicable), other relevant haematological disease 
SNOMED RT Codes SNOMED  RT Codes and terms for the diagnosis 
Stage Pathological stage grouping for the diagnosis 
Comment Texts relating to other issues noted during the pathology  
reporting in associated section context(s) 
Table 8.3 Structured template of the lymphoma corpus. The default possible value is “N/A” (not applicable). 
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Template section Template item Medical entity type Linguistic category 
Diagnostic Summary Summary 
 
  
Comment 
 
  
Supporting 
Information 
 
CLINICAL Description 
 
  
Site and laterality De:Site and Laterality  
Clinical diagnosis 
 
Sy:Diagnosis, Sy:Subtype*,  En:Associated naevus 
(type) 
Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
Specimen type De:Specimen Type  
Prev. Rx / Trauma De:Cosmetic Changes, De:Specimen Type* Li:Temporality 
Previous melanoma Sy:Diagnosis Li:Temporality 
Distant metastasis Sy:Diagnosis  
Other medical 
history 
En:Primary Lesion, En:Associated naevus (type), 
De:Cosmetic Changes, De:Size*, En:Lesion (other)* 
Li:Temporality* 
MACROSCOPIC Description 
 
  
Size of specimen De:Size  
Other lesions En:Lesion (other) Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
MICROSCOPIC 
 
Description 
 
  
Diagnosis 
 
Sy:Diagnosis Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
Tumour thickness In:Breslow Thickness (mm)  
Excision margins: 
Invasive 
 
Ma:Excision Invasive, Ma:Excision Clear  
Excision margins: 
In-situ 
 
Ma:Excision In Situ, Ma:Excision Clear  
Excision margins: Ma:Excision Deep, Ma:Excision Clear  
Chapter 8 Structured Output Generation 
223 
 
Deep 
 
Ulceration (mm 
diam) 
 
De:Ulceration  
Mitotic rate De:Dermal Mitoses  
Microsatellites En:Satellites  
Level of invasion 
(Clark) 
In:Clark Level  
Lymphovascular 
invasion 
In:Vascular/Lymphatic Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
TILs Re:TILs Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
TILs: Distribution Re:TILs Li:Mood and Comment Adjuncts 
TILs: Density Re:TILs Li:Mood and Comment Adjuncts 
Regression 
 
Sy:Regression Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality, Li:Temporality, Li:Mood and 
Comment Adjuncts 
Desmoplasia Re:Desmoplasia Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
Neurotropism In:Neurotropism Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
Assoc. benign 
naevus 
 
En:Associated naevus (type) Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
Cell growth 
 
De:Cell Growth Pattern Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
Subtype Sy:Subtype Li:Lexical Polarity Positive, Li:Lexical Polarity 
Negative, Li:Modality 
Table 8.4 Mapping strategy for the melanoma corpus.  Entity type marked with * suggests it was added after first round error analysis. 
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Template section Template item Medical entity type 
Diagnostic Summary 
 
Summary  
Comment Sy:Comment , En:Coexistent Pathology,  De:Ancillary Studies  
Supporting Information 
 
CLINICAL 
 
Site De:Tumour Site  
Other sites of disease En:Distant Spread or Metastases*, Ex:Extent* 
Medical history Sy:Medical History 
MACROSCOPIC 
 
Specimen type De:Specimen Type 
Tissue banking De:Tissue Banking 
Specimen images De:Specimen Images 
Specimen length De:Specimen Size 
Tumour site De:Tumour Site  
Peritoneal reflection De:Peritoneal Reflection 
Mesorectal integrity De:Mesorectal Integrity 
Tumour size De:Tumour Size 
Extramuscular spread Ex:Extramuscular Spread 
Tumour description De:Tumour Description 
Overlying serosa De:Serosa Description  
Perforation De:Perforation 
Margins:Proximal Ma:Proximal or Distal Margin, Ma:Clear 
Margins:Distal Ma:Proximal or Distal Margin, Ma:Clear 
Margins:Radial Ma:Circumferential Margin,  Ma:Clear 
Lymph nodes En:Lymph Nodes  
Metastases  En:Distant Spread or Metastases  
Blocks selected De:Specimen Blocks 
Comment Sy:Comment, En:Coexistent Pathology,  De:Ancillary Studies  
Chapter 8 Structured Output Generation 
225 
 
MICROSCOPIC 
 
Histological type (WHO) Sy:Histological Type 
Histological grade Sy:Histological Grade 
Depth of invasion In:Depth of Invasion 
Serosal involvement Ex:Serosal Involvement 
Small vessel invasion In:Venous and Small Vessel Invasion  
Venous invasion In:Venous and Small Vessel Invasion  
Perineural invasion In:Perineural Invasion 
TILs Re:TILS and Peritumoural Lymphocytes 
Margins:Proximal Ma:Proximal or Distal Margin, Ma:Clear 
Margins:Distal Ma:Proximal or Distal Margin,  Ma:Clear 
Margins:Radial Ma:Circumferential Margin,  Ma:Clear 
Lymph nodes En:Lymph Nodes, Ex:Lymph Node Involvement 
Number involved Ex:Lymph Node Involvement 
Distant spread En:Distant Spread or Metastases 
Response to Rx Re:Response to Rx 
Comment Sy:Comment , En:Coexistent  Pathology,  De:Ancillary Studies 
ANCILLARY STUDIES Description De:Ancillary Studies 
SYNTHESIS 
 
TNM stage:T  Met:T Value 
TNM stage:N Met:N Value 
TNM stage:M Met:M Value 
Stage group Met:Anatomic Stage 
Residual tumour (R) En:Residual Tumour 
Comment Sy:Comment , En:Coexistent Pathology,  De:Ancillary Studies  
Table 8.5 Mapping strategy for the colorectal cancer corpus.  Entity type marked with * suggests it was added after first round error analysis. 
 
Template section Template item Medical entity type Linguistic category Relation Type 
Diagnostic Summary 
 
Summary    
Comment    
Supporting CLINICAL Site and laterality De:Topography,  De:Anatomical  Spatial 
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Information 
 
 Structure, De:Laterality Specialization 
Presentation Sy:Presentation   Li:Temporality  
Indication for biopsy Sy:Indication for Biopsy, 
De:Specimen Type 
  
Clinical impression Sy:Clinical Impression,  
Sy:Diagnosis Subtype 
Li:Lexical Modality  
Disease extent Ex:Disease Extent   
Other sites of disease Ex:Other Sites of Disease Li:Lexical Polarity Negative, 
Li:Lexical Polarity Positive, 
Li:Lexical Modality 
 
Const. symptoms Sy:Constitutional Symptoms  Li:Lexical Polarity Negative, 
Li:Lexical Polarity Positive, 
Li:Lexical Modality 
 
Medical history Sy:Medical History Li:Lexical Polarity Negative, 
Li:Lexical Polarity Positive, 
Li:Lexical Modality 
 
Predisposing factors Sy:Predisposing Factors    
SPECIMEN 
 
Specimen type De:Specimen Type   
Size De:Specimen Size   
Received in De:Preservative Fluid   
Triage De:Sample Triage   
Description    
MICROSCOPIC Pattern of infiltration De:Architecture  Li:Lexical Polarity Negative, 
Li:Lexical Polarity Positive, 
Li:Lexical Modality 
 
Cell size De:Cell Size    
Cytomorphology De:Cytomorphology  Li:Lexical Polarity Negative, 
Li:Lexical Polarity Positive, 
Li:Lexical Modality 
 
Tissue reactions Re:Tissue Reaction  Li:Lexical Polarity Negative, 
Li:Lexical Polarity Positive, 
Li:Lexical Modality, Li:Mood and 
Comment Adjuncts 
 
Grade Sy:WHO Grade  Li:Lexical Polarity Negative,  
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Li:Lexical Polarity Positive, Li: 
Lexical Modality 
Description    
IMMUNOPHENOTYPING 
 
Immunohistochemistry: 
Positive for 
An:Biomarker, 
An:Immunohistochemistry-Positive 
 Result-Positive 
Immunohistochemistry: 
Negative for 
An:Biomarker, 
An:Immunohistochemistry-Negative 
 Result-
Negative 
Immunohistochemistry: 
Equivocal for 
An:Biomarker, 
An:Immunohistochemistry-Equivocal 
 Result-
Equivocal 
Immunohistochemistry: 
Comment 
An:Immunohistochemistry-Comment   
Flow cytometry: 
Positive for 
An:Biomarker, An:Flow Cytometry-
Positive 
 Result-Positive 
Flow cytometry: 
Negative for 
An:Biomarker, An:Flow Cytometry-
Negative 
 Result-
Negative 
Flow cytometry: 
Comment 
An:Flow Cytometry-Comment   
CYTOGENETICS 
 
FISH An:FISH Results   
Cytogenetics:  Comment An:Cytogenetics Comment   
MOLECULAR 
 
PCR: IgH An:IgH Test   
PCR: TCRgamma An:TCRgamma Test   
PCR: Comment An:PCR Comment   
SYNTHESIS Lineage De:Lineage, Sy:Diagnosis, 
Sy:Diagnosis Subtype 
  
Clonality De:Cell Clonality   
Diagnosis (WHO) Sy:Diagnosis, Coexistent Pathology,  
Sy:Diagnosis Subtype, Sy:WHO 
Grade 
Li:Lexical Polarity Negative, 
Li:Lexical Polarity Positive, 
Li:Lexical Modality 
 
SNOMED RT Codes Sy:SNOMED RT Codes   
Stage Sy:Stage   
Comment Sy:Comment   
Table 8.6 Mapping strategy for the lymphoma corpus. 
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1. The “Description” field in both “SPECIMEN” and “MICROSCOPIC” sections would 
populate all contents in associated section context(s) rather than part of them in case of 
omission of any relevant information. 
2. Item “Classical cytogenetics” was removed from the sample template, as only fluorescence 
in situ hybridization (FISH) tests were performed in the reports. 
3. Item “ICD O-3” was replaced with “SNOMED RT Codes”, since pathologists tended to use 
SNOMED Reference Terminology (SNOMED RT) (Spackman et al., 1997) to encode the 
diagnosis summary in the reports. 
4. Possible values for several fields were restricted to the descriptors or examples indicated in 
the standards or guidelines in the protocol if provided, such as “Cell size” and 
“Cytomorphology”. It is worth pointing out that: 
• Some descriptors or examples were excluded if they did not fit the training data. 
• Additional descriptors or examples were obtained from the training data if they 
represented a prominent proportion of the data. 
• Some fields could not be utilized with the descriptors even if they were provided in 
the protocol. For example, as the candidates to be populated for “Tissue reactions” 
had very high lexical variability, which makes the standardization of them to the 
specific descriptors quite difficult, thus there was no such restriction on the 
population of this field. 
 
8.3 Mapping Strategies 
8.3.1 Mapping Strategy for the Melanoma Corpus 
The mapping strategy for the melanoma corpus is illustrated in Table 8.4. From this table, except for 
“Summary”, “Comment”, and “Description”, the associated medical entity types and linguistic 
categories were identified for other fields. Note that since some medical entity types were mapped to 
multiple fields, during population process it holds that: 
• Section context detection is critical for utilizing the medical entity type to populate the field.  
• The lexical items of the entity can affect the population of a particular field. 
• The medical entity is subject to the co-occurring linguistic category for the population of a 
field. 
 
For example, if a Sy:Diagnosis entity is found in “MICROSCOPIC”,  it should be considered as a 
candidate to  populate “Diagnosis”;  if  it is found in “CLINICAL HISTORY” or “SPECIMEN”, and 
if it contains a lexicon about “metastasis”, it is likely to be a value for “Distant metastasis”; if  a 
Li:Temporality entity regarding  “past  history” co-occurs with it and it contains a lexicon about 
“melanoma”, it is probably a value for “Previous melanoma”; otherwise, it matches to “Clinical 
diagnosis”. 
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8.3.2 Mapping Strategy for the Colorectal Cancer Corpus 
Table 8.5 displays the mapping strategy for the colorectal cancer corpus. In this table, except for 
“Summary”, other fields have their associated medical entity types. There are some medical entity 
types mapped to multiple fields. For the reasons above, it also implies that they may need a sub-
classification process to find the suitable candidate for a particular field. For instance, sub-classifying 
In:Venous and Small Vessel Invasion  entities into “small vessel” and “venous” groups is suitable for 
the candidates for populating the associated fields “Small vessel invasion” and  “Venous invasion”. 
Some fields involve more than one medical entity type, which reveals that related information of these 
fields are distributed dispersedly, and a complete population of the field should take into account more 
than one associated medical entity type if applicable. For example, to populate “Lymph nodes” in 
“MICROSCOPIC”, both En:Lymph Nodes and Ex:Lymph Node Involvement entities  in 
“MICROSCOPIC” should be considered to be used to compute the number of  lymph nodes identified 
in the microscopic examination, as pathologists sometimes  would not record the number of  identified 
lymph node separately, but record it implicitly as or wrapped with the number of malignantly 
involved ones. 
 
8.2.3 Mapping Strategy for the Lymphoma Corpus 
Table 8.6 presents the mapping strategy for the lymphoma corpus. Not only medical entity types and 
linguistic categories account for the population of most fields, but also relation types correspond to the 
population of some fields, such as Result-Positive for “Immunohistochemistry: Positive for” and  
Result-Negative for “Immunohistochemistry: Negative for”. Most medical entity types are correlated 
to one particular field. There are also exceptions indicating multiple or repetitive roles they play in the 
fields. For instance, biomarkers are requisites for performing immunohistochemistry tests and flow 
cytometry, thus An:Biomarker is one of major medical entity types for the population of the result 
fields in “IMMUNOPHENOTYPING” section. The annotation schema required the annotation of 
Sy:Diagnosis should consider as long a span as possible to denote a WHO category of the disease, 
therefore lineage is often subsumed in the span of a Sy:Diagnosis entity.  The Sy:Diagnosis entities 
can be directly populated to “Diagnosis (WHO)”, while the lineages inside them need to be stripped 
from them to populate “Lineage”. The reason for fields involving more than one medical entity type is 
similar to the one above, with a goal to attain complete populations of the fields by considering as 
many medical entity types as possible. 
 
8.4 Rule-based System for Structured Output Generation 
As can be seen from the above sections, the population of most fields requires extraction of very large 
segments of text in the reports, e.g., all the contents in “DIAGNOSIS” are needed to populate the 
“Summary” in the structured template of the melanoma corpus; or inferences from the associated 
Chapter 8 Structured Output Generation 
230 
 
medical entities, e.g., “40mm” is the maximum measured dimension for the De:Tumour Size entity 
“40x30mm”.  A statistical method will not be able to infer them reliably or construct them properly, 
thus rule-based approaches were used to generate the structured outputs.  
 
Consequently, a rule-based system was established for structured output generation (SOG), including 
four main processes: document classification, specimen context detection, candidate preparation and 
extensible mark-up language (XML) generation.  
 
8.4.1 Document Classification 
A Document Classifier had inserted into a heuristic rule to classify the documents to multiple 
specimen/tumour documents (documents containing more than one specimen or tumour) or single 
specimen/tumour documents (documents containing only one specimen or tumour), based on the 
entity or subheading recognition results on En:Specimen Identifier from the melanoma corpus and the 
lymphoma corpus,  St:Subheading from the colorectal cancer corpus. 
 
The heuristic rule is to detect whether the identifier (id) has a lexicon that can be converted to a 
numeric value larger than 1, e.g., “2”, “iii”, “d”, etc; if it has, the document is classified to a multiple 
specimen/tumour document; else, it is a single specimen/tumour document. 
 
8.4.2 Specimen Context Detection 
A context detection engine was built to detect the section context information for each specimen for 
multiple specimen/tumour documents. Basically, it separates the sections by the positions of the 
specimen ids, e.g., the text span between the positions of specimen id 1 and specimen id 2 in 
“MICROSCOPIC” results in “MICROSCOPIC” for specimen id 1. There are also several rules to 
handle special cases. Here are some examples: 
• If specimen id 1 is missing, but specimen id 2 is found in a section, the text span between the 
section start and the position of specimen id 2 can yield an output as the associated section 
context for specimen id 1. 
• If both specimen id 1 and specimen id 2 are found in “MICROSCOPIC”, but none of them 
can be detected in “MACROSCOPIC”, it will yield a collective “MACROSCOPIC” for 
specimen id 1 and specimen id 2 as a result for the text span in “MACROSCOPIC”. 
 
8.4.3 Candidate Preparation 
The candidate preparation process was to find appropriate candidates for the population to the 
templates, implemented with a series of post-processing modules and ranking criteria.  Concise 
descriptions about these post-processing modules and ranking criteria are presented in Tables 8.7 and 
8.8 respectively. 
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Post-processing 
module 
Entity type  Brief description 
General process 
module 
Most medical entity types listed in Tables 8.4, 8.5 and 8.6. This module includes several general pre-processes that can be applied to most 
fields before ranking and some post-processes to handle candidates after 
ranking.  
 
Measurement 
module 
 
De:Ulceration (mm), In:Breslow Thickness (mm), Ma:Excision 
Deep, Ma:Excision In Situ, Ma:Excision Invasive, Ma:Excision 
Clear; 
In:Depth of Invasion, Ex:Extramuscular Spread, Ma:Circumferential 
Margin, Ma:Proximal or Distal Margin 
This module extracts one-dimension size from candidates. 
Naevus module En:Associated Naevus (type) This module extracts the type of naevus from candidates. 
Level module In: Clark level This module extracts Roman numeral(s) from candidates. Arabic numeral (s) 
is converted to Roman numeral(s) if applicable. 
Temporality 
module 
Li:Temporality This module extracts Li:Temporality entities within a context window. 
Regress module Sy:Regression This module extracts stage or characteristic of regression from candidates. 
Rate module De:Dermal Mitoses This module extracts mitotic rate from candidates. 
Dimension 
processor 
De:Size; 
De:Tumour Size; 
De:Specimen Size 
This module extracts the size or maximum dimension of a specimen or 
tumour. It converts measurements in “cm” to “mm” if applicable. 
 
Node number 
module 
En:Lymph Nodes This module extracts numeric value(s) from candidates. 
Involvement 
number module 
Ex:Lymph Node Involvement This module extracts numeric value(s) from candidates. If no number is found, 
but negation is detected, then assigns the output to be “0”. 
Sub-classification 
module 
Ma:Excision Clear; 
Ma:Proximal or Distal Margin, Ma:Clear, In:Venous and Small 
Vessel Invasion, En:Distant Spread or Metastases, Re:TILS and 
Peritumoural Lymphocytes 
This module classifies the candidate to a specific sub-type. 
Tils module Re:TILS, Li:Mood and Comment Adjuncts;  
Re:TILS and Peritumoural Lymphocytes 
This module extracts any lexical items in the distribution gazetteer, density 
gazetteer and degree gazetteer from the input. 
Mood degree 
module 
Li:Mood and Comment Adjuncts   The module returns the Li:Mood and Comment Adjuncts entities around the 
candidate and their associated scores, which can be used by the mood degree 
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criterion or contribute to the population of the associated field. 
Subheading module Multiple entity types listed in Table 8.5 This module verifies whether the candidate is a synoptic field with an 
associated subheading. 
Tumour border 
status module 
Ex:Extramuscular Spread This module extracts the status of tumour border/ margin from candidates. 
Tumour description 
module 
De:Tumour Description The module verifies whether the candidate matches a certain pattern and 
extracts the non-prepositional phrase from the candidate. 
Clear processor Ma:Excision Deep, Ma:Excision In Situ, Ma:Excision Invasive; 
Ma:Circumferential Margin, Ma:Proximal or Distal Margin 
This module detects whether lexical items “clear” or “clearance” is in the 
candidate. 
 
Tumour site 
processor 
De:Tumour Site This module extracts the anatomical site and laterality from the candidate. 
Specimen length 
processor 
De:Specimen Size The module verifies whether the candidate matches a certain pattern. 
Descriptor 
convertor 
Sy:Indication for Biopsy, De:Specimen Type, De:Architecture, 
De:Cell Size, De:Cytomorphology, De:Lineage 
The module standardizes the lexical variants in the candidates of associated 
entity types to the descriptors defined as the possible values for some fields if 
applicable. 
Id validation 
module 
De:Sample Triage, all entity types in Ancillary category The module determines the specimen id(s) for the population of fields under 
some section contexts. 
Special candidate 
selection module 
Sy:Diagnosis, Sy:Subtype,  En:Associated naevus (type), 
De:Cosmetic Changes, De:Specimen Type, En:Primary Lesion, 
De:Size, En:Lesion (other), De:Cell Growth Pattern 
The module tackles special cases where the best candidate(s) cannot be 
determined by ranking. 
Table 8.7 Entity types involved and brief descriptions of post-processing modules.   
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Criterion Entity type  Condition considered Possible 
score 
Other module required 
Span length criterion De:Site and Laterality, De:Specimen Type, De:Ulceration (mm), 
In:Vascular/Lymphatic, En:Associated naevus (type) 
Length of text span 0, 1  
Uppercase criterion De:Site and Laterality, De:Ulceration (mm), 
In:Vascular/Lymphatic; 
De:Tumour Site,  
Uppercase -1, 0, 1  
Negation uncertainty 
inapplicability criterion 
Multiple medical entity types listed in Tables 8.4, 8.5 and 8.6. Assertion -1, 0, 0.3, 
0.5, 0.8, 1, 2 
Negation and 
uncertainty detection 
modules 
Measurement criterion De:Ulceration (mm), In:Breslow Thickness (mm), Ma:Excision 
Deep, Ma:Excision In Situ, Ma:Excision Invasive, Ma:Excision 
Clear; 
In:Depth of Invasion, Ex:Extramuscular Spread, 
Ma:Circumferential Margin, Ma:Proximal or Distal Margin 
Numeric value 0, 0.5, 0.8, 1 Measurement module 
Clear criterion Ma:Excision Deep, Ma:Excision In Situ, Ma:Excision Invasive Sentence distance to Ma:Excision 
Clear entity 
0, 1  
Frequency criterion De:Site and Laterality, Sy:Diagnosis, En:Associated naevus 
(type); 
De:Specimen Type 
Frequencies of overlapping tokens Variable 
scores 
 
Primary criterion Ma:Excision Deep, Ma:Excision In Situ, Ma:Excision Invasive Information about the primary lesion 0, 1  
Temporality criterion De:Specimen Type, Sy:Regression; 
De:Topography, De:Anatomical Structure, De:Laterality 
Temporality or lexicons regarding it -1, 0, 1 Temporality module 
Body structure criterion De:Site and Laterality Medical category in SNOMED CT 0, 1  
Laterality criterion De:Site and Laterality; 
De:Topography 
Lexical entries in the laterality 
gazetteer 
0, 1  
Melanoma criterion Sy:Diagnosis Lexical entries in the melanoma 
gazetteer 
0, 1, 2  
Naevus type criterion En:Associated naevus (type) Naevus type 0, 1 Naevus module 
Level criterion In: Clark level Roman numeral(s) 0, 1 Level module 
Regress criterion Sy:Regression Adjective, Lexical entries in the 
regress gazetteer 
0, 1 Regress module 
Dimension criterion De:Size 
 
Dimension of the size 0, 1  
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Position criterion De:Size; 
De:Specimen Size 
Position 0, 1  
Specimen distance 
criterion 
De:Size; 
De:Specimen Size 
Sentence distance to De:Specimen 
type entity or the lexicon “specimen” 
0, 1  
Margin criterion Ma:Excision Clear Sentence distance to Ma:Excision In 
Situ, Ma:Excision Invasive, or 
Ma:Excision Deep entity 
0, 1  
Distribution density 
degree criterion 
Re:TILS; 
Re:TILS and Peritumoural Lymphocytes 
Lexical entries in the distribution 
gazetteer, density gazetteer and 
degree gazetteer 
Variable 
scores 
Tils module 
Rate criterion De:Dermal Mitoses Mitotic rate 0, 1 Rate module 
Acronym criterion Sy:Diagnosis, Sy:Subtype, Re:TILS Acronym -1, 0  
Margin type criterion Ma:Excision Clear Margin type 0, 1 Sub-classification 
module 
Invasive criterion Ma:Excision Invasive Information about an invasive lesion 0, 1  
Mood degree criterion En:Associated naevus (type);  
De:Architecture 
Li:Mood and Comment Adjuncts 
entity  
0, 0.5, 1, 
1.5, 2, 2.5, 3 
Mood degree module 
Diagnosis criterion Sy:Subtype Token and sentence distance to 
Sy:Diagnosis entity 
0, 1, 2  
Breslow criterion In:Breslow Thickness (mm) The lexicon “Breslow”  0, 1  
Specific criterion De:Specimen Type Specific biopsy type 0, 1  
Type criterion Sy:Subtype Lexical items “type” or “pattern” 0, 1  
Summary criterion Multiple entity types listed in Table 8.5 Associated subheading 0, 1 Subheading module 
Tumour site criterion De:Tumour Site, De:Specimen Type 
 
Lexical entries in the tumour site 
gazetteer 
Variable 
scores 
 
Sub-classification 
criterion 
Ma:Excision Clear; 
Ma:Proximal or Distal Margin, Ma:Clear, In:Venous and Small 
Vessel Invasion, En:Distant Spread or Metastases, Re:TILS and 
Peritumoural Lymphocytes 
Specific sub-type 0, 1, 2 Sub-classification 
module 
Maximum 
measurement criterion 
De:Specimen Size, De:Tumour Size Maximum value 0, 1 Dimension processor 
Medical category 
criterion 
De:Specimen Type Medical category in SNOMED CT 0, 1  
Specimen length De:Specimen Size Measured length 0, 1, 2 Dimension processor 
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criterion 
Size criterion De:Tumour Size Measured volume or area 0, 1, 2 Dimension processor 
Tumour description 
criterion 
De:Tumour Description Certain patterns 0, 1, 2 Tumour description 
module 
Location criterion De:Peritoneal Reflection Relationship of the tumour to the 
anterior peritoneal reflection 
0, 1  
Involvement number 
criterion 
Ex:Lymph Node Involvement Numeric value, total count 0, 1, 2 Involvement number 
module 
Node number criterion En:Lymph Nodes Numeric value, total count 0, 1, 2 Node number module 
T stage criterion In:Depth of Invasion Lexical entries in the T stage 
gazetteer 
0, 1  
R status criterion En:Residual Tumour Lexical entries in the R status 
gazetteer 
0, 1  
Tumour distance 
criterion 
De:Tumour Size Sentence distance to lexical items 
“tumour” or “it” 
0, 1  
Procedure criterion De:Specimen Type Specific surgical procedure 0, 1  
Integrity criterion De:Mesorectal Integrity Intactness of the mesorectum 0, 1  
Tumour boarder status 
criterion 
Ex:Extramuscular Spread Lexical entries in the tumour boarder 
status gazetteer 
0, 1 Tumour border status 
module 
Depth criterion In:Depth of Invasion The lexicon “depth” 0, 1  
Regression grade 
criterion 
Re:Response to Rx Regression grade 0, 1  
Maximum dimension 
criterion 
De:Tumour Size Maximum measured dimension 0, 1  
Specimen id criterion De:Specimen Size, De:Tumour Site Specimen id’s (or ids’) context, 
De:Tumour Size or De:Tumour 
Description entity 
0, 1  
Abbreviation criterion De:Specimen Type Abbreviation 0, 1  
Revision criterion Met:Anatomic Stage, Met:M Value, Met:N Value, Met:T Value Revised classification of the stage 0, 1  
Noun phrase criterion De:Topography, De:Anatomical Structure Noun 0, 1  
Grade criterion Sy:WHO Grade Expression of the grade -1, 0, 1  
Total criterion De:Specimen Size Total size 0, 1  
Cell size criterion De:Architecture Sentence distance to De:Cell Size 
entity 
0, 1  
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Architecture criterion De:Architecture Lexical entries in the architecture 
gazetteer 
0, 1  
Pattern criterion De:Architecture Lexical entries in the pattern gazetteer 0, 1  
Pos criterion Re:Tissue Reaction 
 
Part-of-speech tag -1, 0, 1  
Classification criterion Sy:WHO Grade Grade from classification systems -1, 0, 1  
Tissue reaction 
criterion 
De:Cell Size Token and sentence distance to 
Re:Tissue Reaction entity 
0, 1  
Malignancy criterion Sy:Medical History Specific malignant disease -1, 0  
Addition criterion De:Specimen Size Additional size 0, 1  
Table 8.8 Brief descriptions of ranking criteria. These include associated entity types, specific conditions to be considered, possible score to be returned and other modules as 
prerequisite. 
 
Criterion/Module Gazetteer Lexical entry 
Temporality module Regression 
temporality gazetteer* 
late, early, past, current, prior 
Regress module Regress gazetteer* partly, completely, partial, complete, patchy, minor patchy 
Tumour site processor Tumour gazetteer* carcinoma, cancer, mass, adenocarcinoma, lesion, neoplasm, carcinomas, polyp, tumour, tumour, tumours 
Special candidate 
selection module 
Trauma/treatment 
gazetteer* 
trauma, surgical, incision, excision, biopsy, injured,   treatment, graft,  therapy 
Laterality criterion Laterality gazetteer* l, r, (l), (r), left, right, mid, central, lt, rt, (lt), (rt),  anterior, bilateral, middle, l., r., central, posterior, medial, upper, lower 
Melanoma criterion Melanoma gazetteer melanoma, malignant, malignancy, tumour 
TILs module Distribution 
gazetteer* 
band, band-like, extensive, diffuse, peripheral,  scattered, focal, patchy, variably distributed, band like, focally                            
TILs module Density gazetteer sparse, dense, heavy, light, heavily, quite dense, moderately dense, low density 
TILs module Degree gazetteer brisk, prominent, moderate, minimal, marked, mild to moderate, limited, little, mild, moderate to marked, modest, 
numerous, occasional, scanty, scant, inconspicuous, minor, significant, infrequent, small numbers, abundant, smaller 
numbers, conspicuous 
Tumour site criterion Tumour site 
gazetteer* 
Preferable terms: colon, sigmoid, rectum, rectal, rectosigmoid, flexure, bowel, caecum, caecal, cecum, ascending, 
descending, lower, upper,  transverse, low, left, right, splenic, hepatic, verge, mid, ileocaecal, recto-sigmoid, appendix 
Unfavourable terms: colonic, colorectal, wall, dentate, border, part, specimen, mucosa 
Additional unfavourable terms: margin, donut, donuts, small, liver, nodule, end, node, fallopian, tube, ring, stump 
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Tumour description 
module 
 
General tumour 
gazetteer 
tumour, mass, lesion, carcinoma, tumour 
Tumour boarder 
status module 
Tumour boarder 
status gazetteer 
infiltrative, circumscribed,  infiltrating, pushing, expanding, expansile, serpiginous 
Specimen site 
criterion 
Specimen site 
gazetteer* 
Preferable Terms: colon, rectum, sigmoid, caecum, colorectal, colorectum, recto-sigmoid, rectosigmoid, ascending, 
descending, lower, upper, transverse, low, left, right, mid, large bowel 
Unfavourable terms: terminal, mesentery, accompanying, attached, appendix, fat, ileum, mesenteric, omentum, small, 
doughnut, pericolic, perirectal, anus, mesosigmoid, tissue, spleen, lymph, gallbladder, omental, pericolonic, skin, cervix, 
anal, annulus, vaginal, mesorectum, apron, stump, meso-colon, peri-colorectal, mesocolon, ileo-colic,ileocolic, meso-
appendix, mesoappendix, mesocolic, peri-colic, bladder, both, donut, donuts, ring, rings, each, duct, tube, fragment, nodule, 
short, material, valve, ovary, liver,  meso-rectum, end, one, other, smaller, separate, shorter, single, stalk, stoma, stomach, 
stomal, two, unremarkable, uterus, wedge, separate, structure, part 
Architecture criterion Architecture 
gazetteer* 
diffuse, nodular, follicular,  perivascular, angiocentric, deep, follicles, nodules 
Pattern criterion Pattern gazetteer* Preferable terms: infiltrate, pattern, areas, proliferation, structures, infiltration, process, patterns, fashion, patterns, 
collections, sheets, formations, architecture 
Unfavourable terms: effacement, effaced, effaces, altered, normal, loss, effacing 
T stage criterion T stage gazetteer T0, T1, T2, T3, T4, TX, Tis 
R status criterion R status gazetteer R0, R1, R2, RO, RX 
Mood degree module Specific mood 
gazetteer* 
some, occasional, several, numerous, rare, few, numbers, number, amounts, amount 
Table 8.9 Lexical entries of each gazetteer. Gazetteer marked with * means it was modified after the first round error analysis. 
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Table 8.9 presents the lexical entries of each gazetteer adopted by some post-processing modules and 
ranking criteria. The details of each post-processing module and ranking criterion can be referred to 
Appendix I. The application of the post-processing modules and ranking criteria for the structured 
fields in each corpus is displayed in Appendix II. Note that general process module is applied to most 
structured fields except for “Summary”, “Description” or “Comment” fields. 
 
8.4.4 XML Generation 
The XML generator generates the outputs in XML format with the candidates extracted from the 
above processes, as XML is one of the accepted standards for representing and distributing structured 
reports within a clinical environment.  To increase semantic interoperability so as to ensure the 
representation of clinical information to be rich, detailed, and unambiguous, Health Level 7 Clinical 
Document Architecture (HL7 CDA) (Dolin et al., 2001) will be adopted in future work.   
 
Generally, for most fields with associated medical entity types, if a field involves a post-processing 
module(s), the value to be populated is the result(s) from the module(s) (Result A); if it involves the 
negation uncertainty inapplicability criterion, the value to be populated is the result from the negation 
and uncertainty detection modules (Result B) or integrated with the texts of  the candidate(s)  after 
general processing; if both post-processing module(s) and the criterion are involved, the value to be 
populated is the combination of Result A and  Result B; if none of them are involved,  the value to be 
populated is the texts of  the candidate(s)  after the general processing. For those fields with associated 
relation types, the results from the relation extraction system should also be considered during 
population. For example, if an An:Biomarker entity has a Result-Positive relation with an 
An:Immunohistochemistry-Positive entity, the An:Biomarker entity is populated to the field 
“Immunohistochemistry: Positive for”. More details for the population process are presented in Table 
8.1, 8.2 and 8.3. 
 
There are some additional processes to ensure or enhance the quality of the population process as 
well: 
 
Template Construction 
For a single specimen document, the template for each corpus is shown in Section 8.2.  However, for 
a multiple specimen document, the template may need to be modified to facilitate the populating. 
There are three strategies to construct such a template: 
1. The template should be separated by each specimen id, and each subset under an id is a copy 
of the fields in the template of a single specimen document. 
2. No change is made to the template; the value is populated to the associated field as that in the 
template of a single specimen document without specification of specimen ids. 
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3. The template is flexible according to the combination of specimen ids detected under the 
associated section contexts. If the specimen ids are separate under a section, the section of 
the template can be reported by specimen id; otherwise, the section of the template can be 
reported by a set of specimen ids. 
 
To find out which strategy is most suitable for the study, each of them was applied to the melanoma, 
colorectal cancer and lymphoma corpora respectively: Strategy 1 for the melanoma corpus, Strategy 2 
for the colorectal cancer corpus and Strategy 3 for the lymphoma corpus. 
 
Subtype Standardization 
To follow the standard reporting convention for “Subtype”, lexical items “type”, “pattern”, 
“component” (and “in” if present) are stripped from the candidates. 
 
Severity Maximization 
The severity of the tumour invasion can be revealed by the values in “Tumour thickness” and “Level 
of invasion (Clark)”. Thus, the severity maximization module aims to find the greatest numeric value 
from the In:Breslow Thickness (mm) candidates and Roman numerals from  the In:Clark Level 
candidates to be populated to the two associated fields. 
 
Node Number Accumulation   
As the fields “Lymph nodes” and “Number involved” require populating the total count of the lymph 
nodes identified or involved, thus a special module is needed to merge the count of each candidate if 
there are multiple best candidates after ranking.   
Take merging the count of the candidates for “Number involved” as an example. Check the candidates 
against these predicates: 
 a. Whether they have any numeric value as a measurement; 
 b. Whether they have a ratio denoted with slash “/”; 
 c. Which one has a smaller count from the Involvement Number module;  
 d. Whether comma “,” or bracket “(” between them or lexical item “these” is inside one of 
them.  
Rule out the candidate matches Predicate a, Predicates c and d, and include the one matches Predicate 
b. Finally, sum the count from the remaining best candidate(s). 
 
The count merging process for “Lymph nodes” in the “MACROSCOPIC” section is quite simple, 
which is to sum the count of each candidate, except where the count of the candidate is fuzzy (e.g., a 
number starts with “<” or “>”), which will be populated directly to the structured report field. 
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The count merging process for “Lymph nodes” in the “MICROSCOPIC” section is more complicated, 
as it involves two entity types. For Ex:Lymph Node Involvement candidates, the process is similar to 
that described above, with slight differences: the involvement number module is replaced with the 
node number module in Predicate c; lexical item “addition” is added to Predicate d. The sum from the 
count of these candidates is called the extra count, while the sum from the count of En:Lymph Nodes 
candidates called the original count. The final count is the original count or the sum of both counts, 
determined by the following conditions: 
• If the original count is smaller than the extra count, the final count is the sum of both counts. 
• If the original count is larger or equal to the extra count, the final count is the original count. 
• If the original count is larger than the extra count; the extra count is larger than zero; there is 
only one En:Lymph Nodes candidate and lexical items “additional” or “'further” is inside the 
candidate,  the final count is the sum of both counts. 
• If the two counts are in different specimen ids’ contexts, the final count is also the sum of 
both counts. 
 
Convention Configuration 
After the first round error analysis, an apparent issue arose that the population of some fields did not 
follow the standard conventions, especially the fields involving multiple entity types, which caused a 
considerable number of errors. A convention configuration module was developed to resolve this 
issue. For example, for “Diagnosis (WHO)” in the lymphoma corpus, the reporting convention is 
defined as 
• The combination of the candidates in each associated section context should be in the 
following order: Sy:Diagnosis, Sy:Diagnosis Subtype, Sy:WHO Grade, and En:Coexistent 
Pathology. 
• The result in “SUMMARY” is called primary diagnosis, and the one in 
“SUPPLEMENTARY SUMMARY” is called supplementary diagnosis.  Like the 
overlapping candidate reduction process, the repetitive or less informative diagnosis should 
be removed. If both diagnoses are present, a prefix “Primary:” is added to primary diagnosis, 
while “Supplementary:” is added to supplementary diagnosis.  
 
Given some sample input, output examples of the final values for the population of some structured 
fields are presented in Appendix III. Note that the effects of the id validation module and template 
construction are not reported in these tables, as they involve the detection of global contexts in a 
document. 
 
8.5 Results 
The performance of the system was measured by the standard Precision, Recall and F-score metrics. 
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Firstly, an initial evaluation was performed on the structured outputs to find out the competence of the 
rules. Then another evaluation was carried out to reflect the improvement by the refinement of the 
rules. Tables 8.10, 8.11 and 8.12 show the results from the Structured Output Generation (SOG) 
system of first and second round evaluations on the training sets in each corpus. 
 
Field Number First round evaluation Second round evaluation Precision Recall F-score Precision Recall F-score 
Assoc. benign 
naevus 437 79.03% 83.76% 81.33% 100.00% 98.32% 99.15% 
Cell growth 437 52.63% 53.40% 53.01% 96.64% 97.05% 96.84% 
Clinical diagnosis 437 73.94% 72.19% 73.05% 97.73% 96.63% 97.18% 
Desmoplasia 437 76.47% 86.67% 81.25% 93.33% 93.33% 93.33% 
Diagnosis 437 95.01% 92.03% 93.50% 99.28% 99.04% 99.16% 
Distant metastasis 437 68.42% 68.42% 68.42% 94.74% 94.74% 94.74% 
Excision margins: 
Deep 437 99.15% 84.06% 90.98% 100.00% 98.56% 99.28% 
Excision margins: 
In-situ 437 85.19% 85.19% 85.19% 98.31% 100.00% 99.15% 
Excision margins: 
Invasive 437 94.78% 90.08% 92.37% 96.39% 97.17% 96.77% 
Level of invasion 
(Clark) 437 99.09% 98.20% 98.65% 100.00% 99.70% 99.85% 
Lymphovascular 
invasion 437 97.29% 97.29% 97.29% 99.55% 99.55% 99.55% 
Microsatellites 437 95.83% 95.83% 95.83% 100.00% 100.00% 100.00% 
Mitotic rate 437 98.88% 98.32% 98.60% 100.00% 100.00% 100.00% 
Neurotropism 437 97.92% 97.92% 97.92% 100.00% 100.00% 100.00% 
Other lesions 437 91.18% 93.94% 92.54% 100.00% 100.00% 100.00% 
Other medical 
history 437 74.39% 69.71% 71.98% 90.96% 96.07% 93.44% 
Prev. Rx/Trauma 437 66.67% 10.00% 17.39% 84.21% 88.89% 86.49% 
Previous 
melanoma 437 85.71% 100.00% 92.31% 100.00% 100.00% 100.00% 
Regression 437 89.63% 81.21% 85.21% 96.69% 97.33% 97.01% 
Site and laterality 437 96.66% 94.00% 95.31% 98.74% 98.49% 98.62% 
Size of specimen 437 94.87% 93.95% 94.40% 99.03% 98.31% 98.67% 
Specimen type 437 95.44% 95.22% 95.33% 98.09% 97.62% 97.86% 
Subtype 437 65.08% 82.00% 72.57% 96.98% 97.35% 97.16% 
TILs 437 97.47% 99.48% 98.47% 99.48% 99.48% 99.48% 
TILs: Density 437 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
TILs: Distribution 437 96.43% 84.38% 90.00% 96.77% 96.77% 96.77% 
Tumour thickness 437 99.71% 97.73% 98.71% 99.72% 99.72% 99.72% 
Ulceration(mm 
diam) 437 95.30% 96.54% 95.91% 99.13% 99.13% 99.13% 
Overall 12236 90.73% 89.77% 90.25% 98.36% 98.42% 98.39% 
Table 8.10 Scores from structured output generation system of first and second round evaluations on 
the melanoma training set. 
 
Field Number First round evaluation Second round evaluation 
Precision Recall F-score Precision Recall F-score 
Ancillary Studies 397 98.28% 96.61% 97.44% 100.00% 98.31% 99.15% 
Blocks selected 397 97.18% 98.70% 97.93% 100.00% 99.74% 99.87% 
Comment 
(DIAGNOSTIC) 
397 96.07% 97.16% 96.61% 99.44% 100.00% 99.72% 
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Comment 
(MACROSCOPIC) 
397 99.17% 99.17% 99.17% 100.00% 99.45% 99.72% 
Comment 
(MICROSCOPIC) 
397 99.31% 98.30% 98.80% 100.00% 99.32% 99.66% 
Comment 
(SYNTHESIS) 
397 100.00% 99.23% 99.61% 100.00% 100.00% 100.00% 
Depth of invasion 397 98.10% 96.56% 97.32% 99.06% 97.84% 98.45% 
Distant spread 397 93.06% 93.06% 93.06% 97.22% 100.00% 98.59% 
Extramuscular 
spread 
397 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
Histological grade 397 99.61% 100.00% 99.81% 100.00% 100.00% 100.00% 
Histological type 
(WHO) 
397 99.67% 100.00% 99.83% 99.67% 100.00% 99.83% 
Lymph nodes 
(MACROSCOPIC) 
397 80.30% 89.08% 84.46% 99.16% 99.16% 99.16% 
Lymph nodes 
(MICROSCOPIC) 
397 97.87% 97.87% 97.87% 99.39% 99.39% 99.39% 
Margins: Distal 
(MACROSCOPIC) 
397 99.71% 97.99% 98.84% 99.71% 99.14% 99.42% 
Margins: Distal 
(MICROSCOPIC) 
397 100.00% 98.52% 99.25% 99.63% 100.00% 99.81% 
Margins: Proximal 
(MACROSCOPIC) 
397 99.07% 95.96% 97.49% 99.10% 98.65% 98.88% 
Margins: Proximal 
(MICROSCOPIC) 
397 99.62% 99.25% 99.44% 99.63% 100.00% 99.81% 
Margins: Radial 
(MACROSCOPIC) 
397 100.00% 91.67% 95.65% 100.00% 100.00% 100.00% 
Margins: Radial 
(MICROSCOPIC) 
397 100.00% 90.50% 95.01% 99.50% 99.50% 99.50% 
Medical history 397 87.36% 88.37% 87.86% 100.00% 100.00% 100.00% 
Mesorectal 
integrity 
397 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
Metastases 397 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
Number involved 397 99.70% 99.70% 99.70% 99.70% 99.70% 99.70% 
Other sites of 
disease 
397 0.00% 0.00% 0.00% 93.02% 100.00% 96.39% 
Overlying serosa 397 94.81% 99.22% 96.97% 99.26% 99.26% 99.26% 
Perforation 397 100.00% 97.44% 98.70% 100.00% 97.44% 98.70% 
Perineural invasion 397 99.43% 99.43% 99.43% 100.00% 100.00% 100.00% 
Peritoneal 
reflection 
397 96.97% 96.97% 96.97% 100.00% 100.00% 100.00% 
Residual tumour 
(R) 
397 100.00% 98.41% 99.20% 100.00% 98.41% 99.20% 
Response to Rx 397 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
Serosal 
Involvement 
397 99.18% 100.00% 99.59% 99.18% 100.00% 99.59% 
Site 397 82.31% 83.16% 82.74% 100.00% 100.00% 100.00% 
Small vessel 
invasion 
397 98.63% 99.31% 98.97% 99.32% 100.00% 99.66% 
Specimen images 397 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
Specimen length 397 57.61% 95.78% 71.95% 93.39% 95.36% 94.36% 
Specimen type 397 84.66% 96.68% 90.27% 97.81% 97.01% 97.41% 
Stage Group 397 99.53% 99.53% 99.53% 100.00% 100.00% 100.00% 
TILs 397 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
TNM stage: M 397 99.11% 99.11% 99.11% 100.00% 99.56% 99.78% 
TNM stage: N 397 98.83% 99.41% 99.12% 99.42% 100.00% 99.71% 
TNM stage: T 397 98.26% 99.12% 98.69% 98.84% 100.00% 99.42% 
Tissue banking 397 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
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Tumour 
description 
397 98.12% 98.38% 98.25% 98.40% 99.46% 98.93% 
Tumour site 397 90.68% 94.27% 92.44% 97.84% 97.00% 97.41% 
Tumour size 397 98.95% 98.69% 98.82% 99.21% 99.21% 99.21% 
Venous invasion 397 96.48% 97.51% 96.99% 98.58% 98.93% 98.76% 
Overall 18262 94.88% 96.96% 95.91% 99.21% 99.28% 99.24% 
Table 8.11 Scores from structured output generation system of first and second round evaluations on 
the colorectal cancer training set. 
 
Field Numbe
r 
First round evaluation Second round  evaluation 
Precisio
n 
Recall F-score Precisio
n 
Recall F-score 
Cell size 321 93.15% 95.33% 94.23% 94.59% 96.77% 95.67% 
Clinical impression 246 98.45% 92.03% 95.13% 100.00
% 
98.55% 99.27% 
Comment 298 100.00
% 
100.00
% 
100.00
% 
100.00
% 
100.00
% 
100.00
% 
Const symptoms 246 21.88% 77.78% 34.15% 100.00
% 
100.00
% 
100.00
% 
Cytogenetics 
comment 
294 37.50% 37.50% 37.50% 50.00% 80.00% 61.54% 
Cytomorphology 321 90.68% 91.45% 91.06% 92.86% 99.15% 95.90% 
Diagnosis (WHO) 298 97.57% 96.23% 96.90% 99.32% 99.66% 99.49% 
Disease extent 246 100.00
% 
100.00
% 
100.00
% 
100.00
% 
100.00
% 
100.00
% 
FISH 294 60.00% 66.67% 63.16% 66.67% 85.71% 75.00% 
Flow cytometry: 
Comment 
321 95.31% 98.39% 96.83% 95.24% 96.77% 96.00% 
Flow cytometry: 
Negative for 
321 0.00% 0.00% 0.00% 40.00% 66.67% 50.00% 
Flow cytometry: 
Positive for 
321 0.00% 0.00% 0.00% 40.00% 66.67% 50.00% 
Grade 321 85.51% 95.16% 90.08% 91.30% 98.44% 94.74% 
IgH 232 80.00% 66.67% 72.73% 100.00
% 
100.00
% 
100.00
% 
Immunohistochemistr
y: Comment 
321 91.94% 93.44% 92.68% 97.60% 98.39% 97.99% 
Immunohistochemistr
y: Equivocal for 
321 86.21% 96.15% 90.91% 89.29% 96.15% 92.59% 
Immunohistochemistr
y: Negative for 
321 97.78% 92.63% 95.14% 98.43% 99.47% 98.95% 
Immunohistochemistr
y: Positive for 
321 93.63% 89.25% 91.39% 97.30% 99.08% 98.18% 
Indication for biopsy 246 100.00
% 
84.00% 91.30% 100.00
% 
100.00
% 
100.00
% 
Lineage 298 99.36% 98.11% 98.73% 99.38% 100.00
% 
99.69% 
Medical history 246 97.10% 97.10% 97.10% 98.59% 100.00
% 
99.29% 
Other sites of disease 246 81.82% 81.82% 81.82% 100.00
% 
100.00
% 
100.00
% 
PCR comment 232 80.00% 66.67% 72.73% 100.00
% 
100.00
% 
100.00
% 
Pattern of infiltration 321 88.41% 81.46% 84.80% 93.22% 93.75% 93.48% 
Predisposing factors 246 86.21% 100.00
% 
92.59% 96.43% 100.00
% 
98.18% 
Presentation 246 90.20% 66.67% 76.67% 100.00 95.71% 97.81% 
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% 
Received in 371 98.65% 100.00
% 
99.32% 98.65% 100.00
% 
99.32% 
SNOMED RT codes 227 100.00
% 
100.00
% 
100.00
% 
100.00
% 
100.00
% 
100.00
% 
Site and laterality 246 90.45% 95.67% 92.99% 93.67% 96.73% 95.17% 
Specimen size 371 98.04% 96.16% 97.10% 99.45% 98.63% 99.04% 
Specimen type 371 93.61% 94.91% 94.25% 94.12% 95.41% 94.76% 
Stage 298 100.00
% 
100.00
% 
100.00
% 
100.00
% 
100.00
% 
100.00
% 
TCRgamma 232 50.00% 33.33% 40.00% 100.00
% 
100.00
% 
100.00
% 
Tissue reactions 321 92.31% 78.69% 84.96% 93.55% 97.48% 95.47% 
Triage 371 92.57% 98.42% 95.41% 98.48% 98.98% 98.73% 
Overall 10253 93.57% 93.01% 93.29% 96.71% 98.17% 97.44% 
Table 8.12 Scores from structured output generation system of first and second round evaluations on 
the lymphoma training set. Note that score for “Clonality” is not presented, as there is no valid sample 
in the training set. 
 
From Tables 8.10, 8.11 and 8.12, the melanoma training set attained the biggest improvement by 
about 8.1%, while the smallest improvement was achieved by the colorectal cancer training set. This 
is probably because the performance on the first round evaluation was relatively low on the melanoma 
training set (90.25%) and that was very high on the colorectal cancer training set (95.91%). Finally, 
the rule-based system obtained over 97% F-score on all training sets in the second round evaluation, 
suggesting the rules worked well on the training sets. 
 
Each error was manually inspected and summarized into several categories: incorrect annotations, 
errors from other processing engines, errors from mapping strategies, weaknesses in ranking criteria, 
weaknesses in post-processing modules, errors from negation and uncertainty detection, insufficiency 
of ranking criteria, insufficiency of post-processing modules, inappropriate application of ranking 
criteria or post-processing modules, usability problems and other errors.  
 
8.5.1 First Round Evaluation on the Training Sets 
In total, 714, 598 and 417 errors were identified in the first round evaluation on the melanoma, 
colorectal cancer and lymphoma training sets respectively. Table 8.13 presents the distribution of the 
errors in each category in the first round evaluation. From table 8.13, most errors in the melanoma 
training set were due to usability problems, incorrect annotations and weaknesses in post-processing 
modules; insufficiency of post-processing modules and weaknesses in ranking criteria accounted for 
most errors in the colorectal cancer training set; the majority of the errors in the lymphoma training set 
were due to incorrect annotations, weaknesses in ranking criteria, weaknesses in post-processing 
modules and errors from other processing engines. 
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Usability Problems 
A standard language convention and format is indispensible for data analysis. Inappropriate language 
usage in some fields (e.g., “Clinical diagnosis” and “Subtype”) is the main reason for lower 
performance of those fields in the melanoma training set. For instance, “superficial spreading” is the 
standard phrasal convention rather than “superficial spreading type” as the value for “Subtype” from 
the example “there is an intraepidermal element [“En:Primary Lesion”] of superficial spreading type 
[“Sy:Subtype”]”.  Likewise, a potential value “caecal” or “rectal” for “Site” or “Tumour site” in the 
colorectal cancer training set should be standardized to “caecum” or “rectum”.  Lack of this 
standardization is the major cause for lower F-score of “Site”. 
 
Error category Melanoma 
training set 
(N=714) 
Colorectal cancer 
training set 
(N=598) 
Lymphoma 
training set 
(N=417) 
Incorrect annotations 22.13% 4.52% 21.34% 
Errors from other processing 
engines  
3.50% 0.67% 17.51% 
Errors from mapping strategies  6.02% 12.04% 0.00% 
Weaknesses in ranking criteria 2.94% 15.38% 19.18% 
Weaknesses in post-processing 
modules 
16.67% 11.04% 17.99% 
Errors from negation and 
uncertainty detection 
8.12% 2.01% 5.28% 
Insufficiency of ranking 
criteria 
3.36% 1.84% 2.64% 
Insufficiency of post-
processing modules 
6.86% 33.78% 4.08% 
Inappropriate application of 
ranking criteria or post-
processing modules 
2.24% 3.85% 0.96% 
Usability problems 25.21% 12.71% 1.92% 
Other  2.94% 2.17% 9.11% 
Table 8.13 Distribution of the errors in each category in the first round evaluation. The two largest 
error sources are shown in bold. 
 
Another usability problem is misspelling correction and abbreviation/acronym expansion.  For 
example, “kxcision” is needed to be corrected to “excision” for “Specimen type”; “t/v” is needed to be 
expanded to “transverse” for “Site”. This was addressed before the second round evaluation. 
After the first round evaluation, subtype standardization, severity maximization and convention 
configuration modules were developed for the purpose of improving the usability of the system. 
 
Incorrect Annotations 
Although during reflexive validation, most annotation errors have been identified and corrected, there 
were still a few errors detected in the first round evaluation, accounting for the lower F-scores of “Cell 
growth” and “Prev. Rx/Trauma” in the melanoma training set, and “Const symptoms” and 
“Presentation” in the lymphoma training set.  For example, “nausea”, “vomiting”, “haematuria” and 
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“lethargy” should be annotated as Sy:Constitutional Symptoms entities instead of Sy:Presentation 
entities, according to the advice of medical consultants. 
 
Insufficiency of Post-processing Modules 
This is a notable issue for the colorectal cancer training set, especially for “Specimen length”. This is 
probably because: 
1. The specification of this field is not very clear in the protocol, which doesn’t indicate 
whether the entire length of the specimen should be recorded or length of each segment in the 
specimen should be recorded. To simplify the problem, it was decided to only populate the 
entire length of the specimen (for single specimen documents) or the length of the main 
specimen(s) (for multiple specimen documents) in this study. 
2. Some pathologists tended to report the lengths for each segment of the specimen rather than 
the length of the entire specimen, which can complicate the computation of the length. An 
example is shown below: 
Specimen Dimensions [“St:Subheading”] 
Colon - 270mm long [“De:Specimen Size”]. 
Mesentery - 230 x 60mm [“De:Specimen Size”]. 
Ileum - 120mm [“De:Specimen Size”]. 
Appendix - 95mm long and 5mm wide [“De:Specimen Size”]. 
3. In some cases, the description of the measurement of a specimen or segment was quite 
ambiguous (e.g., “caecum and ascending colon measuring 80mm”), which did not always 
indicate it is a measurement of length.   
 
As a result, a specific post-processing module named Specimen Length Processor was designed to 
cope with this issue after the first round evaluation. 
 
The Margins Clear Processor was prepared to fix some errors on the three and six fields describing 
excision margins in the melanoma and colorectal cancer training sets respectively: “Excision margins: 
Deep”, “Excision margins: In-situ” , “Excision margins: Invasive” , “Margins:Distal 
(MACROSCOPIC)”, “Margins:Distal (MICROSCOPIC)”, “Margins:Proximal (MACROSCOPIC)”, 
“Margins:Proximal (MICROSCOPIC)”, “Margins:Radial (MACROSCOPIC)” and  “Margins:Radial 
(MICROSCOPIC)” after the first round evaluation. 
 
Weaknesses in Ranking Criteria 
The weaknesses in the ranking criteria consist of: the conditions for applying the criteria, lexical 
entries in the associated gazetteers of the criteria, and incorrect scores assigned for the criteria. For 
instance, in the original medical category criterion, both “Body structure” and “Procedure” were the 
preferred SNOMED CT categories. This brought several errors in populating values for “Specimen 
type”. Both “Rectosigmoid colon” and “anterior resection” were populated from this example: 
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1. [“St:Subheading”] Labelled - Rectosigmoid colon [“De:Specimen Type”]: The anterior 
resection [“De:Specimen Type”] specimen….  
By excluding “Body structure” from the criterion, only “anterior resection” would be populated, 
which is the correct value for the field.   
 
Another example is the lexical entries in the pattern gazetteer of the pattern criterion. Adding the 
lexicon “collections” to the gazetteer, so that the system can yield “nodular” besides “diffuse” for 
“Pattern of infiltration” from this example: 
The sections show [“Li:Lexical Polarity Positive”] a mass composed of nodular collections 
of lymphocytes [“De:Architecture”] separated by densely sclerotic, hyalinised stroma 
[“Re:Tissue Reaction”] as well as more diffuse areas [“De:Architecture”] of atypical 
lymphocytes in a sclerotic stroma [“Re:Tissue Reaction”].  
 
Incorrect weighting of the candidates with assertions of present and absent in the negation uncertainty 
inapplicability criterion resulted in a few errors as well. For example, “no malignancy” was produced 
as the value for “Diagnosis” rather than “dysplastic junctional naevus” in this example: 
This is a dysplastic junctional naevus [“Sy:Diagnosis”]. No [“Li:Lexical Polarity Negative”] 
evidence [“Li:Lexical Polarity Positive”] of malignancy [“Sy:Diagnosis”] seen. 
 
Adjusting the weights in the criterion was one of the improvements after the first round evaluation. 
 
Weaknesses in Post-processing Modules 
In the initial design of the post-processing modules, some useful information failed to be captured 
from the candidates. For example, “preexisting” is occasionally missed for populating “Assoc. benign 
naevus” in examples like “A preexisting benign dysplastic naevus [“En:Associated naevus (type)”]  is 
noted [“Li:Lexical Polarity Positive”].” The possible reason is that the results from the GENIA tagger 
were used to determine the boundary of a noun phrase in a En:Associated naevus (type) candidate; in 
some cases, the tagger would tag “preexisting” as “VBG”, which is out of the scope of the noun 
phrase, hence it could not be populated correctly. 
 
The Dimension Processor initially could only generate a value “15x0.5mm” from a Specimen Size 
candidate “12 and 15mm in length and up to 0.5mm in diameter”; by modifying the extraction and 
combination rules in the module, it could also generate another value “12x0.5mm” from the candidate. 
The order for choosing candidates in different section contexts were also be adjusted, especially for 
those to be populated to the fields under “IMMUNOPHENOTYPING”, “CYTOGENETICS” and 
“MOLECULAR” sections in lymphoma corpus, as the locations of the candidates for these fields are 
very flexible, all of the associated section contexts should be considered at the same time rather than 
sequentially.      
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Errors from Other Processing Engines 
The Errors from other processing engines, such as specimen context detection, section detection, and 
sentence boundary detection. 
 
Incorrect results from specimen context detection could consequently affect the construction of the 
structured template. This caused up to 55 errors in a single record on the lymphoma training set, 
wherein 14 were false negatives that underreported for a set of specimen ids, while the others were 
false positives that over-generated for each specimen id. 
 
All characters in the reports were assumed to be encoded in “utf-8”. However, due to mistakes of 
scanning or OCR, some characters were actually not encoded in “utf-8”, which led to several invalid 
outputs. An extra pre-process was required to resolve this issue. 
 
Errors from Mapping Strategies 
In the initial mapping strategies, the incorrect or insufficient mapping of entity types to the associated 
fields was the major cause for the drop of F-scores on “Other medical history” in the melanoma 
training set and  “Other sites of disease” in the colorectal cancer training set. For example, initially, 
only En:Primary Lesion, En:Associated naevus (type) and De:Cosmetic Changes were mapped to 
“Other medical history”, which led to occasional omission of some important information such as the 
history or duration of change (derived from Li:Temporality),  and size of lesion (derived from 
De:Size);  En:Coexistent Pathology was mapped  incorrectly to “Other sites of disease” , which 
yielded no gain on the field.  The mapping strategies were modified before second round evaluation 
(see Tables 8.4 and 8.5 for more details). 
 
Errors from Negation and Uncertainty Detection 
The results from the negation and uncertainty detection modules applied the negation uncertainty 
inapplicability criterion to determine the assertions of the candidates. First round evaluation revealed 
several problems in these modules, such as  
• Deficient lexical entries of terminal terms led to the failure to delimitate the negation or 
uncertainty scope. 
• The keywords and rules used to validate the cue and the scope would not work well for some 
special cases. 
 
Most of these issues were resolved before the second round evaluation.  
 
Insufficiency of Ranking Criteria 
The first round evaluation also revealed that some fields might need additional ranking criteria to 
refine the candidates.  For instance, a specific ranking criterion was designed to assign scores for 
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particular biopsy types (e.g., punch biopsy and wide excision), so that both “punch biopsy” and 
“ellipse of skin” for “Specimen type” can be populated from the example: 
The specimen [“En:Specimen Identifier”] consists of a punch biopsy [“De:Specimen Type”] 
of skin 6 x 9mm [“De:Size”] bearing a pigmented [“De:Shape”]  lesion [“En:Primary 
Lesion”] 3mm in diameter [“De:Size”] and an ellipse of skin [“De:Specimen Type”]  
measuring 14 x 12 x 3mm [“De:Size”]. 
 
For the same reason, an acronym criterion was prepared to decrease the weight of a Sy:Subtype 
candidate  “HMF”, such that it can be ruled out to be the best candidate for “Subtype” from the 
example: 
CLARK LEVEL 3 [“In:Clark Level”] AND WHICH IS ARISING FROM A LENTIGO 
MALIGNA [“Sy:Subtype”] (HMF [“Sy:Subtype”]) WITH THE LATTER REACHING 
INTO EACH LATERAL EDGE. 
 
Inappropriate Application of Ranking Criteria or Post-processing Modules 
Inappropriate application of ranking criteria or post-processing modules includes deficient application 
or misuse of ranking criteria or post-processing modules. For example, due to the lack of application 
of a special candidate selection module (which restricts the assertion of a valid candidate), the false 
positive output “pre-existing dysplastic naevus” was populated to “Assoc. benign naevus” from the 
example: 
Sections [“En:Specimen Identifier”] show [“Li:Lexical Polarity Positive”] an invasive 
malignant melanoma [“Sy:Diagnosis”], possibly [“Li:Modality”] arising in a pre-existing 
dysplastic naevus [“En:Associated Naevus (type)”]. 
 
Initially, a site ranking criterion was applied to assign a score for the De:Specimen Size candidates  
with the same lexical items as De:Tumour Site items. Thus, “100mm” was populated to “Specimen 
length”, instead of “205mm” from the example: 
An anterior resection specimen [“De:Specimen Type”]  of total length 205mm in length 
[“De:Specimen Size”], consisting of 105mm length of sigmoid [“De:Specimen Size”] and 
100mm length of rectum [“De:Specimen Size”]. 
 
This criterion was removed after the first round evaluation. 
 
Other Errors 
Other errors consist of missing specimen id(s) in the original reports, abnormal grammatical 
structures, irregular language usage, etc. 
For example, as a specimen id “3” was missed in the following example: 
2. [“En:Specimen Identifier”] R flank [“De:Site and Laterality”] ? [“Li:Modality”] 
acanthoma [“Sy:Diagnosis”]. Biopsy [“De:Specimen Type”] lesion [“En:Primary Lesion”] 
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central T spine [“De:Site and Laterality”]. ? [“Li:Modality”] Sup spreading BCC 
[“Sy:Diagnosis”]. 
false outputs for “Clinical diagnosis” and  “Other medical history”  were generated under specimen 
ids “2” and “3” respectively. 
 
The unit “mm” was omitted in the example “There is a brown, circumferential and stenosing tumour 
[“De:Tumour Description”] 35 in length [“De:Tumour Size”] and 20mm circumference [“De:Tumour 
Size"]…”, hence an incorrect value “20mm” rather than 35mm was produced  for “Tumour size”. 
 
Inconsistent use of specimen ids in different sections seemed to be a prominent issue for the 
lymphoma training set.  Here is an example: 
In “SPECIMEN” section, the pathologist used “2” and “3” as specimen ids: 
2. Right axillary lymph nodes [“De:Topography”] x 2 (SNB [“De:Specimen Type”] x 2). 
3. Left intermuscular space lymph nodes [“De:Topography”] x 3 (SNB [“De:Specimen 
Type”] x 3). 
However, in other sections (e.g., “MACROSCOPIC” and “MICROSCOPIC”), specimen ids “2” and 
“3” were used to refer to the two specimens descried under specimen id 2 in “SPECIMEN”; “4”, “5” 
and  “6”  were used to represent the three specimens mentioned under specimen id 3 in “SPECIMEN”.  
 
Such arbitrary use of specimen ids had negative influence on specimen context detection, and 
consequently resulted in the errors of the fields under these specimen ids. 
 
8.5.2 Second Round Evaluation on the Training Sets 
After the first round evaluation, several measures were taken to resolve the issues above, such as 
corrected annotations, revised mapping strategies, modified ranking criteria and post-processing 
modules, the design of additional ranking criteria and post-processing modules, and representation of 
outputs to follow standard convention and format.  Most measures have been illuminated in detail in 
Section 8.4.3. The performance of revised negation and uncertainty detection modules are displayed in 
Chapter 6 Section 6.4. 
 
The second round evaluation revealed that a great number of errors had been amended, and the total 
amount of errors reduced dramatically to 118, 124 and 168 on the melanoma, colorectal cancer and 
lymphoma training sets respectively.  From Tables 8.10, 8.11 and 8.12, the performances for most 
fields were quite good (with F-scores over 90%), except for “Prev. Rx/Trauma”,  “Cytogenetics 
comment”, “FISH”, “Flow cytometry: Negative for” and  “Flow cytometry: Positive for”, probably 
owing to their  small sample sizes  (none exceeded 20). The distribution of the errors in each category 
in the second round evaluation is displayed in Table 8.14. 
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Error category Melanoma 
training set 
(N=118) 
Colorectal cancer 
training set 
(N=124) 
Lymphoma 
training set 
(N=168) 
Errors from other processing engines  4.24% 2.42% 36.31% 
Weaknesses in ranking criteria 22.03% 30.65% 17.86% 
Weaknesses in post-processing 
modules 
21.19% 46.77% 13.69% 
Errors from negation and uncertainty 
detection 
11.86% 0.81% 4.17% 
Insufficiency of ranking criteria 3.39% 3.23% 1.79% 
Insufficiency of post-processing 
modules 
5.93% 4.84% 2.98% 
Inappropriate application  of ranking 
criteria or post-processing modules 
1.69% 0.00% 0.00% 
Usability problems 11.02% 0.81% 0.60% 
Other  18.64% 10.48% 22.62% 
Table 8.14 Distribution of the errors in each category in the second round evaluation. The two largest 
error sources are shown in bold. 
 
From Table 8.14, the modification or augmentation of the ranking criteria and post-processing 
modules improved the performance significantly, but might also have had some adverse effects on the 
system, which is the possible reason for a large proportion of errors still being categorized as 
weaknesses in them.  
 
Although there were a considerable amount of specimen context detection errors unfixed on the 
lymphoma training set, they were clustered in one document. Considering the adjustment of the 
specimen detection engine to one special document might affect the generality of the engine, the 
engine was not modified. 
 
The errors in the Other category remained, as they were poor-writing of the original reports rather 
than defects of the system, which were thought to be too difficult to resolve at present.  
 
8.5.3 End-to-End Evaluation on the Test Sets 
Finally, the best models for medical entity recognition (MER) and relation extraction (described in 
Chapters 5 and 7) were utilized to predict the test sets, and then generated the structured outputs with 
the above refined rule-base system. Tables 8.15, 8.16 and 8.17 display the results of end-to-end 
evaluation on the melanoma, colorectal cancer and lymphoma test sets respectively.  From Tables 
8.15, 8.16 and 8.17, the best performance was on the melanoma test set (86.49% F-score), and the 
worst on the lymphoma test set (78.90% F-score). One possible reason is that the test sample sizes for 
most fields in the lymphoma test set were much smaller than those in the melanoma test set (the 
smallest was 57), which might lead to poorer scalability; in addition, some fields (up to 3), such as 
“IgH” and “TCRgamma”, could not be evaluated in the lymphoma test set owing to lack of test 
samples. 
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Field Number TP FP FN Precision Recall F-score 
Assoc. benign naevus 108 27 5 5 84.38% 84.38% 84.38% 
Cell growth 108 45 9 16 83.33% 73.77% 78.26% 
Clinical diagnosis 108 44 4 10 91.67% 81.48% 86.27% 
Desmoplasia 108 3 1 4 75.00% 42.86% 54.55% 
Diagnosis 108 94 4 10 95.92% 90.38% 93.07% 
Distant metastasis 108 1 1 4 50.00% 20.00% 28.57% 
Excision margins: Deep 108 23 3 7 88.46% 76.67% 82.14% 
Excision margins: In-situ 108 4 3 18 57.14% 18.18% 27.59% 
Excision margins: 
Invasive 
108 48 17 11 73.85% 81.36% 77.42% 
Level of invasion (Clark) 108 81 3 9 96.43% 90.00% 93.10% 
Lymphovascular 
invasion 
108 47 2 4 95.92% 92.16% 94.00% 
Microsatellites 108 3 1 5 75.00% 37.50% 50.00% 
Mitotic rate 108 46 1 6 97.87% 88.46% 92.93% 
Neurotropism 108 32 2 4 94.12% 88.89% 91.43% 
Other lesions 108 1 1 4 50.00% 20.00% 28.57% 
Other medical history 108 32 12 16 72.73% 66.67% 69.57% 
Prev. Rx/Trauma 108 4 1 4 80.00% 50.00% 61.54% 
Previous melanoma 108 0 1 3 0.00% 0.00% 0.00% 
Regression 108 31 5 4 86.11% 88.57% 87.32% 
Site and laterality 108 81 14 10 85.26% 89.01% 87.10% 
Size of specimen 108 94 5 10 94.95% 90.38% 92.61% 
Specimen type 108 89 12 10 88.12% 89.90% 89.00% 
Subtype 108 64 7 7 90.14% 90.14% 90.14% 
TILs 108 51 2 6 96.23% 89.47% 92.73% 
TILs: Density 108 7 3 3 70.00% 70.00% 70.00% 
TILs: Distribution 108 9 1 8 90.00% 52.94% 66.67% 
Tumour thickness 108 84 5 12 94.38% 87.50% 90.81% 
Ulceration(mm diam) 108 56 3 6 94.92% 90.32% 92.56% 
Overall 3024 1101 128 216 89.59% 83.60% 86.49% 
Table 8.15 Results of end-to-end evaluation on the melanoma test set. TP: true positive, FP: false 
positive, and FN: false negative. 
 
Field Number TP FP FN Precision Recall F-score 
Ancillary Studies 215 13 7 5 65.00% 72.22% 68.42% 
Blocks selected 215 137 39 52 77.84% 72.49% 75.07% 
Comment (DIAGNOSTIC) 215 43 26 36 62.32% 54.43% 58.11% 
Comment (MACROSCOPIC) 215 87 84 65 50.88% 57.24% 53.87% 
Comment (MICROSCOPIC) 215 52 67 60 43.70% 46.43% 45.02% 
Comment (SYNTHESIS) 215 50 19 22 72.46% 69.44% 70.92% 
Depth of invasion 215 112 26 27 81.16% 80.58% 80.87% 
Distant spread 215 19 3 7 86.36% 73.08% 79.17% 
Histological grade 215 113 1 8 99.12% 93.39% 96.17% 
Histological type (WHO) 215 136 3 7 97.84% 95.10% 96.45% 
Lymph nodes 
(MACROSCOPIC) 
215 60 9 11 86.96% 84.51% 85.71% 
Lymph nodes (MICROSCOPIC) 215 136 18 26 88.31% 83.95% 86.08% 
Margins: Distal 
(MACROSCOPIC) 
215 144 19 21 88.34% 87.27% 87.80% 
Margins: Distal 
(MICROSCOPIC) 
215 124 4 14 96.88% 89.86% 93.23% 
Margins: Proximal 
(MACROSCOPIC) 
215 78 13 14 85.71% 84.78% 85.25% 
Margins: Proximal 215 128 5 11 96.24% 92.09% 94.12% 
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Table 8.16 Results of end-to-end evaluation on the colorectal cancer test set. TP: true positive, FP: 
false positive, and FN: false negative. Note that scores for “Extramuscular spread” and “Specimen 
images” are not presented, as there are no test samples for them. 
 
Field Number TP FP FN Precision Recall F-score 
Cell size 89 38 2 13 95.00% 74.51% 83.52% 
Clinical impression 65 23 8 8 74.19% 74.19% 74.19% 
Comment 76 16 0 1 100.00% 94.12% 96.97% 
Const symptoms 65 3 2 2 60.00% 60.00% 60.00% 
Cytogenetics comment 77 0 2 1 0.00% 0.00% 0.00% 
Cytomorphology 89 27 0 2 100.00% 93.10% 96.43% 
Diagnosis (WHO) 76 58 8 11 87.88% 84.06% 85.93% 
Disease extent 65 2 1 2 66.67% 50.00% 57.14% 
FISH 77 0 1 1 0.00% 0.00% 0.00% 
Flow cytometry: 
Comment 89 6 2 4 75.00% 60.00% 66.67% 
Flow cytometry: 
Negative for 89 0 0 1 0.00% 0.00% 0.00% 
Flow cytometry: 
Positive for 89 0 0 1 0.00% 0.00% 0.00% 
Grade 89 13 5 8 72.22% 61.90% 66.67% 
Immunohistochemistry: 
Comment 89 4 19 23 17.39% 14.81% 16.00% 
Immunohistochemistry: 89 3 0 3 100.00% 50.00% 66.67% 
(MICROSCOPIC) 
Margins: Radial 
(MACROSCOPIC) 
215 46 2 10 95.83% 82.14% 88.46% 
Margins: Radial 
(MICROSCOPIC) 
215 77 11 15 87.50% 83.70% 85.56% 
Medical history 215 16 4 21 80.00% 43.24% 56.14% 
Mesorectal integrity 215 2 0 2 100.00% 50.00% 66.67% 
Metastases 215 4 1 6 80.00% 40.00% 53.33% 
Number involved 215 139 14 22 90.85% 86.34% 88.54% 
Other sites of disease 215 13 8 7 61.90% 65.00% 63.41% 
Overlying serosa 215 48 7 10 87.27% 82.76% 84.96% 
Perforation 215 3 0 4 100.00% 42.86% 60.00% 
Perineural invasion 215 84 1 7 98.82% 92.31% 95.45% 
Peritoneal reflection 215 10 1 7 90.91% 58.82% 71.43% 
Residual tumour (R) 215 18 0 7 100.00% 72.00% 83.72% 
Response to Rx 215 14 4 5 77.78% 73.68% 75.68% 
Serosal Involvement 215 41 3 12 93.18% 77.36% 84.54% 
Site 215 113 31 29 78.47% 79.58% 79.02% 
Small vessel invasion 215 134 2 13 98.53% 91.16% 94.70% 
Specimen length 215 118 2 17 98.33% 87.41% 92.55% 
Specimen type 215 179 18 18 90.86% 90.86% 90.86% 
Stage Group 215 112 3 21 97.39% 84.21% 90.32% 
TILs 215 48 13 8 78.69% 85.71% 82.05% 
TNM stage: M 215 86 5 26 94.51% 76.79% 84.73% 
TNM stage: N 215 150 3 22 98.04% 87.21% 92.31% 
TNM stage: T 215 155 5 16 96.88% 90.64% 93.66% 
Tissue banking 215 10 0 0 100.00% 100.00% 100.00% 
Tumour description 215 167 24 24 87.43% 87.43% 87.43% 
Tumour site 215 76 30 38 71.70% 66.67% 69.09% 
Tumour size 215 163 13 34 92.61% 82.74% 87.40% 
Venous invasion 215 132 2 14 98.51% 90.41% 94.29% 
Overall 9460 3590 550 801 86.71% 81.76% 84.16% 
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Equivocal for 
Immunohistochemistry: 
Negative for 89 32 5 13 86.49% 71.11% 78.05% 
Immunohistochemistry: 
Positive for 89 38 5 12 88.37% 76.00% 81.72% 
Indication for biopsy 65 1 1 7 50.00% 12.50% 20.00% 
Lineage 76 33 0 1 100.00% 97.06% 98.51% 
Medical history 65 7 3 7 70.00% 50.00% 58.33% 
Other sites of disease 65 1 0 3 100.00% 25.00% 40.00% 
PCR comment 60 0 0 1 0.00% 0.00% 0.00% 
Pattern of infiltration 89 35 2 9 94.59% 79.55% 86.42% 
Predisposing factors 65 0 2 3 0.00% 0.00% 0.00% 
Presentation 65 6 4 11 60.00% 35.29% 44.44% 
Received in 109 16 2 5 88.89% 76.19% 82.05% 
SNOMED RT codes 57 54 1 2 98.18% 96.43% 97.30% 
Site and laterality 65 44 11 13 80.00% 77.19% 78.57% 
Specimen size 109 89 5 16 94.68% 84.76% 89.45% 
Specimen type 109 47 16 27 74.60% 63.51% 68.61% 
Tissue reactions 89 19 4 12 82.61% 61.29% 70.37% 
Triage 109 30 2 9 93.75% 76.92% 84.51% 
Overall 2588 645 113 232 85.09% 73.55% 78.90% 
Table 8.17 Results of end-to-end evaluation on the lymphoma test set. TP: true positive, FP: false 
positive, and FN: false negative. Note that scores for “Stage”, “IgH” and “TCRgamma” are not 
presented, as there are no test samples for them. 
 
There were 306, 1164 and 300 errors identified in the melanoma, colorectal cancer and lymphoma test 
sets respectively.  Table 8.18 summarizes the error types for each test set.  
 
Error category Melanoma 
test set 
Colorectal 
cancer test set 
Lymphoma 
test set 
1. Errors from entity recognition 88.89% 84.79% 83.00% 
1.1 Errors from specimen id detection 44.77% 0.00% 2.33% 
1.2 Errors from section heading detection 2.61% 2.58% 0.00% 
1.3 Errors from medical and linguistic entity  
recognition 
41.50% 82.22% 80.67% 
2. Errors from relation extraction 0.00% 0.00% 3.00% 
3. Errors from structured output generation 7.52% 8.33% 6.33% 
3.1 Weaknesses in ranking criteria 0.98% 1.72% 2.33% 
3.2 Weaknesses in post-processing modules 2.61% 4.64% 1.67% 
3.3 Errors from  negation and uncertainty 
detection 
1.31% 0.60% 0.33% 
3.4 Inappropriate application or insufficiency 
of ranking criteria or post-processing modules 
1.63% 0.34% 2.00% 
3.5 Errors from other processing engines 0.00% 1.03% 0.00% 
3.6 Usability problems 0.98% 0.00% 0.00% 
4. Poor-writing of the original report 3.59% 6.87% 7.67% 
Table 8.18 Error types for each test set. 
 
The greatest contribution to the errors was due to the poor performance of MER, accounting for 83% 
or more of the total errors in each test set, wherein incorrect specimen id detection attributed to over 
half of the errors in MER on the melanoma test set. Only about 6.3-8.3% of the errors on the test sets 
were due to the weaknesses in the SOG components, which is consistent with the results in the 
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training sets. It is also worth pointing out that around 6.9% and 7.7% of the errors on the colorectal 
cancer and lymphoma test sets were caused by the poor-writing of the original reports. Except for 
those issues mentioned in the Other category, an occasional but notable issue on the colorectal cancer 
test set is misuse of the section headings by the pathologists in some documents (e.g., use 
“SPECIMEN” as a “MICROSCOPIC” heading; in fact, it stands for a “MACROSCOPIC” heading in 
the training set), which affects section context detection and eventually leads to the invalid outputs. 
 
The micro-averaged F-scores in most fields were over 60%, except for six fields in the melanoma test 
set: “Desmoplasia”, “Distant metastasis”, “Excision margins: In-situ”, “Microsatellites”, “Other 
lesions” and “Previous melanoma”; five fields in the colorectal cancer test set: “Comment 
(DIAGNOSTIC)”, “Comment (MACROSCOPIC)”, “Comment (MICROSCOPIC)”, “Medical 
history” and “Metastases”; ten fields in the lymphoma test set: “Cytogenetics comment”, “FISH”, 
“Flow cytometry: Negative for”, “Flow cytometry: Positive for”, “Immunohistochemistry: 
Comment”, “Indication for biopsy”, “Medical history”, “Other sites of disease”, “PCR comment” and 
“Predisposing factors”.  
 
Incorrect results from the MER prevented correct population of the structured fields in the first place. 
Most of the fields with poorer performances were because of the worse results on the associated 
medical entity types obtained from the MER, for four possible reasons: 
1. The associated medical entity types were scanty in the training sets, such as “Desmoplasia”, 
“Microsatellites”, “Cytogenetics comment”, “FISH”, “Flow cytometry: Negative for”, “Flow 
cytometry: Positive for”, “Indication for biopsy” and “PCR comment”, each with a frequency 
smaller than 30.  
2. High lexical variability occurs in the associated medical entity types of some fields (e.g., 
“Other sites of disease” and “Immunohistochemistry: Comment”), which makes the MER 
model hard to identify the entities in the test sets.  
3. Abbreviations proved to be a challenge for MER during the training phase, which also 
increased the difficulty for testing. This is highlighted on “Medical history” and 
“Predisposing factors”, where entities presented as abbreviations or acronyms cannot be 
identified by the models in many cases. 
4. Ambiguity is another possible reason for the lower F-scores on some fields, such as “Other 
lesions” and “Excision margins: In-situ”. The instances of associated entity types En:Lesion 
(other) and Ma:Excision In Situ are frequently misclassified to other two entity types: 
En:Primary Lesion and Ma:Excision Invasive, as they have similar lexical items and 
linguistic constructions, and the machine learner tends to misclassify the instances to the 
dominant types: En:Primary Lesion and Ma:Excision Invasive.  
 
Besides poor MER results, the lower F-scores on several fields may also be due to:  
• The  values for “Comment (DIAGNOSTIC)”, “Comment (MICROSCOPIC)” and “Comment 
(MACROSCOPIC)” are combinations of the instances of three entity types (“Sy:Comment”,  
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“En:Coexistent Pathology” and “De:Ancillary Studies”) situated  in “CONCLUSION”, 
“MICROSCOPIC” and  “MACROSCOPIC” sections respectively, which makes them more 
error-prone, since only when all these types of instances are recognized accurately, can the 
fields be populated correctly. 
• The distribution of the entity type En:Distant Spread or Metastases in the colorectal cancer 
training set is not even: the largest portion (34.3%)  locates  in the “MICROSCOPIC” 
section. Thus the performance of “Distant spread” (derived from the entities in the 
“MICROSCOPIC” section) was much better than the performances of “Metastases” (derived 
from the entities in the “MACROSCOPIC” section), the F-scores of which were 79.17% and 
53.33% respectively on the test set.  
• In the melanoma training set, the distribution of the associated entity type Sy:Diagnosis is 
also uneven: the “MICROSCOPIC” section holds more than a half of the total amount, while 
only about 15.7% of these entities occur in “CLINICAL HISTORY” section. Additionally, 
the positive fields (where the values are not “N/A”) of “Distant metastasis” and “Previous 
melanoma” are scarce (with training sample sizes of 19 and 6) so that the extraction rules 
derived from the training data may not fit for the test data. 
 
The whole system has been released to the research community as a web page for testing (see 
http://www.icims.com.au/QUPPDemo for more details). Some examples are demonstrated in 
Appendix IV. 
 
8.6 Discussion 
8.6.1 Comparison of Different Template Construction Strategies 
From Table 8.16, incorrect specimen id detection accounted for diverse proportion of total errors: 
largest for the melanoma test set; minimal for the lymphoma test set; none for the colorectal cancer 
test set, because of different template construction strategies applied to them. For a multiple 
specimen/tumour document, in the melanoma and lymphoma corpora, the template sections were 
reported by specimen id or a set of specimen ids; in the colorectal cancer corpus, the reporting did not 
rely on specimen ids. Therefore, accurate detection of specimen ids is much more important for the 
other two corpora than in the colorectal cancer corpus. Moreover, it is critical for the melanoma 
corpus, as the template sections are reported under each specimen id. If a specimen id is missed (a 
false negative on specimen id detection), a template section under that id will be underreported; if a 
specimen id is misclassified (a false positive on specimen id detection), a template section under that 
id will be over-generated. By modifying this strategy to allow the template sections to be reported 
under multiple ids if the ids share the same contexts, the effect of incorrect specimen id detection 
declined dramatically to a minimum on the lymphoma test set. 
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In terms of the usability, a structured report constructed by the strategy used for the melanoma corpus 
is clear and easy to follow, as the sections are separated by specimen id, but it is vulnerable to 
incorrect specimen id detection. That constructed by the strategy for the colorectal cancer corpus is 
stable, since the amount of reportable fields will not change according to the number of specimen or 
tumour ids, yet implicit, as it is hard to tell whether the value in a field is reported against a single 
specimen/tumour or multiple specimens/tumours. That constructed by the strategy for the lymphoma 
corpus is preferable: it is explicit, similar to the one in the melanoma corpus.  It is more robust to the 
errors from specimen id detection, which diminishes the risks of underreporting or over-generation of 
template sections.    
 
8.6.2 Comparison with Other Works 
In comparison with MedTAS/P, the system achieved comparable performance (F-scores) in some 
fields, such as “Histological grade”: 0.96 vs. “Grade value”: 0.98, “Specimen length”:0.93 vs. “Gross 
description part”: 0.90, “Metastases”: 0.53 and “Distant spread”: 0. 79 vs. “Metastatic tumor”: 0.65, 
and poorer performance in certain fields, for instance, “Site”: 0.79 vs. “Anatomical site”:0.97, 
“Tumour size”: 0.87 vs. “Dimension”: 1.00. Other fields can not be compared, as they are out of the 
scope of this study (e.g., “Date”), or the definitions of them are quite different, for example, in the 
evaluation of MedTAS/P, for “Lymph nodes”, the total number of excised nodes is recorded as is the 
number of positive ones; in this study, it was devided into the total number of excised nodes in 
macroscopic examination (“Lymph nodes (MACROSCOPIC)” ) and microscopic examination 
(“Lymph nodes (MICROSCOPIC)”),  and the number of positive ones (“Number involved”). 
Moreover, the system provides additional information of clinical significance, which MedTAS/P 
lacked, such as “Perineural invasion”, “Small vessel invasion” and “Venous invasion”. 
 
The system performance is not compared to those of existing natural language processing (NLP) 
systems like MedLEE (Friedman et al., 2004) and cTAKES (Garla et al., 2011), since these systems 
have achieved relatively high performance on encoding of clinical documents or recognizing medical 
entities, at the cost of maintaining a lexically variant-rich encoding table or dictionary, but the goal of 
this study is different, that is to extract pertinent information from the free texts to populate structured 
templates rather than encoding. 
 
The results presented above are also not compared to other works (e.g., the works of Qu et al (Qu et 
al., 2007) and  Nguyen et al (Nguyen et al., 2012)), as those works either focused on the usability 
(e.g., the designs of user interface) , or the inference of TNM stage values from the narratives, and 
they did not report any error rate on populating structured fields. 
 
8.6.3 Discussion of the Three Corpora 
Although this study was focused on three specific cancer diseases, the rules still have some generality. 
For example, the negation uncertainty inapplicability criterion was frequently applied to many fields 
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across the three corpora, which demonstrates that this is a common criterion that fits a variety of 
cancer pathology notes. Likewise, the Clear Processor and Measurement module were used to post-
process the fields involved in excision margins in both the melanoma and colorectal cancer corpora, 
which indicates that these modules can also be reused in other cancer pathology reports to extract 
information about excision margins if applicable. Table 8.19 presents these general criteria and the 
modules used in common across the corpora. 
 
Corpus Criterion/Module 
Melanoma, colorectal 
cancer, lymphoma 
Frequency criterion, negation uncertainty inapplicability criterion; 
Dimension Processor 
Melanoma, colorectal 
cancer 
Specimen distance criterion, measurement criterion, uppercase 
criterion, distribution density degree criterion; 
Clear Processor, measurement module, sub-classification module 
Melanoma, lymphoma Laterality criterion, position criterion, temporality criterion, specific 
criterion, mood degree criterion; 
Temporality module 
Colorectal cancer, 
lymphoma 
Medical category criterion, size criterion, procedure criterion 
Table 8.19 General criteria and modules usage across the corpora. 
 
Error analysis showed that a single specimen/tumour report with standard headings and the presence 
of simple and concise statements was significantly associated with correct populating. This is 
probably because: 
 
The poorer performance of En:Specimen Identifier and  Specimen Identifier on MER could affect the 
final populations in the melanoma corpus to a great extent and lesser extent to the lymphoma corpus.  
For example, “A.” can be presented as a block id rather than specimen id in some cases. If a specimen 
id is missed or misclassified, it could directly affect the results of document classification and 
specimen context detection, and then finally negatively influence the structured outputs. A detailed 
analysis shows that a good representation of a specimen id can start with a lexicon “Specimen”, 
include brackets or period for a numeral (e.g., “Specimen A”, “(1)”, “2.”), and the representation 
needs to remains consistent in the whole report. 
 
Correct detection of section contexts is requisite for SOG, thus misuse or omission of section headings 
will hinder section context detection, and consequently affect the final transposition. 
A simple and concise statement was also more likely to be detected by the machine learning 
algorithms. For instance, it seemed too difficult to populate correct values for “Excision margins: In-
situ” and “Excision margins: Invasive” from the example: 
The nearest resection margins for the dysplastic junctional naevus [“En:Associated naevus 
(type)”], in situ and invasive melanoma [“Sy:Diagnosis”]  measure 1.8, 2.5 and 3.5mm 
respectively [“Ma:Excision In Situ”, “Ma:Excision Invasive”]. 
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Firstly, current machine learning methods such as Conditional Random Fields (CRF) cannot assign 
more than one tag for an overlap instance; secondly, even if the instances can be recognized correctly, 
it still needs more complex rules to extract values from them. 
 
Error analysis also addressed a critical and yet general issue that MER appeared to be the bottleneck 
of the whole study, which resulted in most of the errors on end-to-end evaluation. Some solutions may 
be useful to improve the system performance, which have been discussed in Chapter 5, such as 
exploring other features for better feature selection, ensemble multiple classifiers or machine learning 
algorithms. 
 
The system performed better on well-written reports than the poorly-written ones, as the poor-writing 
brought several issues that are difficult to handle (which have been discussed above). Some examples 
of these poorly-written reports are presented in Appendix V. 
 
8.6.4 Limitations 
One of the limitations of this work is that the sample size for testing is not enough to carry out a 
thorough evaluation, especially for the lymphoma corpus. Several fields cannot be evaluated in the 
test sets (e.g., “Specimen images”, “IgH” and “TCRgamma”) due to lack of test samples. It is likely 
that the system performance is limited by insufficient sample size. 
 
At first, the structured outputs were displayed in a web page for pathologists to evaluate, but we have 
been unsuccessful in recruiting any pathologist to engage fully with the task although a number 
volunteered initially. The extracts were validated by computational linguists trained to do this task. 
While they may not have been able to interpret the extractions as precisely as pathologists, their work 
has face validity and is internally consistent, which has been shown in a previous work on the project 
(Patrick and Scolyer, 2008). 
 
8.7 Conclusion 
In this chapter, the detailed process of generating structured outputs was described, including the 
design of the predefined templates, mapping strategies and a rule-based system for populating these 
templates.   
 
The good performances of the structured output generation system on the training sets in the second 
round evaluation (all F-scores exceeded 97%) revealed that the rules were competent at populating the 
structured outputs based on the gold-standard annotations. This was also consistent with the findings 
in end-to-end evaluation on the test sets, where weaknesses in the structured output generation system 
contributed a small number of errors. 
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Error analysis on end-to-end evaluation also demonstrated that medical entity recognition is the 
bottleneck of the whole study, as the majority of total errors were due to its incorrect results.  
 
It is believed that the rules proposed have some generality, which are not limited to the cancer 
diseases in the study, as some general ranking criteria and post-processing modules can be reused or 
easily adapted across the three sets of cancer pathology notes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 9 Conclusions 
261 
 
Chapter 9 Conclusions 
 
In this thesis the problem of automatic population of structured reports from narrative pathology 
reports was studied and several sub-tasks of the study presented. In the pathology domain, traditional 
narrative reports commonly have some problems. For example, essential elements are occasionally 
omitted, especially negative results which are not always reported clearly; the referring doctors often 
find it difficult to identify the necessary elements to justify a given diagnosis. Compared to free-text 
reports, there are a number of advantages for the use of structured reports, which can improve the 
communication between pathologists and clinicians. For instance, they can improve the completeness 
of pathology reporting; they are more concise and easy to read and, they can improve the efficiency 
for cancer registries, clinical audits and epidemiology research. Natural language processing (NLP) is 
one promising approach to extracting critical findings and diagnoses and incorporating them into a 
predefined structured template, thereby achieving the goal of automatic population of structured 
reports. 
 
Generally, this application of NLP technology is an information extraction (IE) task in the clinical 
domain, but it is more difficult to achieve than IE tasks in the general domain, as it requires deep 
understanding of the domain knowledge. It has to deal with specific and complex lexicons that cannot 
be found in common medical terminologies. Moreover, in different clinical sub-domains, there are 
different sub-languages used, which need to be also considered in the task. 
 
 
Figure 9.1 Pipeline system architecture for automatic structured reporting. Dashed lines indicate that 
the subsequent processes were applied to the lymphoma corpus. 
 
The work presented in this thesis has demonstrated that an IE system that combined a supervised 
machine learning based approach enhancing by some rule-based methods was a feasible strategy for 
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accomplishing this task, and achieved promising results. The complete pipeline architecture is 
illustrated in Figure 9.1.  
 
As shown in the diagram, raw records are passed to the pre-processing engine, including sentence 
boundary detection, tokenization, part-of-speech (POS) tagging, and section context detection. In a 
separate process, the training data are annotated manually to create gold-standards. Subsequently 
errors in the manual annotations are identified by performing recursive validation on the training data. 
The errors were corrected manually so that the model would not learn from the incorrect examples. 
After pre-processing, a supervised machine-learning based-approach is used to recognise medical 
entities from the corpora, using Conditional Random Fields (CRF) (Lafferty et al., 2001) and 
integrating various features. The negation and uncertainty detection modules are applied to detect the 
assertions of particular entities. For the lymphoma records, a relation extraction system is prepared to 
extract specific relations between entities, consisting of a rule-based module and a Support Vector 
Machine (SVM) (Cristianini and Shawe-Taylor, 2000) classifier. Then the rule-based structured 
output generator populates the final outputs conforming to the structured templates. 
 
The main contribution of the research is that it is a pilot study investigating how narrative pathology 
reports can be automatically converted into structured reports by building a hybrid system that 
demonstrates the feasibility and accuracy of it. Researchers can use it as a baseline for the 
development of more complex models in the future. Accordingly, the development of the system can 
be divided into the developments of the following sub-systems or modules focusing on: medical entity 
recognition (MER), negation and uncertainty detection, relation extraction (RE), and structured output 
generation respectively.   
 
9.1 Thesis Overview 
This thesis began with an introduction of the work in Chapter 1, including the significance of the 
study, background knowledge about IE tasks in the clinical domain, the main barriers to the task, the 
research problems and proposed solutions. 
 
Chapter 2 surveyed some previous work related to the field, which reviewed current state of the art 
techniques focusing on four main sub-tasks: MER, negation and uncertainty detection, RE and 
automatic structuring. Generally, there are two main steams: rule-based methods and statistical 
approaches. On one hand, rule-based methods tend to provide reliable results with a relatively small 
amount of training data, and the hand-crafted rules are comprehensible for the developers or domain 
experts, which eases the error analysis effort. However, these methods face difficulty when dealing 
with unfamiliar or erroneous input data, and the rules are usually tailored for a specific task, which 
may not be readily reusable for other tasks. On the other hand, statistical approaches can handle 
problematic data by learning from training examples. Also, statistical approaches can achieve 
comparable or better performance by simply adopting features extracted from the corpus, thus they are 
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usually more portable than their rule-based counterparts, but they also require a large amount of 
training data to create gold-standards. Therefore, a combination of statistical methods and rule-based 
approaches is preferable to build a hybrid system for a complex IE task. 
 
Chapter 3 presented the detailed analyses conducted on the corpora. The lexical analysis demonstrated 
that specific characteristics of the texts in pathology notes are distinguishable from those in other 
genres of texts. Several significant language phenomena were observed, including abbreviations, 
unknown words, misspellings, non-alphabetic tokens, lexical variants and complex vocabulary, which 
indicated the challenges that may be encountered in the following processes, which require 
sophisticated NLP techniques to resolve. The quantitative completeness analysis showed the coverage 
of most fields is unsatisfactory, revealing several issues to be addressed in the following processes, 
especially in the construction of the structured templates. 
 
Chapter 4 described three semantically annotated corpora: the melanoma corpus, the colorectal cancer 
corpus and the lymphoma corpus, which were annotated with entities or relationships between the 
entities. The whole annotation process was illuminated, including the design of the annotation 
schemas and guidelines. The correspondence analysis showed that the annotation schemas had 
appropriate granularity that could capture most information related to the structured fields without too 
much ambiguity. A mixed conveyor method with a two phase validation was adopted, which 
improved the efficiency and reduced the difficulty of the annotation process. The main annotation 
process was carried out by computational linguists, and they were competent to accomplish the task 
once they were properly trained and detailed annotation guidelines were provided. Moreover, 
recursive validation was performed on the initial gold-standard annotations to attain higher 
consistency among them. As a result, these unique annotations of high quality were suitable for future 
experiments. 
 
A supervised machine learning-based approach was proposed in Chapter 5 to recognize medical 
entities in the corpora. CRF-based models were able to capture a significant portion of the entity 
boundaries by utilizing contextual features, since the spans of most entities were within a nine-token 
window. Rich feature sets provided a great number of useful clues for classifying the entity types. By 
feature engineering, the best feature configurations were attained and achieved significant gains on the 
models. Some common effective features were identified: lowercase of tokens, lemma, POS tag (or 
bag of POS tags), medical category, ring-fenced tag (or bag of ring-fenced tags), suffixes, bag of 
prefixes, and section context, which can also be beneficial for other MER tasks using similar 
approaches. 
 
The negation and uncertainty detection modules were presented in Chapter 6. First, a case study of 
negation detection was performed on the lymphoma corpus, where three different methods were 
experimented with: the lexicon-based approach was a rule-based method, modified from NegEx 
(Chapman et al., 2001b), an existing negation detection algorithm, relying on the application of trigger 
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terms and termination clues; the syntax-based approach was a rule-based method as well, 
implemented with a set of rules and negation patterns designed according to the dependency output 
from the Stanford Parser (Klein and Manning, 2003); an SVM classifier armed with a number of 
features was adopted in the machine learning-based approach.  The syntax-based approach and 
machine learning-based approach performed best on the training set and test set respectively, at the 
cost of very long run time, while the lexicon-based approach was simple and efficient, and yielded 
reliable performance, thus it was applied to the other two corpora. A similar approach was also 
prepared for uncertainty detection. The main adjustment of the approaches for the other two corpora 
was modifying the entries of trigger terms, pseudo-trigger terms and termination clues. The modules 
obtained very good performances on the training sets. The dramatic drop of F-scores on the test sets 
were mainly due to incorrect MER rather than errors from the modules. 
 
A RE system was described in Chapter 7 to extract four relations from the lymphoma corpus. It 
included a rule-based module where simple heuristic rules were applied, and an SVM classifier that 
adopted several useful features. The system achieved very good performance on the training set, and 
the most effective features for the classifier were the contextual, positional and semantic features. 
 
In Chapter 8, the process of generating structured outputs was described in detail. It illuminated the 
design of the predefined templates, mapping strategies and a rule-based system for the population of 
these templates. The rule-based system had four processes: document classification, specimen context 
detection, candidate preparation and XML generation. The main process was candidate preparation, 
implemented with a series of post-processing modules and ranking criteria. The rule-based system was 
improved significantly by the refinement of the rules, which performed very well on the training sets. 
MER was the bottleneck of the whole study, as incorrect results from it were the major cause of total 
errors in end-to-end evaluations on the test sets, while the structured output generation system 
contributed to a small number of errors. Although the rules were proposed based on three specific 
cancer diseases, they still had some generality, since several post-processing modules or ranking 
criteria can be reused or easily adapted for other cancer pathology notes. 
 
9.2 Future Work 
9.2.1 Further Improvement 
In view of the complexity and variability of language embedded in narrative reports, coupled with the 
existing error rate of the system, the system is capable of further improvement.  
 
Improvement for the Quality of Annotations 
Both the quality and the size of training data can significantly affect the performance for machine 
learning-based approaches. Given limited time and resources, three corpora with relatively small sizes 
were annotated for the study.  
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The size of annotated corpora should be increased if more cancer pathology notes are available. The 
size of the annotated data is also subject to the time spent on the annotations. An active learning 
approach (Thompson et al., 1999) is a possible solution to reduce the annotation effort, as only the 
most informative instances are annotated in this approach. 
 
The quality of annotated data can be improved by enhancing the clarity of the annotation schemas and 
the consistency of applying the annotation guidelines. For example, the annotation guidelines can be 
further refined by employing more medical and linguistic knowledge, adding more specifications and 
detailed examples. 
  
Improvement for Medical Entity Recognition 
The supervised machine learning-based system did not exhaust all potential useful features. 
Additional features could be introduced to the models. For instance, besides a local contextual 
window and section context, more complicated contextual clues involving the adjacent sentences 
could be utilised to remedy the ambiguous classification of entity types.  
 
The combination of the features could be explored as well. Other features were tried in combination 
with the nine-token contextual window in the study, so the combination with different window sizes 
could be investigated to improve the system performance. 
 
Other machine learning algorithms could be used to recognize entities with long spans (over nine 
tokens), which seems to be a drawback of CRF++. CRF tends to misclassify the minority entity types 
to the majority counterparts, especially when they have ambiguous expressions. One possible solution 
is to apply the stacking or voting strategies to the aggregation of the results from different machine 
leaning classifiers (Dzeroski and Zenko, 2004; Wang and Patrick, 2009). By overcoming the problems 
brought by a single classifier, the combination of multiple classifiers may yield better classification 
performance. 
 
Improvement for Negation and Uncertainty Detection 
The fixed four-word window size for uncertainty detection led to the occasional omission of some 
distant entities from the uncertainty trigger terms, thus a more flexible window size could be 
considered to determine the scope for uncertainty. 
 
Inappropriate clustering of the trigger terms resulted in some false outputs. Simple positional clusters 
were not able to handle some cases properly, which require thorough cluster analysis to tackle. 
Specific conditions should be considered in complex clusters. 
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The lexicon-based detection approaches could not cope with complicated cases, which is likely to be 
overcome by resolving coreference or introducing syntactic clues. They also failed to determine the 
scope involving particular prepositions correctly. Employing domain knowledge or global context 
information may be helpful to resolve this issue. 
 
Insufficient predefined trigger terms hindered the performances of the modules, hence the predefined 
trigger term lists should be augmented with additional lexical entries. 
 
A more comprehensive integration of different detection modules should be taken into account in 
order to avoid some problems caused by current weak integration of the modules. 
 
Improvement for Relation Extraction 
One of the obstacles to better RE is incorrect results from sentence boundary detection and 
dependency parsing. This requires a more sophisticated sentence boundary detector and parser trained 
on the domain. 
 
Deficient feature extraction and construction also brought some problems. For example, the implicit 
meaning implied by particular tokens between the paired entities was not considered, which caused 
the failure to exclude some invalid relations. There should be further consideration on these tokens 
when applying the related feature. The categorization of dependency distances may be too ambiguous, 
which needs to be split into finer grained categories in future work. 
 
The current feature selection method is a “bottom-up” method (Whitney, 1971), where an initial 
empty feature set is incremented progressively with features to find the best configuration. It suffered 
from the nesting effect where features once added cannot be removed. Other advanced methods, such 
as the stepwise feature selection and sequential forward floating search methods (Pudil et al., 1994; 
Sahiner et al., 2000), can be used instead, where the system performance is assessed on more flexible 
combinations of features. For example, in a sequential forward floating search method (Pudil et al., 
1994), the number of features is added or removed at each step dynamically, and the stopping criterion 
is controlled by a predefined amount of desired features. 
 
Improvement for Structured Output Generation 
The small sample size for testing could not support thorough evaluation on the system, especially for 
the lymphoma corpus. The scalability of the system performance is subject to the limited sample size. 
Therefore, besides increasing the size of training data, the size of test data also needs to be increased. 
 
At present, the structured outputs have been validated by computational linguists with training. 
However, a stricter validation should be conducted by pathologists, for further application of the 
system to the clinical settings.  
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In addition, to assess the portability of the methodology in this work, the system can be modified and 
adapted for other cancer pathology notes, and then the system performance can be evaluated on them. 
To attain better usability, pathologists could take part in the testing, with their feedback taken into 
account for the improvement of the system. 
 
9.2.2 Further Development 
Given the structured outputs obtained from the system, there are several potential uses for them: 
 
Screening Tool 
Using structured reports can result in more complete and consistent pathology reports. The system can 
be implemented as a screening tool, which screens pathology reports prior to finalization by 
prompting pathologists about important findings that may be inadvertently left out and inconsistent 
with the structured fields. For example, in the AJCC Cancer Staging Manual (Edge et al., 2010), N 
stage is classified based on the number of malignantly involved regional lymph nodes. By validating 
the values in the fields “Number involved” and “TNM stage: N”, it can tell pathologists whether they 
have provided the correct N stage values in the reports. Likewise, if “follicular” is populated to the 
field “Pattern of infiltration”, while “Diffuse large B-cell lymphoma” is a value for the field 
“Diagnosis (WHO)”, it can remind pathologists that they may have made a wrong diagnosis in the 
report.  Additionally, it can also reduce the ambiguity of medical terms used, and decrease variability 
in their interpretation. 
 
Decision Support 
Some structured fields can help clinicians to decide further clinical management of the patients. Here 
are some examples: 
1. Three fields about excision margins in the melanoma corpus: “Excision margins: Deep”, 
“Excision margins: In-situ” and “Excision margins: Invasive”. Given the thicknesses of the 
melanomas, where there are different requirements for the width of the surgical margin. For 
example, a 1-cm margin is recommended for the excisions of melanomas with thickness <1 
mm; melanomas that are >2 mm thick should be excised with 2-cm surgical margins (Balch, 
2002; Reintgen, 2001). Hence, if any of the numeric values populated to the three fields are 
smaller than those indicated in the requirements, re-excision may be advised in case of 
residual melanoma at the primary site. 
2. Two fields about metastases: “Distant spread” and “Metastases” in the colorectal cancer 
corpus.  According to the clinical practice guidelines, first- or second-line chemotherapy is 
standard treatment for colorectal cancer patients with metastases (Van Cutsem et al., 2010). 
Thus, if “present” occurs in any of the two fields, clinicians should consider chemotherapy as 
a preferable treatment for the patients. 
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Automated Encoding  
Encoding the structured fields is highly significant. The structured outputs can be mapped to existing 
terminologies (such as SNOMED CT, ULMS, ICD-O) so that they can be accessed reliably by other 
automated clinical applications at different institutions and used for a broader range of purposes. 
Currently, only medical entities in the lymphoma corpus are encoded in SNOMED RT codes, which is 
limited to the diagnostic summary. By integrating with some existing automated encoding tools (e.g., 
Friedman et al’s  and Patrick et al’s works (Friedman et al., 2004; Patrick et al., 2007a)) or designing 
new tools,  the structured outputs from the narrative pathology notes can be converted into codes or 
concept identifiers defined in the terminologies, to ease the data storage and facilitate effective 
retrieval.    
 
Appendix I Details of the Post-processing Modules and Ranking Criteria for the Structured Fields in Each Corpus 
269 
 
Appendix I Details of the Post-processing Modules and 
Ranking Criteria for the Structured Fields in Each Corpus 
I.1 Post-processing Modules 
General Process Module 
This module includes several general pre-processes that can be applied to most fields before ranking, 
such as misspelling correction and expansion of acronyms or abbreviations.  
 
During ranking, for those fields in a section with multiple associated section contexts, the candidates 
in the primary section context take precedence over those in the supplementary section context. For 
example, in the lymphoma corpus, if two candidates for “Site and laterality” locate in “CLINICAL 
HISTORY” and the “SUPPLEMENTARY REPORT” respectively; the one in “CLINICAL 
HISTORY” is considered first. The results from specimen context detection also affect the order for 
the selection. The candidates in a single specimen id’s context are preferable to the one in a multiple 
specimen ids’ context. 
  
There are also some post-processes to handle the candidates after ranking. For example, a process 
called overlapping candidate reduction is to remove the repetitive or less informative candidates, by 
comparing the token length and similarity among the candidates. 
 
Measurement Module 
For the melanoma corpus, the module processes according to the following steps:  
1. Check whether there is any measurement unit (e.g., mm, cm, and millimetre) in the candidate 
and extract it if it exists. 
2. Check whether there is any numeral (e.g., 1, 20, and 0.8) in the candidate and extract it if it 
exists. 
3. Check whether there is any alphabetic word that can be converted to an Arabic numeral (e.g., 
one, two, and three) in the candidate and convert it if it exists. 
4. Check whether there is any keyword or punctuation that suggests the value is fuzzy (e.g., -, 
>, greater, less) in the candidate and extract it if it is a punctuation or convert it to an 
associated sign if it is a keyword, e.g., “less” is converted to “<”. 
5. Check whether there is any conjunction (e.g., and, or) in the candidate and extract it if it 
exists. 
Finally, the module combines all the values from the steps above to yield the output. 
 
After revision, a pre-process to remove extra white space inside a potential numeric value (e.g., “1. 
5mm”) was added in the beginning of all the steps. 
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For the colorectal cancer corpus, the fifth step was skipped, thus if multiple numeric values were 
extracted, the first one was used as the output in the initial design. This was modified to allow all the 
extracted values to be considered as appropriate output after first round error analysis. 
 
Naevus Module 
This module processes as follows: exclude any prepositional phrase from the candidate; find the noun 
phrase in the candidate; strip the determiner from the noun phrase if applicable; the remaining part of 
the phrase becomes the output. 
 
After revision, the lexicon “cell” and “cells” were also stripped from the noun phrase to yield a 
standard output. 
 
Level Module 
There are five Clark’s levels defined in the protocol: Level I, II, III, IV, and V. First, the module tries 
to identify whether the candidate has any of these Roman numerals, or any Arabic numeral that can be 
converted to these Roman numerals, and then extracts the numeral or converts it if applicable; detects 
lexical items “to” and “or” in the candidate, and convert them to “-”and “/” respectively if applicable.  
 
Temporality Module 
The module firstly detects whether there is a Li:Temporality entity inside the five-token window and 
the same sentence of the candidate; if there is, the entity is extracted as the result. 
 
After the first round error analysis on the melanoma training set, the result would be ruled out if it is 
not an entry in the regression temporality gazetteer and the candidate is a Sy:Regression entity. 
 
Regress Module 
Initially, the module finds any adjective (except “regressive”) in the candidate.  
 
After the first round error analysis, the module also finds an adverb in the candidate or the 
surrounding Li:Mood and Comment Adjuncts entities if it is an entry in the regress gazetteer. 
 
Rate Module 
The processes in this module are similar to those in measurement module, replaced with different 
predefined units, such as “/mm2”, “/sqmm”, “per hpf”, “per square millimetre” and “in a high power 
field”. The default unit is “/mm2”, if no particular unit can be detected from the candidate. 
 
Dimension Processor 
The module processes according to the following steps: 
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1. Unify the lexical variants of dimensions. There are four standard dimensions in total, which 
are “diameter”, “length”, “width”, and “depth”. For example, phrases referring to “length” 
can be expressed as “long”, “length”, “longitudinally”, “longitudinal”, “axially”, and so on; if 
any of them is detected in the candidate, it will be standardized to the dimension “length”. 
2. Detect the dimensionality of the candidate. A simple rule is used for the detection: check the 
number of the multiply sign “×” between numeric value(s) in the candidate: for a two-
dimensional size, there should be two “×”; three “×” for a three-dimensional size; no “×” for 
a one-dimensional size. 
3. Extract the numeric value(s) from the candidate. Extract any numeral and unit from the 
candidate, and integrate with the detected dimension to yield dimension pairs. For a one-
dimensional size, the dimension pair is denoted as {the standardization in Step 1: one-
dimensional size}; for a two-dimensional size, the dimension pair is rendered as {“area”: 
two-dimensional size}; for a three-dimensional size, the dimension pair is shown as 
{“volume”: three-dimensional size}; the default one is {“dimension”: one-dimensional size}, 
if none of the standard dimensions, but a one-dimensional size is detected in above steps. 
4. For the melanoma and lymphoma corpora, an extra step is used to handle special cases, e.g., 
multiple one-dimensional sizes with different keys in the pairs or hybrid dimensional sizes (a 
two-dimensional size and a one-dimensional size) are detected in the candidate. The module 
can merge them together with “×”. For the melanoma corpus, the dimension of “diameter” 
should always be indicated in the result if applicable (advised by the pathologist).  
5. For the colorectal cancer corpus: If the candidate is a De:Specimen Size entity, the module 
will only generate a result for dimension pairs with keys of “length”, “dimension”, “area” 
and “volume”; for “area” and “volume”, the first numeric value is used to generate the result. 
If the candidate is a De:Tumour Size entity, the result is the maximum  numeric value from a 
dimension pair with a key of “area” and “volume” or  a standard dimension with multiple 
extracted one-dimensional sizes; the numeric value for a dimension pair with a key of a 
standard dimension with single extracted one-dimensional size. 
 
After the first round error analysis, the module was slightly modified to tackle more complex cases. 
 
Node Number Module 
There are several steps in this module: 
1. Extract any numeral or any alphabetic word which can be converted to an Arabic numeral 
(e.g., “twenty-five” and “eighteen”) from the candidate if applicable. Note that numeric 
values for measurements of the lymph nodes are ruled out, such as “2mm” and “3-10mm”. 
2. If the candidate is an Ex:Lymph Node Involvement entity,  the ratio between involved nodes 
and identified ones should also be detected, and the number of identified ones is extracted if 
applicable, e.g., “30” is extracted from “none of which are involved by metastatic  
adenocarcinoma (0/30) including the apical lymph node” and “16” is extracted from “4 out of 
16 lymph nodes show metastatic carcinoma”. 
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3. If no numeral or alphabetic counterpart is detectable, check whether the candidate has 
negation inside and assign number “0” if it is negated (e.g., “no lymph node in the 
appendiceal area”). Note that this step cannot be applied to an Ex:Lymph Node Involvement 
candidate (e.g., the count for “Two proximal ileocaecal nodes are clear of tumour” is “2” 
instead of “0”). 
4. Check whether the candidate is the total count of nodes. 
5. Special rules are applied to find extra counts of nodes. For example, assign number “1” for 
“apical lymph node is identified 4mm in diameter” and “single local lymph node”. 
 
Involvement Number Module 
Most processes are similar to those in node number module, except that in Step 2, the number of 
involved nodes is extracted instead of that of identified ones; Step 3 is always applied to the 
candidate. 
 
Sub-classification Module 
This module tries to classify the candidate to a specific sub-type. The sub-type result will be used for 
ranking, or become part of the population to the associated field. 
 
Specific sub-types of some entity types are listed below: 
• Ma:Proximal or Distal Margin: “Proximal”, “Distal” 
• Ma:Clear: “Proximal”, “Distal”, “Radial” 
• In:Venous and Small Vessel Invasion: “Large vessel”, “Small vessel” 
• En:Distant Spread or Metastases: “Distant spread”, “Metastases” 
• Re:TILS and Peritumoural Lymphocytes: “Tils”, “Peritumoural  lymphocytes ”, “Crohn’s-
like reaction” 
• Ma:Excision Clear:  “Invasive”, “In-situ”, “Deep” 
 
TILs Module 
This module extracts any lexical items in particular gazetteers from the input as the output. 
 
For the melanoma corpus, the input is the candidate or surrounding Li:Mood and Comment Adjuncts 
entities; particular gazetteers refer to the distribution and  density gazetteers. 
 
For the colorectal cancer corpus, the input is the candidate; particular gazetteers refer to the 
distribution, density or degree gazetteers; an additional step is to map the lexical items in the degree 
gazetteer to six predefined categories: “minimal”, “mild”, “mild to moderate”, “moderate”, “moderate 
to marked” and “marked”. 
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Mood Degree Module 
The Li:Mood and Comment Adjuncts entities were assigned with various scores according to the 
degree or intensity they indicated, ranging from 0.5 to 3 (e.g., “minimal”: 0.5, “mild”: 1, “moderate”: 
2, “prominent”: 3). The module returns the Li:Mood and Comment Adjuncts entities around the 
candidate and their associated scores, which can be used by mood degree criterion or contribute to the 
population to the associated field. Note that for a Re:Tissue Reaction candidate, the lexical items of 
the extracted Li:Mood and Comment Adjuncts entities need to be verified against the specific mood 
gazetteer. 
 
Subheading Module 
This module verifies whether the candidate is a synoptic field with an associated subheading. First, the 
candidate is checked if it has one of these patterns: colon “:”, hyphen “-”, or two titlecase tokens 
inside the candidate. If it has, the potential subheading is extracted from the candidate, spanning from 
the first character to the previous character before the punctuation or the second titlecase character. 
The potential subheading is validated against particular subheading lexical items by entity types. For 
instance, “Site” is a valid subheading for a De:Tumour Site candidate “Site: Caecum”; whereas, 
“Polyps” is not a valid subheading for an En:Coexistent Pathology candidate “Polyps: Present, benign 
hyperplastic”. The valid subheadings are used for ranking, and then stripped from the candidate to 
facilitate other processes. 
 
Tumour Border Status Module 
This module extracts any lexicon belonging to an entry in the tumour border status gazetteer. 
 
Tumour Description Module 
The module verifies whether the candidate matches one of these patterns: 
Pattern 1: a non-propositional phrase + an entry in the general tumour gazetteer 
Pattern 2: an adjectival phrase without any preposition 
Pattern 3: a noun phrase without preposition “to” and plural nouns  
Pattern 4: non-prepositional phrase 1 + an entry in the general tumour gazetteer + preposition 
“with” + non-propositional phrase 2 
Pattern 5: an entry in the general tumour gazetteer + verb “is” + a non-prepositional phrase  
 
For Pattern 1 and Pattern 5, the non-prepositional phrase is extracted as the result; for Pattern 4, both 
non-prepositional phrases are extracted as the result; for Pattern 2, the adjectival phrase is extracted as 
the result; for Pattern 3, the noun phrase is extracted as the result. 
 
After revision, the main changes were the adjustment of lexical entries in the general tumour 
gazetteer.  
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Clear Processor 
This module returns the result as “clear” if lexical items “clear” or “clearance” is detected in the 
candidate. 
 
Tumour Site Processor 
This module aims to extract the anatomical site and laterality from the candidate. It tries to remove 
lexical items from the candidate if they are the entries in the tumour gazetteer, the determiner “the” 
and prepositions like “in”, “of” and “to”.  
 
After revision, the tumour gazetteer was introduced with more lexical entries, and the module also 
converted two very frequent terms: “rectal” and “caecal” to “rectum” and “caecum” if applicable, to 
enhance the usability. 
 
Specimen Length Processor 
After the first round error analysis, the module, Specimen Length Processor, was required to validate 
the candidate (the details are discussed in Section 8.5.1), with the processes below: 
1. Validate the dimensions. By counting the keys in dimension pairs from Dimension Processor on 
all candidates, the candidate is validated against whether it is the only one candidate with a 
dimension of “length”, “dimension”, “area” or “volume”. 
2. Validate the lexical items. The candidate is validated against: a) whether it obtains a positive 
score from the specimen site criterion; b) whether it obtains a zero score from the specimen site 
criterion. The criterion is depicted below: 
It returns variable values depending on the amount of lexical entries in the specimen site 
gazetteer the candidate has; else 0. The entries in the specimen site gazetteer can be sub-
classified to preferable terms and unfavourable terms. For a preferable term detected in the 
candidate, the criterion gain +1 score, while, a -1 score is obtained if the candidate has an 
unfavourable term. 
3. Validate the position. The candidate is validated against whether it appears first in all candidates. 
4. Validate the totality. The candidate is validated against whether it obtains a positive score from 
the total criterion (see Section I.2). 
5. Validate the size. The candidate is validated against whether it obtains a positive score from the 
maximum measurement criterion (also see Section I.2). 
 
The valid patterns are described as follows: 
Pattern 1: the candidate satisfies Conditions 1, 2a, and 3. 
Pattern 2: the candidate satisfies Conditions 3 and 4. 
Pattern 3: the candidate satisfies Conditions 2b, 3 and 5. 
Pattern 4: the candidate satisfies Conditions 1, 3 and 5. 
If the candidate matches one of the above patterns, it is verified as valid. 
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Descriptor Convertor 
Given the descriptors defined as the possible values for some fields (e.g., “Cell size” and 
“Cytomorphology”), the convertor standardizes the lexical variants in the candidates of associated 
entity types to these descriptors if applicable. 
 
Id Validation Module 
This module aims to solve an issue recognized in the first round error analysis that the system 
occasionally cannot assign a value to a specimen id under certain sections in a multiple specimen 
document. The basic idea is to determine the specimen id(s) for the population of fields under some 
section contexts without sufficient ids by checking whether the id(s) occur in other specific section 
contexts. For example, as the “SPECIMEN” section usually lacks specimen ids, the Sample Triage 
candidates are hard to assign for each specimen id. In contrast, the “FROZEN SECTION” often 
contains specimen ids. This module can determine whether a Sample Triage entity referred to in the 
“SPECIMEN” section can be populated for a particular specimen id by checking whether this id 
occurs in the “FROZEN SECTION”.   
 
Special Candidate Selection Module 
This is a complicated module designed to handle special cases where the best candidate(s) cannot be 
found by ranking but rather by particular rules.  
 
One of the examples is finding the appropriate De:Cell Growth Pattern candidates. Initially, all 
candidates were considered, unless their assertions are absent; after revision, their assertions were 
restricted to present and probable. 
 
Another example is choosing candidates for fields “Prev. Rx / Trauma” and “Other medical history” 
from De:Cosmetic Changes entities. Firstly, an entity is checked against: a) if the lexical items inside 
it are in the trauma/treatment gazetteer; b) if there is a valid result from the temporality module or the 
entity has the lexicon “following”; c) if the entity does not have the lexicon “scar”. If the entity 
satisfies Conditions a and b, it is classified to a candidate of “Prev. Rx / Trauma”; else, if it satisfies 
Condition c, it is categorized to a candidate of “Other medical history”. 
 
I.2 Ranking Criteria 
The motivation for creating ranking criteria was when multiple candidates for a field were present, 
only one or some of them should be used to populate to the field. Here is an example:  
… a raised tan-brown tumour [“De:Tumour Description”] with a polypoid surface partially 
covered in fibrinous exudate [“De:Tumour Description”], measuring 45mm proximal to 
distal [“De:Tumour Size”], 30mm in height [“De:Tumour Size”], 60mm wide [“De:Tumour 
Size”] and occupying approximately 65% of the mucosal circumference [“Ex:Extent”]… 
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There are up to three candidates for “Tumour size”: 45mm, 30mm and 60 mm, but apparently only 
60mm should be populated to the field. 
 
Ranking criteria were targeted to find the best candidate(s) by comparing the measure of each 
candidate resulting from a set of criteria; that is, a potential candidate was assigned a salience measure 
based on the criteria, and the one with the highest salience measure was selected as the best candidate.    
 
Span Length Criterion 
This criterion returns 1, if the candidate has the longest text span; else 0. 
 
Uppercase Criterion 
Thorough analyses show that pathologists tended to indicate the significance of certain terms by using 
uppercase in the melanoma corpus, while a De:Tumour Site entity in uppercase usually represents a 
non-specific location in the colorectal cancer corpus. 
 
For the melanoma corpus: This criterion returns 1, if the candidate is in uppercase; else 0. 
 
For the colorectal cancer corpus: This criterion returns -1, if the candidate is in uppercase; else 0. 
 
Negation Uncertainty Inapplicability Criterion 
If inapplicability is detected by the negation and uncertainty detection modules described in Chapter 
6, this criterion returns -1; if uncertainty is detected by the modules, it returns various scores 
depending on the category of the uncertainty: 0.3 for “cannot exclude”, 0.5 for “possible”, 0.8 for 
“probable” and 1 for “definite”. 
 
For the colorectal corpus: If negation is detected by the modules, it returns -1; if the assertion of the 
candidate is present, it returns 1. 
 
For the other two corpora: Initially, if the assertion of the candidate is present or absent, it returns 1. 
After revision, if the assertion of the candidate is absent, it returns -1. If the assertion of the candidate 
is present, it returns 1; for particular entity types, it returns 2, if a Li:Lexical Polarity Positive term is 
also present in the same sentence with the candidate, given the influence of the term. These entity 
types are Sy:Diagnosis and Sy:Subtype.  
 
Measurement Criterion 
Detailed analyses indicate that the representation of measurement in the melanoma corpus is simpler 
than that in the colorectal cancer corpus, thus extra weights of score were prepared for candidates in 
the colorectal cancer corpus. 
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For the melanoma corpus: This criterion returns 1, if there is a valid result from the measurement 
module; else 0. 
 
For the colorectal cancer corpus: Initially, it returns 2, if there is an exact numeric value obtained from 
the module; it returns 1, if there is a fuzzy numeric value obtained from the module; else 0. After 
revision, it returns 1 and 0.5 for the above first and second conditions respectively; it returns 0.8, if 
more than one valid result is obtained from the module. 
 
Clear Criterion 
This criterion returns 1, if a Ma:Excision Clear entity and the candidate are in the same sentence; else 
0. 
 
Frequency Criterion 
This criterion returns variable scores according to the frequencies of the tokens inside the candidate 
occurring in other candidates in the same specimen id’s (or ids’) context; if none of the tokens occur 
in other candidates, it returns 0.  
 
Note that there may be restrictions for the section contexts. For example, it excludes other candidates 
located in “CLINICAL HISTORY” for the colorectal cancer corpus. 
 
It should also be noticed that for the lymphoma corpus, when the candidate is a De:Topography entity, 
not only other candidates of the same type, but also the ones of De:Anatomical Structure should also 
be taken into consideration in the application of this criterion. After revision, tokens like “lymph” and 
“nodes” were ruled out during ranking, as these are general terms which reduce the specificity of the 
criterion. 
 
After the first round error analysis, the full form of the token should be used if it is an acronym or 
abbreviation. 
 
Primary Criterion 
This criterion returns 1, if the candidate refers to information about the primary lesion; else 0. 
 
Temporality Criterion 
This criterion returns 1, if the candidate is a Sy:Regression entity, and there is a valid result from the 
temporality module; it returns -1, if the candidate is a De:Topography or De:Anatomical Structure 
entity, and the result does not contain any of the lexical items “now”, “current” and “currently”; it 
returns -1, if the candidate is an entity of other entity types, and there is a valid result from temporality 
module; else 0. 
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Body Structure Criterion 
This criterion returns 1, if the medical category in SNOMED CT of the candidate is “Body structure”; 
else 0. 
 
Laterality Criterion 
This criterion returns 1, if the candidate contains an entry in the laterality gazetteer; else 0. 
 
Note that several lexical items were added to the gazetteer after first round error analysis. 
 
Melanoma Criterion 
Initially, this criterion returns 1, if the candidate contains an entry in the melanoma gazetteer; else 0.  
 
After revision, it was adjusted as follows: it returns 2, if the candidate contains the lexicon 
“melanoma”; 1, if the candidate contains another lexical entry in the melanoma gazetteer; else 0. 
 
Naevus Type Criterion 
This criterion returns 1, if there is a valid result from the naevus module; else 0. 
 
Level Criterion 
This criterion returns 1, if there is a valid result from the level module; else 0. 
 
Regress Criterion 
This criterion returns 1, if there is a valid result from the regress module; else 0. 
 
Dimension Criterion 
This criterion returns 1, if the candidate is a two or three dimensional size; else 0. 
 
Position Criterion 
Thorough analyses suggest that the requirement for applying this criterion is more stringent for the 
melanoma corpus that those for the lymphoma corpus, hence the conditions are specified for the two 
corpora. 
 
For the melanoma corpus: This criterion returns 1, if the candidate appears first in all candidates; else 
0. After revision, it was applied under a specific condition that the sentence where the candidate 
locates should have only one De:Specimen Type entity.  
 
For the lymphoma corpus: This criterion returns 1, if the candidate appears first or in the same 
sentence with the one that appears first; else 0. 
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Specimen Distance Criterion 
Initially, this criterion returned 1, if a De:Specimen type entity or the lexicon “specimen” and the 
candidates are in the same sentence; else 0. After revision, a four-word window size of the candidate 
is a specific condition that restricts the application of it for the melanoma corpus. 
 
Margin Criterion 
This criterion returns 1, if the candidate is a Ma:Excision Clear entity and co-occurs with any entity of 
Ma:Excision In Situ, Ma:Excision Invasive, or Ma:Excision Deep in the same sentence; else 0. 
 
Distribution Density Degree Criterion 
This criterion returns variable scores depending on the amount of valid results from the TILs module; 
for each valid result, it gains a +1 score. 
 
Rate Criterion 
This criterion returns 1, if there is a valid result from the rate module; else 0. 
 
Acronym Criterion 
This criterion returns -1, if the candidate has an acronym; else 0. 
 
Margin Type Criterion 
This criterion returns 1, if there is a valid result from the sub-classification module; else 0. 
 
Invasive Criterion 
This criterion returns 1, if the candidate refers to information about an invasive lesion; else 0. 
 
Mood Degree Criterion 
This criterion returns a score > 0 according to the result from the mood degree module; else 0. Note 
that if the candidate is a De:Architecture entity, it returns 1, if there is a valid result from the mood 
degree module. 
 
Diagnosis Criterion 
This criterion returns 2, if the candidate is adjacent to a Sy:Diagnosis entity; it returns 1, if they are in 
the same sentence; else 0. 
 
Breslow Criterion 
This criterion returns 1, if the candidate is a “Breslow thickness”; else 0. 
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Specific Criterion 
This criterion returns 1, if the candidate represents a specific biopsy type; else 0. 
 
Type Criterion 
This criterion returns 1, if the candidate ends with lexical items “type” or “pattern”; else 0. 
 
Summary Criterion 
This criterion returns 1, if there is a valid result from the subheading module; else 0. 
 
Tumour Site Criterion 
In this criterion, the lexical items inside the candidate are verified against the tumour site gazetteer, 
which includes preferable terms and unfavourable terms; for each preferable term, a +1 score is 
gained, while, a -1 score is assigned for each unfavourable term. If the candidate is a De:Specimen 
Type entity, additional unfavourable terms should be considered. 
 
Sub-classification Criterion 
This criterion returns 2, if the result from the sub-classification module meets the requirement of the 
field; it returns a score >=1, if part of the result meets the requirement of the field; else 0. 
 
For example, for “Venous invasion”, the sub-type requirement is “Large vessel”. For a In:Venous and 
Small Vessel Invasion candidate “venous invasion: not identified”, the criterion returns 2, as its sub-
type result is “Large vessel”; for another In:Venous and Small Vessel Invasion candidate 
“lymphovascular invasion: present”, the criterion returns 1, since it has a sub-type result: “Large 
vessel” and “Small vessel”. 
  
Maximum Measurement Criterion 
This criterion returns 1, if the result from the Dimension Processor is the maximum one in all 
candidates; else 0. 
 
After revision, this criterion cannot not be applied to a De:Tumour Size entity if the report is a 
multiple tumour document. 
 
Medical Category Criterion 
Initially, this criterion returns 1, if the medical category in SNOMED CT of the candidate is “Body 
structure” or “Procedure”; else 0.  
 
After revision, “Body structure” was excluded from the criterion. 
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Specimen Length Criterion 
This criterion returns 2, if there is a valid result from the Dimension Processor and the result is a 
measured length; it returns 1, if  the result is another measured dimension instead of length; else 0. 
 
Size Criterion 
This criterion returns 2, if there is a valid result from the Dimension Processor and the result is a 
measured volume or area; it returns 1, if the result is another measured dimension; else 0. 
 
Tumour Description Criterion 
The five patterns for verifying the candidates have been described in the tumour description module. 
This criterion returns 3, if the candidate matches Patterns 1, 2, or 4; it returns 2, if the candidate 
matches Pattern 3; it returns 1, if the candidate matches Pattern 5; else 0.  
 
After revision, additional lexical items “largest”, “polyp” and “nodule” were used to verify against the 
lexical items inside the candidate if it matches Pattern 3 or 5; for each match of these lexical items, a 
+1 score is assigned. 
 
Location Criterion 
This criterion returns 1, if the candidate indicates the relationship of the tumour to the anterior 
peritoneal reflection; else 0. 
 
Involvement number Criterion 
This criterion returns 1, if there is a valid result from the involvement number module; It returns 2, if 
the result represents the total count; else 0. 
 
Node number Criterion 
This criterion returns 1, if there is a valid result from the node number module; it returns 2, if the 
result represents the total count; else 0. 
 
T stage Criterion 
This criterion returns 1, if the candidate has an entry in the T stage gazetteer; else 0. 
 
R status Criterion 
This criterion returns 1, if the candidate has an entry in the R status gazetteer; else 0. 
 
Tumour Distance Criterion 
This criterion returns 1, if a De:Tumour Description entity, lexical items “tumour” or “it”, and the 
candidate is in the same sentence; else 0. 
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Procedure Criterion 
This criterion returns 1, if the candidate is a specific surgical procedure, such as “right 
hemicolectomy”, “anterior resection” and “Hartmann’s procedure”; else 0. 
 
Integrity Criterion 
This criterion returns 1, if the candidate indicates the intactness of the mesorectum; else 0. 
 
Tumour Boarder Status Criterion 
This criterion returns 1, if there is a valid result from the tumour border status module; else 0. 
 
Depth Criterion 
This criterion returns 1, if the candidate has the keyword “thickness”; else 0.  
 
The keyword was replaced with “depth” after revision. 
 
Regression Grade Criterion 
This criterion returns 1, if the candidate indicates the regression grade; else 0. 
 
Maximum Dimension Criterion 
This criterion returns 1, if the candidate represents the maximum measured dimension; else 0. 
 
Specimen id Criterion 
This criterion returns 1, if the candidate is in the same specimen id’s (or ids’) context with a 
De:Tumour Size or De:Tumour Description entity; else 0. 
 
Abbreviation Criterion 
This criterion returns 1, if the candidate is an abbreviation; else 0. 
 
Revision Criterion 
This criterion returns 1, if the candidate represents a revised classification of the stage; else 0. 
 
Noun Phrase Criterion 
This criterion returns 1, if the candidate has a noun (or nouns); else 0. 
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Grade Criterion 
This criterion returns 1, if the candidate is an explicit expression of the grade, e.g., “grade 1”; it 
returns -1, if the candidate is an implicit expression of the grade, e.g., “lower grade”; else 0.  
 
Total Criterion 
This criterion returns 1, if the candidate represents the total size; else 0. 
 
Cell Size Criterion 
This criterion returns 1, if a De:Cell Size entity and the candidate are in the same sentence; else 0. 
 
Architecture Criterion 
This criterion returns 1, if the candidate has an entry in the architecture gazetteer; else 0.  
 
The lexical entries in the gazetteer were modified after first round error analysis. 
 
Pattern Criterion 
Initially, this criterion returns 1, if the candidate has an entry in the pattern gazetteer; else 0.  
 
After first round error analysis, the pattern gazetteer was divided into preferable terms and 
unfavourable terms, and the ranking process resembled that in specimen site criterion. 
 
POS Criterion 
This criterion returns 1, if the candidate has a noun or adjective; it returns -1, if the candidate has a 
verb; else 0. 
 
Classification Criterion 
This criterion returns 1, if the candidate is a grade from WHO ICD-10 classification system; it returns 
-1, if the candidate is a grade from other classification systems, such as the Revised European 
American Lymphoma Classification (REAL) and Working Formulation (WF); else 0. 
 
Tissue Reaction Criterion 
This criterion returns 1, if a Re:Tissue Reaction entity precedes the candidate, and they are in the same 
sentence, or a Re:Tissue Reaction entity succeeds the candidate within a three-token window; else 0. 
 
Malignancy Criterion 
This criterion returns -1, if the candidate does not indicate a specific malignant disease; else 0. 
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Addition Criterion 
This criterion returns 1, if the candidate represents an additional size; else 0. 
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Appendix II Application of the Post-processing Modules and Ranking Criteria for the Structured Fields in 
Each Corpus 
II.1 Melanoma Corpus  
Template section Template item Post-processing module Ranking criterion 
Diagnostic Summary Summary 
 
  
Comment 
 
  
Supporting 
Information 
 
CLINICAL Description 
 
  
Site and laterality  Span length criterion, uppercase criterion, frequency criterion, body 
structure criterion, laterality criterion 
Clinical diagnosis 
 
Special candidate selection module Negation uncertainty inapplicability criterion 
Specimen type  Span length criterion, temporality criterion*, specific criterion* 
Prev. Rx / Trauma Special candidate selection module  
Previous melanoma Special candidate selection module  
Distant metastasis Special candidate selection module Negation uncertainty inapplicability criterion 
Other medical 
history 
Special candidate selection module  
MACROSCOPIC Description 
 
  
Size of specimen Dimension Processor Dimension criterion, position criterion, specimen distance criterion 
Other lesions  Negation uncertainty inapplicability criterion 
MICROSCOPIC 
 
Description   
Diagnosis 
 
 Uppercase criterion, frequency criterion, negation uncertainty 
inapplicability criterion, acronym criterion*, melanoma criterion 
Tumour thickness Measurement module Measurement criterion, Breslow criterion* 
Excision margins: 
Invasive 
Clear Processor*, measurement 
module, sub-classification module* 
Measurement criterion, clear criterion, primary criterion*, margin 
criterion, margin type criterion*, invasive criterion* 
Appendix II Application of the Post-processing Modules and Ranking Criteria for the Structured Fields in Each Corpus 
286 
 
 
Excision margins: 
In-situ 
 
Clear Processor, measurement 
module, sub-classification module* 
 
Measurement criterion, clear criterion, primary criterion*, margin 
criterion, margin type criterion* 
Excision margins: 
Deep 
 
Clear Processor, measurement 
module, sub-classification module* 
Measurement criterion, clear criterion, primary criterion*, margin 
criterion, margin type criterion* 
Ulceration (mm 
diam) 
 
Measurement module Span length criterion, uppercase criterion, negation uncertainty 
inapplicability criterion, measurement criterion 
Mitotic rate Rate module Rate criterion 
Microsatellites  Negation uncertainty inapplicability criterion 
Level of invasion 
(Clark) 
Level module 
 
Uppercase criterion, level criterion 
Lymphovascular 
invasion 
 Span length criterion, uppercase criterion, negation uncertainty 
inapplicability criterion 
TILs  Negation uncertainty inapplicability criterion, acronym criterion* 
TILs: Distribution TILs module Distribution density degree criterion 
TILs: Density TILs module Distribution density degree criterion 
Regression 
 
Temporality module, regress module Temporality criterion, regress criterion, negation uncertainty 
inapplicability criterion 
Desmoplasia  Negation uncertainty inapplicability criterion 
Neurotropism  Negation uncertainty inapplicability criterion 
Assoc. benign 
naevus 
 
Naevus module, special candidate 
selection module* 
 
Span length criterion, frequency criterion*, negation uncertainty 
inapplicability criterion, naevus type criterion, mood degree 
criterion* 
Cell growth 
 
Special candidate selection module  
Subtype  Frequency criterion*, negation uncertainty inapplicability criterion, 
acronym criterion*, diagnosis criterion*, type criterion* 
Note: Module or criterion marked with * means it was added after the first round error analysis.  
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II.2 Colorectal Cancer Corpus 
Template section Template item Post-processing module Ranking criterion 
Diagnostic Summary 
 
Summary   
Comment   
Supporting 
Information 
 
CLINICAL 
 
Site Tumour Site Processor Measurement criterion, tumour site criterion 
Other sites of disease   
Medical history   
MACROSCOPIC 
 
Specimen type Subheading module Summary criterion, tumour site criterion, medical category criterion, 
procedure criterion, abbreviation criterion*, frequency criterion* 
Tissue banking  Negation uncertainty inapplicability criterion 
Specimen images  Negation uncertainty inapplicability criterion 
Specimen length Dimension Processor, Specimen 
Length Processor* 
Maximum measurement criterion, specimen length criterion, specimen 
distance criterion, specimen id criterion 
Tumour site Tumour Site Processor, subheading 
module 
Measurement criterion, summary criterion, tumour site criterion, 
uppercase criterion*, specimen id criterion* 
Peritoneal reflection Descriptor Convertor, subheading 
module 
Summary criterion, location criterion 
Mesorectal integrity Descriptor Convertor Integrity criterion 
Tumour size Dimension Processor, subheading Summary criterion, maximum measurement criterion, size criterion, 
tumour distance criterion, maximum dimension criterion 
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module 
Extramuscular 
spread 
Measurement module, tumour 
boarder status module 
Measurement criterion, tumour boarder status criterion 
Tumour description Subheading module, tumour 
description module 
Summary criterion, tumour description criterion 
Overlying serosa Subheading module* Summary criterion* 
Perforation Subheading module Summary criterion, negation uncertainty inapplicability criterion 
Margins:Proximal Measurement module, subheading 
module, Clear Processor* 
Measurement criterion, summary criterion, sub-classification criterion 
Margins:Distal Measurement module, subheading 
module, Clear Processor* 
Measurement criterion, summary criterion, sub-classification criterion 
Margins:Radial Measurement module, subheading 
module, Clear Processor* 
Measurement criterion, summary criterion, sub-classification criterion 
Lymph nodes Node number module, subheading 
module 
 
Summary criterion, node number criterion 
Metastases  Subheading module Summary criterion, sub-classification criterion, negation uncertainty 
inapplicability criterion 
Blocks selected   
Comment   
MICROSCOPIC 
 
Histological type 
(WHO) 
Subheading module Summary criterion, negation uncertainty inapplicability criterion 
Histological grade Subheading module Summary criterion 
Appendix II Application of the Post-processing Modules and Ranking Criteria for the Structured Fields in Each Corpus 
289 
 
Depth of invasion Subheading module Measurement criterion, summary criterion, T stage criterion, depth 
criterion 
Serosal involvement Subheading module Summary criterion, negation uncertainty inapplicability criterion 
Small vessel invasion Subheading module Summary criterion, sub-classification criterion, negation uncertainty 
inapplicability criterion 
Venous invasion Subheading module Summary criterion, sub-classification criterion, negation uncertainty 
inapplicability criterion 
Perineural invasion Subheading module Summary criterion, negation uncertainty inapplicability criterion 
TILs TILs module, sub-classification 
module 
Summary criterion, sub-classification criterion, distribution density 
degree criterion, negation uncertainty inapplicability criterion 
Margins:Proximal Measurement module, subheading 
module, Clear Processor* 
Measurement criterion, summary criterion, sub-classification criterion 
Margins:Distal Measurement module, subheading 
module, Clear Processor* 
Measurement criterion, summary criterion, sub-classification criterion 
Margins:Radial Measurement module, subheading 
module, Clear Processor* 
Measurement criterion, summary criterion, sub-classification criterion 
Lymph nodes Node number module, subheading 
module 
Summary criterion, node number criterion 
Number involved Involvement number module, 
subheading module 
Summary criterion, involvement number criterion 
Distant spread Subheading module Summary criterion, sub-classification criterion, negation uncertainty 
inapplicability criterion 
Response to Rx  Regression grade criterion 
Comment   
ANCILLARY 
STUDIES 
Description    
SYNTHESIS TNM stage:T Subheading module* Revision criterion* 
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 TNM stage:N Subheading module* Revision criterion* 
TNM stage:M Subheading module* Revision criterion* 
Stage group Subheading module Revision criterion* 
Residual tumour (R) Subheading module Summary criterion, R status criterion 
Comment   
Note:  Module or criterion marked with * means it was added after the first round error analysis. 
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II.3 Lymphoma Corpus 
Template section Template item Post-processing 
module 
Ranking criterion 
Diagnostic Summary 
 
Summary   
Comment   
Supporting 
Information 
 
CLINICAL 
 
Site and laterality  Noun phrase criterion, frequency criterion, temporality criterion, laterality 
criterion 
Presentation Temporality 
module 
 
Indication for biopsy Descriptor 
Convertor 
 
Clinical impression  Negation uncertainty inapplicability criterion 
Disease extent   
Other sites of disease  Negation uncertainty inapplicability criterion 
Const. symptoms  Negation uncertainty inapplicability criterion 
Medical history  Malignancy criterion* 
 
Predisposing factors  Negation uncertainty inapplicability criterion 
SPECIMEN 
 
Specimen type Descriptor 
Convertor 
 
Frequency criterion*, medical category criterion, procedure criterion, 
specific criterion 
Size Dimension 
Processor 
 
Position criterion, size criterion, total criterion, addition criterion* 
Received in   
Triage Id validation 
module* 
 
Description   
MICROSCOPIC Pattern of infiltration Descriptor 
Convertor 
 
Negation uncertainty inapplicability criterion, mood degree criterion, cell 
size criterion, architecture criterion, pattern criterion 
Cell size Descriptor Position criterion, tissue reaction criterion* 
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Convertor 
 
Cytomorphology Descriptor 
Convertor 
 
Negation uncertainty inapplicability criterion 
Tissue reactions Mood degree 
module 
 
Negation uncertainty inapplicability criterion, POS criterion* 
Grade  Negation uncertainty inapplicability criterion, grade criterion, 
classification criterion* 
Description   
IMMUNOPHENOTYPING 
 
Immunohistochemistry: 
Positive for 
Id validation 
module 
 
 
Immunohistochemistry: 
Negative for 
Id validation 
module 
 
Immunohistochemistry: 
Equivocal for 
Id validation 
module 
 
Immunohistochemistry: 
Comment 
Id validation 
module 
 
Flow cytometry: 
Positive for 
Id validation 
module 
 
Flow cytometry: 
Negative for 
Id validation 
module 
 
Flow cytometry: 
Comment 
Id validation 
module 
 
CYTOGENETICS 
 
FISH Id validation 
module 
 
Cytogenetics:  
Comment 
Id validation 
module 
 
MOLECULAR 
 
PCR: IgH Id validation 
module 
 
PCR: TCRgamma Id validation 
module 
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PCR: Comment Id validation 
module 
 
SYNTHESIS Lineage Descriptor 
Convertor 
 
Clonality   
Diagnosis (WHO)  Negation uncertainty inapplicability criterion 
SNOMED RT Codes   
Stage   
Comment   
Note: Module or criterion marked with * means it was added after the first round error analysis. 
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Appendix III Output Examples for Some Structured Fields in Each Corpus 
III.1 Melanoma Corpus 
Template section Template item Input  Output 
Diagnostic Summary Summary 
 
  
Comment 
 
  
Supporting 
Information 
 
CLINICAL Description 
 
  
Site and laterality (1) L Arm 
(2) (R) face  
(1) left arm 
(2) right face 
Clinical diagnosis 
 
(1) ? [“Li:Modality”] lentigo maligna [“Sy:Subtype”]  
(2) exclude[“Li:Lexical Polarity Negative”]  malignant melanoma 
[“Sy:Diagnosis”]  
(1) possible lentigo maligna 
(2) no malignant melanoma 
Specimen type   
Prev. Rx / Trauma previous [“Li:Temporality”] surgical procedure [“De:Cosmetic Changes”] surgical procedure (previous) 
Previous 
melanoma 
Past history [“Li:Temporality”]  of malignant melanoma [“Sy:Diagnosis”]  present 
Distant metastasis metastasis present 
Other medical 
history 
Skin lesion [“En:Primary Lesion”]  from right thigh [“De:Site and Laterality”] 
(small [“Li:Mood and Comment Adjuncts”] recent [“Li:Temporality”] increase 
in size [“De:Cosmetic Changes”]) 
lesion; increase in size (recent) 
MACROSCOPIC Description 
 
  
Size of specimen (1) 4mm in diameter and 2mm in depth  
(2) 9.5mm dia  
(3) 7x6mm  
(4) 5 x 6 mm to a depth of 3 mm  
(5) 65mm in length, width of 30mm and maximum thickness of 13mm  
(6) 15mm in maximal dimension  
(1) 4mm  diameter and 2mm  
depth (4mm dia x 2mm) 
(2) 9.5mm diameter 
(3) 7mm x 6mm 
(4) 5mm x 6mm x 3mm 
(5) 65mm x 30mm x 13mm 
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(6) 15mm 
Other lesions A second, separate area [“En:Lesion (other)”] of purple discolouration 
[“De:Shape”] is present [“Li:Lexical Polarity Positive”] 
present 
MICROSCOPIC 
 
Description 
 
  
Diagnosis 
 
(1) no [“Li:Lexical Polarity Negative”]   evidence [“Li:Lexical Polarity 
Positive”] of malignancy [“Sy:Diagnosis”]  
(2) sections [“En:Specimen Identifier”] show [“Li:Lexical Polarity Positive”] a 
malignant melanoma [“Sy:Diagnosis”] 
(1) no malignancy 
(2) malignant melanoma 
Tumour thickness (1) thickness of 5.0mm 
(2) maximum depth of 1.0mm  
(1) 5.0mm 
(2) 1.0mm 
Excision margins: 
Invasive 
 
(1) Excision appears complete [“Ma:Excision Clear”]; Clearance values are 
2.1mm and 1.1mm laterally [“Ma:Excision Invasive”] and 0.7mm to the deep 
surface [“Ma:Excision Deep”].  
(2) nearest margin of excision is 2.4mm  
(1) clear - 2.1mm and 1.1mm 
(2) 2.4mm 
Excision margins: 
In-situ 
 
(1) clear of the resection margins [“Ma:Excision Clear”] with a minimum 
measured deep clearance (from the invasive component) of 4.3mm 
[“Ma:Excision Invasive”] and a minimum measured lateral clearance (from the 
intraepidermal in-situ component) of 2.3mm [“Ma:Excision In Situ”].  
(2) close to one lateral border, within 0.2mm  
(1) clear - 2.3mm 
(2) 0.2mm 
Excision margins: 
Deep 
 
(1) Excision appears complete [“Ma:Excision Clear”]; Clearance values are 
2.1mm and 1.1mm laterally [“Ma:Excision Invasive”] and 0.7mm to the deep 
surface [“Ma:Excision Deep”].  
(2) deep margin is 1.4mm  
(1) clear - 0.7mm 
(2) 1.4mm 
Ulceration (mm 
diam) 
(1) THE SURFACE ULCERATION MEASURES 4.5MM  
(2) no [“Li:Lexical Polarity Negative”] ulceration [“De:Ulceration”]  
(1) present (4.5mm) 
(2) absent 
Mitotic rate (1) four to eight mitoses per high power field  
(2) Mitoses are less than ten per high powered fields  
(3) average 3-4 per mm square  
(4) mitotic activity of up to 2 mitoses/mm2  
(5) average 1 per 5 high power fields  
(1) 4-8/hpf 
(2) less than 10/hpf 
(3) 3-4/mm2 
(4) 2/mm2 
(5) 1/5 hpf 
Microsatellites  ? [“Li:Modality”] SATELLITE FOCUS [“En:Satellites”]   possible 
Level of invasion 
(Clark) 
(1) Clark level IV  
(2) Clark level 3-4  
(1) IV 
(2) III-IV 
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Lymphovascular 
invasion 
no [“Li:Lexical Polarity Negative”] vascular invasion 
[“In:Vascular/Lymphatic”] identified [“Li:Lexical Polarity Positive”] 
absent 
TILs Scanty [“Li:Mood and Comment Adjuncts”] tumour infiltrates of lymphocytes 
[“Re: TILs”] are noted [“Li:Lexical Polarity Positive”]. 
present 
TILs: Distribution (1) heavy [“Li:Mood and Comment Adjuncts”]  band-like lymphocytic infiltrate 
[ “Re:TILs”]  
(2) sparse [“Li:Mood and Comment Adjuncts”]   patchy [“Li:Mood and 
Comment Adjuncts”]   lymphoid infiltrate [“Re:TILs”]  
(1) band-like 
(2) patchy 
TILs: Density (1) heavy [“Li:Mood and Comment Adjuncts”]  band-like lymphocytic infiltrate 
[ “Re:TILs”]  
(2) sparse [“Li:Mood and Comment Adjuncts”]  patchy [“Li:Mood and 
Comment Adjuncts”]  lymphoid infiltrate [“Re:TILs”] 
(1) heavy 
(2) sparse 
Regression 
 
(1) possible [“Li:Modality”]  partial regression [“Sy:Regression”]  
(2) in keeping with [“Li:Lexical polarity Positive”]  active regression 
[“Sy:Regression”] 
(3) consistent with [“Li:Lexical polarity Positive”] early [“Li:Temporality”] 
regression [“Sy:Regression”]  
(1) possibly (partial) 
(2) present (active) 
(3) present (early) 
Desmoplasia no [“Li:Lexical Polarity Negative”] obvious [“Li:Mood and Comment 
Adjuncts”] desmoplasia [“Re:Desmoplasia”] 
absent  
Neurotropism No [“Li:Lexical Polarity Negative”] perineural invasion [“In:Neurotropism”] is 
seen 
absent 
Assoc. benign 
naevus 
 
(1) arising from a dysplastic naevus  
(2) no [“Li:Lexical Polarity Negative”] associated naevus [“En:Associated 
naevus (type)”]  
(1) dysplastic naevus 
(2) absent 
Cell growth 
 
an asymmetrical poorly circumscribed proliferation [“De:Cell Growth Pattern”] 
of atypical melanocytes [“De:Cell Type”] arranged in confluent units and nests 
[“De:Cell Growth Pattern”] 
asymmetrical poorly 
circumscribed proliferation, 
confluent units and nests 
Subtype (1) malignant melanoma [“Sy:Diagnosis”] of superficial spreading type 
[“Sy:Subtype”] 
(2) Sections [“En:Specimen Identifier”] show [“Li:Lexical Polarity Positive”] a 
nodular [“Sy:Subtype”] malignant melanoma [“Sy:Diagnosis”] 
(1) superficial spreading 
(2) nodular 
Note: Multiple samples are separated by semicolon “;”; sample text without specification suggests the whole text is an entity of the associated medical entity type. 
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III.2 Colorectal Cancer Corpus 
Template section Template item Input  Output 
Diagnostic Summary 
 
Summary   
Comment   
Supporting 
Information 
 
CLINICAL 
 
Site (1) Ca.rectum  
(2) Ca.R.colon  
(3) 4 cm from anal wrge  
(1) rectum 
(2) right colon 
(3) 4 cm from anal verge 
Other sites of 
disease 
  
Medical history   
MACROSCOPIC 
 
Specimen type (1) Specimen type: Extended right hemicolectomy 
(2) AP resection 
(1) extended right 
hemicolectomy 
(2) abdominoperineal 
resection 
Tissue banking Tissue Banking - not done no 
Specimen images Macroscopic Photos - not taken no 
Specimen length (1) A length of large bowel 200mm [“De:Specimen Size”] with attached mesocolon 
70mm wide [“De:Specimen Size”] 
(2) An anterior resection [“De:Specimen Type”] specimen comprising recto-sigmoid 
colon measuring 150mm [“De:Specimen Size”] with attached peri-colic fat up to 
60mm [“De:Specimen Size”] 
(3) A right hemicolectomy [“De:Specimen Type”] consisting of terminal ileum 
(45mm in length and 35mm in circumference) [“De:Specimen Size”], caecum and 
ascending colon (120mm in length and 80mm in circumference) [“De:Specimen 
Size”], mesenteric fat (115mm in width) [“De:Specimen Size”] 
(1) 200mm 
(2) 150mm 
(3) N/A 
Tumour site (1) Located within the transverse colon [“De:Tumour Site”] (165mm distal to 
ileocaecal valve [“De:Tumour Site”], and 55mm proximal to the distal resection 
margin [“Ma:Proximal or Distal Margin”]) 
(1) transverse colon, 165mm 
distal to ileocaecal valve 
(2) caecum, just above the 
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(2) Site of tumour : Caecum, just above the ileocaecal valve  ileocaecal valve 
Peritoneal 
reflection 
(1) 10mm above the anterior peritoneal reflection  
(2) below the level of the peritoneal reflection 
(3) straddling the line of peritoneal reflection  
(1) above 
(2) below 
(3) astride 
Mesorectal 
integrity 
(1) distal half of the mesorectal excision is incomplete  
(2) status of mesorectal excision: intact  
(3) intactness of mesorectum: complete  
(1) incomplete 
(2) complete 
(3) complete 
Tumour size (1) 22 x 18mm  
(2) 28mm in axial length and 25mm in transverse dimension  
(3) 32mm in axial length and 35mm in  width  
(4) 4.0x4.0 cm  
(1) 22mm 
(2) 28mm 
(3) 35mm 
(4) 40mm 
Extramuscular 
spread 
(1) just beyond it to a depth of 0.8 mm  
(2) tumour edge – infiltrative 
(3) broad pushing front  
(1) 0.8mm 
(2 ) infiltrative 
(3) pushing 
Tumour 
description 
(1) annular constricting  tumour  
(2) brown ulcerated tumour with rounded raised border  
(3) bulky, ulcerated  
(4) central area of  ulceration  
(5) bulk of the tumour is exophytic  
(1) annular constricting 
(2) brown ulcerated with 
rounded raised border 
(3) bulky, ulcerated 
(4) central area of  ulceration 
(5) exophytic 
Overlying serosa (1) serosa is smooth 
(2) Overlying serosa: Puckered 
(1) serosa is smooth 
(2) puckered  
Perforation (1) perforated area near to the tumour 
(2) Perforation: Present, 12 x 8 mm in area, 30 mm proximal to tumour 
(1) present 
(2) present 
Margins:Proximal (1) distal and proximal resection margins are clear of tumour  [“Ma:Clear”] (at least 
20mm [“Ma:Proximal or Distal Margin”])  
(2) Distance from proximal margin: 3.5cm (measured from the tumour in sigmoid 
colon) [“Ma:Proximal or Distal Margin”]; Proximal resection margin: No 
involvement, as confirmed histologically” [“Ma:Clear”]  
(3) 75mm from the proximal ileal resection margin [“Ma:Proximal or Distal 
Margin”] 
(1) clear (20mm) 
(2) clear (3.5cm) 
(3) 75mm 
 
Margins:Distal (1) 110mm from the distal resection margin [“Ma:Proximal or Distal Margin”]; not 
seen on the free margin of the specimen [“Ma:Clear”]   
(2) Distance from distal margin: 2.5cm (measured from the tumour in rectum) 
(1) clear (110mm) 
(2) clear (2.5cm)  
(3) 130mm 
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[“Ma:Proximal or Distal Margin”]; Distal resection margin: No involvement, as 
confirmed histologically [“Ma:Clear”]   
(3) 130mm from the distal resection margin [“Ma:Proximal or Distal Margin”]  
 
Margins:Radial (1) 0.1cm from the nearest radial margin [“Ma:Circumferential Margin”] 
(2) 1.1mm from the serosal margin [“Ma:Circumferential Margin”]  
(3) tumour extends to within 0.5mm of the visceral peritoneum [“Ma:Circumferential 
Margin”]; resection margin show unremarkable small and large bowel [“Ma:Clear”]  
(1) 0.1cm 
(2) 1.1mm 
(3) clear (0.5mm) 
 
Lymph nodes (1) 12 lymph nodes are identified, 2 to 6mm in greatest  dimension 
(2) Approximately twenty lymph nodes found  
(3) No nodes are  identified  
(4) No apical node is identified; Up to thirty-five  mesenteric nodes have been 
submitted for histological assessment 
(5) 20 pericolonic lymph nodes were identified  ranging from 3mm to 5mm in 
diameter; five high tie lymph nodes  ranging from 4mm to 7mm in diameter were 
identified  
(1) 12 
(2) 20 
(3) 0 
(4) 35 
(5) 25 
 
Metastases  (1) 3 separate tumour deposits,4-5mm in greatest dimension, are also present 
(2) No metastases 
(1) present 
(2) absent 
Blocks selected   
Comment   
MICROSCOPIC 
 
Histological type 
(WHO) 
(1) mucinous adenocarcinoma 
(2) HISTOLOGICAL TUMOUR TYPE: Adenocarcinoma, NOS 
(1) mucinous adenocarcinoma 
(2) Adenocarcinoma, NOS 
Histological grade (1) moderately differentiated 
(2) Degree of differentiation: Moderately differentiated 
(1) moderately differentiated 
(2) Moderately differentiated 
Depth of invasion (1) Tumour invades through the mucosa into the  inner layers of the muscularis 
propria 
(2) Local invasion: Beyond muscularis propria (pT3) 
(3) Tumour extends to lie approximately 0.2mm from the closest serosal surface 
 
(1) Tumour invades through 
the mucosa into the  inner 
layers of the muscularis 
propria 
(2) Beyond muscularis propria 
(pT3) 
(3) Tumour extends to lie 
approximately 0.2mm from 
the closest serosal surface 
Serosal 
involvement 
(1) serosa is clear 
(2) invades the serosa 
(1) absent 
(2) present 
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Small vessel 
invasion 
(1) focal infiltration of lymphatic vessels 
(2) Focal intra-lymphatic tumour permeation is highly suspicious 
(1) present 
(2) probable 
Venous invasion (1) Extramural vein invasion Not identified 
(2) Venous  invasion is identified 
(1) absent 
(2) absent 
Perineural invasion (1) focal perineural invasion 
(2) Perineural invasion: No 
(1) present 
(2) absent 
TILs (1) Tumour infiltrating lymphocytes are   inconspicuous 
(2) Tumour infiltrating lymphocytes and/or Crohn's-like inflammation: No  
(3) no significant peritumoral diffuse or nodular lymphocytic inflammatory response  
(1) TILs: present (minimal). 
(2) TILs: absent. 
      Crohn's like: absent. 
(3) Peritumoural: absent. 
Margins:Proximal (1) 160mm from one surgical margin [“Ma:Proximal or Distal Margin”] and 140mm 
from the opposite surgical margin [“Ma:Proximal or Distal Margin”]   
(2) proximal ileal and distal colonic resection margins are clear of the tumour 
[“Ma:Clear”]  
(3) all  resection margins are well clear of the tumour [“Ma:Clear”]   
(1) 160mm/140mm 
(2) clear 
(3) clear 
Margins:Distal (1) 160mm from one surgical margin [“Ma:Proximal or Distal Margin”] and 140mm 
from the opposite surgical margin [“Ma:Proximal or Distal Margin”]  
(2) proximal ileal and distal colonic resection margins are clear of the tumour 
[“Ma:Clear”]  
(3) all  resection margins are well clear of the tumour [“Ma:Clear”]   
(1) 160mm/140mm 
(2) clear 
(3) clear 
Margins:Radial (1) nearest soft tissue resection margin to tumour appears to be that around dome of 
bladder, which is 10mm away [“Ma:Circumferential Margin”]; nearest mesenteric 
resection margin is 30mm away [“Ma:Circumferential Margin”] 
(2) “clear of the radical resection margin” [“Ma:Clear”]   
(3) all  resection margins are well clear of the tumour [“Ma:Clear”]   
(1) 10mm/30mm 
(2) clear 
(3) clear 
Lymph nodes (1) All 8 lymph nodes dissected from the mesentery are small and reactive,  
including the apical [“En:Lymph Nodes”]  
(2) Ten separate regional mesenteric lymph nodes have been examined [“En:Lymph 
Nodes”]   
(3) One (1) of sixteen (16) lymph nodes show a small deposit of  metastatic 
carcinoma [ “Ex:Lymph Node Involvement”]  
(4) Node summary 1/57 [ “Ex:Lymph Node Involvement”]  
(5) three lymph nodes were seen in fat associated  with sections of the wall 
[“En:Lymph Nodes”]; Eight lymph nodes were isolated from pericolic fat 
(1) 8 
(2) 10 
(3) 16 
(4) 57 
(5) 27 
(6) 5 
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[“En:Lymph Nodes”]; Two lymph nodes are in  identified pericolic fat associated 
with the wall of the bowel [“En:Lymph Nodes”]; Fourteen lymph nodes were 
isolated  from pericolic fat [“En:Lymph Nodes”] 
(6) Three of the local lymph nodes shows metastatic mucinous tumour including the 
large proximal node [ “Ex:Lymph Node Involvement”] ; “Two proximal ileocaecal 
nodes are clear of tumour” [ “Ex:Lymph Node Involvement”]  
Number involved (1) 2 are infiltrated by malignant cells  
(2) Eleven benign lymph nodes  identified  
(3) Three of thirteen lymph nodes are involved by  metastatic carcinoma  
(4) 4 out of 16 lymph nodes show  metastatic  carcinoma  
(5) 1/26  
(6) Three of the local lymph nodes shows metastatic mucinous tumour including the 
large proximal node; Two proximal ileocaecal nodes are clear of tumour  
(7) 10 are positive for tumour; apical lymph node is replaced by  mucinous tumour 
with some associated scarring  
(8) seven of which contain  metastatic tumour; six of which contain metastatic  
tumour 
(1) 2 
(2) 0 
(3) 3 
(4) 4 
(5) 1 
(6) 3 
(7) 11 
(8) 13 
Distant spread (1) consistent with metastatic deposit in the bladder 
(2) Mesenteric deposits:  Nil 
(1) present 
(2) absent 
Response to Rx   
Comment   
ANCILLARY 
STUDIES 
Description    
SYNTHESIS 
 
TNM stage:T   
TNM stage:N   
TNM stage:M   
Stage group   
Residual tumour 
(R) 
(1) Residual tumour - none notified 
(2) Residual tumour (R) 0 
(3) residual tumour  
(1) none notified 
(2) R0 
(3) residual tumour 
Comment   
Note: Multiple samples are separated by semicolon “;”; sample text without specification suggests the whole text is an entity of the associated medical entity type. 
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III.3 Lymphoma Corpus 
Template section Template item Input  Output 
Diagnostic Summary 
 
Summary   
Comment   
Supporting 
Information 
 
CLINICAL 
 
Site and laterality (1) (L) [“De:Laterality”] recurrent [“Sy:Indication for Biopsy”] 
parotid [“De:Anatomical Structure”] tumour 
(2) cervical LN [“De:Topography”] 
(1) left parotid 
(2) cervical lymph node 
Presentation (1) Swelling [“Sy:Presentation”] Lt distal femur 
[“De:Topography”] & knee [“De:Anatomical Structure”] since 
2mths [“Li:Temporality”] 
(2) Generalised [“Ex:Disease Extent”] lymphadenopathy 
[“Sy:Presentation”] 
(1) swelling (since 2 months) 
(2) lymphadenopathy 
Indication for biopsy (1) ? [“Li:Lexical Modality”] NHL recurrence [“Sy:Indication for 
Biopsy”] 
(2) Core bx [“De:Specimen Type”] inconclusive [“Sy:Indication 
for Biopsy”] 
(1) relapse 
(2) core biopsy inconclusive 
Clinical impression (1) ? [“Li:Lexical Modality”]  lymphoma [“Sy:Clinical 
Impression”] 
(2) suspicions for [“Li:Lexical Modality”] Hodgkin's Lymphoma 
[“Sy:Clinical Impression”] 
(1) possible lymphoma 
(2) possible Hodgkin's 
lymphoma 
Disease extent   
Other sites of disease (1) ? [“Li:Lexical Modality”] maybe [“Li:Lexical Modality”] 
spreading to kidney [“Ex:Other Sites of Disease”] 
(2) involving mediastinum 
(1) possible 
(2) present  
Const. symptoms (1) Night sweats [“Sy:Constitutional Symptoms”], weight loss 
[“Sy:Constitutional Symptoms”] 
(2) He initially experienced flu-like symptoms [“Sy:Constitutional 
Symptoms”]  6 weeks ago [“Li:Temporality”] 
(1) night sweats, weight loss 
(2) flu-like symptoms 
Medical history   
Predisposing factors (1) Hep C 
(2) Post CTx 
(1) hepatitis c 
(2) post chemotherapy 
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SPECIMEN 
 
Specimen type (1) Excision Bx 
(2) core biopsies 
(1) excision biopsy 
(2) core biopsy 
Size (1) 8 and 3mm across 
(2) 40 x 20 x 15mm 
(3) 4 to 13mm across 
(4) 20mm in length and diameter 3mm 
(1) 8 and 3mm 
(2) 40x20x15mm 
(3) 4-13mm 
(4) 20x3mm 
Received in   
Triage   
Description   
MICROSCOPIC Pattern of infiltration (1) Sections show [“Li:Lexical Polarity Positive”] a diffuse 
proliferation [“De:Architecture”] of atypical lymphoid cells (2) 
though focal lymphoepithelial lesions [“De:Architecture”] are seen 
(3) scattered [“Li:Mood and Comment Adjuncts”] lymphoid 
follicles/nodules [“De:Architecture”] 
(1) diffuse 
(2) lymphoepithelial lesions 
(3) follicular, nodular 
Cell size (1) small lymphoid cells 
(2) small to intermediate lymphoid cells 
(3) variable size 
(1) small 
(2) small to medium 
(3) mixed 
Cytomorphology (1) Occasional binucleate Reed-Sternberg cells 
[“De:Cytomorphology”] are identified [“Li:Lexical Polarity 
Positive”]. 
(2) Most [“Li:Mood and Comment Adjuncts”] of the cells in the 
follicles [“De:Architecture”] are small [“De:Cell Size”] irregular 
cleaved centrocytes [“De:Cytomorphology”] 
(3) non-cleaved centroblasts [“De:Cytomorphology”] 
(1) Reed-Sternberg 
(2) centrocytic 
(3) centroblastic 
Tissue reactions (1) an ulcerated lesion with necrosis [“Re:Tissue Reaction”] 
(2) one of which consists mostly [“Li:Mood and Comment 
Adjuncts”] of tumourous tissue within sclerotic fibrous stroma 
[“Re:Tissue Reaction”] 
(1) necrosis 
(2) sclerotic fibrous stroma 
 
Grade (1) The features are of follicular lymphoma [“Sy:Diagnosis”], 
WHO grade 2 [“Sy:WHO Grade”]. 
(2) frequent mitoses suggests [“Li:Lexical Polarity Positive”]  it is 
high grade [“Sy:WHO Grade”] 
(1) WHO grade 2 
(2) high grade 
Description   
IMMUNOPHENOTYPING Immunohistochemistry: (1) Positive [“An:Immunohistochemistry-Positive”] - CD30 (1) CD30, CD15, CD20 
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 Positive for [“An:Biomarker”] +++ [“An:Immunohistochemistry-Positive”], 
CD15 [“An:Biomarker”]  ++ [“An:Immunohistochemistry-
Positive”], CD20 [“An:Biomarker”] ++ 
[“An:Immunohistochemistry-Positive”] 
(2) On immunohistochemical stains the cells show [“Li:Lexical 
Polarity Positive”] diffuse strong membranous staining 
[“An:Immunohistochemistry-Positive”] for CD20 
[“An:Biomarker”], CD79a [“An:Biomarker”] and CD10 
[“An:Biomarker”] with moderate widespread membrane staining 
[“An:Immunohistochemistry-Positive”] for CD30 
[“An:Biomarker”]. 
(3) Immunohistochemical stains show [“Li:Lexical Polarity 
Positive”] that the abnormal lymphoid cells are positive 
[“An:Immunohistochemistry-Positive”] for CD10 
[“An:Biomarker”], CD20 [“An:Biomarker”] and bcl-2 
[“An:Biomarker”]. 
(2) CD20, CD79a, CD10, 
CD30 
(3) CD10, CD20, bcl-2 
Immunohistochemistry: 
Negative for 
(1) Negative [“An:Immunohistochemistry-Negative”] : CD10 
[“An:Biomarker”], Cyclin D1 [“An:Biomarker”] 
(2) Stains for CD3 [“An:Biomarker”], CD5 [“An:Biomarker”] and 
cyclin D1 [“An:Biomarker”] are negative 
[“An:Immunohistochemistry-Negative”]. 
(3) Immunohistochemistry shows [“Li:Lexical Polarity Positive”] 
that the neoplastic cells are CD79a [“An:Biomarker”] + 
[“An:Immunohistochemistry-Positive”], CD20 [“An:Biomarker”] 
+ [“An:Immunohistochemistry-Positive”], CD10 
[“An:Biomarker”] + [“An:Immunohistochemistry-Positive”], 
CD23 [“An:Biomarker”] + [“An:Immunohistochemistry-
Positive”], CD5 [“An:Biomarker”] - [“An:Immunohistochemistry-
Negative”], cyclin D1 [“An:Biomarker”] - 
[“An:Immunohistochemistry-Negative”] and CD30 
[“An:Biomarker”] -[“An:Immunohistochemistry-Negative”]. 
(1) CD10, Cyclin D1 
(2) CD3, CD5, cyclin D1 
(3) CD5, cyclin D1, CD30 
Immunohistochemistry: 
Equivocal for 
(1) Equivocal [“An:Immunohistochemistry-Equivocal”] - CD5 
[“An:Biomarker”] (weak staining of atypical cells), bcl-6 
[“An:Biomarker”] (some weak nuclear staining present). 
(2) Occasional cells show very weak and equivocal staining 
(1) CD5, bcl-6 
(2) CD30 
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[“An:Immunohistochemistry-Equivocal”] for CD30 
[“An:Biomarker”]. 
Immunohistochemistry: 
Comment 
  
Flow cytometry: 
Positive for 
Positive [“An:Flow Cytometry-Positive”] for: Kappa 
[“An:Biomarker”], CD19 [“An:Biomarker”], CD10 
[“An:Biomarker”], CD45 [“An:Biomarker”], CD38 
[“An:Biomarker”] 
Kappa, CD19, CD10, CD45, 
CD38 
Flow cytometry: 
Negative for 
Negative [“An:Flow Cytometry-Negative”]: CD23 
[“An:Biomarker”], kappa [“An:Biomarker”], CD10 
[“An:Biomarker”] 
CD23, kappa, CD10 
Flow cytometry: 
Comment 
  
CYTOGENETICS 
 
FISH   
Cytogenetics:  Comment   
MOLECULAR 
 
PCR: IgH   
PCR: TCRgamma   
PCR: Comment   
SYNTHESIS Lineage (1) Malignant lymphoma, diffuse and follicular [“Sy:Diagnosis”], 
large [“De:Cell Size”] B cells [“De:Lineage”] predominating 
(2) HODGKINS LYMPHOMA [“Sy:Diagnosis”] 
(3) Precursor T lymphoblastic lymphoma [“Sy:Diagnosis”] 
(1) B-cell 
(2) Hodgkin-like 
(3) T-cell 
Clonality   
Diagnosis (WHO) (1) WHO GRADE 1 [“Sy:WHO Grade”] FOLLICULAR 
LYMPHOMA [“Sy:Diagnosis”] 
(2) Diffuse large B cell lymphoma [“Sy:Diagnosis”] (up to 30%) 
and follicular lymphoma [“Sy:Diagnosis”] 
(3) LOW GRADE [“Sy:WHO Grade”] EXTRANODAL 
MARGINAL ZONE B-CELL LYMPHOMA 
OF MALT TYPE [“Sy:Diagnosis”] (WHO 2001 Classification) 
(4) No [“Li:Lexical Polarity Negative”] significant [“Li:Mood and 
Comment Adjuncts”] abnormality [“Sy:Diagnosis”] 
(1) FOLLICULAR 
LYMPHOMA, WHO 
GRADE 1 
(2) Diffuse large B cell 
lymphoma, follicular 
lymphoma 
(3) EXTRANODAL 
MARGINAL ZONE B-
CELL LYMPHOMA OF 
mucosa-associated lymphoid 
tissue TYPE, LOW GRADE  
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(4) no abnormality 
SNOMED RT Codes   
Stage   
Comment   
Note: Sample text without specification suggests the whole text is an entity of the associated medical entity type. 
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Appendix IV Screenshots from the Structured Reporting Web Page 
Melanoma Report 
View 1. Annotations of a single specimen document
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View 2. Structured reporting on a single specimen document 
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View 3. Annotations of a multiple specimen document 
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View 4. Structured reporting on a multiple specimen document – Part 1 
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View 5. Structured reporting on a multiple specimen document – Part 2
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Colorectal Cancer Report 
 
 
View 6. Annotations of a single specimen document 
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View 7. Structured reporting on a single specimen document – Part 1
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View 8. Structured reporting on a single specimen document – Part 2 
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View 9. Annotations of a multiple specimen document 
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View 
View 10. Structured reporting on a multiple specimen document – Part 1 
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View 11. Structured reporting on a multiple specimen document – Part 2 
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Lymphoma Report 
 
 
View 12. Annotations of a single specimen document 
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View 13. Structured reporting on a single specimen document – Part 1
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View 14. Structured reporting on a single specimen document – Part 2 
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View 15. Annotations of a multiple specimen document 
 
Appendix IV Screenshots from the Structured Reporting Web Page 
322 
 
 
View 16. Structured reporting on a multiple specimen document – Part 1 
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 View 17. Structured reporting on a multiple specimen document – Part 2 
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Appendix V Examples of Poorly-written Reports 
In most cases, the reports were written in a similar way with comparable headings for each section. 
However, the individual writing styles or language preferences of the pathologists did play an 
important role in determining how easy or difficult the automatic structured reporting was to perform 
on a narrative report. 
 
Each of the following examples is representative of the poorly-written reports drawn from the test 
sets, with reasons following it. 
 
Example 1 - Report #1 in the Melanoma Test Set 
Specimen: 
RIGHT INNER ANKLE 
 
Macroscopic: VT/FHS 
The specimen is a skin ellipse 15 x 7 mm. In the centre there is an irregular black lesion 6x7 mm and 
close to the nearest line of resection. (Four pieces, one block). 
 
Microscopic: 
Sections show an area of SUPERFICIAL SPREADING MALIGNANT MELANOMA with 
NODULAR MELANOMA invading the dermis to a depth of 0.6 mm. There is marked regressive 
change at the base of the lesion and the line of excision is clear laterally by less than 0.5 mm in one 
area; the deep line is clear by 5 mm. In the area where the lesion is very close to the line of resection 
this is superficial spreading malignant melanoma and it is a skip lesion separated by relatively 
normal epidermis from the main lesion. 
 
Discussion: 
There are several issues in this report: 
1. There is no “CLINICAL HISTORY” section, which suggests that some important 
information such as the patient’s past history and a posited diagnosis are not available in the 
report. 
2. It lacks of diagnosis summary, so the final diagnosis is not immediately visible. 
3. The report uses over-complicated clause structure, hindering clear information expression 
and making it difficult to follow. 
4. A number of items of vital information are omitted in the report, e.g., the presence or absence 
of lymphovascular invasion and neurotropism. 
On the whole, this report is short and limited. 
 
 
Example 2 - Report #2 in the Melanoma Test Set 
HISTOPATHOLOGY 
 
MACROSCOPIC: 
SPECIMEN CONSISTS OF ONE ELLIPSE OF SKIN AND FAT MEASURING 22X13X5MM 
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AND BEARING A CENTRAL, DARK PAPULE MEASURING 5MM. EXCISION ? MARGINS 
INKED. LESION ALL FOR SECTION IN TWO PIECES. (BFQ) 
 
MICROSCOPIC: 
SECTIONS OF THE "LEFT ELBOW" LESION SHOW AN ULCERATED MALIGNANT 
MELANOMA, CLARK LEVEL IV, BRESLOW THICKNESS 1.65MM WITH A MINIMAL 
ADJACENT COMPONENT OF SUPERFICIAL SPREADING PATTERN. THE CLOSEST 
PERIPHERAL MARGIN FROM THE IN-SITU 
MELANOMA MEASURES 1.35MM. THE CELLS ARE DEVOID OF PIGMENT AND 
PREDOMINANTLY 
EPITHELIOID IN TYPE. SCATTERED MITOSES ARE READILY SEEN. THERE IS NO 
VASCULAR/LYMPHATIC INVASION PRESENT. NO NEUROTROPISM IS SEEN. 
FEATURES OF EARLY REGRESSION ARE NOTED AT THE EDGES OF THE LESION. 
 
CONCLUSION: 
SKIN "LEFT ELBOW" 
ULCERATED, MALIGNANT MELANOMA, CLARK LEVEL IV, BRESLOW THICKNESS 
1.65MM WITH AN ADJACENT COMPONENT OF SUPERFICIAL SPREADING PATTERN 
AND EARLY REGRESSION. 
THE CLOSEST PERIPHERAL MARGIN MEASURES 1.35MM. 
IMMUNOHISTOCHEMISTRY IS PROCEEDING TO CONFIRM THE DEPTH OF THE LESION. 
 
Discussion: 
Several problems are presented with this report: 
1. The arbitrary use of All Caps font in the whole report increases the difficulty for processing. 
2. It has the same issue discussed in the previous report, without a “CLINICAL HISTORY” 
section.  
3. Some vital information is omitted, such as the distribution and density of tumour-infiltrating 
lymphocytes, any associated benign melanocytic lesion.  
This report provides more details and uses more precise language than the previous one, but it is still 
hard for processing. 
 
 
Example 3 - Report #3 in the Melanoma Test Set 
SURGICAL PATHOLOGY 
 
CLINICAL DETAILS 
1. ? NMM left knee. 
2. Irritated naevus right neck. 
 
NATURE OF SPECIMEN                              
I) Skin biopsy.  
II) Skin biopsy. 
 
MACROSCOPIC: 
Specimen I: Labelled "L knee", the specimen consists of an ellipse of skin, 15x9x7mm, bearing on 
its surface a brown seborrhoeic dome shaped lesion 7x6mm, Block 1A - two transverse sections; lB-
lC - ends. 
 
Specimen II: Labelled "Right neck", the specimen consists of an ellipse of skin, 14x5x3mm, bearing 
on its surface a keratotic grey papule 3mm in diameter. Block 2A - two transverse sections; 2B-2C - 
ends. 
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30/3 JG: nm 30/03/01 
 
MICROSCOPIC: 
Specimen I: Sections show nodular malignant melanoma. The lesion is composed of large 
pleomorphic spindled cells arranged in a somewhat "Spitzoid" pattern.  Clark level is IV (dermal-
subcutaneous interface); Breslow thickness is 2.5mm.  Although, the lesion gives a low power 
impression of 'symmetrical' growth, high power examination of the centre of base of the lesion 
shows small nests and single atypical melanocytes invading lower reticular dermis and infiltrating 
sweat glands at the dermal-subcutaneous junction. This is confirmed on immunoperoxidase stains for 
Melan A and S100. The lesion is positive in its superficial aspect for HMB45, There is a 
moderate amount of pagetoid invasion of the epidermis. There is no junctional component 
beyond the dermal component.  There is no surface ulceration. There is a mild patchy lymphocyte 
response. Very occasional mitoses are present (<l/mm sg.) however one of these is an atypical 
mitosis. The lesion is clear of resection margins by a minimum of 1.2mm (lateral). 
 
CONCLUSION: Nodular malignant melanoma; Level IV, 2.5mm thick. 
 
Specimen II: Sections show excoriated intradermal naevus. There is no evidence of malignancy. 
Lines of resection are clear of the lesion. 
  
Discussion: 
The main issues in this report are: 
1. The representation of specimen identifiers (ids) is not consistent in the whole report: in 
“CLINICAL HISTORY” section, an id is denoted as an Arabic numeral followed with period 
“.”; in “SPECIMEN” section, an id is rendered as a Roman numeral tailed with bracket “)”; 
in “MACROSCOPIC” and “MICROSCOPIC” sections, an id is started with the lexicon 
“Specimen”. Such inconsistent representation of ids is complicating specimen id detection, 
which results in incorrect specimen context detection. 
2. Delimitation of several sentences is incorrect (highlighted in bold), which hinders the 
sentence boundary detection on them. 
3. The diagnosis summary is misplaced by being placed before the end of the 
“MICROSCOPIC” section, which can affect the section context detection. 
4. The improper unit for mitotic rate (“/mm sg.”) prevents extraction of the correct value.    
In brief, this is a poorly-written multiple specimen report with abnormal grammatical structures. 
 
 
Example 4 - Report #1 in the Colorectal Cancer Test Set 
CLINICAL NOTES:  Anterior resection for rectosigmoid cancer - another one fond in the sigmoid. 
1: Distal and proximal rings. 2: Sigmoid-rectum bowel (two primary cancers). 
MACROSCOPIC DESCRIPTION:  (A) Sigmoid colon: A segment of large bowel measuring 
210mm in length and 59mm in internal circumference at proximal resection margin, and 67mm in 
internal circumference at distal resection margin. Approximately 50mm from the proximal resection 
margin there is a fungating ulcerating pale tan tumour measuring 24 x 13mm in area and 
approximately 7mm above surrounding mucosa. This tumour invades the surrounding mesenteric fat 
and reaches within 1mm of the serosal surface without penetrating through. The serosal surface at 
this area is puckered and slightly roughened. 100mm distal to this tumour there is a second larger 
fungating ulcerated tumour measuring 30mm in diameter and up to 10mm in thickness. This larger 
tumour also involves the surrounding pericolic fat and reaches within 1mm of serosal surface which 
is slightly roughened and darker brown. Elsewhere there are two pale tan small polypoid lesions; the 
more distal one approximately 5mm from distal resection margin. The polyps measure up to 3mm 
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and 4mm and are 10mm apart. Nineteen lymph nodes identified in the surrounding mesenteric fat, 
the largest measuring up to 7mm. Specimen inking: serosal surface inked  with silver nitrate, 
proximal margin inked blue, distal margin inked green.  *** 10/03.  Representative sections.  A1-
A13. A1: proximal resection margin.  A2-A4: smaller more proximal tumour. A5: section from 
bowel mucosa between the two tumours. A6-A7: the more distal larger tumour. A8-A9: composite 
blocks showing the larger tumour and its distance to distal resection margin (yellow ink on adjoining 
edges). A10: two small polyps near distal resection margin. A11-A13: lymph nodes.  Tissue Bank - 
A small piece of larger tumour submitted in TB1.  (B) Proximal sphincter donut: Received on a spike 
is a bowel donut measuring 13mm in length and 20mm in external diameter. Macroscopically 
unremarkable.  *** 10/03.  No blocks submitted.  (C) Distal sphincter donut: A bowel donut 
measuring 14mm in length and 22mm in external diameter. Macroscopically unremarkable.  *** 
10/03.  No blocks submitted. SS/SR PREVIOUS BIOPSY/CYTOLOGY: Nil. 
MICROSCOPIC DESCRIPTION:  (A) The tumour 50mm from the proximal resection margin is a 
moderately well differentiated adenocarcinoma with puckering of the bowel wall associated with 
transmural infiltration of the muscularis by tumour glands with short extension into the perimuscular 
lamina.  No extramural vascular invasion is identified.   The tumour 100mm distal to this is larger 
with extensive ulceration, is less differentiated, shows transmural spread into the pericolic fat where 
extramural vascular invasion is identified.   Within the submucosa, vascular invasion is also 
prominent.  The tumour is clear of the serosal surface.  The two discrete polyps separate from the 
tumour are metaplastic polyps with regular serrated glands gaping towards the surface and lined by 
hypermature mucinous epithelium.  A total of twenty three lymph  nodes are identified, two are 
largely replaced by metastatic carcinoma and  one node shows two small nests of tumour within the 
peripheral sinus one  0.4mm, the other 0.13mm.  The tumours are clear of the mucosal and radial 
resection margin. 
ANTERIOR RESECTION OF RECTOSIGMOID:  SYNCHRONOUS ADENOCARCINOMA OF 
THE COLON.  PROXIMAL TUMOUR; MODERATELY WELL DIFFERENTIATED, 
TRANSMURAL SPREAD, NO EXTRAMURAL VASCULAR INVASION.  pT3 DISTAL 
TUMOUR;  POORLY DIFFERENTIATED ADENOCARCINOMA,  TRANSMURAL SPREAD,  
EXTRAMURAL VASCULAR INVASION.  pT3 LYMPH NODE METASTASES (2/20) + 
ISOLATED TUMOUR CELLS  pN1b  BOTH CLEAR OF MUCOSAL AND RADIAL 
RESECTION MARGINS. 
 
Discussion: 
This report is problematic, as 
1. The inconsistent use of specimen ids in different sections.  The specimen id “(A)” in 
“MACROSCOPIC” section refers to id “2” in “CLINICAL HISTORY” section. The id “1” 
in “CLINICAL HISTORY” section is divided into ids “(B)” and “(C)” in 
“MACROSCOPIC” section. 
2. Besides lack of several mandatory information items (e.g., the presence or absence of tumour 
perforation and the microscopic residual tumour status), the tumour site and specimen type is 
not mentioned explicitly in the “MACROSCOPIC” section. 
3. The T and N stage values are scattered in the diagnosis summary, which makes their 
extraction more difficult. 
4. In the “MICROSCOPIC” section, when describing the differentiation of the tumour, “poorly 
differentiated” is preferred to use rather than “less differentiated”. 
Generally, this report is relatively well-organized, but with imprecise language usage. 
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Example 5 - Report #2 in the Colorectal Cancer Test Set 
Dysplastic polyp. Transverse colon - Right hemicolectomy. 
One specimen container received labelled `GLASSENBURY`. The name and biopsy number on the 
cassettes supplied match those on the specimen request and the specimen containers.  The contents 
are labelled `Right hemi colon`.  The specimen consists of a length of large bowel 240mm long with 
terminal ileum measuring 25mm in length and appendix measuring 60mm in length.  There is 
mesenteric fat measuring up to 60mm in width attached to the specimen as well as omentum 
measuring 180x110x up to 45mm.  The serosal surface of the bowel is unremarkable.  On opening 
there is a sessile polyp measuring 65x40mm.  The polyp is located 40mm from the distal resection 
margin.  There is a 2mm raised area of mucosa located 60mm from the ileocaecal junction.  There is 
a diverticulum located 115mm from the ileocaecal junction.  No other focal abnormalities are 
identified within the mucosa.  Blocks: 1a - distal  margin, 1b - terminal ileal margin, 1c-1u - the  
polyp all blocked,  1v - diverticulum, 1w - appendix, 1x - the 2mm  polyp, 1y - apical  lymph nodes 
x 2, 1z - five mesenteric lymph nodes,  1aa - five  mesenteric lymph nodes, 1ab - five mesenteric 
lymph nodes,  1ac -  five lymph nodes, 1ad - three lymph nodes.  Tissue remains. 
Sections confirm a large (65x 40mm) tubulo-villous adenoma with moderate cytologic atypia. In 
blocks 1g and 1i there is an invasive adenocarcinoma with tumour islands seen within the submucosa 
but not entering the muscularis propria. There is no evidence of lymphovascular space permeation 
although there is some retraction artefact noted in block 1i.  A small amount of black dye is present 
within the adenoma but separate to the tumour.  There is no evidence of nodal metastasis in 22 
nodes.  A separate tubular adenoma with focal low grade dysplasia is also present 60mm from the 
ileo-caecal junction.  The resection margins are free of adenomatous and dysplastic change. 
CACOLON      Procedure         Right hemicolectomy 240mm large bowel, 25 small.    Tumour type :     
Adenocarcinoma arising in atubulovillous  adenoma   Tumour grade:            Well differentiated 
(AJCC)  Location :              Transverse colon     Size :  3mm Longitudinal and 2mm transverse    
Depth of invasion:      T1=Into  submucosa but not not muscularis.    Resection margins:      Clear  
Mesenteric deposits and other organs:   Nil    Perforation:  Absent      Lymphovascular invasion: 
Absent     Perineural invasion:  Absent      Tumour Border:           Infiltrative    Lymph nodes:  Apical 
node not specifically identified.                             22 lymph nodes sampled.                             0 
lymph nodes show tumour                             Capsular involvement not seen.  NO = No regional 
nodes    Polyps :  Tumour arose in a tubulovillous  adenoma.    Non-tumorous bowel:  separate 
tubular adenoma, diverticulum present and black dye in lamina propria consistent with previous 
biopsy site.          Staging:         Stage 1 = T1 or T2 N0 M0  Stage IIa = T3 N0  M0       Stage IIb = 
T4 N0 M0       Stage IIIa =  T1-2, N1, M0        Stage IIIb = T3-4, N2, M0       Stage IIIc = Any T,  
N2, M0        Stage IV   = Any T, Any N, M1       p = Pathologist, x =  Dont know 
 
Discussion: 
Several issues are apparent in this report: 
1. Lack of section headings, which is the main obstacle to section context detection. 
2. The expression of staging information is inappropriate: only content regarding the diagnosis 
should be recorded (highlighted in bold) and other references of staging should be excluded. 
3. In the last paragraph, “25 small” is incomplete, which should be modified to “25mm small 
bowel”. 
Briefly, most of the sentences are in regular structures, though each major aspect if kept to one clause 
or sentence would have been beneficial. 
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Example 6 - Report #3 in the Colorectal Cancer Test Set 
CLINICAL HISTORY:  Ultra low anterior resection for rectal carcinoma.  Recto-sigmoid resection 
and proximal and distal donuts. 
SPECIMEN:  Two pots received.  1.  Rectal tumour:  A segment of large bowel comprising 
approximately 125mm length of sigmoid and 95mm length of rectum.  The segment of true 
mesentery is 130mm length x 80mm width, which falls away to perirectal fat.  Arising from the 
antimesenteric side of the mucosa, at 14mm from distal surgical margin, there is a fungating, 
ulcerated, bleeding tumour (56x45mm), which obscures approximately 70% of the lumen.  The 
tumour invades muscularis propria and extends into perirectal fat; the tumour is 9mm from the radial 
soft tissue margin.  At 30mm proximal to the peritoneal reflection, the serosa is focally drawn into 
the tumour, but does not appear to breach the surface.  The tumour is well clear of the proximal 
resection margin (greater than 150mm).  1A:  Tumour with deepest invasion (radial soft tissue 
margin green).  1B and 1C:  Sections of tumour with overlying puckered serosa.  1D:  Distal surgical 
resection margin.  1E:  Proximal surgical resection margin.  1F:  Further representative section of 
tumour.  1G:  Tumour and adjacent proximal mucosa.  Throughout sigmoid colon there are 
approximately one dozen diverticula, one of which is ulcerated at the base.  There are no other 
masses or polyps along the bowel wall.  1H and 1J:  Two diverticula.  A total of 27 lymph nodes are 
found within the mesentery, up to 16mm diameter.  None of the nodes grossly appear to contain 
tumour.  No vessels grossly contain tumour.  1K:  Vascular mesenteric resection margin.  1L:  Apical 
lymph node.  1M:  Six lymph nodes.  1N:  Six lymph nodes.  1P:  Six lymph nodes.  1Q:  Six lymph 
nodes.  1R:  Two lymph nodes.  2.  Proximal and distal donuts:  Two specimens received in the pot.  
The first is an intact donut (20x16x12mm).  The mucosa is unremarkable and there are no masses.  
Radial margin is inked black.  2A and 2B:  Intact donut trisected.  The non-intact segment is a 
crescent-shaped piece of intestine (20x25x11mm).  There is an area of ulcerated mucosa (15x4mm), 
at one end.  The specimen cannot be oriented, all margins are inked green.  2C to 2F:  Eleven 
transverse slices processed.  All processed.  (LJ/tb/sf)   
SPECIMEN:  The specimen is a recto-sigmoid resection along with proximal and distal donuts.  
LARGE BOWEL IN GENERAL:  There is hypertrophy of main muscle coat and then indication of 
formation of diverticulae.  None of the diverticulae sectioned is inflamed and so the patient has 
diverticulosis with no evidence of diverticulitis in the sections.  TUMOUR:  The mucosa gives way 
to a moderately and rather poorly differentiated adenocarcinoma which is raised at its edges and 
ulcerated in its central portion.  The appearances of the tumour are quite consistent with a primary 
arising in large bowel.  Some foci of tumour have considerable necrosis and there is also spotty 
calcification.  TUMOUR SPREAD:  1.  Direct spread:  The proximal and distal margins of excision 
will be  considered under the heading of donuts.  The tumour itself is through main muscle coat and 
is out into pericolic fat.  2.  Vascular and perivascular spread:  There are foci which indicate that 
there is possible lymphovascular spread.  3.  Neural and perineural infiltration:  This has not been 
identified.  4.  Lymphatic spread:  Twenty-five (25) genuine lymph nodes have been found and none 
contain metastatic tumour (0 out of 25).  1.  In summary, there is an elevated and ulcerated 
moderately and poorly differentiated adenocarcinoma of the large bowel associated with necrosis 
and calcification.  The tumour is through the wall and through the serosa and out into surrounding 
fat.  There are no lymph node metastases.  2.  There is evidence of diverticular disease in this 
material with hypertophy of main muscle coat and diverticulae forming.  However no malignancy 
has been identified.  3.  There are rather haemorrhagic fragments of large bowel including mucosa 
and main muscle coat.  There is no evidence of malignancy in this material.  The absence of 
malignancy in both the proximal and distal donuts indicates that the proximal and distal margins of 
this specimen are free of tumour.  Immunoperoxidase studies will be carried out on lymph nodes to 
determine if micrometastases are present or not and a supplementary report will be issued when 
available. 
MICROSCOPY: 
11-2393   CONCLUSION:  Recto-sigmoid resection in which there is moderately and poorly 
differentiated adenocarcinoma which is through to the pericolic fat.  There are no lymph node 
metastases (Dukes` B).  SYNOPTIC REPORT FOR LARGE BOWEL MALIGNANCY 
SUPPLEMENTARY Immunoperoxidase stains were carried out looking for micrometastases in 
lymph nodes and none were found. 
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Discussion: 
The major issues in this report include: 
1. Misuse of “SPECIMEN” as a microscopic examination heading (highlighted in bold), can 
lead to inaccurate section context detection. 
2. No content is reported under “SYNOPTIC REPORT” heading. 
3. TNM stages are not reported in “CONCLUSION” section. 
Generally, this report is also in poor organization, without sufficient information. 
 
 
Example 7 - Report #4 in the Colorectal Cancer Test Set 
CLINICAL HISTORY:  Low rectal cancer.  Rectosigmoid colon and distal donut. 
SPECIMEN:  1.  Low anterior resection:  Received in formalin is a segment of large  bowel (170mm 
length x 45mm diameter), that is half sigmoid and half  rectum.  The attached mesentery is 90mm 
length x 125mm width, which folds away to peri-rectal fat.  At 9mm from the distal (false) surgical 
margin there is an exophytic fungating tumour (25x24mm) and an adjacent ulcer that extends 
proximally for a total dimension of 65mm length x 26mm diameter.  The exophytic area of the 
tumour appears to invade only muscularis propria but where the ulcer extends proximally there is  
invasion of muscularis propria into surrounding peri-rectal fat, to a  depth of 4mm.  The tumour is 
heterogeneous white/tan with ulceration and haemorrhage throughout.  The tumour is well clear of 
the deep fatty resection margin (28mm).  The rest of the bowel mucosa is unremarkable without any 
polyps or other masses.  1A:  Proximal surgical margin.  1B:  Distal (false) surgical margin.  1C to 
1F.  Sections of ulcer/mass with invasion into surrounding fat.  1G to 1J:  Sections of exophytic 
portion of tumour.  Fifty-two (52) possible lymph nodes are found, up to 14mm diameter.  Many of 
the nodes appear grossly involved by firm white tumour and several are haemorrhagic.  1K to 1M:  
Three high tie vascular mesenteric resection margins.  1N:  Two high tie lymph nodes.  1P:  Two 
lymph nodes grossly involved.  1Q:  Four lymph nodes.  1R:  Six lymph nodes.  1S:  Four lymph 
nodes.  1T:  Four lymph nodes.  1U:  Five lymph nodes.  1V:  Five lymph nodes.  1W:  Five lymph 
nodes.  1X:  Five lymph nodes.  1Y:  Five lymph nodes.  1Z:  Five lymph nodes.  2.  Distal donut:  In 
formalin a short segment of bowel (8mm length x 20mm diameter) that is unremarkable.  All 
processed as five transverse slices.  Two blocks.  (LJ/sas/gr) 
MICROSCOPY: 
11-1923 CONCLUSION:  1 and 2.  Recto-sigmoid colon in which ulcerated adenocarcinoma of the 
large bowel has been identified.  There are numerous lymph node metastases. 
SYNOPTIC REPORT FOR LARGE BOWEL MALIGNANCY SPECIMEN.  1.  The specimen is 
a recto-sigmoid colon with an associated distal donut.  TUMOUR:  The tumour is a moderately and 
sometimes poorly differentiated adenocarcinoma consistent with a primary arising in large bowel.  
The tumour tends to be exophytic in its pattern of growth on the margins and endophytic in the 
centre.  The centre also tends to be ulcerated and a little scarred with acutely inflamed slough on the 
surface.  The bowel outside the tumour appears normal.  EXTENT OF SPREAD:  The proximal and 
distal margins of excision are free of tumour.  The tumour is through main muscle coat and is well 
out into surrounding fat.  LYMPHOVASCULAR INVASION:  Lymphovascular invasion has been 
identified.  NEURAL AND PERINEURAL INFILTRATION:  No definite neural or perineural 
infiltration has been identified.  LYMPH NODES:  Numerous lymph nodes were found and many 
contain metastatic disease.  Fourteen (14) lymph nodes contain metastatic carcinoma associated with 
considerable necrosis.  The number of lymph nodes found in total is forty-two (42).  In summary, 
there is an ulcerated moderately and poorly differentiated adenocarcinoma arising in the large bowel 
which is through main muscle coat and into surrounding fat.  There are numerous lymph node 
metastases (Dukes` C).  2.  Sections taken from the donuts are free of tumour. 
 
Discussion: 
There are several issues in this report: 
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1. Misuse of “SYNOPTIC REPORT” as a microscopic examination heading (highlighted in 
bold), hindering the detection of section context. 
2. It also lacks staging information in the “CONCLUSION” section. 
3. It omits to record other vital information as well, such as tumour site in “MACROSCOPIC” 
section and the status of the nonperitonealised circumferential margin in the 
“MICROSCOPIC” section. 
Likewise, this is also a poorly-organised report, with limited information. 
 
 
Example 8 - Report #5 in the Colorectal Cancer Test Set 
69 yo male LGIE found caecal cancer CT Abdo -> ? paracolic LN  Laparoscopic R hemicolectomy 
One specimen container received labelled `WOOD`. The name and biopsy number on the cassettes 
supplied match those on the specimen request and the specimen containers.  The contents are 
labelled `Right hemicolectomy`. The specimen consists of 100mm of the ceacum/right colon, 40mm 
of terminal ileum and appendix 65mm in length. There is mesenteric fat up to 110x90mm attached to 
the specimen. The serosal surface is deeply indented over an area measuring 15x10mm adjacent to 
the base of the appendix.  On opening the mucosal surface underlying, this indentation corresponds 
to an ulcerated fungating tumour 50mm in diameter.  Tumour is located at least 60mm from the 
distal resection margin and is adjacent to the ileocaecal junction. On sectioning through the tumour, 
it extends into pericolic fat. On examination of the rest of the mucosa no polyps or other focal 
abnormalities are identified.  Blocks selected 1a - distal margin, 1b - terminal ileal  margin, 1c-e  - 
deepest part of tumour, 1f&g - tumour and appendix,  1h&i - tumour  and normal mucosa, 1j - 
appendix, 1k - 3 apical lymph  nodes, 1l- 1  mesenteric lymph node bisected, 1m - 4 mesenteric 
lymph  nodes, 1o -  4 mesenteric lymph nodes, 1p - 3 mesenteric lymph nodes.  Tissue remains. 
Procedure: Right hemicolectomy.       Tumour type: Mucin secreting adenocarcinoma.     Tumour 
grade: Moderately differentiated.  Location: See macroscopic description.      Size:  50mm.      Depth 
of invasion: Into pericolic fat.      Resection margins: Clear of tumour.  Mesenteric deposits: Nil.      
Perforation: Nil.      Lymphovascular invasion: Nil seen.      Perineural invasion: Nil seen.      Border:  
Infiltrative.      Lymph nodes: 22 lymph nodes including apical lymph nodes - all clear of tumour. 
Section of additional lymph node to follow. Supplementary report to follow.       Non-tumourous 
bowel:  Diverticular disease. 
 
The additional lymph node is clear of tumour. 
 
Discussion: 
The major problems in this report include: 
1. Similar to Example 5, it has no section headings. 
2. It seems that the contents for the microscopic examination are missing. 
3. A subheading referring to “Supplementary Report” is omitted from the last paragraph. 
4. No staging information is provided. 
5. Frequent use of abbreviations or acronyms, such as “yo” and “R”, increases the difficulty for 
medical entity recognition. 
In summary, this report is less-organised, short and limited.  
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Example 9 - Report #1 in the Lymphoma Test Set 
REF_NO       Contributor_system, APHIS  DATE 
                     MRN:  REF_NO  CMRN:  REF_NO    ID:  REF_NO 
         Procedure:  Clinical Notes 
                        (R) inguinal LN mass max.  diam. 4cm - Splenic lesions also on CT 
 
         Procedure:  Nature and Site of Specimen 
                        18G core x 3 from (R) groin LN mass - 1. in saline - 2. in formalin - by DR_NAME. 
 
         Procedure:  Macroscopic Description 
                        Two specimens received. 
 
                        1.  "R lymph node core".  Two pale tan cores of tissue 9 x 10mm in length received in 
formalin. 
                        Almost all embedded in one block.  A small portion retained in formalin in case 
ultrastructural studies required. 
 
                        2.  "(R) lymph core".  A pale tan core 14mm in length received in saline.  Most sent 
for Flow Cytometry and a small portion frozen for molecular studies if required.  No 
blocks taken. (wc/pjt) 
 
         Procedure:  Microscopic Report 
                        1.  "R lymph node core". 
                        The core biopsies show effacement of any normal lymph node architecture. There is 
abundant stromal fibrosis and a heterogenous infiltrate of lymphoid cells. There are 
numerous atypical large lymphoid cells, some with bizarre nuclear morphology. 
Some of these cells have prominent nucleoli and there are some binucleate forms with 
the appearance of Reed-Sternberg cells. In the background there are small lymphoid 
cells as well as occasional plasma cells, macrophages and eosinophils. 
                         
                       The features favour Hodgkins lymphoma. (wac/swm) 
 
                        DR_NAME comments: 
 
                        There is a lymphoid infiltrate in a fibrous background.  Scattered large cells are 
present which often have double or multiple blurred nuclei. 
 
                        Immunoperoxidase stains show: 
 
                        CD30 repeated +/- only occasional large cells faint cytoplasmic staining 
                        CD20 large cells negative  ; CD3 small cells only ++ 
                        CD15 some large cells positive 
                        CD83 large cells strongly positive 
                        Fascin -large cells strongly positive 
 
                        The appearances are very suggestive of Hodgkin's disease but not entirely diagnostic. 
 
                        2.  "(R) lymph core". 
                        Flow cytometry showed "NO RESULTS AS INSUFFICIENT CD45 POSITIVE 
VIABLE        CELLS PRESENT". 
 
         Procedure:  Summary 
                        Lymph node, R groin - Hodgkin's disease 
                     SNOMED CODES: 
                     1  M-96500 965-966 HODGKIN'S DISEASE 
                        T-C4000 Lymph node 
                        T-D7000 Inguinal region, NOS 
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         Procedure:  History Upload Request Detail 
                        Req Dr: DR_NAME - REF_NO 
                        Client: HOSP_NAME   MRN: REF_NO 
 
Discussion: 
There are two main issues in this report: 
1. Specimen ids are used contradictorily in different sections. The specimen id “1” in 
“SPECIMEN” section corresponds to id “2” in the “MACROSCOPIC” section, while id “2” 
in “SPECIMEN” section is referred to id “2” in “MACROSCOPIC” section. 
2. The ambiguous use of “R lymph node” or “(R) lymph” in the “MACROSCOPIC” and 
“MICROSCOPIC” sections, obstructing clear information about the site of the biopsy.   
Except for these problems, this is a relatively well-organized report. 
 
 
Example 10 - Report #2 in the Lymphoma Test Set 
Procedure:  Clinical Notes 
                        (R) femoral pathological fracture ?lymphoma. Large lytic lesion mid femur 
                          Flow cytometry : CLL 
         Procedure:  Macroscopic Description 
                        Three specimens received. 
 
                        1.  "Right femur bone".  A piece of bony tissue 40 x 15 x 5mm.  The periosteum 
appears ragged, irregular and shows some eburnation.  The inner surface shows some 
congestion.  The specimen kept in decalcification. 
 
                        2.  "Curettings from right thigh lesion in formalin".  Soft congested partly pale tan 
tissue                        including blood clot measuring 30 x 30mm in aggregate.  All 
embedded in one block. 
 
                        3.  "Fracture haematoma from right femur".  A friable part of semisolid altered blood 
clot 30 x 30mm.  Some embedded in one block. 
                        (rw/kms) 
 
         Procedure:  Microscopic Report 
                        1,2,3.  Apart from evidence of recent fracture and repair (extensive haemorrhage, 
granulation tissue and newbone all three specimens show poorly defined sheets of 
small and medium sized lymphoid cells. 
 
                        Positive  :  CD20 +++, CD23 + 
                                       :  CD3 (++ scattered small lymphocytes) 
                        Negative :  CD10, CD56, CD5, MPO, CD138 
 
                        Bone Tumour Meeting DATE 
                        DR_NAME agreed that the features were indicative of a diffuse small cell malignant 
lymphoma. 
                        DR_NAME and DR_NAME could not remember a similar case with localised bone 
involvement. 
 
         Procedure:  Summary 
                        L. femur - diffuse, small cell malignant lymphoma, CLL type. 
                     SNOMED CODES: 
                     1  M-96703 Malignant lymphoma, small lymphocytic 
                        T-12710 Femur 
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         Procedure:  History Upload Request Detail 
                        Req Dr: DR_NAME - REF_NO 
                        Client: HOSP_NO   MRN: REF_NO 
 
         Procedure:  Supplementary Report 
                        Addendum 
 
                        DR_NAME comments: 
                        I agree that such extensive involvement of the bone marrow of one bone would be 
unusual in CLL, especially without peripheral blood involvement.  There are some 
cells with largish vesicular nuclei and prominent nucleoli.  These could be 
paraimmunoblasts of CLL but they might be large cells on the outskirts of a diffuse 
large B-cell malignant lymphoma. 
 
         Procedure:  Supplementary Summary 
                        L. femur - diffuse malignant lymphoma ? large B cell ? CLL type. 
 
         Procedure:  History Upload Request Detail 
                        Req Dr: DR_NAME - REF_NO 
                        Client: HOSP_NAME   MRN: REF_NO 
 
Discussion: 
Major issues in this report include: 
1. The laterality of biopsy in the diagnosis summary is inconsistent with those indicated in other 
sections (“left” vs. “right”), making it difficult to follow the report precisely. 
2. No specimen id is provided in “SUPPLEMENTARY REPORT” section, increasing the 
difficulty for specimen context detection. 
3. The hedging expressions for the diagnosis are not appropriate in the diagnosis summary 
(highlighted in bold). 
On the whole, this report is difficult to follow with contrary language usage. 
 
 
Example 11 - Report #3 in the Lymphoma Test Set 
REF_NO         
                     MRN:  REF_NO 
         Procedure:  Referred MRN 
                        HOSP_NAME    MR REF_NO 
 
         Procedure:  Clinical Notes 
                        3 lesions in (R) lobe liver fund in liver incidentally on CT scan. 
 
         Procedure:  Nature and Site of Specimen 
                        Right hemihepatectomy / cholecystectomy. 
 
         Procedure:  Macroscopic Description 
                        Two specimens were received. 
 
                        1. "Liver in formalin".  A portion of the right lobe of liver that appears to include       
segments VI and VII as well as V and VIII.  The falciform ligament is not present on 
the specimen.  It measures 210 x 160 x 110mm and weighs 1280g.  The capsular 
surface is smooth and shows no focal abnormalities. Serial slicing reveals two ill-
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defined pale grey lesions. The first measures up to 20mm in diameter and appears to 
be the lower portion of segment VIII.  It is more than 30mm from the surgical margin. 
The second lesion is up to 15mm across and abuts the capsule in the lower portion of 
what appears to be segment VII.  It is greater than 70mm from the surgical margin. 
On the anterior surface of segment V there is a small inconspicous pale grey lesion 
causing a very slight puckering of the overlying capsule.  It measures up to 5mm 
across (lesion 3).  In addition, in the lateral portion of segment VII, there is an ill-
defined haemorrhagic blush in the subcapsular location up to 40mm across (?surgical 
artifact).  No other focal abnormalities are identified.  The uninvolved liver 
parenchyma appears normal and is not cirrhotic. 
                        A&B. Lesion 1. 
                        C&D. Lesion 2. 
                        E&F. Lesion 3. 
                        G.      Ill-defined haemorrhagic appearing area. 
                        H.      Representative normal appearing liver. 
 
                        2. "Gallbladder".  A gallbladder 90mm in length and up to 75mm in open 
circumference.  The serosal surface is unremarkable.  The wall thickness is up to 
2mm. The mucosal surface is velvety and green and shows no focal abnormalities.  
No stones are present with the specimen. 
 
                        A. Cystic duct at surgical margin and neck of galbladder. 
                        B. Body and fundus. 
                        (wac/mcm) 
 
         Procedure:  Microscopic Report 
                        1. "Liver in formalin". 
                        All three of the liver lesions have a similar appearance and are characterised by a 
localised atypical lymphoid infiltrate causing marked expansion and confluence of 
portal tracts. The infiltrate is composed predominantly of small lymphoid cells with a 
very thin rim of cytoplasm, together with occasional centroblast-like cells and 
scattered plasma cells. Occasional small groups of lymphoid cells appear to infiltrate 
into bile duct epithelium suggestive of lymphoepithelial lesions. In addition, there are 
a number of small follicle centres throughout the infiltrate. 
                        Immunohistochemical stains show the majority of cells are CD20, CD79a positive B 
cells with focal staining for CD5. The cells also show expression of CD43. 
                        The tumour cells appear to be negative for CD10, CD23 and cyclin D1. 
                        There are numerous CD3 positive T cells mostly at the periphery of the lymphoid 
infiltrate. Very ocasional CD138 positive plasma cells are present. 
                        CD21 highlights residual small follicle centres. 
 
                        The uninvolved liver has a normal architecture and shows moderate panlobular macro 
and microvesicular steatosis. By contrast, the liver lobules between the involved 
portal tracts lack significant amounts of steatosis. No Mallory's hyaline is identified. 
The portal tracts and lobules are otherwise unremarkable and lack significant 
inflammation or fibrosis. 
                         
                        The features are of a B cell non-Hodgkins lymphoma. The morphological and                         
immunohistochemical findings suggest either a mantle cell lymphoma or an 
extranodal marginal zone B cell lymphoma. 
                        Further immunoperoxidase stains are in progress in an attempt to further classify the 
tumour. An addendum report will be issued. 
                        The resection appears are well clear of the tumours (at least 30mm clearance). 
 
                        2. "Gallbladder" 
                        Sections of gallbladder showing a few foci of perivascular lymphoid infiltration in the 
subserosa. 
                        There is no mucosal inflammation. No other significant histological abnormalities are 
identified. 
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         Procedure:  Summary 
                        Liver: 
                         - Low to intermediate grade B-cell lymphoma. 
                         - Steatosis. 
                         - Further immunoperoxidase stains pending. An addendum report will be issued. 
                        / 
                        Gallbladder - No significant abnormality. 
                     SNOMED CODES: 
                     1  M-50080 Fatty degeneration 
                        M-95903 Malignant lymphoma 
                        P3-44202IPX 
                        T-62000 Liver 
                        T-E0000 Cell, NOS 
                     2  M-00100 Normal tissue 
                        T-63000 Gall bladder 
 
         Procedure:  Pathologist Notes - Not for Publication 
                        Also seen by DR_NAME and DR_NAME, who agree with the above. 
 
         Procedure:  History Upload Request Detail 
                        Req Dr: DR_NAME - REF_NO 
                        Client: HOSP_NAME   MRN: REF_NO 
 
         Procedure:  Supplementary Report 
                        Further immunoperoxidase stains performed revealed the following characteristics: 
                        Positive: CD20, CD79a, CD43, CD5 
                        Equivocal: cyclin D1 (Repeated also by HOSP_NAME.) 
                        Negative: CD10, CD23 
                        CD138 positive plasma cells are present. 
                        CD21 highlights residual small follicle centres. 
 
                        The slides were also reviewed by DR_NAME and DR_NAME. The consensus view 
is that the tumour should be regarded as a Mantle cell lymphoma (W.H.O. 
classification). Common sites of involvement by this lymphoma are lymph nodes, 
spleen and bone marrow. Extranodal sites include GI tract and Waldeyer's ring. Liver 
involvement is uncommon but has been previously reported. 
 
         Procedure:  Supplementary Summary 
                        Liver: 
                         - Mantle cell lymphoma (an intermediate grade B-cell lymphoma). 
                         - Steatosis. 
                         - Further immunoperoxidase stains pending. An addendum report will be issued. 
                        / 
                        Gallbladder - No significant abnormality. 
 
         Procedure:  History Upload Request Detail 
                        Req Dr: DR_NAME - REF_NO 
                        Client: HOSP_NAME   MRN: REF_NO 
 
Discussion: 
Despite the report’s length, there is no mention of specimen handling or triage and the definite WHO 
grade (though it is implicitly referred to as “intermediate grade”). It is notable that there is no 
specimen id used in the diagnosis summary and “SUPPLEMENTARY REPORT” section, which is a 
disadvantage for specimen context detection. The test results and interpretation for ancillary studies 
are not clear. For instance, it is difficult to tell from “The cells also show expression of CD43" 
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whether it is a positive result. All of these features lead to a long-winded report which is not 
immediately informative.  
 
 
Example 12 - Report #4 in the Lymphoma Test Set 
REF_NO        
                     MRN:  REF_NO  CMRN:  REF_NO   ID: REF_NO      Procedure:  CLINICAL 
DETAILS 
                        Liver R lobe laterally. Core needles: 3x 18G passes. 
 
         Procedure:  MACROSCOPIC DESCRIPTION 
                        (DR_NAME) 
 
                        "LIVER BIOPSY 18G X 3". Five pale tan core biopsies 12, 8, 7, 6 and 4mm in length 
and small tiny white fragments up to 2mm across.  Specimen entirely embedded in 
blocks A - B. 
 
         Procedure:  MICROSCOPIC REPORT 
                        The core biopsies show the hepatic mass lesion is malignant lymphoma, diffuse large 
cell type. 
                        The cells are large, pleomorphic, and show foci of single cell necrosis. 
                        It has a very high Ki67 labelling. 
                        Immunochemically the tumour cells stain for CD45, CD20, CD79a, CD10 and bcl-2. 
                        The tumour is negative for CD30, ALK-1, CD138, MPO, TdT and CK. 
                        Only scanty reactive T-cells are admixed. 
                        The adjacent liver tissue shows moderate macrovesicular steatosis. 
 
         Procedure:  COMMENT 
                        See CS-08-932 for the complete report. 
 
         Procedure:  SUMMARY 
                        Liver / core bx  -  MALIGNANT LYMPHOMA. 
                                  Diffuse large cell type, B-cell, lambda. 
                        . 
                     SNOMED CODES: 
                     1  M-95903 Malignant lymphoma, NOS 
                        M-96803 Malignant lymphoma, large cell, diffuse 
                        P1-03120Core biopsy 
                        T-62000 Liver, NOS 
 
Discussion: 
This report omits some vital information, such as the fluid delivering the specimen, specimen 
handling or triage. It also contains imprecise language.  For example, “the tumour cells stain for 
CD45, CD20, CD79a, CD10 and bcl-2” is too ambiguous to report a positive result for ancillary 
studies. In summary, this is a less informative report with imprecise language. 
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Example 13 - Report #5 in the Lymphoma Test Set 
REF_NO       
                     MRN:  REF_NO   CMRN: REF_NO   ID: REF_NO        Procedure:  CLINICAL 
DETAILS 
                        Tru-cut biopsies (L) glenoid - ? Met ?Lymphoma / myeloma. Histopath. 
 
         Procedure:  MACROSCOPIC DESCRIPTION 
                        (DR_NAME) 
 
                        "BIOPSY LEFT GLENOID". Five fragments of grey tissue from 2 to 6mm across. 
All                         embedded in one block. Levels and spares ordered. 
 
         Procedure:  MICROSCOPIC REPORT 
                        (DR_NAME/DR_NAME) 
 
                        "BIOPSY LEFT GLENOID". The core biopsies consist of fibrous and adipose tissue 
diffusely infiltrated by discohesive malignant cells. Tumour cells are round to oval 
with irregular nuclear contours and a variably prominent central nucleoli. Large 
amounts of eosinophilic cytoplasm are present. The mitotic activity is brisk (up to 8 
per 10 high power fields) with abnormal forms seen. 
                        Apoptotic debris is scattered in the background. A few admixed osteoclasts are 
present and a small amount of woven bone is also seen. 
 
                        Immunohistochemical stains show the tumour cells staining positively with CD20, 
CD79a and negatively with CD138, CD3 and CD30. Ki 67 stains approximately 40 % 
of the tumour cells.  
                        The appearances are consistent with a diffuse large B cell lymphoma. 
          
Procedure:  SUMMARY 
                        Left glenoid, biopsy - Diffuse large B cell lymphoma. 
                     SNOMED CODES: 
                     1  M-95903 Lymphoma, NOS 
                        T-E0000 THE CELL 
 
         Procedure:  COMMENT 
                        Bone Tumour Meeting DATE. 
                        Left shoulder pain 4/12. 
                        MRI - large destructive lesion with permeative changes involving the glenoid. 
                        DR_NAME, DR_NAME and DR_NAME agreed with diffuse large B cell lymphoma.  
NAME DATE. 
 
Discussion: 
This report does not provide sufficient information, e.g., the fluid delivering the specimen; cell size is 
implicitly indicated in the diagnosis “diffuse large B cell lymphoma”; a vague expression of specimen 
type: “biopsy” is used in “MACROSCOPIC” section and the diagnosis summary. It is preferable for 
the clinical history heading to begin on a new line. In brief, this report is subject to insufficient or 
underreported information. 
 
Summary 
Recommendations for writing a melanoma pathology report have been provided in a previous work on 
the project (Patrick and Scolyer, 2008). It can be seen from the above examples that most of the issues 
addressed should be taken into consideration when writing pathology reports of other cancer diseases. 
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1. Appropriate Use of Section Headings 
A report should have at least four major section headings to delimitate the contents in the associated 
sections of clinical history, macroscopic examination, microscopic examination, and diagnosis 
summary.  
 
2. Proper Use of Specimen Identifiers 
In a multiple specimen document, it is critical to use specimen identifiers properly in every section, 
and the representation of them should remain consistent in the whole document. 
 
3. Simple Grammatical Structure 
Pathologists should try to use simple clauses and sentence structures to describe their findings. For 
example, each major aspect is kept to one clause or sentence (e.g., “No extramural vascular invasion is 
identified.”). Short sentences are preferable, as they are easier to read and comprehend, which clearly 
delineates where description of a feature starts and ends.  
 
4. Careful Use of “ALL-CAPS” Font 
ALL-CAPS font should only be used in the diagnosis summary section, to highlight the key features 
of the cancer disease. 
 
5. Precise Language 
Precise language makes the report easier to follow. Ambiguous expressions of the findings or 
diagnoses, which can complicate the reading, should be avoided. 
 
Pathologists should carefully consider these suggestions when writing a cancer pathology report. A 
precise and easy-to-read report will ultimately lead to better automatic structured reporting of it. 
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